细胞株Cell Lines 87及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格:¥19200
- 货 号:NTCC-CV87
- 产 地:北京
- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作QQ:1843439339 (微信同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID SES-MaBr-3
AC CVCL_Z129
DR CLO; CLO_0050497
DR NISES; SK0004
DR RCB; RCB0276
RX CelloPub=CLPUB00372;
RX DOI=10.1303/aez.20.496;
RX PubMed=1367489;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275016
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SES-MaBr-4
AC CVCL_Z130
DR CLO; CLO_0050500
DR NISES; SK0007
DR RCB; RCB0404
RX CelloPub=CLPUB00372;
RX DOI=10.1303/aez.20.496;
RX PubMed=1367489;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275017
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SES-MaBr-5
AC CVCL_Z131
DR CLO; CLO_0050498
DR NISES; SK0011
DR RCB; RCB0429
RX CelloPub=CLPUB00372;
RX DOI=10.1303/aez.20.496;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275018
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SESX
AC CVCL_M778
DR Cosmic; 922394
RX PubMed=3491924;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SET-2
AC CVCL_2187
SY Set-2; Set2; SET2
DR BTO; BTO:0004766
DR EFO; EFO_0006486
DR BioSample; SAMN03473274
DR CCLE; SET2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1012054
DR Cosmic; 1519162
DR Cosmic; 1633513
DR Cosmic; 1943610
DR Cosmic; 2306995
DR Cosmic-CLP; 1659820
DR DSMZ; ACC-608
DR GDSC; 1659820
DR GEO; GSM887564
DR GEO; GSM888647
DR GEO; GSM1374868
RX PubMed=10637490;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~60-80 hours (DSMZ).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,10
ST D16S539: 9,10
ST D18S51: 13,16
ST D21S11: 30
ST D3S1358: 14,16
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 13,14
ST FGA: 19,23
ST Penta D: 11
ST Penta E: 16,20
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C7965; Adult acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SEWA
AC CVCL_2188
DR DSMZ; ACC-523
CC Doubling time: ~28 hours (DSMZ).
CC Breed/subspecies: A.SW.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID SEWA-CL-3
AC CVCL_1N79
SY SEWA 1Rclone3:4R; SEWA1Rclone3:4R; Clone 3:4
RX PubMed=7129936;
CC Breed/subspecies: A.SW.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2188 ! SEWA
SX Male
CA Cancer cell line
//
ID SEWA/Rec4
AC CVCL_4Y75
SY SEWA1Rrec4; SEWA1Rrec4R; Rec4; Rec 4
RX PubMed=7129936;
CC Breed/subspecies: A.SW.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2188 ! SEWA
SX Male
CA Cancer cell line
//
ID SEWA/Rec4TC1
AC CVCL_6C61
SY Rec4TC1
RX PubMed=3078951;
CC Breed/subspecies: A.SW.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4Y75 ! SEWA/Rec4
SX Male
CA Cancer cell line
//
ID SEWA/TC13
AC CVCL_4Y76
SY SEWA1RTC13R; TC13
RX PubMed=7129936;
CC Breed/subspecies: A.SW.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2188 ! SEWA
SX Male
CA Cancer cell line
//
ID SEWA/TC13MTXr10
AC CVCL_4Y77
SY TC13MTXr10
RX PubMed=6668215;
RX PubMed=7129936;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
CC Breed/subspecies: A.SW.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4Y76 ! SEWA/TC13
SX Male
CA Cancer cell line
//
ID Sez 627
AC CVCL_5364
SY SEZ 627; Sez627; SEZ627; Sez.627
RX PubMed=3023492;
RX PubMed=3263317;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=Sez627
CC Characteristics: IL2 dependent.
DI NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Sez-4
AC CVCL_8330
SY Sez 4; SeZ4; SZ-4
RX PubMed=1987293;
RX PubMed=11021758;
RX PubMed=11737246;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SF [Human fibroblast]
AC CVCL_4790
CC Miscellaneous: Fibroblast-like foreskin cell line that was distributed by Viromed.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID SF [Seabass]
AC CVCL_S008
SY Seabass Fry
RX DOI=10.1016/S0044-8486(00)00465-8;
CC Group: Fish cell line.
OX NCBI_TaxID=8187; ! Lates calcarifer
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Sf 1 Ep
AC CVCL_3795
SY Sf1Ep; sf1Ep; Sf 1Ep; Sf 1 Ep (NBL-11); NBL-11; CTEp
DR CLO; CLO_0008983
DR CLO; CLO_0008986
DR CLDB; cl4275
DR CLDB; cl4276
DR ATCC; CCL-68
DR ATCC; CRL-6502
DR ECACC; 90092702
DR IZSLER; BS CL 78
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9988; ! Sylvilagus floridanus
SX Male
CA Finite cell line
//
ID SF 181
AC CVCL_D682
DR BCRJ; 0220
ST Source(s): BCRJ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 13
ST D19S433: 14
ST D21S11: 28,31
ST D2S1338: 19,20
ST D3S1358: 15
ST D5S818: 10,13
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 20,24
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C67383; Epidermolysis bullosa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Sf-9ET
AC CVCL_1D71
SY SF-9ET; Sf-9 Easy Titer; Sf9-ET; Sf9-Easy Titer; Sf9 Easy Titer
RX PubMed=19852765;
WW http://www.ott.nih.gov/erma/development-sf-9et-easy-titer-inset-determining-baculovirus-titers
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0549 ! Sf9
SX Female
CA Spontaneously immortalized cell line
//
ID SF-CMTI-2
AC CVCL_HE69
DR Millipore; SF-CMTI-2
CC Characteristics: Pre-adapted to serum-free and feeder-free cell culture conditions and is intended for use with the ESGRO cell culture system.
CC Breed/subspecies: C57BL/6.Cg-Thy1<a>.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K037 ! Bruce-4
SX Male
CA Embryonic stem cell
//
ID SF-TY
AC CVCL_3163
DR BioSample; SAMN03471063
DR JCRB; JCRB0075
DR JCRB; NIHS0016
CC Discontinued: JCRB; NIHS0016; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 11
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID SF-xL
AC CVCL_D590
SY SFxl
DR BTO; BTO:0005311
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SF1-1
AC CVCL_Y495
SY ESHyb
DR EFO; EFO_0003972
RX PubMed=9584126;
CC Breed/subspecies: C57BL/6 x CBA/Ca.
OX NCBI_TaxID=186842; ! Mus musculus x Mus spretus
SX Male
CA Embryonic stem cell
//
ID SF1-1.1.10
AC CVCL_G147
DR CLO; CLO_0008984
DR ATCC; HB-159
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID SF1-3
AC CVCL_Y496
RX PubMed=9584126;
CC Breed/subspecies: C57BL/6 x CBA/Ca.
OX NCBI_TaxID=186842; ! Mus musculus x Mus spretus
SX Male
CA Embryonic stem cell
//
ID SF1-8
AC CVCL_Y497
RX PubMed=9584126;
CC Breed/subspecies: C57BL/6 x CBA/Ca.
OX NCBI_TaxID=186842; ! Mus musculus x Mus spretus
SX Male
CA Embryonic stem cell
//
ID SF1-G
AC CVCL_Y498
RX PubMed=9584126;
CC Breed/subspecies: C57BL/6 x CBA/Ca.
OX NCBI_TaxID=186842; ! Mus musculus x Mus spretus
SX Female
CA Embryonic stem cell
//
ID SF126
AC CVCL_1688
SY SF-126; SF 126
DR EFO; EFO_0005450
DR BioSample; SAMN03472774
DR CCLE; SF126_CENTRAL_NERVOUS_SYSTEM
DR CCRID; 3111C0001CCC000049
DR CGH-DB; 153-1
DR ChEMBL-Cells; CHEMBL3307444
DR ChEMBL-Targets; CHEMBL614905
DR Cosmic; 909712
DR Cosmic; 1175814
DR Cosmic; 1217678
DR Cosmic; 2367543
DR Cosmic; 2516033
DR Cosmic-CLP; 909712
DR GDSC; 909712
DR GEO; GSM887565
DR GEO; GSM888648
DR GEO; GSM1670416
DR IFO; IFO50286
DR KCB; KCB 200818YJ
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2829496;
RX PubMed=3708752;
RX PubMed=16232199;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
WW https://btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=62
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 35 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 8,10
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Sf158
AC CVCL_2074
SY SF158; Sf-158; SF-158; SF 158; Sf 158
DR CLO; CLO_0008985
DR DSMZ; ACC-292
RX PubMed=2159542;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Doubling time: ~70 hours (DSMZ).
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0518 ! Sf21
SX Female
CA Spontaneously immortalized cell line
//
ID SF17
AC CVCL_6947
DR CCRID; 3111C0001CCC000084
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SF172
AC CVCL_V613
SY SF-172
DR CCLE; SF172_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 2516034
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 24 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SF188
AC CVCL_6948
SY SF-188; SF 188
DR BTO; BTO:0002824
DR ChEMBL-Cells; CHEMBL3307445
DR ChEMBL-Targets; CHEMBL614906
DR Cosmic; 849884
DR Cosmic; 1875113
DR GEO; GSM2197886
DR GEO; GSM2197887
DR GEO; GSM2197888
DR GEO; GSM2197889
DR GEO; GSM2197890
DR GEO; GSM2197891
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2829496;
RX PubMed=3708752;
RX PubMed=22570425;
RX PubMed=19365568;
WW https://btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html
CC Doubling time: 26 hours (PubMed=19365568).
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 13
ST D16S539: 11
ST D18S51: 17
ST D21S11: 31
ST D3S1358: 15,18
ST D5S818: 11,14
ST D7S820: 8,10
ST D8S1179: 13,15
ST FGA: 22,22.2
ST Penta D: 14
ST Penta E: 10,13
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Sf21
AC CVCL_0518
SY SF21; Sf-21; SF-21; IPLB-SF-21-AE; IPLB-Sf21-AE; IPLB-SF21-AE; IPLB-SF 21AE; IPLB-Sf21AE; IPLB-SF21AE; IPLB-SF-21; IPLB-Sf-21; IPLB-SF 21; IPLB-Sf21; IPLB-SF21
DR BTO; BTO:0001196
DR CLO; CLO_0008987
DR MCCL; MCC:0000416
DR CLDB; cl2906
DR DSMZ; ACC-119
DR ECACC; 05022801
DR ECACC; 05030202
DR KCB; KCB 201008YJ
DR NCBI_Iran; C503
DR Wikidata; Q2276068
RX CelloPub=CLPUB00177;
RX PubMed=68913;
RX PubMed=1367489;
RX PubMed=8314732;
RX PubMed=8799737;
RX PubMed=10777062;
RX PubMed=12623313;
RX PubMed=15926859;
RX PubMed=16346059;
RX PubMed=24672045;
WW https://en.wikipedia.org/wiki/Sf21
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-382.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-385.html
WW http://www.ars.usda.gov/sp2userfiles/person/3489/sf21.pdf
WW http://oetltd.com/product/sf21-cells-plaque-assay/
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Doubling time: 26-30 hours (PubMed=68913); ~3 days (DSMZ); 24 hours (ECACC).
CC Misspelling: Occasionally 'IPBL-SF-21' or 'IPBL-SF-21AE'.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
SX Female
CA Spontaneously immortalized cell line
//
ID SF210
AC CVCL_M425
SY SF-210; SF 210
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2829496;
WW https://btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SF268
AC CVCL_1689
SY SF-268; SF 268
DR BTO; BTO:0003772
DR EFO; EFO_0005451
DR BioSample; SAMN03471159
DR ChEMBL-Cells; CHEMBL3307499
DR ChEMBL-Cells; CHEMBL3308689
DR ChEMBL-Targets; CHEMBL613977
DR ChEMBL-Targets; CHEMBL614907
DR ChEMBL-Targets; CHEMBL614936
DR Cosmic; 687581
DR Cosmic; 905986
DR Cosmic; 974239
DR Cosmic; 1092629
DR Cosmic; 1175815
DR Cosmic; 1305358
DR Cosmic; 1436039
DR Cosmic; 1998472
DR Cosmic; 2367544
DR Cosmic; 2550357
DR Cosmic-CLP; 905986
DR GDSC; 905986
DR GEO; GSM50175
DR GEO; GSM50239
DR GEO; GSM750787
DR GEO; GSM750790
DR GEO; GSM799323
DR GEO; GSM799386
DR GEO; GSM847112
DR GEO; GSM844680
DR GEO; GSM844681
DR GEO; GSM1153392
DR GEO; GSM1181244
DR GEO; GSM1181320
DR GEO; GSM1670417
DR SKY/M-FISH/CGH; 2819
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2041050;
RX PubMed=2829496;
RX PubMed=17088437;
RX PubMed=19365568;
RX PubMed=19372543;
RX PubMed=22336246;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=59
WW http://tcpaportal.org/mclp/
CC Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC Part of: JFCR39 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 33.1 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SP-268' in ChEMBL CHEMBL614936 and CHEMBL3308689.
ST Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9,13
ST D18S51: 16
ST D19S433: 13,15.2
ST D21S11: 30,32.2
ST D2S1338: 19,24
ST D3S1358: 14,16
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 14
ST FGA: 21
ST Penta D: 9,12
ST Penta E: 12,14
ST TH01: 6,9
ST TPOX: 8,10
ST vWA: 17,19
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SF295
AC CVCL_1690
SY SF-295; SF 295
DR BTO; BTO:0004213
DR EFO; EFO_0005452
DR CCLE; SF295_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3307738
DR ChEMBL-Cells; CHEMBL3308690
DR ChEMBL-Targets; CHEMBL614908
DR ChEMBL-Targets; CHEMBL614937
DR Cosmic; 875897
DR Cosmic; 897438
DR Cosmic; 905985
DR Cosmic; 974240
DR Cosmic; 1044248
DR Cosmic; 1092630
DR Cosmic; 1175816
DR Cosmic; 1305359
DR Cosmic; 1436040
DR Cosmic; 1998473
DR Cosmic; 2367545
DR Cosmic; 2516035
DR Cosmic; 2550358
DR Cosmic-CLP; 905985
DR GDSC; 905985
DR GEO; GSM50176
DR GEO; GSM50240
DR GEO; GSM750783
DR GEO; GSM799324
DR GEO; GSM799387
DR GEO; GSM847113
DR GEO; GSM844682
DR GEO; GSM887566
DR GEO; GSM888649
DR GEO; GSM1153393
DR GEO; GSM1153394
DR GEO; GSM1181245
DR GEO; GSM1181260
DR GEO; GSM1670418
DR SKY/M-FISH/CGH; 2746
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2041050;
RX PubMed=2829496;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=60
WW http://www.addexbio.com/productdetail?pid=415
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 27 hours (PubMed=25984343); 29.5 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SP-295' in ChEMBL CHEMBL614937 and CHEMBL3308690.
ST Source(s): Cosmic-CLP; PubMed=19372543
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 10
ST D16S539: 12,13
ST D18S51: 15,18
ST D19S433: 12,15
ST D21S11: 28,30
ST D2S1338: 15,20
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 9,13
ST D8S1179: 13,14
ST FGA: 22,25
ST TH01: 9.3 (Cosmic-CLP)
ST TH01: 9.3,10 (PubMed=19372543)
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SF3061
AC CVCL_5892
SY SF-3061; SF3061-Parental
DR BTO; BTO:0004515
RX PubMed=16554968;
CC Characteristics: Has a finite life span like most meningioma-derived cell lines.
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID SF3061-hTERT
AC CVCL_M426
RX PubMed=16554968;
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5892 ! SF3061
CA Telomerase immortalized cell line
//
ID SF4068
AC CVCL_5893
SY SF-4068; SF4068-Parental
DR BTO; BTO:0004516
RX PubMed=16554968;
CC Characteristics: Has a finite life span like most meningioma-derived cell lines.
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID SF4068-E6/E7-hTERT
AC CVCL_M427
RX PubMed=16554968;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5893 ! SF4068
CA Transformed cell line
//
ID SF4433
AC CVCL_5894
SY SF-4433; SF4433-Parental
DR BTO; BTO:0004517
RX PubMed=16554968;
CC Characteristics: Has a finite life span like most meningioma-derived cell lines.
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID SF4433-E6/E7-hTERT
AC CVCL_M428
RX PubMed=16554968;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5894 ! SF4433
CA Transformed cell line
//
ID SF539
AC CVCL_1691
AS CVCL_F230
SY SF-539; SF-539 BT; SF 539
DR BTO; BTO:0004214
DR EFO; EFO_0005453
DR BioSample; SAMN03471111
DR ChEMBL-Cells; CHEMBL3307721
DR ChEMBL-Targets; CHEMBL614860
DR Cosmic; 687582
DR Cosmic; 875893
DR Cosmic; 905984
DR Cosmic; 974238
DR Cosmic; 1092631
DR Cosmic; 1175817
DR Cosmic; 1305360
DR Cosmic; 1312342
DR Cosmic; 1436041
DR Cosmic; 1998474
DR Cosmic; 2367546
DR Cosmic; 2550359
DR Cosmic-CLP; 905984
DR GDSC; 905984
DR GEO; GSM50177
DR GEO; GSM50241
DR GEO; GSM750784
DR GEO; GSM799325
DR GEO; GSM799388
DR GEO; GSM847114
DR GEO; GSM844683
DR GEO; GSM844684
DR GEO; GSM1153395
DR GEO; GSM1181246
DR GEO; GSM1181261
DR GEO; GSM1670419
DR SKY/M-FISH/CGH; 2744
RX PubMed=2041050;
RX PubMed=3019542;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=22336246;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=61
WW http://tcpaportal.org/mclp/
CC Part of: JFCR39 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 35.4 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11,13 (Cosmic-CLP)
ST CSF1PO: 11,13 (PubMed=19372543; PubMed=25877200)
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 20
ST D19S433: 14
ST D21S11: 29
ST D2S1338: 17,23
ST D3S1358: 15
ST D5S818: 14
ST D7S820: 11
ST D8S1179: 15,17
ST FGA: 20,21
ST Penta D: 10
ST Penta E: 12,15
ST TH01: 7,8,9 (Cosmic-CLP)
ST TH01: 7,8 (PubMed=19372543; PubMed=25877200)
ST TPOX: 9,10
ST vWA: 16,17
DI NCIt; C3796; Gliosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SF763
AC CVCL_6949
SY SF-763; SF 763
DR BTO; BTO:0004215
DR CCRID; 3111C0001CCC000050
DR Cosmic; 849885
DR Cosmic; 1175818
DR Cosmic; 1217677
DR Cosmic; 2367500
RX PubMed=22570425;
WW https://btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html
ST Source(s): PubMed=22570425
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 10,12
ST D16S539: 10
ST D18S51: 16
ST D21S11: 27,30
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 22
ST Penta D: 11,12
ST Penta E: 5,13
ST TH01: 9
ST TPOX: 10,11
ST vWA: 16,17
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SF767
AC CVCL_6950
SY SF-767; SF 767
DR BTO; BTO:0001557
DR BioSample; SAMN03151844
DR CCLE; SF767_CENTRAL_NERVOUS_SYSTEM
DR CCRID; 3111C0001CCC000051
DR Cosmic; 849886
DR Cosmic; 2036688
DR Cosmic; 2367501
DR Cosmic; 2516036
RX PubMed=22570425;
RX PubMed=25984343;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 29 hours (PubMed=25984343).
CC Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC Omics: shRNA library screening.
ST Source(s): PubMed=22570425
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 12,13
ST D18S51: 12
ST D21S11: 30,31
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 14
ST FGA: 23
ST Penta D: 9,14
ST Penta E: 12,14
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 15,17
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1401 ! ME-180
SX Female
CA Cancer cell line
//
ID SF7761
AC CVCL_IT45
DR Cosmic; 1925952
DR GEO; GSM1508943
DR GEO; GSM1508944
DR GEO; GSM1508945
DR GEO; GSM1508946
DR GEO; GSM1508947
DR GEO; GSM1508948
DR GEO; GSM1508951
RX PubMed=22983601;
RX PubMed=23603901;
RX PubMed=25939062;
RX PubMed=26115193;
CC Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).
CC Omics: CNV analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID SF8402
AC CVCL_K062
DR CLO; CLO_0050657
DR BioSample; SAMN03472292
DR RCB; RCB0580
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9,13
ST D5S818: 13
ST D7S820: 8,12
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_K066 ! SF8410
SX Female
CA Finite cell line
//
ID SF8404
AC CVCL_K063
SY SF A-2; SFA2
DR CLO; CLO_0050658
DR BioSample; SAMN03472293
DR RCB; RCB0582
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9,9.3
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8405
AC CVCL_K064
SY SF A-3; SFA3
DR CLO; CLO_0050688
DR BioSample; SAMN03472294
DR RCB; RCB0583
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 12
ST D16S539: 11,13
ST D5S818: 10,13
ST D7S820: 8,10
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8406
AC CVCL_K065
SY SF A-4; SFA4
DR CLO; CLO_0050659
DR BioSample; SAMN03472295
DR RCB; RCB0584
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,9
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 9,10
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8410
AC CVCL_K066
DR CLO; CLO_0050678
DR BioSample; SAMN03472261
DR RCB; RCB0635
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9,13
ST D5S818: 13
ST D7S820: 8,12
ST TH01: 7,9
ST TPOX: 7,9,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_K062 ! SF8402
SX Female
CA Finite cell line
//
ID SF8413
AC CVCL_K067
SY SF A-8; SFA8
DR CLO; CLO_0050677
DR BioSample; SAMN03472260
DR RCB; RCB0634
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,13
ST D16S539: 10
ST D5S818: 10,11
ST D7S820: 9,11
ST TH01: 6,7
ST TPOX: 11,13
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8414
AC CVCL_K068
SY SF B-12; SFB12
DR CLO; CLO_0050676
DR BioSample; SAMN03472259
DR RCB; RCB0633
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11,13
ST D16S539: 12,13
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8416
AC CVCL_K069
SY SF D2-12; SFD212
DR CLO; CLO_0050675
DR BioSample; SAMN03472257
DR RCB; RCB0631
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 8,11
ST D16S539: 9,13
ST D5S818: 10,11,12
ST D7S820: 8,12
ST TH01: 7,9,9.3
ST TPOX: 9
ST vWA: 14,16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8425
AC CVCL_K070
DR CLO; CLO_0050674
DR BioSample; SAMN03472256
DR RCB; RCB0624
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 8,10
ST D5S818: 9,11
ST D7S820: 12
ST TH01: 9
ST TPOX: 11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_K071 ! SF8428
SX Female
CA Finite cell line
//
ID SF8428
AC CVCL_K071
DR CLO; CLO_0050673
DR BioSample; SAMN03472255
DR RCB; RCB0621
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,9,12
ST D16S539: 8,10
ST D5S818: 9,11
ST D7S820: 12
ST TH01: 9,9.3
ST TPOX: 11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_K070 ! SF8425
SX Female
CA Finite cell line
//
ID SF8429
AC CVCL_K072
SY SF D2-13; SFD213
DR CLO; CLO_0050672
DR BioSample; SAMN03472254
DR RCB; RCB0620
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,10
ST D16S539: 10
ST D5S818: 10,12,13
ST D7S820: 8,13
ST TH01: 9
ST TPOX: 8,10
ST vWA: 14,16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8433
AC CVCL_K073
SY SF D1-2; SFD12
DR CLO; CLO_0050671
DR BioSample; SAMN03472253
DR RCB; RCB0617
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 8,12
ST TH01: 7,9,9.3
ST TPOX: 8,12
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8536
AC CVCL_K074
SY SF C2-7; SFC27
DR CLO; CLO_0050670
DR BioSample; SAMN03472252
DR RCB; RCB0614
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 7,10
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8538
AC CVCL_K075
SY SF B-11; SFB11
DR CLO; CLO_0050669
DR BioSample; SAMN03472251
DR RCB; RCB0613
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,11
ST D16S539: 10,12
ST D5S818: 10,12
ST D7S820: 8,10
ST TH01: 7,9,9.3
ST TPOX: 8,11
ST vWA: 15,16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8541
AC CVCL_K076
SY SF A-10; SFA10
DR CLO; CLO_0050668
DR BioSample; SAMN03472250
DR RCB; RCB0610
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11,12
ST D16S539: 11,13
ST D5S818: 11,13
ST D7S820: 12
ST TH01: 9,9.3
ST TPOX: 9,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8543
AC CVCL_K077
SY SF B-14; SFB14
DR CLO; CLO_0050667
DR BioSample; SAMN03472249
DR RCB; RCB0608
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,11
ST D16S539: 9,11
ST D5S818: 10,11,12
ST D7S820: 11,12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8546
AC CVCL_K078
SY SF A-11; SFA11
DR CLO; CLO_0050693
DR RCB; RCB0605
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8628
AC CVCL_IT46
SY SF-8628
DR Cosmic; 1925953
DR GEO; GSE59366
DR GEO; GSE59496
DR GEO; GSM1508949
DR GEO; GSM1508952
RX PubMed=23603901;
CC Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).
CC Omics: Deep RNAseq analysis.
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SF8647
AC CVCL_K079
SY SF D1-5; SFD15
DR CLO; CLO_0050692
DR RCB; RCB0604
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8649
AC CVCL_K080
SY SF D1-6; SFD16
DR CLO; CLO_0050666
DR BioSample; SAMN03472248
DR RCB; RCB0603
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 8,10
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8650
AC CVCL_K081
SY SF D1-7; SFD17
DR CLO; CLO_0050665
DR BioSample; SAMN03472246
DR RCB; RCB0602
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,10
ST D16S539: 9
ST D5S818: 10
ST D7S820: 9,12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8653
AC CVCL_K082
SY SF C2-6; SFC26
DR CLO; CLO_0050716
DR BioSample; SAMN03472245
DR RCB; RCB0600
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 10,12
ST D5S818: 13
ST D7S820: 8
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8655
AC CVCL_K083
SY SF C2-9; SFC29
DR CLO; CLO_0050691
DR BioSample; SAMN03472244
DR RCB; RCB0598
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 11,13
ST TH01: 6,8
ST TPOX: 11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8656
AC CVCL_K084
SY SF A-13; SFA13
DR CLO; CLO_0050664
DR BioSample; SAMN03472243
DR RCB; RCB0597
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10
ST D16S539: 11,13
ST D5S818: 10,13
ST D7S820: 12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8657
AC CVCL_K085
SY SF A-14; SFA14
DR CLO; CLO_0050660
DR BioSample; SAMN03472297
DR RCB; RCB0585
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID SF8758
AC CVCL_K086
SY SF D2-16; SFD216
DR CLO; CLO_0050663
DR BioSample; SAMN03472242
DR RCB; RCB0596
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 9,13
ST D5S818: 10,12
ST D7S820: 8,13
ST TH01: 8,9
ST TPOX: 11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8759
AC CVCL_K087
SY SF D1-9; SFD19
DR CLO; CLO_0050661
DR BioSample; SAMN03472298
DR RCB; RCB0587
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8760
AC CVCL_K088
SY SF D2-17; SFD217
DR CLO; CLO_0050689
DR BioSample; SAMN03472299
DR RCB; RCB0588
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 11
ST TH01: 9
ST TPOX: 8,9
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8761
AC CVCL_K089
SY SF B-6; SFB6
DR CLO; CLO_0050690
DR BioSample; SAMN03472300
DR RCB; RCB0589
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,10,11
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 9,11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SF8762
AC CVCL_K090
SY SF D1-10; SFD110
DR CLO; CLO_0050662
DR BioSample; SAMN03472241
DR RCB; RCB0590
RX PubMed=1762123;
RX PubMed=2354455;
CC Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 10,11
ST D5S818: 13
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Sf9
AC CVCL_0549
SY SF9; SF-9; Sf-9; Sf 9; Spodoptera frugiperda clone 9; Sf clone 9; IPLB-Sf-9AE; IPLB-SF-9AE; IPLB-SF-9; IPLB-Sf-9; IPLB-Sf9
DR BTO; BTO:0001240
DR CLO; CLO_0008988
DR CLO; CLO_0008989
DR CLO; CLO_0008990
DR MCCL; MCC:0000450
DR CLDB; cl4277
DR CLDB; cl4278
DR CLDB; cl4279
DR ATCC; CRL-1711
DR BCRC; 60011
DR CCLV; CCLV-RIE 0352
DR ChEMBL-Cells; CHEMBL3308860
DR CLS; 604328/p700_Sf9
DR DSMZ; ACC-125
DR ECACC; 05011001
DR ECACC; 89070101
DR IZSLER; BS CL 157
DR KCB; KCB 200807YJ
DR MeSH; D061987
DR NCBI_Iran; C425
DR NISES; SK0002
DR RCB; RCB0563
DR TOKU-E; 3107
DR Wikidata; Q7459700
RX DOI=10.3923/jas.2007.4040.4043;
RX PubMed=1367489;
RX PubMed=8314732;
RX PubMed=8799737;
RX PubMed=10777062;
RX PubMed=12052082;
RX PubMed=14668217;
RX PubMed=15926859;
RX PubMed=19003226;
RX PubMed=19941903;
RX PubMed=23891577;
RX PubMed=24375231;
RX PubMed=24672045;
WW https://en.wikipedia.org/wiki/Sf9
WW http://www.thermofisher.com/order/catalog/product/B82501
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-311.html
WW http://www.ars.usda.gov/sp2userfiles/person/3489/sf9.pdf
WW http://oetltd.com/product/sf9-cells/
WW http://www.the-scientist.com/?articles.view/articleNo/40052/title/Virus-Found-in-Sf9-Cell-Line/
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Characteristics: Heterogeneous, contains a mixture of diploid and tetraploid cells.
CC Doubling time: ~50 hours (DSMZ).
CC Omics: ESTs sequenced.
CC Discontinued: RCB; RCB0563; true.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0518 ! Sf21
SX Female
CA Spontaneously immortalized cell line
//
ID Sf9-P35AcV5-1
AC CVCL_Z457
DR ATCC; PTA-3099
RX Patent=US7405038;
RX PubMed=11513084;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Transfected with: UniProtKB; P08160; AcMNPV p35.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0549 ! Sf9
SX Female
CA Spontaneously immortalized cell line
//
ID Sf9-P35AcV5-3
AC CVCL_Z458
DR ATCC; PTA-3100
RX Patent=US7405038;
RX PubMed=11513084;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Transfected with: UniProtKB; P08160; AcMNPV p35.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0549 ! Sf9
SX Female
CA Spontaneously immortalized cell line
//
ID Sf900+
AC CVCL_4U10
DR ATCC; CRL-12579
RX Patent=US6103526;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Discontinued: ATCC; CRL-12579; probable.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0549 ! Sf9
SX Female
CA Spontaneously immortalized cell line
//
ID Sf9S
AC CVCL_Z459
SY Sf9s; Sf-9S
DR ATCC; PTA-4047
RX Patent=US7041500;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0549 ! Sf9
SX Female
CA Spontaneously immortalized cell line
//
ID SFAF-PI 38
AC CVCL_9V84
DR NCBI_Iran; C465
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SFAT-3
AC CVCL_1N75
SY Spleen Focus-derived Ascites Tumor-3
RX PubMed=5973415;
CC Breed/subspecies: DDD.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID Sfbeta4GalT
AC CVCL_Z364
RX PubMed=9597545;
RX PubMed=11181556;
RX PubMed=12475259;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Transfected with: UniProtKB; P08037; Bovine B4GALT1.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0549 ! Sf9
SX Female
CA Spontaneously immortalized cell line
//
ID Sfbeta4GalT/ST6
AC CVCL_Z365
RX PubMed=11181556;
RX PubMed=12475259;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Transfected with: UniProtKB; P08037; Bovine B4GALT1.
CC Transfected with: RGD; 3676; St6gal1.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_Z364 ! Sfbeta4GalT
SX Female
CA Spontaneously immortalized cell line
//
ID SFBF-PI 39
AC CVCL_9V85
DR NCBI_Iran; C467
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SFBF-PI 41
AC CVCL_9V86
DR NCBI_Iran; C469
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SFEC
AC CVCL_IM35
SY Souther Flounder Embryonic Cell line
RX CelloPub=CLPUB00053;
CC Group: Fish cell line.
OX NCBI_TaxID=141886; ! Paralichthys lethostigma
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SFH-R
AC CVCL_0I79
DR CCLV; CCLV-RIE 0042
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SFIF-PI 44
AC CVCL_9V87
DR NCBI_Iran; C472
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SFK
AC CVCL_R925
SY Southern Flounder Kidney
RX PubMed=21210550;
CC Group: Fish cell line.
OX NCBI_TaxID=141886; ! Paralichthys lethostigma
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SFKF-PI 37
AC CVCL_9V88
DR NCBI_Iran; C464
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SFLF-PI 35
AC CVCL_9V89
DR NCBI_Iran; C460
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SFLSF-PI 36
AC CVCL_9V90
DR NCBI_Iran; C462
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SFR3-DR5
AC CVCL_9237
DR CLO; CLO_0008992
DR ATCC; HB-151
DR IZSLER; BS Hy 14
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID SFR8-B6
AC CVCL_9238
DR CLO; CLO_0008993
DR ATCC; HB-152
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID SFSF-PI 45
AC CVCL_9V91
DR NCBI_Iran; C473
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SfSWT-1
AC CVCL_Z366
SY Sf SWT1; SfSWT1; Mimic; Mimic Sf9
RX PubMed=12475259;
RX PubMed=12626399;
RX PubMed=20574041;
WW http://www.thermofisher.com/order/catalog/product/12552014
WW http://tools.thermofisher.com/content/sfs/manuals/mimic_cell_man.pdf
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Transfected with: HGNC; 7044; MGAT1.
CC Transfected with: HGNC; 7045; MGAT2.
CC Transfected with: MGI; MGI:1316743; St3gal4.
CC Transfected with: RGD; 3676; St6gal1.
CC Transfected with: UniProtKB; P08037; Bovine B4GALT1.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_Z364 ! Sfbeta4GalT
SX Female
CA Spontaneously immortalized cell line
//
ID SfSWT-3
AC CVCL_Z367
SY Sf SWT3; SfSWT3
RX PubMed=12626399;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Transfected with: HGNC; 7044; MGAT1.
CC Transfected with: HGNC; 7045; MGAT2.
CC Transfected with: MGI; MGI:1337124; Cmas.
CC Transfected with: MGI; MGI:2149820; Nans.
CC Transfected with: MGI; MGI:1316743; St3gal4.
CC Transfected with: RGD; 3676; St6gal1.
CC Transfected with: UniProtKB; P08037; Bovine B4GALT1.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_Z366 ! SfSWT-1
SX Female
CA Spontaneously immortalized cell line
//
ID SFT-8606
AC CVCL_IS67
SY SFT8606
RX PubMed=10929770;
RX PubMed=16557275;
RX PubMed=19756736;
DI NCIt; C3714; Epithelioid sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SFT-R
AC CVCL_Y470
SY SFTR
DR CCLV; CCLV-RIE 0043
RX PubMed=19941903;
OX NCBI_TaxID=9940; ! Ovis aries
CA Finite cell line
//
ID SFTF-PI 40
AC CVCL_9V92
DR NCBI_Iran; C468
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SFTF-PI 42
AC CVCL_9V93
DR NCBI_Iran; C470
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SFTF-PI 43
AC CVCL_9V35
SY SFTF-PI43
DR NCBI_Iran; C471
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID SG
AC CVCL_M617
RX PubMed=8689637;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SG0002
AC CVCL_5G99
DR ECACC; 00040402
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0003
AC CVCL_5H00
DR ECACC; 00040403
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0004
AC CVCL_5H01
DR ECACC; 00040404
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0005
AC CVCL_5H02
DR ECACC; 00040405
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG0008
AC CVCL_5H03
DR ECACC; 00040408
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0010
AC CVCL_5H04
DR ECACC; 00040410
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0015
AC CVCL_5H05
DR ECACC; 00041910
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0018
AC CVCL_5H06
DR ECACC; 00041913
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0020
AC CVCL_5H07
DR ECACC; 00041915
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0022
AC CVCL_5H08
DR ECACC; 00041917
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0024
AC CVCL_5H09
DR ECACC; 00041919
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0026
AC CVCL_5H10
DR ECACC; 00041921
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0030
AC CVCL_5H11
DR ECACC; 00042213
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0034
AC CVCL_5H12
DR ECACC; 00051819
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0035
AC CVCL_5H13
DR ECACC; 00051820
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0038
AC CVCL_5H14
DR ECACC; 00051823
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0040
AC CVCL_5H15
DR ECACC; 00051825
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0041
AC CVCL_5H16
DR ECACC; 00051826
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0042
AC CVCL_5H17
DR ECACC; 00051827
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0046
AC CVCL_5H18
DR ECACC; 00052307
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0052
AC CVCL_5H19
DR ECACC; 00052313
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0054
AC CVCL_5H20
DR ECACC; 00052315
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0055
AC CVCL_5H21
DR ECACC; 00052401
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG0057
AC CVCL_5H22
DR ECACC; 00052403
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0058
AC CVCL_5H23
DR ECACC; 00052404
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0059
AC CVCL_5H24
DR ECACC; 00052405
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0060
AC CVCL_5H25
DR ECACC; 00052406
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG0062
AC CVCL_5H26
DR ECACC; 00052408
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG0063
AC CVCL_5H27
DR ECACC; 00052409
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0064
AC CVCL_5H28
DR ECACC; 00052410
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0066
AC CVCL_5H29
DR ECACC; 00052512
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0067
AC CVCL_5H30
DR ECACC; 00052514
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0069
AC CVCL_5H31
DR ECACC; 00052516
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0070
AC CVCL_5H32
DR ECACC; 00052517
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0071
AC CVCL_5H33
DR ECACC; 00052518
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG0072
AC CVCL_5H34
DR ECACC; 00052519
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0073
AC CVCL_5H35
DR ECACC; 00052520
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG0074
AC CVCL_5H36
DR ECACC; 00052521
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0077
AC CVCL_5H37
DR ECACC; 00052524
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0078
AC CVCL_5H38
DR ECACC; 00052525
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG0080
AC CVCL_5H39
DR ECACC; 00052527
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0081
AC CVCL_5H40
DR ECACC; 00052528
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0082
AC CVCL_5H41
DR ECACC; 00052529
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0084
AC CVCL_5H42
DR ECACC; 00052531
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0086
AC CVCL_5H43
DR ECACC; 00052533
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0088
AC CVCL_5H44
DR ECACC; 00052535
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0089
AC CVCL_5H45
DR ECACC; 00052536
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0090
AC CVCL_5H46
DR ECACC; 00052537
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0094
AC CVCL_5H47
DR ECACC; 00052541
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0095
AC CVCL_5H48
DR ECACC; 00052542
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0097
AC CVCL_5H49
DR ECACC; 00052544
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0099
AC CVCL_5H50
DR ECACC; 00052546
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0100
AC CVCL_5H51
DR ECACC; 00052447
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0101
AC CVCL_5H52
DR ECACC; 00052413
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0102
AC CVCL_5H53
DR ECACC; 00052414
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0104
AC CVCL_5H54
DR ECACC; 00052416
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0105
AC CVCL_5H55
DR ECACC; 00052417
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0107
AC CVCL_5H56
DR ECACC; 00052419
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0109
AC CVCL_5H57
DR ECACC; 00052548
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0111
AC CVCL_5H58
DR ECACC; 00052550
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0112
AC CVCL_5H59
DR ECACC; 00052551
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0114
AC CVCL_5H60
DR ECACC; 00052553
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG0115
AC CVCL_5H61
DR ECACC; 00052554
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0117
AC CVCL_5H62
DR ECACC; 00052556
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG0118
AC CVCL_5H63
DR ECACC; 00052557
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SG0120
AC CVCL_5H64
DR ECACC; 00052559
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG0121
AC CVCL_5H65
DR ECACC; 00052560
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG0125
AC CVCL_5H66
DR ECACC; 00052564
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SG231
AC CVCL_0519
SY PCI:SG231; PCI-SG231; PCI:SG-231
DR BTO; BTO:0002935
DR MCCL; MCC:0000417
DR ATCC; CRL-2126
DR BioSample; SAMN03472551
RX CelloPub=CLPUB00275;
RX PubMed=2176543;
CC Discontinued: ATCC; CRL-2126; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9,10
ST D16S539: 14
ST D5S818: 12
ST D7S820: 11
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SG3
AC CVCL_Y569
RX PubMed=15141090;
CC Group: Fish cell line.
CC Breed/subspecies: Albino strain i3.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Male
CA Spontaneously immortalized cell line
//
ID Sg4
AC CVCL_Z707
SY Sf4; SF4
DR EFO; EFO_0005839
DR DGRC; 179
DR ENCODE; ENCBS418XCA
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
RX PubMed=25262759;
WW http://flybase.org/reports/FBrf0205934.html
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z232 ! Schneider 2
SX Female
CA Spontaneously immortalized cell line
//
ID Sg4-PP-27F
AC CVCL_5I18
DR DGRC; 238
RX PubMed=26450921;
CC Group: Insect cell line.
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z707 ! Sg4
SX Female
CA Spontaneously immortalized cell line
//
ID Sg4-PP-3A
AC CVCL_5I19
DR DGRC; 237
RX PubMed=26450921;
CC Group: Insect cell line.
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z707 ! Sg4
SX Female
CA Spontaneously immortalized cell line
//
ID Sg4-PP-49B
AC CVCL_5I20
DR DGRC; 239
RX PubMed=26450921;
CC Group: Insect cell line.
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z707 ! Sg4
SX Female
CA Spontaneously immortalized cell line
//
ID Sg4-PP-57B
AC CVCL_5I21
DR DGRC; 241
RX PubMed=26450921;
CC Group: Insect cell line.
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z707 ! Sg4
SX Female
CA Spontaneously immortalized cell line
//
ID Sg4-PP-70F
AC CVCL_5I22
DR DGRC; 242
RX PubMed=26450921;
CC Group: Insect cell line.
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z707 ! Sg4
SX Female
CA Spontaneously immortalized cell line
//
ID Sg4-PP-84E
AC CVCL_5I23
DR DGRC; 240
RX PubMed=26450921;
CC Group: Insect cell line.
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z707 ! Sg4
SX Female
CA Spontaneously immortalized cell line
//
ID SG5-1.13
AC CVCL_U457
RX PubMed=12514093;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_U450 ! G5
SX Male
CA Transformed cell line
//
ID SG5-2
AC CVCL_U458
RX PubMed=12514093;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_U450 ! G5
SX Male
CA Transformed cell line
//
ID SGBS
AC CVCL_GS28
DR GEO; GSM1543665
DR GEO; GSM1543666
DR GEO; GSM1543667
RX PubMed=11244452;
RX PubMed=25925588;
CC Omics: Deep RNAseq analysis.
DI NCIt; C118787; Simpson Golabi Behmel syndrome type 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Spontaneously immortalized cell line
//
ID SGC-7901
AC CVCL_0520
SY SGC 7901; SGC7901
DR BTO; BTO:0002392
DR EFO; EFO_0006293
DR MCCL; MCC:0000418
DR CCRID; 3111C0001CCC000236
DR CCRID; 3131C0001000700046
DR ChEMBL-Cells; CHEMBL3307739
DR ChEMBL-Targets; CHEMBL614909
DR GEO; GSM844685
DR GEO; GSM1374869
DR TOKU-E; 3764
RX DOI=10.1360/sb1982-27-12-1355;
RX DOI=10.1007/978-4-431-68252-3_114;
RX PubMed=6443274;
CC Omics: Transcriptome analysis.
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SGC-996
AC CVCL_M737
SY SGC996
RX CelloPub=CLPUB00379;
RX PubMed=22387537;
CC Doubling time: ~48 hours (CelloPub=CLPUB00379).
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SGE-1
AC CVCL_2189
SY SGE1
DR CLO; CLO_0008999
DR DSMZ; ACC-343
RX PubMed=3242847;
CC Doubling time: 21.6 hours (PubMed=3242847); ~33 hours (DSMZ).
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID SGE-RC
AC CVCL_X538
DR Cosmic; 849368
RX PubMed=11146448;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SGHPL-4
AC CVCL_0521
SY CTB-CL-MC4; MC4; Saint Georges Hospital Placental cell Line-4
DR BTO; BTO:0003980
DR MCCL; MCC:0000419
RX PubMed=9804259;
RX PubMed=10498850;
RX PubMed=11723542;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SGHPL-5
AC CVCL_D727
SY SGHPL5; Saint Georges Hospital Placental cell Line-5
RX PubMed=11723542;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Misspelling: 'SHGPL-5' in PubMed=16896069.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SGP
AC CVCL_6F88
SY Snakeskin Gourami caudal Peduncle
RX PubMed=1717644;
CC Group: Fish cell line.
OX NCBI_TaxID=313238; ! Trichopodus pectoralis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SGS
AC CVCL_4007
SY Sarcoma Galliera strain; SGS-2
DR BTO; BTO:0001210
DR CLO; CLO_0009000
DR CLDB; cl4284
RX DOI=10.1007/978-1-4612-5008-1_23;
RX PubMed=652394;
RX PubMed=2982624;
CC Breed/subspecies: Galliera.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID SGS/3A
AC CVCL_F738
DR CLO; CLO_0009001
DR CLDB; cl4285
CC Breed/subspecies: Galliera.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4007 ! SGS
CA Cancer cell line
//
ID SGS/4A
AC CVCL_L436
RX PubMed=10832101;
CC Breed/subspecies: Galliera.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4007 ! SGS
CA Cancer cell line
//
ID SH [Dog hemangiosarcoma]
AC CVCL_GY96
DR GEO; GSM1122231
RX PubMed=24582862;
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID SH [Sturgeon]
AC CVCL_S945
SY Sturgeon Heart
RX DOI=10.1139/z85-427;
CC Group: Fish cell line.
OX NCBI_TaxID=36177; ! Acipenser oxyrinchus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Sh #1
AC CVCL_1E45
SY SH #1; SH 1
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=994214;
RX PubMed=5030962;
CC Doubling time: 30 hours (at 41th passage), 31 hours (at 142th passage) (PubMed=994214).
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SH-10-TC
AC CVCL_5167
SY SH10TC; SH-10
DR CCLE; SH10TC_STOMACH
DR Cosmic; 889109
DR Cosmic; 1187292
DR GEO; GSM887567
DR GEO; GSM888650
DR RCB; RCB1940
DR TKG; TKG 0338
DR TKG; TKG 0412
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB; TKG
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C5248; Mucinous gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SH-2 [Human contaminated breast cancer]
AC CVCL_M622
SY SH2
DR BioSample; SAMN03151757
RX CelloPub=CLPUB00114;
RX CelloPub=CLPUB00262;
RX PubMed=1246601;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=6451928, PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID SH-2 [Human leukemia]
AC CVCL_2190
DR BioSample; SAMN03473457
DR DSMZ; ACC-643
RX PubMed=18715689;
CC Doubling time: ~80 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,12
ST D16S539: 9
ST D5S818: 10,11
ST D7S820: 12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 18,20
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SH-224
AC CVCL_S708
DR Cosmic; 1493302
RX PubMed=21372829;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SH-289
AC CVCL_S709
DR Cosmic; 1493303
RX PubMed=21372829;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SH-3
AC CVCL_M383
SY SH3
DR BioSample; SAMN03151758
RX CelloPub=CLPUB00114;
RX CelloPub=CLPUB00262;
RX PubMed=1246601;
RX PubMed=1260689;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=6451928, PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID SH-34
AC CVCL_F764
DR CLO; CLO_0009004
DR ATCC; CRL-2405
RX PubMed=3614206;
CC Monoclonal antibody target: ChEBI; CHEBI:27938; Asialo-GM1 ganglioside.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID SH-39-HOM
AC CVCL_C585
DR ESTDAB; ESTDAB-060
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,11
ST FGA: 23
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C577 ! RE-25-HOM
SX Male
CA Cancer cell line
//
ID SH-4
AC CVCL_1692
SY SH4
DR CLO; CLO_0009006
DR ATCC; CRL-7724
DR BCRJ; 0337
DR BioSample; SAMN03471142
DR CCLE; SH4_SKIN
DR ChEMBL-Cells; CHEMBL3308177
DR ChEMBL-Targets; CHEMBL2366309
DR Cosmic; 687440
DR Cosmic; 909713
DR Cosmic; 2159447
DR Cosmic-CLP; 909713
DR GDSC; 909713
DR GEO; GSM887568
DR GEO; GSM888651
DR GEO; GSM1670420
DR IGRhCellID; SH4
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1176156;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 13
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SH-405
AC CVCL_S710
DR Cosmic; 1493308
RX PubMed=21372829;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SH-416
AC CVCL_S711
DR Cosmic; 1493305
RX PubMed=21372829;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SH-437
AC CVCL_S712
DR Cosmic; 1493307
RX PubMed=21372829;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SH-450
AC CVCL_S713
DR Cosmic; 1493306
RX PubMed=21372829;
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SH-498
AC CVCL_S714
DR Cosmic; 1493309
RX PubMed=21372829;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SH-543
AC CVCL_S715
DR Cosmic; 1493304
RX PubMed=21372829;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SH-A
AC CVCL_0C25
DR Cosmic; 2239085
RX PubMed=1311980;
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=9815546;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SH-EP
AC CVCL_0524
SY SHEP
DR BTO; BTO:0005397
DR EFO; EFO_0006294
DR MCCL; MCC:0000423
DR Cosmic; 1212535
DR Cosmic; 2393640
DR GEO; GSM1622295
RX PubMed=2535691;
RX PubMed=6137586;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-530.html
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0531 ! SK-N-SH
SX Female
CA Cancer cell line
//
ID SH-EP007
AC CVCL_0522
SY SH-EP 007 SH-EPII
DR MCCL; MCC:0000420
RX PubMed=2364393;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0524 ! SH-EP
SX Female
CA Cancer cell line
//
ID SH-EP1
AC CVCL_0F47
SY SH-EPi
DR BTO; BTO:0005788
DR ATCC; CRL-2269
RX PubMed=6137586;
RX PubMed=6582512;
CC Discontinued: ATCC; CRL-2269; true.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 8,13
ST D5S818: 12
ST D7S820: 7,10
ST TH01: 7,10
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0524 ! SH-EP
SX Female
CA Cancer cell line
//
ID SH-FE
AC CVCL_W973
RX PubMed=6137586;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0531 ! SK-N-SH
SX Female
CA Cancer cell line
//
ID SH-IN
AC CVCL_W974
RX PubMed=2535691;
RX PubMed=6137586;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0531 ! SK-N-SH
SX Female
CA Cancer cell line
//
ID SH-J1
AC CVCL_HE82
RX PubMed=11850072;
CC Characteristics: Has lost chromosome Y.
DI NCIt; C43627; Sarcomatoid hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SH-SY5Y
AC CVCL_0019
SY SHSY5Y; SHSY-5Y; SH-Sy5y; SK-SH-SY5Y; SY5Y
DR BTO; BTO:0000793
DR CLO; CLO_0009015
DR EFO; EFO_0002717
DR MCCL; MCC:0000421
DR CLDB; cl4287
DR CLDB; cl4288
DR CLDB; cl4289
DR CLDB; cl4290
DR ATCC; CRL-2266
DR BCRJ; 0223
DR CCLE; SHSY5Y_AUTONOMIC_GANGLIA
DR CCRID; 3111C0001CCC000026
DR CCRID; 3131C0001000700097
DR CCRID; 3142C0001000000486
DR CGH-DB; 63-1
DR ChEMBL-Cells; CHEMBL3307740
DR ChEMBL-Targets; CHEMBL614910
DR CLS; 300154/p822_SH-SY5Y
DR Cosmic; 688084
DR Cosmic; 1019933
DR Cosmic; 1167410
DR Cosmic; 1212536
DR Cosmic; 2058109
DR Cosmic; 2239470
DR Cosmic; 2393641
DR DSMZ; ACC-209
DR ECACC; 94030304
DR ENCODE; ENCBS264AAA
DR GEO; GSM692874
DR GEO; GSM887570
DR GEO; GSM888653
DR GEO; GSM1622294
DR ICLC; HTL95013
DR IZSLER; BS TCL 232
DR KCB; KCB 2006107YJ
DR KCLB; 22266
DR NCBI_Iran; C611
DR PRIDE; PXD003105
DR PRIDE; PXD003914
DR TOKU-E; 3118
DR Wikidata; Q7390126
RX PubMed=2535691;
RX PubMed=2846152;
RX PubMed=4748425;
RX PubMed=6137586;
RX PubMed=15150091;
RX PubMed=16120276;
RX PubMed=22213050;
RX PubMed=22460905;
RX PubMed=25182563;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=28118852;
WW https://en.wikipedia.org/wiki/SH-SY5Y
WW http://www.proteinatlas.org/learn/cellines
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/SH-SY5Y_Farnham_protocol.pdf
WW http://www.addexbio.com/productdetail?pid=63
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-101.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-neuroblastoma-cell-line-sh-sy5y
CC Problematic cell line: Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 810.
CC Doubling time: >55 hours (DSMZ).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Mitochondrial proteome analysis by 2D-DE/MS.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SH-SY5' in ChEMBL CHEMBL614910.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; CLS; DSMZ; ECACC; KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 8,13
ST D18S51: 13,16
ST D21S11: 31,31.2
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 7,10
ST D8S1179: 15
ST FGA: 23.2,24
ST Penta D: 10,12
ST Penta E: 7,11
ST TH01: 7,10
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0531 ! SK-N-SH
SX Female
CA Cancer cell line
//
ID SH-SY5Y Rho0 64/5
AC CVCL_U924
SY Rho0 64/5
RX PubMed=8863494;
CC Characteristics: Cell line devoid of mitochondrial DNA (rho0).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0019 ! SH-SY5Y
SX Female
CA Cancer cell line
//
ID SH-SY5Y-HFE
AC CVCL_5I52
RX PubMed=17194693;
WW https://www.kerafast.com/product/1277/stable-sh-sy5y-hfe-expressing-cell-lines
CC Transfected with: HGNC; 4886; HFE.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0019 ! SH-SY5Y
SX Female
CA Cancer cell line
//
ID SH-SY5Y-HFE C282Y
AC CVCL_5I53
RX PubMed=17194693;
WW https://www.kerafast.com/product/1277/stable-sh-sy5y-hfe-expressing-cell-lines
CC Transfected with: HGNC; 4886; HFE (with Y-282).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0019 ! SH-SY5Y
SX Female
CA Cancer cell line
//
ID SH-SY5Y-HFE H63D
AC CVCL_5I54
RX PubMed=17194693;
WW https://www.kerafast.com/product/1277/stable-sh-sy5y-hfe-expressing-cell-lines
CC Transfected with: HGNC; 4886; HFE (with D-63).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0019 ! SH-SY5Y
SX Female
CA Cancer cell line
//
ID SH-SY5Y-SPA4CT
AC CVCL_0523
SY SH-SY5Y SPA4CT; SHSY5Y-SPA4CT
DR MCCL; MCC:0000422
RX PubMed=8243673;
CC Transfected with: HGNC; 620; APP (1-19 in frame with 672-770).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0019 ! SH-SY5Y
SX Female
CA Cancer cell line
//
ID SH1
AC CVCL_C722
SY SSMUe001-A
DR hPSCreg; SSMUe001-A
RX PubMed=15955827;
CC From: Shanghai Second Medical University; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID SH101-P4
AC CVCL_A669
SY SH101P4; SH-101-P4
DR CGH-DB; 130-1
DR CGH-DB; 9018-4
DR Cosmic; 877039
DR Cosmic; 897531
DR Cosmic; 1122339
DR Cosmic; 1187291
DR Cosmic; 1518240
RX PubMed=8242641;
RX PubMed=15723654;
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SH2 [Human ESC]
AC CVCL_C723
SY SSMUe002-A
DR hPSCreg; SSMUe002-A
RX PubMed=15955827;
CC From: Shanghai Second Medical University; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID SH2 [Mouse hybridoma]
AC CVCL_7700
DR CLO; CLO_0009002
DR ATCC; HB-10743
DR CCRID; 3111C0001CCC000204
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID SH28
AC CVCL_C726
SY SSMUe005-A
DR hPSCreg; SSMUe005-A
DR ISCR; 1592
RX PubMed=15916726;
CC From: Shanghai Second Medical University; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SH3
AC CVCL_7701
DR CLO; CLO_0009003
DR ATCC; HB-10744
DR CCRID; 3111C0001CCC000205
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID SH35
AC CVCL_C727
SY SSMUe006-A
DR hPSCreg; SSMUe006-A
DR ISCR; 1593
RX PubMed=15916726;
CC From: Shanghai Second Medical University; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SH35a
AC CVCL_C728
SY SSMUe007-A
DR hPSCreg; SSMUe007-A
DR ISCR; 1594
CC From: Shanghai Second Medical University; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SH38
AC CVCL_C729
SY SSMUe008-A
DR hPSCreg; SSMUe008-A
DR ISCR; 1595
RX PubMed=15916726;
CC From: Shanghai Second Medical University; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SH39
AC CVCL_C730
SY SSMUe009-A
DR hPSCreg; SSMUe009-A
DR ISCR; 1596
RX PubMed=15916726;
CC From: Shanghai Second Medical University; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SH4 [Human ESC]
AC CVCL_C724
SY SSMUe004-A
DR hPSCreg; SSMUe004-A
DR ISCR; 1597
RX PubMed=15916726;
CC From: Shanghai Second Medical University; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SH4 [Mouse hybridoma]
AC CVCL_7702
DR CLO; CLO_0009005
DR EFO; EFO_0002327
DR ATCC; HB-10745
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID SH42
AC CVCL_C731
SY SSMUe010-A
DR hPSCreg; SSMUe010-A
DR ISCR; 1598
RX PubMed=15916726;
CC From: Shanghai Second Medical University; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SH7
AC CVCL_C725
SY SSMUe003-A
DR hPSCreg; SSMUe003-A
DR ISCR; 1599
RX PubMed=15955827;
CC From: Shanghai Second Medical University; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SHAC
AC CVCL_D522
SY Shac
DR BTO; BTO:0003763
RX PubMed=3284824;
DI NCIt; C6605; Soft tissue fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Shadow
AC CVCL_0D17
SY SHADOW; SHA
RX PubMed=11467477;
RX PubMed=12944992;
RX PubMed=26842912;
CC Derived from metastatic site: Lung.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Shamba
AC CVCL_R797
RX PubMed=1690682;
RX PubMed=8891732;
WW http://www.zooatlanta.org/home/headlines/gorilla_shamba_50birthday
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Female
CA Transformed cell line
//
ID Shay
AC CVCL_6018
DR JCRB; JCRB0241
RX PubMed=6585112;
CC Breed/subspecies: Wistar.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID sHCC29
AC CVCL_HE83
RX DOI=10.1158/1538-7445.AM2014-3622;
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI NCIt; C43627; Sarcomatoid hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID sHCC63
AC CVCL_HE84
RX DOI=10.1158/1538-7445.AM2014-3622;
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI NCIt; C43627; Sarcomatoid hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID sHCC74
AC CVCL_HE85
RX DOI=10.1158/1538-7445.AM2014-3622;
DI NCIt; C3098; Hepatitis C infection
DI NCIt; C43627; Sarcomatoid hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SHCE
AC CVCL_6E72
SY SV40-immortalized Human Corneal Epithelial cells
RX PubMed=26631824;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SHEE10
AC CVCL_4M96
RX PubMed=11712078;
RX PubMed=12569775;
RX PubMed=12439909;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SHEE100
AC CVCL_4N01
SY H5E973
RX PubMed=16364037;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4N00 ! SHEE85
CA Transformed cell line
//
ID SHEE31
AC CVCL_4M97
RX PubMed=11712078;
RX PubMed=12569775;
RX PubMed=12439909;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4M96 ! SHEE10
CA Transformed cell line
//
ID SHEE61
AC CVCL_4M98
RX PubMed=11712078;
RX PubMed=12569775;
RX PubMed=12439909;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4M97 ! SHEE31
CA Transformed cell line
//
ID SHEE61A
AC CVCL_4M99
RX PubMed=11712078;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4M98 ! SHEE61
CA Transformed cell line
//
ID SHEE85
AC CVCL_4N00
RX PubMed=12015026;
RX PubMed=12439909;
RX PubMed=12851721;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4M98 ! SHEE61
CA Transformed cell line
//
ID Shef1
AC CVCL_9788
SY SHEF1; Shef-1; SHEF-1; Shef 1; SHEFF-1; AXORe001-A
DR EFO; EFO_0005454
DR hPSCreg; AXORe001-A
DR ISCR; 184
RX PubMed=15345125;
RX PubMed=17572666;
RX PubMed=20224972;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-1.aspx
CC From: University of Sheffield; Sheffield; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-05-007, Steering comm. appl. SCSC04-23(1).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Shef2
AC CVCL_9789
SY SHEF2; Shef-2; SHEF-2; Shef 2; SHEFF-2; AXORe002-A
DR EFO; EFO_0005456
DR hPSCreg; AXORe002-A
DR ISCR; 185
RX PubMed=17572666;
RX PubMed=20224972;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-2.aspx
CC From: University of Sheffield; Sheffield; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-05-028, Steering comm. appl. SCSC04-23(2).
CC Misspelling: 'SHEP-2' in EFO EFO_0005456.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Shef3
AC CVCL_9790
SY SHEF3; Shef-3; SHEF-3; Shef 3; SHEFF-3; AXORe003-A; UOSe003-A
DR EFO; EFO_0005455
DR hPSCreg; UOSe003-A
DR ISCR; 1405
RX PubMed=17572666;
RX PubMed=20224972;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-3.aspx
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=423
CC From: University of Sheffield; Sheffield; UK.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0077.
CC Registration: UK Stem Cell Bank (UKSCB); R-05-008, Steering comm. appl. SCSC04-24.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Shef3.2
AC CVCL_BW72
CC Group: Clinical grade hESC cell line.
CC From: University of Sheffield; Sheffield; UK.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-34.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9790 ! Shef3
SX Male
CA Embryonic stem cell
//
ID Shef4
AC CVCL_9791
SY SHEF4; Shef-4; SHEF-4; Shef 4; AXORe004-A
DR hPSCreg; AXORe004-A
DR ISCR; 1406
RX PubMed=20224972;
CC From: University of Sheffield; Sheffield; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-05-029, Steering comm. appl. SCSC05-22.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Shef5
AC CVCL_9792
SY SHEF5; Shef-5; SHEF-5; Shef 5; AXORe005-A
DR hPSCreg; AXORe005-A
DR ISCR; 1407
RX PubMed=20224972;
CC From: University of Sheffield; Sheffield; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-08-009, Steering comm. appl. SCSC05-22.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Shef6
AC CVCL_9793
SY SHEF6; Shef-6; SHEF-6; Shef 6; AXORe006-A; UOSe006-A
DR hPSCreg; UOSe006-A
DR ISCR; 1408
RX PubMed=20224972;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-6.aspx
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=424
CC From: University of Sheffield; Sheffield; UK.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0078.
CC Registration: UK Stem Cell Bank (UKSCB); R-05-031, Steering comm. appl. SCSC05-23.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Shef6.1
AC CVCL_BW73
RX PubMed=26607962;
CC Group: Clinical grade hESC cell line.
CC From: University of Sheffield; Sheffield; UK.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-35.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9793 ! Shef6
SX Female
CA Embryonic stem cell
//
ID Shef7
AC CVCL_9794
SY SHEF7; Shef-7; SHEF-7; Shef 7; AXORe007-A
DR hPSCreg; AXORe007-A
DR ISCR; 1409
RX PubMed=20224972;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-7.aspx
CC From: University of Sheffield; Sheffield; UK.
CC From: Pfizer, Inc.
CC Registration: UK Stem Cell Bank (UKSCB); R-07-008, Steering comm. appl. SCSC06-30.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Shef8
AC CVCL_9795
SY SHEF8; Shef-8; Shef 8
DR ISCR; 1410
RX PubMed=20224972;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-8.aspx
CC From: University of Sheffield; Sheffield; UK.
CC From: Pfizer, Inc.
CC Registration: UK Stem Cell Bank (UKSCB); R-08-015, Steering comm. appl. SCSC07-31.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SHEP-SF
AC CVCL_2A38
SY SH-EP/SF
DR EFO; EFO_0002857
RX PubMed=15150091;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0524 ! SH-EP
SX Female
CA Cancer cell line
//
ID SHEP-TR-miR-17-92
AC CVCL_EI12
DR PRIDE; PRD000321
RX PubMed=21145484;
CC Characteristics: Transfected with a Tet-on system to induce the oncogenic miR-17-92 cluster with the addition of tetracycline to the culture medium.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0524 ! SH-EP
SX Female
CA Cancer cell line
//
ID SHER-I
AC CVCL_M782
SY SHER-1
DR Cosmic; 1590842
RX PubMed=15126569;
RX PubMed=19424640;
RX PubMed=22038905;
DI NCIt; C3879; Thyroid gland medullary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SHEFP-1
AC CVCL_Z071
RX DOI=10.1007/BF01404489;
CC Group: Hybridoma fusion partner cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6544 ! WIL2
SX Male
CA Transformed cell line
//
ID SHF-1
AC CVCL_6F89
SY SheepsHead Fin-1
RX DOI=10.1139/f78-081;
CC Group: Fish cell line.
OX NCBI_TaxID=119682; ! Archosargus probatocephalus
SX Male
CA Spontaneously immortalized cell line
//
ID SHG [Channa]
AC CVCL_6F90
SY SnakeHead Gonad
RX CelloPub=CLPUB00305;
CC Group: Fish cell line.
OX NCBI_TaxID=64152; ! Channa striata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SHG [Verasper]
AC CVCL_IN54
SY Spotted Halibut Gill
RX CelloPub=CLPUB00366;
CC Group: Fish cell line.
CC Doubling time: 43.6 hours (CelloPub=CLPUB00366).
OX NCBI_TaxID=82366; ! Verasper variegatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SHG-139
AC CVCL_2H28
SY SHG139; Suzhou Human Glioma-139
RX PubMed=25879429;
RX PubMed=25975682;
DI NCIt; C4322; Fibrillary astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SHG-44
AC CVCL_6728
SY SHG 44; SHG44; Suzhou Human Glioma-44
DR BTO; BTO:0003231
DR CCRID; 3131C0001000700048
RX DOI=10.3321/j.issn:1000-5404.2001.03.006;
RX PubMed=6525937;
RX PubMed=22038279;
RX PubMed=25333456;
CC Doubling time: 26.67 hours (PubMed=25333456).
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SHG-44/ADM
AC CVCL_HF68
RX PubMed=25333456;
CC Doubling time: 32.22 hours (PubMed=25333456).
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Misspelling: 'SGH-44/ADM' in abstract and many part of text of PubMed=25333456.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6728 ! SHG-44
CA Cancer cell line
//
ID SHH [Snakehead heart Japan]
AC CVCL_R856
SY SnakeHead Heart
RX DOI=10.1577/1548-8667(1993)005<0137:EACOSC>2.3.CO;2;
RX DOI=10.3147/jsfp.28.27;
CC Group: Fish cell line.
OX NCBI_TaxID=64152; ! Channa striata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SHH [Snakehead heart Philippine]
AC CVCL_6F91
SY SnakeHead Heart
RX CelloPub=CLPUB00305;
CC Group: Fish cell line.
OX NCBI_TaxID=64152; ! Channa striata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Shh Light II
AC CVCL_2721
SY Shh-Light II; Shh Light 2; Shh LIGHT 2; Shh Light2; Shh-L2
DR CLO; CLO_0009010
DR ATCC; CRL-2795
DR ATCC; JHU-68
CC Transfected with: UniProtKB; P27652; Renilla-type luciferase.
CC Discontinued: ATCC; CRL-2795; true.
CC Discontinued: ATCC; JHU-68; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID SHH-1
AC CVCL_IQ83
SY ShowChwan-Hwang-Hu-1
RX PubMed=17554590;
CC Doubling time: 36 hours (PubMed=17554590).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SHhES1
AC CVCL_C732
SY SJTUe001-A
DR hPSCreg; SJTUe001-A
DR ISCR; 1399
RX PubMed=16319131;
CC From: Shanghai Institutes for Biological Sciences; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SHhES2
AC CVCL_C733
DR ISCR; 584
RX PubMed=20186511;
CC From: Shanghai Institutes for Biological Sciences; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SHhES3
AC CVCL_C734
DR ISCR; 1400
RX PubMed=20186511;
CC From: Shanghai Institutes for Biological Sciences; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID SHhES4
AC CVCL_C735
DR ISCR; 1401
RX PubMed=20186511;
CC From: Shanghai Institutes for Biological Sciences; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID SHHT
AC CVCL_S148
SY SnakeHead HearT
RX PubMed=15801161;
CC Group: Fish cell line.
OX NCBI_TaxID=64152; ! Channa striata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SHI-1
AC CVCL_2191
DR BTO; BTO:0005745
DR BioSample; SAMN03473459
DR Cosmic; 1601065
DR DSMZ; ACC-645
RX PubMed=15951289;
CC Doubling time: ~60-70 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9
ST D16S539: 9,10
ST D5S818: 12,13
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Shi/FeT-1C
AC CVCL_V314
DR ATCC; CRL-11976
RX Patent=US5846825;
CC Discontinued: ATCC; CRL-11976; probable.
OX NCBI_TaxID=9685; ! Felis catus
HI CVCL_3686 ! FeT-1C
CA Spontaneously immortalized cell line
//
ID Shimozuma-1
AC CVCL_F748
RX PubMed=2579855;
CC Characteristics: Infected by porcine retrovirus Tsukuba-1.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Cancer cell line
//
ID SHIN-3
AC CVCL_A670
SY SHIN3; Shin3
DR Cosmic; 877481
DR Cosmic; 945374
DR Cosmic; 1152561
DR Cosmic; 1526883
DR GEO; GSM459739
RX CelloPub=CLPUB00115;
RX DOI=10.5795/jjscc.27.926;
RX PubMed=2314830;
RX PubMed=2469292;
RX PubMed=8718548;
RX PubMed=15677628;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SHIN-3/PTEN
AC CVCL_W128
RX PubMed=18347155;
CC Transfected with: HGNC; 9588; PTEN.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A670 ! SHIN-3
SX Female
CA Cancer cell line
//
ID ShiPS-miFF1
AC CVCL_1E69
SY ShiPS-MIFF1; MIFF1; MIFF-1; UOSi001-A
DR hPSCreg; UOSi001-A
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2769 ! CCD-1112Sk
SX Male
CA Induced pluripotent stem cell
//
ID ShiPS-miFF3
AC CVCL_1E70
SY ShiPS-MIFF3; MIFF3; MIFF-3; UOSi001-B
DR hPSCreg; UOSi001-B
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2769 ! CCD-1112Sk
SX Male
CA Induced pluripotent stem cell
//
ID SHJO
AC CVCL_E827
SY SH.JO; SMJ
DR dbMHC; 49018
DR ECACC; 94022547
DR IHW; IHW9239
DR IMGT/HLA; 11384
WW http://bioinformatics.hsanmartino.it/ecbr/cl239.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SHK [Halibut]
AC CVCL_W850
SY Spotted Halibut Kidney
RX DOI=10.1007/s11802-010-0162-1;
CC Group: Fish cell line.
OX NCBI_TaxID=82366; ! Verasper variegatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SHK [Snakehead]
AC CVCL_6F92
SY SnakeHead Kidney
RX CelloPub=CLPUB00305;
CC Group: Fish cell line.
OX NCBI_TaxID=64152; ! Channa striata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SHK-1
AC CVCL_4299
SY SHK1; Salmon Head Kidney-1
DR ECACC; 97111106
RX DOI=10.1006/fsim.1996.0076;
RX PubMed=7782764;
RX PubMed=15825496;
RX PubMed=19162334;
CC Group: Fish cell line.
OX NCBI_TaxID=8030; ! Salmo salar
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SHL
AC CVCL_6F93
SY SnakeHead Liver
RX CelloPub=CLPUB00305;
CC Group: Fish cell line.
OX NCBI_TaxID=64152; ! Channa striata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SHM-D33
AC CVCL_3419
SY SHMD-33; SHMD33; D-33
DR CLO; CLO_0009011
DR CLDB; cl4294
DR CLDB; cl4295
DR ATCC; CRL-1668
DR ICLC; ATL94001
DR RCB; RCB0267
RX PubMed=6316357;
CC Group: Hybridoma fusion partner cell line.
CC Discontinued: RCB; RCB0267; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
HI CVCL_J236 ! FU-266 clone E1
CA Hybrid cell line
//
ID Shmac 1
AC CVCL_AR57
DR ECACC; 11102001
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,9
ST D16S539: 12
ST D5S818: 10,12
ST D7S820: 7,10
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Shmac 2
AC CVCL_F280
RX PubMed=17163777;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Shmac 3
AC CVCL_F281
RX PubMed=17163777;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Shmac 4
AC CVCL_2722
DR ECACC; 10112302
RX PubMed=17163777;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11,14
ST D5S818: 12,13
ST D7S820: 7,10
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Shmac 5
AC CVCL_2723
DR ECACC; 10112303
RX PubMed=17163777;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12,13
ST D16S539: 11,12
ST D5S818: 12,14
ST D7S820: 7,12
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Shmac 6
AC CVCL_F282
RX PubMed=17163777;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SHMS
AC CVCL_S149
SY SnakeHead MuScle
RX PubMed=15801161;
CC Group: Fish cell line.
OX NCBI_TaxID=64152; ! Channa striata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SHOK
AC CVCL_3164
SY Syrian Hamster Osaka-Kanazawa cells
DR CLO; CLO_0009012
DR CLDB; cl4296
DR ECACC; 90071805
DR IFO; IFO50367
DR RCB; RCB0453
RX PubMed=2181436;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_8153 ! GHE-L
CA Spontaneously immortalized cell line
//
ID Shox2
AC CVCL_2Z99
DR ATCC; CRL-3256
RX PubMed=23877224;
CC Breed/subspecies: 129S1/SvImJ.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_C316 ! CJ7
SX Male
CA Finite cell line
//
ID SHP-77
AC CVCL_1693
SY SHP77; Shadyside Hospital Pittsburgh-77
DR BTO; BTO:0003726
DR CLO; CLO_0009013
DR EFO; EFO_0002328
DR ATCC; CRL-2195
DR BioSample; SAMN03472563
DR CCLE; SHP77_LUNG
DR ChEMBL-Cells; CHEMBL3308363
DR ChEMBL-Targets; CHEMBL612569
DR Cosmic; 724872
DR Cosmic; 844577
DR Cosmic; 877392
DR Cosmic; 1152487
DR Cosmic; 1759309
DR Cosmic; 1995626
DR Cosmic; 2125288
DR Cosmic; 2239081
DR Cosmic-CLP; 724872
DR ECACC; 98110201
DR GDSC; 724872
DR GEO; GSM169447
DR GEO; GSM887569
DR GEO; GSM888652
DR GEO; GSM1374870
DR IGRhCellID; SHP77
RX PubMed=212181;
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=9815546;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 96 hours (ECACC).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11
ST TH01: 7
ST TPOX: 9,11
ST vWA: 16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID sHPT-1
AC CVCL_0I22
RX PubMed=17126301;
DI NCIt; C3630; Benign parathyroid gland neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SHS
AC CVCL_6F94
SY SnakeHead Spleen
RX CelloPub=CLPUB00305;
CC Group: Fish cell line.
OX NCBI_TaxID=64152; ! Channa striata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SHSB
AC CVCL_S150
SY SnakeHead Swim Bladder
RX PubMed=15801161;
CC Group: Fish cell line.
OX NCBI_TaxID=64152; ! Channa striata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SHT-1
AC CVCL_IQ81
SY ShowChwan-Hwang-Tsai-1
RX PubMed=17554590;
CC Doubling time: 39 hours (PubMed=17554590).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SHT290
AC CVCL_G213
RX PubMed=15772261;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID SHY
AC CVCL_E828
DR dbMHC; 49019
DR IHW; IHW9379
DR IMGT/HLA; 25988
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID SHZ-88
AC CVCL_7163
DR CCRID; 3131C0001001000005
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID Si-1
AC CVCL_3165
DR JCRB; JCRB1369
RX PubMed=6122826;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9543; ! Macaca fuscata fuscata
CA Transformed cell line
//
ID Si-2
AC CVCL_3166
DR JCRB; JCRB1321
RX PubMed=6309601;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
OX NCBI_TaxID=9543; ! Macaca fuscata fuscata
SX Male
CA Transformed cell line
//
ID Si-IIA
AC CVCL_X690
RX PubMed=2118885;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Male
CA Transformed cell line
//
ID SI-PMEC
AC CVCL_W953
SY Spontaneously Immortalized-Porcine Mammary Epithelial Cell line
RX PubMed=16919976;
CC Breed/subspecies: Landrace.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Spontaneously immortalized cell line
//
ID SIA
AC CVCL_F582
SY TER197
DR IMGT/HLA; 12184
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SIB-1
AC CVCL_S924
RX PubMed=8039117;
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SIB186
AC CVCL_F406
DR CLO; CLO_0051119
DR RCB; HSC0096
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SICE
AC CVCL_R922
SY Sahul Indian Catla Eye
RX DOI=10.1111/j.1095-8649.2008.01851.x;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=18
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC018.
OX NCBI_TaxID=72446; ! Gibelion catla
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SICH
AC CVCL_R811
SY Sahul Indian Catla Heart
RX DOI=10.1016/j.aquaculture.2009.05.012;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=19
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC019.
OX NCBI_TaxID=72446; ! Gibelion catla
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SIE-EO-801
AC CVCL_AV41
RX CelloPub=CLPUB00312;
CC Group: Insect cell line.
OX NCBI_TaxID=248899; ! Ectropis obliqua
SX Female
CA Spontaneously immortalized cell line
//
ID SIE-EO-803
AC CVCL_AV42
RX CelloPub=CLPUB00312;
CC Group: Insect cell line.
OX NCBI_TaxID=248899; ! Ectropis obliqua
SX Female
CA Spontaneously immortalized cell line
//
ID SIE-Ha-798
AC CVCL_Z954
RX CelloPub=CLPUB00212;
CC Group: Insect cell line.
OX NCBI_TaxID=29058; ! Helicoverpa armigera
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SIE-Ha-806
AC CVCL_Z955
RX CelloPub=CLPUB00212;
CC Group: Insect cell line.
OX NCBI_TaxID=29058; ! Helicoverpa armigera
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SIG-M5
AC CVCL_1694
SY SigM5; SIGM5
DR CLO; CLO_0009016
DR EFO; EFO_0006751
DR BioSample; SAMN03473111
DR BioSample; SAMN03473559
DR CCLE; SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308248
DR ChEMBL-Targets; CHEMBL2366251
DR Cosmic; 787476
DR Cosmic; 975299
DR Cosmic; 909715
DR Cosmic; 1012117
DR Cosmic; 1281352
DR Cosmic; 1465968
DR Cosmic; 2131558
DR Cosmic; 2306238
DR Cosmic-CLP; 909715
DR DSMZ; ACC-468
DR GDSC; 909715
DR GEO; GSM887571
DR GEO; GSM888654
DR GEO; GSM1374871
DR GEO; GSM1670421
RX PubMed=10848831;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~72 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 15,16,18
ST D21S11: 29,32.2
ST D3S1358: 18
ST D5S818: 11,13
ST D7S820: 9,11 (Cosmic-CLP; PubMed=25877200)
ST D7S820: 9 (DSMZ)
ST D8S1179: 14,16
ST FGA: 22,26
ST Penta D: 10,13
ST Penta E: 7,19
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SIGC
AC CVCL_6729
SY Spontaneously Immortalized Granulosa Cell line
RX PubMed=1845958;
RX PubMed=15541573;
CC Breed/subspecies: Berlin Duckrey (BD IV).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Spontaneously immortalized cell line
//
ID SIGE
AC CVCL_R923
SY Sahul Indian Grouper Eye
RX PubMed=17216384;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=16
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC016.
OX NCBI_TaxID=94232; ! Epinephelus coioides
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SIGi001-A
AC CVCL_EE38
SY iPSC0028; IPSC0028; iPSC Epithelial-1; iPSC EPITHELIAL-1
WW http://www.sigmaaldrich.com/catalog/product/sigma/ipsc0028
ST Source(s): Sigma-Aldrich
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 8,11
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID SIGi001-A-1
AC CVCL_EF83
SY iPSC0028 SLC17A7/GFP E3
DR BioSamples; SAMEA4451096
DR EBiSC; SIGi001-A-1
DR ECACC; 66540356
DR hPSCreg; SIGi001-A-1
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EE38 ! SIGi001-A
SX Female
CA Induced pluripotent stem cell
//
ID SIGi001-A-10
AC CVCL_II92
SY iPSC0028 MAPT P301S+Ex10+16/Clone 7G4A8
DR BioSamples; SAMEA4451117
DR EBiSC; SIGi001-A-10
DR ECACC; 66540358
DR hPSCreg; SIGi001-A-10
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EE38 ! SIGi001-A
SX Female
CA Induced pluripotent stem cell
//
ID SIGi001-A-2
AC CVCL_II91
SY iPSC0028 SLC17A7/GFP C3
DR BioSamples; SAMEA4451116
DR EBiSC; SIGi001-A-2
DR ECACC; 66540357
DR hPSCreg; SIGi001-A-2
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EE38 ! SIGi001-A
SX Female
CA Induced pluripotent stem cell
//
ID SIGi001-A-3
AC CVCL_EF84
SY iPSC0028 MAPT P301L C4
DR BioSamples; SAMEA4448571
DR EBiSC; SIGi001-A-3
DR ECACC; 66540331
DR hPSCreg; SIGi001-A-3
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EE38 ! SIGi001-A
SX Female
CA Induced pluripotent stem cell
//
ID SIGi001-A-4
AC CVCL_EF85
SY iPSC0028 MAPT P301L D4
DR BioSamples; SAMEA4448632
DR EBiSC; SIGi001-A-4
DR ECACC; 66540332
DR hPSCreg; SIGi001-A-4
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EE38 ! SIGi001-A
SX Female
CA Induced pluripotent stem cell
//
ID SIGi001-A-5
AC CVCL_EF86
SY iPSC0028 MAPT P301S 1C9C4
DR BioSamples; SAMEA4448708
DR EBiSC; SIGi001-A-5
DR ECACC; 66540333
DR hPSCreg; SIGi001-A-5
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EE38 ! SIGi001-A
SX Female
CA Induced pluripotent stem cell
//
ID SIGi001-A-6
AC CVCL_EF87
SY iPSC0028 MAPT P301S 1B9C9
DR BioSamples; SAMEA4447426
DR EBiSC; SIGi001-A-6
DR ECACC; 66540326
DR hPSCreg; SIGi001-A-6
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EE38 ! SIGi001-A
SX Female
CA Induced pluripotent stem cell
//
ID SIGi001-A-7
AC CVCL_EF88
SY iPSC0028 MAPT P301S 2G2B7
DR BioSamples; SAMEA4448730
DR EBiSC; SIGi001-A-7
DR ECACC; 66540334
DR hPSCreg; SIGi001-A-7
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EE38 ! SIGi001-A
SX Female
CA Induced pluripotent stem cell
//
ID SIGi001-A-8
AC CVCL_EF89
SY iPSC0028 MAPT P301S+Ex10+16/Clone 7D11A7
DR BioSamples; SAMEA4448777
DR EBiSC; SIGi001-A-8
DR ECACC; 66540335
DR hPSCreg; SIGi001-A-8
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EE38 ! SIGi001-A
SX Female
CA Induced pluripotent stem cell
//
ID SIGi001-A-9
AC CVCL_EF90
SY iPSC0028 MAPT P301S+Ex10+16/Clone 7H6A1
DR BioSamples; SAMEA4447499
DR EBiSC; SIGi001-A-9
DR ECACC; 66540327
DR hPSCreg; SIGi001-A-9
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EE38 ! SIGi001-A
SX Female
CA Induced pluripotent stem cell
//
ID SiHa
AC CVCL_0032
SY Siha; SIHA
DR BTO; BTO:0002210
DR CLO; CLO_0009017
DR EFO; EFO_0002379
DR MCCL; MCC:0000451
DR CLDB; cl4298
DR CLDB; cl4299
DR CLDB; cl4900
DR ATCC; HTB-35
DR BioSample; SAMN03473215
DR CCRID; 3111C0001CCC000294
DR CCRID; 3131C0001000700113
DR CCRID; 3142C0001000000089
DR ChEMBL-Cells; CHEMBL3307968
DR ChEMBL-Targets; CHEMBL612542
DR Cosmic; 760220
DR Cosmic; 809229
DR Cosmic; 846184
DR Cosmic; 877467
DR Cosmic; 925356
DR Cosmic; 928911
DR Cosmic; 930297
DR Cosmic; 1019306
DR Cosmic; 1131517
DR Cosmic; 1193028
DR Cosmic; 1201773
DR Cosmic; 1324212
DR Cosmic; 1995627
DR Cosmic; 2301542
DR Cosmic-CLP; 930297
DR GDSC; 930297
DR GEO; GSM113866
DR GEO; GSM226740
DR GEO; GSM226876
DR GEO; GSM253302
DR GEO; GSM675738
DR GEO; GSM685444
DR GEO; GSM723057
DR GEO; GSM723058
DR GEO; GSM1670422
DR ICLC; HTL98017
DR IGRhCellID; SiHa
DR IZSLER; BS TCL 112
DR KCB; KCB 2013026YJ
DR KCLB; 30035
DR TOKU-E; 3119
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=2990217;
RX PubMed=3029430;
RX PubMed=3029760;
RX PubMed=5529598;
RX PubMed=15531914;
RX PubMed=17311676;
RX PubMed=21439369;
RX PubMed=23881600;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.proteinatlas.org/learn/cellines
WW http://www.addexbio.com/productdetail?pid=372
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-22.html
CC Characteristics: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Omics: CNV analysis.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 12
ST D18S51: 15
ST D21S11: 29,31
ST D3S1358: 16,17
ST D5S818: 9
ST D7S820: 10
ST D8S1179: 13,16
ST FGA: 21
ST Penta D: 9,12
ST Penta E: 10,12
ST TH01: 6,9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SiHa-NTRpuro
AC CVCL_X529
RX PubMed=14997211;
CC Characteristics: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion.
CC Transfected with: UniProtKB; P38489; E.coli nitroreductase nfnB.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0032 ! SiHa
SX Female
CA Cancer cell line
//
ID SiHa/cDDP
AC CVCL_K031
RX PubMed=22650020;
CC Characteristics: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion.
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0032 ! SiHa
SX Female
CA Cancer cell line
//
ID SIHN-005A
AC CVCL_W318
RX PubMed=10760816;
RX PubMed=11497283;
RX PubMed=12124801;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W319 ! SIHN-005B
SX Male
CA Cancer cell line
//
ID SIHN-005B
AC CVCL_W319
RX PubMed=10760816;
RX PubMed=11497283;
RX PubMed=12124801;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W318 ! SIHN-005A
SX Male
CA Cancer cell line
//
ID SIHN-006
AC CVCL_H947
SY SI-HN-006; HN006
DR ChEMBL-Cells; CHEMBL3308668
DR ChEMBL-Targets; CHEMBL614827
RX PubMed=10760816;
RX PubMed=11497283;
RX PubMed=15197768;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SIHN-008
AC CVCL_W320
RX PubMed=10760816;
RX PubMed=11497283;
RX PubMed=12124801;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SIHN-011A
AC CVCL_W321
RX PubMed=10760816;
RX PubMed=11497283;
RX PubMed=12124801;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W322 ! SIHN-011B
CA Cancer cell line
//
ID SIHN-011B
AC CVCL_W322
RX PubMed=10760816;
RX PubMed=11497283;
RX PubMed=12124801;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W321 ! SIHN-011A
CA Cancer cell line
//
ID SIHN-013
AC CVCL_W323
RX PubMed=10760816;
RX PubMed=11497283;
RX PubMed=12124801;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W325 ! SIHN-13/2
CA Cancer cell line
//
ID SIHN-015B
AC CVCL_W324
RX PubMed=10760816;
RX PubMed=11497283;
RX PubMed=12124801;
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SIHN-034B
AC CVCL_W326
RX PubMed=10760816;
RX PubMed=11497283;
RX PubMed=12124801;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SIHN-13/2
AC CVCL_W325
RX PubMed=10760816;
RX PubMed=11497283;
RX PubMed=12124801;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W323 ! SIHN-013
CA Cancer cell line
//
ID SIK
AC CVCL_D525
RX PubMed=7949178;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SIKR
AC CVCL_5T83
RX PubMed=4416368;
RX PubMed=4672577;
CC Breed/subspecies: 129/Sv-SlJ-CP.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID SIKR-OSB
AC CVCL_5T84
RX PubMed=650144;
CC Breed/subspecies: 129/Sv-SlJ-CP.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5T83 ! SIKR
SX Male
CA Cancer cell line
//
ID SIL-6/1
AC CVCL_U118
DR CLO; CLO_0050547
DR RCB; RCB1792
CC Characteristics: IL6 or KITLG dependent.
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_N545 ! A-6
SX Male
CA Factor-dependent cell line
//
ID Silfere
AC CVCL_W936
SY NK9c; NK-9; NK 9
DR CGH-DB; 9202-4
DR Cosmic; 931133
RX PubMed=4174339;
RX PubMed=4178827;
RX PubMed=4320167;
RX PubMed=4321974;
RX PubMed=5786183;
RX PubMed=9473234;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SIM-A9
AC CVCL_5I31
DR ATCC; CRL-3265
RX PubMed=24975292;
WW https://www.kerafast.com/product/2118/microglial-cell-line-sim-a9
CC Doubling time: 2-3 days (Kerafast).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID SIM/EW27
AC CVCL_0097
SY SIM(EW27); SIM-EW27; SIMON; Simon; SIM
DR Cosmic; 721018
CC From: Delattre O.; Institut Curie; Paris; France.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SIM.2
AC CVCL_1Y14
DR NIH-ARP; 511-27
CC Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID SIM.4
AC CVCL_1Y15
DR NIH-ARP; 512-23
CC Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID SiMa
AC CVCL_1695
SY SIMA
DR CLO; CLO_0009018
DR CLDB; cl4300
DR BioSample; SAMN03470930
DR CCLE; SIMA_AUTONOMIC_GANGLIA
DR ChEMBL-Cells; CHEMBL3308828
DR ChEMBL-Targets; CHEMBL2366067
DR Cosmic; 753620
DR Cosmic; 2485949
DR Cosmic-CLP; 753620
DR DSMZ; ACC-164
DR GDSC; 753620
DR GEO; GSM563363
DR GEO; GSM887572
DR GEO; GSM888655
DR GEO; GSM1366410
DR GEO; GSM1670423
RX PubMed=10686945;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~34-100 hours, highly variable (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 14,16
ST D19S433: 13,14
ST D21S11: 28
ST D2S1338: 19,21
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 20,22
ST Penta D: 14
ST Penta E: 11,12
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SIMH
AC CVCL_R924
SY Sahul Indian Milkfish Heart
RX PubMed=17216384;
CC Group: Fish cell line.
OX NCBI_TaxID=29144; ! Chanos chanos
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SINJ
AC CVCL_M783
SY SIN-J
DR Cosmic; 1590843
RX PubMed=12089864;
RX PubMed=15126569;
RX PubMed=21573635;
RX PubMed=22038905;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3879; Thyroid gland medullary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SIPS
AC CVCL_DF10
SY Spontaneously Immortalized Pancreatic Stellate cell line
RX PubMed=14669327;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID SIRC
AC CVCL_2724
SY Sirc; Statens Seruminstitut Rabbit Cornea
DR BTO; BTO:0004495
DR CLO; CLO_0009019
DR CLO; CLO_0009020
DR CLO; CLO_0050407
DR CLDB; cl4301
DR CLDB; cl4302
DR CLDB; cl4304
DR CLDB; cl4305
DR CLDB; cl4306
DR CLDB; cl4307
DR ATCC; CCL-60
DR ATCC; CRL-6595
DR BCRC; 60093
DR BCRJ; 0224
DR ECACC; 89090404
DR ICLC; AL96001
DR IFO; IFO50020
DR IZSLER; BS CL 79
DR JCRB; JCRB9122
DR Lonza; 1197
DR RCB; RCB1835
DR TOKU-E; 3120
RX PubMed=2228906;
RX PubMed=6500159;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/asirc.htm
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6595; true.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Spontaneously immortalized cell line
//
ID SISE
AC CVCL_S946
SY Sahul India Seabass Embryonic
RX PubMed=16919787;
CC Group: Fish cell line.
OX NCBI_TaxID=8187; ! Lates calcarifer
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SISK
AC CVCL_M424
SY Sahul India Seabass Kidney
RX DOI=10.1016/j.aquaculture.2006.01.011;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=14
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC014.
OX NCBI_TaxID=8187; ! Lates calcarifer
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SiSo
AC CVCL_2193
SY SISO
DR CLO; CLO_0009021
DR BioSample; SAMN03470956
DR BioSample; SAMN03473350
DR ChEMBL-Cells; CHEMBL3307272
DR ChEMBL-Targets; CHEMBL613527
DR Cosmic; 1995628
DR Cosmic-CLP; 1240212
DR DSMZ; ACC-327
DR GDSC; 1240212
DR GEO; GSM1670424
RX PubMed=21556646;
RX PubMed=27397505;
CC Doubling time: ~35 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9
ST D18S51: 14,16
ST D19S433: 14,16.2
ST D21S11: 30,31
ST D2S1338: 19
ST D3S1358: 15
ST D5S818: 9,12
ST D7S820: 11,12
ST D8S1179: 12
ST FGA: 23
ST Penta D: 11,13
ST Penta E: 11,13
ST TH01: 7,9 (Cosmic-CLP; DSMZ)
ST TH01: 7 (PubMed=25877200)
ST TPOX: 11
ST vWA: 18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SISS
AC CVCL_R812
SY Sahul Indian Seabass Spleen
RX DOI=10.1016/j.aquaculture.2006.07.034;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=15
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC015.
OX NCBI_TaxID=8187; ! Lates calcarifer
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SJ-89
AC CVCL_S860
RX PubMed=11229593;
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SJ-GBM2
AC CVCL_M141
SY SJ-G2; SJG2
RX PubMed=7634381;
RX PubMed=9220028;
WW http://www.cogcell.org/dl/BrainTumorDataSheets/SJ-GBM2_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 16,17
ST D19S433: 12,14
ST D2S1338: 17,24
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 12
ST D8S1179: 8,12
ST FGA: 24
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SJ-N-CG
AC CVCL_Y141
DR CGH-DB; 76-1
DR CGH-DB; 9102-4
RX PubMed=11129446;
RX PubMed=12702577;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJ-N-KP
AC CVCL_4608
DR CLO; CLO_0009029
DR CLDB; cl4308
DR CGH-DB; 60-1
DR CGH-DB; 9092-4
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=12702577;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID SJ-S6
AC CVCL_AQ32
RX PubMed=9220028;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJ3.6
AC CVCL_B463
RX PubMed=9819136;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID SJD.1
AC CVCL_5895
SY SJD1
DR CLO; CLO_0009022
DR ATCC; CRL-2296
RX PubMed=9891354;
CC Group: Fish cell line.
CC Breed/subspecies: SJD.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SJES-1
AC CVCL_5168
DR Cosmic; 1104563
DR GEO; GSM393029
DR IGRhCellID; SJES1%20GEO
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJES-2
AC CVCL_5169
DR Cosmic; 801763
DR Cosmic; 1104564
DR GEO; GSM393030
DR IGRhCellID; SJES2%20GEO
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJES-3
AC CVCL_5170
DR Cosmic; 801764
DR Cosmic; 1104565
DR GEO; GSM393031
DR IGRhCellID; SJES3%20GEO
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJES-4
AC CVCL_A459
DR Cosmic; 1104566
DR IGRhCellID; SJES4%20GEO
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJES-5
AC CVCL_5171
DR Cosmic; 801765
DR Cosmic; 1104567
DR GEO; GSM393032
DR IGRhCellID; SJES5%20GEO
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJES-6
AC CVCL_5172
DR Cosmic; 801766
DR Cosmic; 1104568
DR GEO; GSM393033
DR IGRhCellID; SJES6%20GEO
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJES-7
AC CVCL_5173
DR Cosmic; 801767
DR GEO; GSM393034
DR IGRhCellID; SJES7%20GEO
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJES-8
AC CVCL_5174
DR Cosmic; 801768
DR GEO; GSM393035
DR IGRhCellID; SJES8%20GEO
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJK-132-20
AC CVCL_4300
SY SJK 132-20
DR CLO; CLO_0009023
DR ATCC; CRL-1640
DR ATCC; TIB-177
DR ECACC; 88041903
RX PubMed=7085672;
CC Monoclonal antibody target: UniProtKB; P09884; Human POLA1.
CC Discontinued: ATCC; TIB-177; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID SJK-237-71
AC CVCL_4301
SY SJK 237-71
DR CLO; CLO_0009024
DR ATCC; CRL-1645
DR ATCC; TIB-178
DR JCRB; JCRB9032
RX PubMed=7085672;
CC Monoclonal antibody target: UniProtKB; P09884; Human POLA1.
CC Discontinued: ATCC; TIB-178; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID SJK-287-38
AC CVCL_4302
SY SJK 287-38
DR CLO; CLO_0009025
DR ATCC; CRL-1644
DR ATCC; TIB-179
DR ECACC; 90112228
RX PubMed=7085672;
CC Monoclonal antibody target: UniProtKB; P09884; Human POLA1.
CC Discontinued: ATCC; TIB-179; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID SJL/JA
AC CVCL_S359
DR ATCC; CRL-6451
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6451; true.
CC Breed/subspecies: SJL/J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID SJL/JB
AC CVCL_5896
DR CLO; CLO_0009026
DR ATCC; CRL-6452
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6452; true.
CC Breed/subspecies: SJL/J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID SJL/JC
AC CVCL_5897
DR CLO; CLO_0009027
DR ATCC; CRL-6453
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6453; true.
CC Breed/subspecies: SJL/J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID SJMRF
AC CVCL_4303
DR CLO; CLO_0009028
DR CLDB; cl4309
DR ATCC; CRL-6072
DR ECACC; 92020421
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6072; true.
OX NCBI_TaxID=9901; ! Bison bison
SX Sex undetermined
CA Finite cell line
//
ID SJNB-1
AC CVCL_8812
SY SJ-NB-1; SJNB1; SJNB-1(EB); NB1
DR ChEMBL-Cells; CHEMBL3308822
DR ChEMBL-Targets; CHEMBL2366284
DR Cosmic; 947712
DR Cosmic; 1037331
DR Cosmic; 1099128
DR Cosmic; 1109106
DR Cosmic; 1153792
DR Cosmic; 1518073
DR Cosmic; 1526641
DR Cosmic; 2131598
DR Cosmic; 2239468
DR GEO; GSM314019
DR GEO; GSM333806
DR GEO; GSM692870
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7838528;
RX PubMed=8516298;
RX PubMed=10935473;
RX PubMed=11550280;
RX PubMed=18923524;
RX PubMed=22213050;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SJNB-10
AC CVCL_1441
SY SJ-NB-10; SJNB10; NB10; NB10-DH
DR ChEMBL-Cells; CHEMBL3308172
DR ChEMBL-Targets; CHEMBL2366243
DR Cosmic; 688069
DR Cosmic; 949171
DR Cosmic; 1109121
DR Cosmic; 1518076
DR Cosmic; 1526644
DR Cosmic; 1543770
DR Cosmic; 2239458
DR Cosmic-CLP; 949171
DR GDSC; 949171
DR GEO; GSM692861
DR GEO; GSM1670146
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=8516298;
RX PubMed=10935473;
RX PubMed=22213050;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SJNB-11
AC CVCL_8813
SY SJNB11; NB11; NB11-DH
DR Cosmic; 688070
RX PubMed=10935473;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJNB-12
AC CVCL_1442
SY SJ-NB-12; SJNB12; NB12
DR ChEMBL-Cells; CHEMBL3308173
DR ChEMBL-Targets; CHEMBL2366285
DR Cosmic; 949172
DR Cosmic; 1109107
DR Cosmic; 1518077
DR Cosmic; 1526645
DR Cosmic; 2239457
DR Cosmic-CLP; 949172
DR GDSC; 949172
DR GEO; GSM692857
DR GEO; GSM1670147
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7838528;
RX PubMed=9516836;
RX PubMed=10935473;
RX PubMed=11550280;
RX PubMed=22213050;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 9.3
ST TPOX: 8
ST vWA: 18,20
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SJNB-13
AC CVCL_1443
SY SJNB13; NB13; NB13-DH
DR ChEMBL-Cells; CHEMBL3308174
DR ChEMBL-Targets; CHEMBL2366225
DR Cosmic; 688071
DR Cosmic; 949177
DR Cosmic; 1526634
DR Cosmic-CLP; 949177
DR GDSC; 949177
DR GEO; GSM1670148
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=8516298;
RX PubMed=10935473;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9,14
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 8,9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SJNB-14
AC CVCL_1444
SY SJNB14; NB14; NB14-DH; NCC
DR BTO; BTO:0005073
DR ChEMBL-Cells; CHEMBL3308827
DR ChEMBL-Targets; CHEMBL2366212
DR Cosmic; 688072
DR Cosmic; 922663
DR Cosmic; 949178
DR Cosmic; 1526635
DR Cosmic-CLP; 949178
DR GDSC; 949178
DR GEO; GSM1670149
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=6171342;
RX PubMed=8516298;
RX PubMed=10935473;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 12
ST TH01: 9.3
ST TPOX: 10
ST vWA: 16,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SJNB-15
AC CVCL_8814
SY SJNB15; NB15
RX PubMed=10935473;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJNB-16
AC CVCL_8815
SY SJNB16; NB16; NB16-DH; NKP
DR Cosmic; 688073
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=6171342;
RX PubMed=8516298;
RX PubMed=10935473;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SJNB-17
AC CVCL_1445
SY SJNB17; NB17; NB17-DH
DR ChEMBL-Cells; CHEMBL3308175
DR ChEMBL-Targets; CHEMBL2366064
DR Cosmic; 688075
DR Cosmic; 922664
DR Cosmic; 949175
DR Cosmic-CLP; 949175
DR GDSC; 949175
DR GEO; GSM1670150
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=10935473;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 10,12
ST TH01: 8
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SJNB-18
AC CVCL_8816
SY SJNB18; NB18
RX PubMed=10935473;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJNB-19
AC CVCL_8817
SY SJNB19; NB19; NB19-DH
DR Cosmic; 688076
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=8516298;
RX PubMed=10935473;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJNB-2
AC CVCL_8818
SY SJNB2; NB2; N0303L
DR Cosmic; 947713
DR Cosmic; 1037332
DR Cosmic; 1099129
DR Cosmic; 1153793
DR Cosmic; 2131584
DR GEO; GSM314020
DR GEO; GSM333807
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=8516298;
RX PubMed=10935473;
RX PubMed=18923524;
CC Omics: SNP array analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SJNB-20
AC CVCL_8819
SY SJNB20; NB20; NB20-DH
DR Cosmic; 688078
DR Cosmic; 922665
RX PubMed=10935473;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJNB-3
AC CVCL_8820
SY SJNB3; NB3; N1003L
DR Cosmic; 947714
DR Cosmic; 1037333
DR Cosmic; 1099130
DR Cosmic; 1153794
DR GEO; GSM314021
DR GEO; GSM333808
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=8516298;
RX PubMed=10935473;
RX PubMed=18923524;
CC Omics: SNP array analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SJNB-4
AC CVCL_8821
SY SJNB4; SJNB-4(SD); NB4; NB4-DH
DR Cosmic; 688079
DR Cosmic; 801747
DR Cosmic; 947715
DR Cosmic; 1037334
DR Cosmic; 1099131
DR Cosmic; 1153795
DR Cosmic; 2131585
DR GEO; GSM314022
DR GEO; GSM333809
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=8516298;
RX PubMed=10935473;
RX PubMed=18923524;
CC Omics: SNP array analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SJNB-5
AC CVCL_8822
AS CVCL_1446
SY SJNB5; NB5; NB5-DH; NJF
DR BTO; BTO:0005072
DR ChEMBL-Cells; CHEMBL3308156
DR ChEMBL-Targets; CHEMBL2366328
DR Cosmic; 688080
DR Cosmic; 922662
DR Cosmic; 949176
DR Cosmic; 947716
DR Cosmic; 1037335
DR Cosmic; 1099132
DR Cosmic; 1153796
DR Cosmic; 1526633
DR Cosmic; 2131586
DR Cosmic-CLP; 949176
DR GDSC; 949176
DR GEO; GSM314023
DR GEO; GSM333810
DR GEO; GSM1670152
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=6171342;
RX PubMed=8516298;
RX PubMed=10935473;
RX PubMed=18923524;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 9,10
ST D5S818: 12,13
ST D7S820: 11
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SJNB-6
AC CVCL_8823
AS CVCL_1447
SY SJ-NB-6; SJNB6; NB6; NB6-DH; N2307L
DR ChEMBL-Cells; CHEMBL3308157
DR ChEMBL-Targets; CHEMBL2366318
DR Cosmic; 688082
DR Cosmic; 949173
DR Cosmic; 1037336
DR Cosmic; 1099133
DR Cosmic; 1109117
DR Cosmic; 1153797
DR Cosmic; 1518074
DR Cosmic; 1526642
DR Cosmic-CLP; 949173
DR GDSC; 949173
DR GEO; GSM314024
DR GEO; GSM333811
DR GEO; GSM692877
DR GEO; GSM1670153
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7838528;
RX PubMed=8516298;
RX PubMed=10935473;
RX PubMed=11550280;
RX PubMed=18923524;
RX PubMed=22213050;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,13
ST D16S539: 9,12
ST D5S818: 13
ST D7S820: 8,11
ST TH01: 8,9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SJNB-7
AC CVCL_8824
AS CVCL_1449
SY SJ-NB-7; SJNB7; NB7; NB7-DH; NCG; SJ-NCG
DR BTO; BTO:0003439
DR ChEMBL-Cells; CHEMBL3308158
DR ChEMBL-Targets; CHEMBL2366345
DR Cosmic; 688083
DR Cosmic; 801748
DR Cosmic; 949174
DR Cosmic; 947717
DR Cosmic; 1037337
DR Cosmic; 1099134
DR Cosmic; 1153798
DR Cosmic; 2131587
DR Cosmic-CLP; 949174
DR GDSC; 949174
DR GEO; GSM314025
DR GEO; GSM333812
DR GEO; GSM1670155
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=6171342;
RX PubMed=8516298;
RX PubMed=10935473;
RX PubMed=18923524;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8,13
ST D16S539: 8,11
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 11
ST vWA: 17,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SJNB-8
AC CVCL_8825
SY SJ-NB-8; SJNB8; NB8; N1108L
DR Cosmic; 947718
DR Cosmic; 1037338
DR Cosmic; 1099135
DR Cosmic; 1109115
DR Cosmic; 1153799
DR Cosmic; 1518075
DR Cosmic; 1526643
DR Cosmic; 1543778
DR Cosmic; 2131588
DR GEO; GSM314026
DR GEO; GSM333813
DR GEO; GSM692860
RX PubMed=7838528;
RX PubMed=8516298;
RX PubMed=9516836;
RX PubMed=10935473;
RX PubMed=11550280;
RX PubMed=18923524;
RX PubMed=22213050;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SJNB-9
AC CVCL_8826
SY SJNB9; NB9
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=8516298;
RX PubMed=10935473;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SJO
AC CVCL_0T73
DR ATCC; CRL-2293
DR BioSample; SAMN03471860
RX PubMed=2299498;
RX PubMed=7615790;
RX PubMed=8106283;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-2293; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,12
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 7
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C3895; Bare lymphocyte syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SJPL
AC CVCL_1T04
SY St. Jude Porcine Lung; St-Jude Porcine Lung
DR ATCC; PTA-3256
DR BioSample; SAMN03152028
RX Patent=WO2009059411A1;
RX PubMed=11533214;
RX PubMed=20200241;
RX PubMed=23148668;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Group: Non-human primate cell line.
CC Problematic cell line: Misidentified. Originally thought to be of pig origin but found to be from Chlorocebus aethiops (PubMed=20200241).
CC Discontinued: ATCC; PTA-3256; probable.
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
SX Sex undetermined
CA Undefined cell line type
//
ID SJSA-1
AC CVCL_1697
SY SJSA1; SJSA; OsA-CL; OSA-CL; OsACL; OSACL; OSA; OsA
DR BTO; BTO:0004216
DR CLO; CLO_0009031
DR EFO; EFO_0002330
DR ATCC; CRL-2098
DR BioSample; SAMN03472540
DR CCLE; SJSA1_BONE
DR ChEMBL-Cells; CHEMBL3308885
DR ChEMBL-Targets; CHEMBL2366298
DR Cosmic; 687931
DR Cosmic; 909717
DR Cosmic; 931911
DR Cosmic; 1070843
DR Cosmic; 1074396
DR Cosmic; 1097756
DR Cosmic; 1188476
DR Cosmic; 1529912
DR Cosmic-CLP; 909717
DR ENCODE; ENCBS327EZG
DR ENCODE; ENCBS489PLT
DR GDSC; 909717
DR GEO; GSM320826
DR GEO; GSM879221
DR GEO; GSM887574
DR GEO; GSM888657
DR GEO; GSM1670426
DR GEO; GSM1676316
DR GEO; GSM1701650
DR IGRhCellID; SJSA1
RX PubMed=8275086;
RX PubMed=12645653;
RX PubMed=15150091;
RX PubMed=19787792;
RX PubMed=21519327;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=26351324;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=64
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 31 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SISA' in Cosmic 1529912.
CC Misspelling: 'SJSA2' in Cosmic 1097756.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 9,10
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 19
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK
AC CVCL_CV33
SY Scatophagus Kidney
RX PubMed=26911257;
CC Group: Fish cell line.
OX NCBI_TaxID=75038; ! Scatophagus argus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SK 7
AC CVCL_L697
SY SK7
DR ATCC; HB-8584
RX Patent=US4665032;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L699 ! KE 37.3.2
CA Hybridoma
//
ID SK 8
AC CVCL_L698
SY SK8
DR ATCC; HB-8585
RX Patent=US4665032;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L699 ! KE 37.3.2
CA Hybridoma
//
ID SK-5
AC CVCL_5H87
SY SK5
DR ChEMBL-Cells; CHEMBL3307446
DR ChEMBL-Targets; CHEMBL614911
RX PubMed=2536714;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID SK-6
AC CVCL_D296
SY SK6; Swine Kidney-6
DR BTO; BTO:0005887
DR BCRJ; 0225
DR CCLV; CCLV-RIE 0262
RX PubMed=4336054;
RX PubMed=19941903;
CC Discontinued: BCRJ; 0225; probable.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID SK-9
AC CVCL_D593
RX PubMed=20471447;
DI NCIt; C4967; Adult acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-Ala-1
AC CVCL_8591
SY SKAla-1
RX PubMed=9717829;
DI NCIt; C40318; Vulvar leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0628 ! SK-LMS-1
SX Female
CA Cancer cell line
//
ID SK-Ala-10
AC CVCL_8592
SY SKAla-10
RX PubMed=17513613;
DI NCIt; C40318; Vulvar leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0628 ! SK-LMS-1
SX Female
CA Cancer cell line
//
ID SK-Ala-14
AC CVCL_8593
SY SKAla-14
RX PubMed=17513613;
DI NCIt; C40318; Vulvar leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0628 ! SK-LMS-1
SX Female
CA Cancer cell line
//
ID SK-Ala-2
AC CVCL_8594
SY SKAla-2
RX PubMed=9717829;
DI NCIt; C40318; Vulvar leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0628 ! SK-LMS-1
SX Female
CA Cancer cell line
//
ID SK-Ala-21
AC CVCL_8595
SY SKAla-21
RX PubMed=17513613;
DI NCIt; C40318; Vulvar leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0628 ! SK-LMS-1
SX Female
CA Cancer cell line
//
ID SK-Ala-3
AC CVCL_8596
SY SKAla-3
RX PubMed=9717829;
DI NCIt; C40318; Vulvar leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0628 ! SK-LMS-1
SX Female
CA Cancer cell line
//
ID SK-AO2
AC CVCL_8567
SY SKAO2; AO2
RX PubMed=6182568;
RX PubMed=8943096;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-astrocyte-IDH1
AC CVCL_Z595
RX PubMed=22343889;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2012-113.
CC Transfected with: HGNC; 5382; IDH1.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID SK-astrocyte-IDH1-R132H
AC CVCL_Z596
RX PubMed=22343889;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2012-113.
CC Transfected with: HGNC; 5382; IDH1 (with H-132).
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID SK-beta2.7
AC CVCL_J125
RX PubMed=8977199;
CC Problematic cell line: Contaminated. Parent cell line (SKW-3) has been shown to be a KE-37 derivative.
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2197 ! SKW-3
SX Male
CA Cancer cell line
//
ID SK-BR-1 III
AC CVCL_T283
SY SK-BR-1-III; SK-Br-1 III; Lev III
DR ATCC; HTB-28
RX PubMed=212193;
RX PubMed=327080;
RX PubMed=833871;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Discontinued: ATCC; HTB-28; true.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-BR-2 III
AC CVCL_T284
SY SK-BR-2-III; SK-Br-2 III; Sal III
DR ATCC; HTB-29
RX PubMed=212193;
RX PubMed=327080;
RX PubMed=833871;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Discontinued: ATCC; HTB-29; true.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-BR-3
AC CVCL_0033
SY SK-Br-3; Sk-Br-3; SKBR-3; SKBr-3; SK-BR3; SKBr3; SkBr3; SKBR3
DR BTO; BTO:0002419
DR CLO; CLO_0009034
DR EFO; EFO_0001236
DR MCCL; MCC:0000424
DR CLDB; cl4310
DR CLDB; cl7143
DR ATCC; HTB-30
DR BCRJ; 0226
DR BioSample; SAMN01821597
DR BioSample; SAMN03471462
DR CCLE; SKBR3_BREAST
DR CCRID; 3111C0001CCC000085
DR CCRID; 3131C0001000700049
DR ChEMBL-Cells; CHEMBL3308062
DR ChEMBL-Targets; CHEMBL613834
DR CLS; 300333/p3803_SK-BR-3
DR Cosmic; 687499
DR Cosmic; 755294
DR Cosmic; 759896
DR Cosmic; 871159
DR Cosmic; 894090
DR Cosmic; 897742
DR Cosmic; 904385
DR Cosmic; 921974
DR Cosmic; 923062
DR Cosmic; 934531
DR Cosmic; 944297
DR Cosmic; 979713
DR Cosmic; 991329
DR Cosmic; 997935
DR Cosmic; 1000127
DR Cosmic; 1010922
DR Cosmic; 1018478
DR Cosmic; 1044209
DR Cosmic; 1046958
DR Cosmic; 1129655
DR Cosmic; 1136357
DR Cosmic; 1176645
DR Cosmic; 1287914
DR Cosmic; 1289405
DR Cosmic; 1308997
DR Cosmic; 1434957
DR Cosmic; 1524342
DR Cosmic; 1571789
DR Cosmic; 1609462
DR Cosmic; 2036669
DR Cosmic; 2165013
DR Cosmic; 2301535
DR Cosmic; 2318379
DR Cosmic; 2361351
DR DSMZ; ACC-736
DR GEO; GSM69195
DR GEO; GSM73742
DR GEO; GSM115115
DR GEO; GSM149978
DR GEO; GSM149986
DR GEO; GSM149994
DR GEO; GSM152556
DR GEO; GSM152557
DR GEO; GSM152558
DR GEO; GSM152559
DR GEO; GSM154096
DR GEO; GSM154097
DR GEO; GSM154098
DR GEO; GSM154099
DR GEO; GSM154100
DR GEO; GSM154101
DR GEO; GSM154102
DR GEO; GSM154104
DR GEO; GSM154107
DR GEO; GSM155215
DR GEO; GSM170624
DR GEO; GSM170625
DR GEO; GSM170626
DR GEO; GSM170627
DR GEO; GSM170630
DR GEO; GSM170631
DR GEO; GSM170633
DR GEO; GSM170634
DR GEO; GSM183440
DR GEO; GSM183441
DR GEO; GSM186457
DR GEO; GSM186458
DR GEO; GSM217596
DR GEO; GSM344357
DR GEO; GSM344407
DR GEO; GSM350501
DR GEO; GSM378146
DR GEO; GSM481334
DR GEO; GSM590106
DR GEO; GSM595617
DR GEO; GSM783927
DR GEO; GSM827582
DR GEO; GSM845399
DR GEO; GSM847432
DR GEO; GSM847499
DR GEO; GSM844686
DR GEO; GSM844687
DR GEO; GSM887575
DR GEO; GSM888658
DR GEO; GSM1008913
DR GEO; GSM1038850
DR GEO; GSM1038851
DR GEO; GSM1038852
DR GEO; GSM1038853
DR GEO; GSM1038854
DR GEO; GSM1214572
DR GEO; GSM1264069
DR GEO; GSM1264074
DR GEO; GSM1264111
DR GEO; GSM1264116
DR GEO; GSM1374872
DR GEO; GSM1374873
DR GEO; GSM1374874
DR GEO; GSM1401659
DR GEO; GSM1661988
DR GEO; GSM1833627
DR ICLC; HTL03005
DR IMGT/HLA; 12368
DR IZSLER; BS TCL 156
DR KCB; KCB 200723YJ
DR KCLB; 30030
DR LINCS; 50057
DR Lonza; 70
DR NCBI_Iran; C207
DR PRIDE; PXD000691
DR PRIDE; PXD002053
DR PRIDE; PXD002057
DR PRIDE; PXD002281
DR PRIDE; PXD002486
DR RCB; RCB2132
DR TOKU-E; 3129
DR Wikidata; Q7390592
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1013510;
RX PubMed=6500159;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=9671407;
RX PubMed=10862037;
RX PubMed=11044355;
RX PubMed=12800145;
RX PubMed=15677628;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=19727395;
RX PubMed=20070913;
RX PubMed=21247443;
RX PubMed=21378333;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=23671654;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=26055192;
RX PubMed=26378940;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/SKBR3
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/sk-br-3.htm
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SK-BR-3
WW http://www.proteinatlas.org/learn/cellines
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.addexbio.com/productdetail?pid=65
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-57.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-breast-cell-line-sk-br-3
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808.
CC Doubling time: ~2-3 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=23671654).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Exosome proteome analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SKBR3B' in PubMed=26378940.
CC Discontinued: RCB; RCB2132; true.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; CLS; DSMZ; KCLB; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 10,13
ST D21S11: 30,30.2
ST D3S1358: 17
ST D5S818: 9,12
ST D7S820: 9,12
ST D8S1179: 11,12 (CLS)
ST D8S1179: 12 (PubMed=25877200)
ST FGA: 20
ST Penta D: 9,13 (CLS)
ST Penta D: 9,12 (PubMed=25877200)
ST Penta E: 10,11
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1074 ! AU565
SX Female
CA Cancer cell line
//
ID SK-BR-3-LR
AC CVCL_4V52
RX PubMed=23811285;
CC Selected for resistance to: ChEBI; CHEBI:49603; Lapatinib.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0033 ! SK-BR-3
SX Female
CA Cancer cell line
//
ID SK-BR-3-Luc
AC CVCL_4Y11
DR JCRB; NIHS0735
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0033 ! SK-BR-3
SX Female
CA Cancer cell line
//
ID SK-BR-5
AC CVCL_5217
SY SKBR-5; SKBr5; SkBr5; SKBR5
DR Cosmic; 997936
DR Cosmic; 1046938
DR Cosmic; 1287912
DR Cosmic; 1289406
DR GEO; GSM1661989
RX PubMed=6582512;
RX PubMed=23601657;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Omics: miRNA expression profiling.
CC Omics: Transcriptome analysis.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-BR-7
AC CVCL_5218
SY SKBR-7; SKBr7; SKBR7
DR Cosmic; 1046946
DR Cosmic; 1287927
DR Cosmic; 1289407
DR GEO; GSM75171
DR GEO; GSM217597
RX PubMed=11044355;
RX PubMed=15677628;
RX PubMed=23601657;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/sk-br-7.htm
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Omics: miRNA expression profiling.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-ChA-1
AC CVCL_6952
SY SK-CHA-1; SK-ChA1; SkChA-1; SkChA1
DR BTO; BTO:0004655
DR Cosmic; 924011
DR Cosmic; 927191
RX CelloPub=CLPUB00275;
RX PubMed=4056357;
RX PubMed=9824643;
RX PubMed=21533411;
CC Doubling time: 26 hours (PubMed=9824643).
CC Derived from metastatic site: Ascites.
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-CO-1
AC CVCL_0626
SY SKCO-1; SKCO1; SKCol1; SK-Col-1; SK Col 1
DR CLO; CLO_0009035
DR EFO; EFO_0006752
DR ATCC; HTB-39
DR BioSample; SAMN03472359
DR BioSample; SAMN03472743
DR CCLE; SKCO1_LARGE_INTESTINE
DR CCRID; 3131C0001001200006
DR ChEMBL-Cells; CHEMBL3308784
DR ChEMBL-Targets; CHEMBL1075576
DR Cosmic; 724846
DR Cosmic; 876726
DR Cosmic; 909718
DR Cosmic; 948125
DR Cosmic; 948852
DR Cosmic; 986016
DR Cosmic; 995402
DR Cosmic; 1071892
DR Cosmic; 1175844
DR Cosmic; 1176593
DR Cosmic; 1187318
DR Cosmic; 1312310
DR Cosmic; 1466820
DR Cosmic; 1479586
DR Cosmic; 1482520
DR Cosmic; 1676740
DR Cosmic; 1805265
DR Cosmic; 2302006
DR Cosmic-CLP; 909718
DR GDSC; 909718
DR GEO; GSM206541
DR GEO; GSM513919
DR GEO; GSM514306
DR GEO; GSM741251
DR GEO; GSM827412
DR GEO; GSM887576
DR GEO; GSM888659
DR GEO; GSM1346852
DR GEO; GSM1374875
DR GEO; GSM1374876
DR GEO; GSM1374877
DR GEO; GSM1448193
DR GEO; GSM1670427
DR SKY/M-FISH/CGH; 5015
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=833871;
RX PubMed=6582512;
RX PubMed=10737795;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=27397505;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-colorectal-adenocarcinoma-cell-line-sk-co-1
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2010-072.
CC Doubling time: 46 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y (ATCC; Cosmic-CLP)
ST Amelogenin: X (PubMed=25877200)
ST CSF1PO: 13
ST D13S317: 14
ST D16S539: 13
ST D18S51: 19
ST D21S11: 28,30
ST D3S1358: 17,18
ST D5S818: 9,11
ST D7S820: 8,10
ST D8S1179: 12,14
ST FGA: 20,25
ST Penta D: 11
ST Penta E: 13,16
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-CO-10
AC CVCL_GS25
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-CO-15
AC CVCL_A337
SY SKCO-15; SK-CO15; SKCO15
DR BTO; BTO:0005068
RX PubMed=2687880;
RX PubMed=22556145;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-DHL2A
AC CVCL_E051
SY SK-DHL2a; SKDHL2A; Manca; MANCA
DR ChEMBL-Cells; CHEMBL3307363
DR ChEMBL-Targets; CHEMBL614320
RX PubMed=6608987;
CC Doubling time: 17.9 +- 2.6 hours (PubMed=6608987).
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-DHL2B
AC CVCL_E052
SY SK-DHL2b; SKDHL2B
RX PubMed=6608987;
CC Doubling time: 17.1 +- 2.1 hours (PubMed=6608987).
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E051 ! SK-DHL2A
SX Male
CA Cancer cell line
//
ID SK-ES-1
AC CVCL_0627
SY Sk-Es-1; Sk-ES-1; SK-ES1; SKES1; SK-ES
DR CLO; CLO_0009036
DR EFO; EFO_0002858
DR ATCC; HTB-86
DR BCRJ; 0266
DR BioSample; SAMN03472758
DR BioSample; SAMN03473516
DR CCLE; SKES1_BONE
DR ChEMBL-Cells; CHEMBL3307826
DR ChEMBL-Targets; CHEMBL613970
DR CLS; 300435/p738_SK-ES-1
DR Cosmic; 684072
DR Cosmic; 759888
DR Cosmic; 1078385
DR Cosmic; 1082505
DR Cosmic; 1388894
DR Cosmic; 1718430
DR Cosmic; 1995629
DR Cosmic; 2060800
DR Cosmic; 2228231
DR Cosmic; 2250467
DR Cosmic-CLP; 684072
DR DSMZ; ACC-518
DR GDSC; 684072
DR GEO; GSM393027
DR GEO; GSM510008
DR GEO; GSM510017
DR GEO; GSM510018
DR GEO; GSM827589
DR GEO; GSM887577
DR GEO; GSM888660
DR GEO; GSM1670428
DR GEO; GSM1676343
DR GEO; GSM1701674
DR IGRhCellID; SKES%20%20GEO
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=8221663;
RX PubMed=8617485;
RX PubMed=19787792;
RX PubMed=22460905;
RX PubMed=25010205;
RX PubMed=25223734;
RX PubMed=26351324;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-es-1-human-ewing-sarcoma-cell-line
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-542.
CC Doubling time: ~35 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,9
ST D16S539: 11 (ATCC; CLS; Cosmic-CLP)
ST D16S539: 12 (DSMZ)
ST D18S51: 13,15
ST D21S11: 30
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 11,13
ST FGA: 20,21
ST Penta D: 11,13
ST Penta E: 11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-ES-2
AC CVCL_T285
DR ATCC; HTB-87
RX PubMed=327080;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Discontinued: ATCC; HTB-87; probable.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-GT-1
AC CVCL_9585
SY SKGT1
RX PubMed=8334620;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-GT-2
AC CVCL_2194
SY SKGT2
DR BioSample; SAMN03473450
DR Cosmic-CLP; 1503364
DR DSMZ; ACC-702
DR ECACC; 11012008
DR GDSC; 1503364
DR GEO; GSM1670430
RX PubMed=8334620;
RX PubMed=27397505;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: ~48 hours (DSMZ); ~44 hours (ECACC).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; DSMZ; ECACC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 11,12
ST D5S818: 10
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 9,12
ST vWA: 15,18
DI NCIt; C8398; Gastric fundus carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-GT-3
AC CVCL_9584
SY SKGT3
RX PubMed=8334620;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C8398; Gastric fundus carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-GT-4
AC CVCL_2195
SY SKGT4
DR EFO; EFO_0001237
DR BioSample; SAMN03473395
DR Cosmic; 1599346
DR Cosmic-CLP; 1503365
DR DSMZ; ACC-712
DR ECACC; 11012007
DR GDSC; 1503365
DR GEO; GSM337722
DR GEO; GSM337723
DR GEO; GSM337724
DR GEO; GSM337725
DR GEO; GSM337726
DR GEO; GSM337727
DR GEO; GSM337730
DR GEO; GSM337732
DR GEO; GSM337733
DR GEO; GSM337734
DR GEO; GSM337735
DR GEO; GSM337736
DR GEO; GSM337737
DR GEO; GSM337738
DR GEO; GSM337739
DR GEO; GSM337740
DR GEO; GSM1374878
DR GEO; GSM1670431
RX PubMed=8334620;
RX PubMed=20075370;
RX PubMed=20139130;
RX PubMed=23795680;
RX PubMed=27397505;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: ~30-35 hours (DSMZ); 39 hours (ECACC).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SJGT4' in GEO GSM337727.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,15
ST D13S317: 9,10
ST D16S539: 11,12,13
ST D5S818: 12
ST D7S820: 7,11
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 17,19
DI NCIt; C4025; Esophageal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-GT-5
AC CVCL_8114
SY SKGT5
DR BioSample; SAMN03151916
RX PubMed=8334620;
RX PubMed=20075370;
RX PubMed=23795680;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SK-GT-2 derivative (PubMed=20075370). Was originally thought to originate from a esophageal adenocarcinoma.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C8398; Gastric fundus carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2194 ! SK-GT-2
SX Male
CA Cancer cell line
//
ID SK-HD-1
AC CVCL_1E50
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=833871;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-HEP-1
AC CVCL_0525
SY SK-Hep-1; SK-Hep1; Sk-Hep1; SK Hep1; SKHEP-1; SKHEP1; SKHep1; SK_HEP1
DR BTO; BTO:0003477
DR CLO; CLO_0009037
DR MCCL; MCC:0000425
DR CLDB; cl4312
DR CLDB; cl4313
DR CLDB; cl4314
DR CLDB; cl4315
DR CLDB; cl7214
DR ATCC; HTB-52
DR BioSample; SAMN01821598
DR BioSample; SAMN01821664
DR BioSample; SAMN03472884
DR CCLE; SKHEP1_LIVER
DR CCRID; 3111C0002000000060
DR CCRID; 3131C0001000700109
DR CCRID; 3142C0001000000133
DR CGH-DB; 9071-4
DR ChEMBL-Cells; CHEMBL3307741
DR ChEMBL-Targets; CHEMBL614912
DR CLS; 300334/p485_SK-HEP-1
DR Cosmic; 684195
DR Cosmic; 928139
DR Cosmic; 932990
DR Cosmic; 979728
DR Cosmic; 873394
DR Cosmic; 735607
DR Cosmic; 909719
DR Cosmic; 1187333
DR Cosmic; 1518231
DR Cosmic; 2162539
DR Cosmic; 2321042
DR Cosmic-CLP; 909719
DR DSMZ; ACC-141
DR ECACC; 91091816
DR GDSC; 909719
DR GEO; GSM481451
DR GEO; GSM565878
DR GEO; GSM887578
DR GEO; GSM888661
DR GEO; GSM936776
DR GEO; GSM1374879
DR GEO; GSM1670432
DR ICLC; HTL10001
DR KCB; KCB 2013038YJ
DR KCLB; 30052
DR PRIDE; PXD002957
DR TOKU-E; 3132
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=2439335;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=12029633;
RX PubMed=20069059;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=25574106;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-397.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-hep-1-human-hepatic-adenocarcinoma-cell-line
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-535.
CC Characteristics: Has lost chromosome Y.
CC Doubling time: ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Secretome proteome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=11416159; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12 (ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=25877200)
ST CSF1PO: 11 (CLS)
ST D13S317: 8,12
ST D16S539: 12
ST D18S51: 13,15
ST D19S433: 12,15.2
ST D21S11: 29,31
ST D2S1338: 20,23
ST D3S1358: 16
ST D5S818: 10,13
ST D7S820: 8,11
ST D8S1179: 13,14
ST FGA: 17
ST Penta D: 13,14
ST Penta E: 13,21 (CLS)
ST Penta E: 13 (PubMed=25877200)
ST TH01: 7,9
ST TPOX: 9
ST vWA: 14,17
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-Hep-1-FIX
AC CVCL_AU01
RX PubMed=26802680;
CC Characteristics: Has lost chromosome Y.
CC Transfected with: HGNC; 3551; F9.
CC Derived from metastatic site: Ascites.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0525 ! SK-HEP-1
SX Male
CA Cancer cell line
//
ID SK-Hep-1-NIS
AC CVCL_6019
SY SK-Hep1-NIS
RX PubMed=15347726;
CC Characteristics: Has lost chromosome Y.
CC Transfected with: HGNC; 11040; SLC5A5.
CC Derived from metastatic site: Ascites.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0525 ! SK-HEP-1
SX Male
CA Cancer cell line
//
ID SK-Hep-1/CDDP
AC CVCL_M182
SY SK-Hep1/DDP
RX PubMed=20109345;
RX PubMed=20458768;
CC Characteristics: Has lost chromosome Y.
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Caution: PubMed=20458768 describes SK-Hep-1/CDDP and does not cite PubMed=20109345 which describes SK-Hep1/DDP. As the two papers are from the same authors and that the described cell lines have identical characteristics it is probable that they are identical.
CC Derived from metastatic site: Ascites.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0525 ! SK-HEP-1
SX Male
CA Cancer cell line
//
ID SK-JHRCC-12
AC CVCL_Z029
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK-JHRCC-12.
CC Derived from metastatic site: Bone.
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-JHRCC-120
AC CVCL_Z030
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK-JHRCC-120.
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-JHRCC-3
AC CVCL_Z031
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK-JHRCC-3.
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-JHRCC-92
AC CVCL_Z032
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK-JHRCC-92.
CC Derived from metastatic site: Bone.
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-L1
AC CVCL_IU60
SY SKL-1; SKL 1; SKL1
RX PubMed=170370;
RX PubMed=5229525;
RX PubMed=4325933;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C7463; Acute myelomonocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-la
AC CVCL_CV34
SY Scatophagus Kidney-low-osmolarity adapted
RX PubMed=26911257;
CC Group: Fish cell line.
OX NCBI_TaxID=75038; ! Scatophagus argus
HI CVCL_CV33 ! SK
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SK-LC-1
AC CVCL_5458
RX PubMed=6582512;
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-10
AC CVCL_5459
SY SK-Luci-10; Sk-Luci-10; SkLuci 10; Luci-10; Luci10
DR Cosmic; 934463
RX PubMed=1778766;
RX PubMed=6582512;
RX PubMed=8384671;
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-11
AC CVCL_5460
RX PubMed=6582512;
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-12
AC CVCL_5461
DR Cosmic; 923381
RX PubMed=1409687;
RX PubMed=6208122;
RX PubMed=6582512;
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-13
AC CVCL_5462
SY SKLC-13; SK-Luci-13; SkLuci 13; Luci-13
DR GEO; GSM784225
RX PubMed=1778766;
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-14
AC CVCL_5463
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-15
AC CVCL_5464
RX PubMed=6582512;
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-16
AC CVCL_5465
DR BTO; BTO:0003229
RX PubMed=6582512;
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-17
AC CVCL_5466
DR GEO; GSM784221
RX PubMed=1409687;
RX PubMed=2540905;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-19
AC CVCL_5467
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-2
AC CVCL_5468
SY SK-LC2
DR Cosmic; 1089233
RX PubMed=2540905;
RX PubMed=6208122;
RX PubMed=6582512;
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-20
AC CVCL_5469
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-21
AC CVCL_5470
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-3
AC CVCL_5471
DR CGH-DB; 209-1
DR CGH-DB; 9171-4
DR Cosmic; 1089219
DR GEO; GSM784256
RX PubMed=6208122;
RX PubMed=6582512;
RX PubMed=14581340;
RX PubMed=15746151;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-4
AC CVCL_5472
RX PubMed=6582512;
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-5
AC CVCL_5473
SY SK-LC5
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-6
AC CVCL_5474
SY SKLC6; SK-Luci-6; Sk-Luci-6; SK-LuCi6; Luci-6; Luci6
DR Cosmic; 923380
DR Cosmic; 1089232
DR NCBI_Iran; C566
RX PubMed=2535957;
RX PubMed=6208122;
RX PubMed=6582512;
RX PubMed=7116286;
RX PubMed=8384671;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-LC-7
AC CVCL_5475
SY SK-Luci-7; Luci-7
RX PubMed=1778766;
RX PubMed=6582512;
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-8
AC CVCL_5476
DR BTO; BTO:0003228
RX PubMed=6208122;
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LC-9
AC CVCL_5477
RX PubMed=6582512;
RX PubMed=9636188;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LMS-1
AC CVCL_0628
SY SKLMS-1; SKLMS1
DR BTO; BTO:0002607
DR CLO; CLO_0009038
DR EFO; EFO_0002331
DR ATCC; HTB-88
DR BioSample; SAMN03472759
DR CCLE; SKLMS1_SOFT_TISSUE
DR ChEMBL-Cells; CHEMBL3308552
DR ChEMBL-Targets; CHEMBL2366096
DR CLS; 300125/p629_SK-LMS-1
DR Cosmic; 687594
DR Cosmic; 909720
DR Cosmic; 1834891
DR Cosmic-CLP; 909720
DR GDSC; 909720
DR GEO; GSM887579
DR GEO; GSM888662
DR GEO; GSM1670433
DR GEO; GSM1676326
DR GEO; GSM1701659
DR IGRhCellID; SKLMS1
DR LINCS; 50042
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=7459858;
RX PubMed=22460905;
RX PubMed=26351324;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-476.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12 (ATCC; CLS)
ST D13S317: 11,12 (Cosmic-CLP)
ST D16S539: 8,11
ST D18S51: 14,19
ST D21S11: 28,30
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 8,9
ST D8S1179: 12
ST FGA: 22,25
ST Penta D: 12,13
ST Penta E: 7,13
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 18,20 (ATCC; Cosmic-CLP)
ST vWA: 18 (CLS)
DI NCIt; C40318; Vulvar leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-LU-1
AC CVCL_0629
SY SK-Lu-1; SK LU 1; SKLU-1; SKLU1
DR BTO; BTO:0003029
DR CLO; CLO_0009032
DR CLO; CLO_0009039
DR CLDB; cl4317
DR CLDB; cl4318
DR CLDB; cl4319
DR ATCC; HTB-57
DR BioSample; SAMN03472748
DR CCLE; SKLU1_LUNG
DR CCRID; 3111C0001CCC000237
DR ChEMBL-Cells; CHEMBL3307447
DR ChEMBL-Targets; CHEMBL614913
DR CLS; 300335/p478_SK-LU-1
DR Cosmic; 724877
DR Cosmic; 909721
DR Cosmic; 929967
DR Cosmic; 932920
DR Cosmic; 933576
DR Cosmic; 1089218
DR Cosmic; 1146944
DR Cosmic; 1434960
DR Cosmic; 1733129
DR Cosmic; 1995631
DR Cosmic-CLP; 909721
DR ECACC; 93120835
DR GDSC; 909721
DR GEO; GSM385525
DR GEO; GSM385536
DR GEO; GSM434291
DR GEO; GSM513973
DR GEO; GSM514560
DR GEO; GSM784226
DR GEO; GSM794407
DR GEO; GSM827413
DR GEO; GSM887580
DR GEO; GSM888663
DR GEO; GSM1670434
DR ICLC; HTL96023
DR IGRhCellID; SK-LU-1%20GEO
DR IZSLER; BS TCL 81
DR KCLB; 30057
DR PRIDE; PXD002556
RX PubMed=833871;
RX PubMed=6935474;
RX PubMed=22460905;
RX PubMed=24135919;
RX PubMed=26361996;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-lu-1-human-lung-cell-line
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2005-049.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10
ST D16S539: 8
ST D18S51: 18
ST D21S11: 29,30.2
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 10
ST FGA: 21,22
ST Penta D: 10,13
ST Penta E: 5
ST TH01: 7
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-LU-1b
AC CVCL_IV51
RX PubMed=6935474;
RX PubMed=7459858;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0629 ! SK-LU-1
SX Female
CA Cancer cell line
//
ID SK-LY-16
AC CVCL_GS22
SY SK-Ly-16; SKLY-16; SKLy-16; SKLY16
RX PubMed=6193516;
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-LY-18
AC CVCL_GS23
SY SK-Ly-18; SKLY-18; SKLY18
RX PubMed=6193516;
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-1
AC CVCL_0068
SY SK-Mel-1; SK Mel 1; SK-Mel1; SKMEL-1; SkMEL-1; SKMEL1; SK 1
DR BTO; BTO:0002129
DR CLO; CLO_0009040
DR EFO; EFO_0002332
DR ATCC; HTB-67
DR BioSample; SAMN01821599
DR BioSample; SAMN01821665
DR BioSample; SAMN03473224
DR CCLE; SKMEL1_SKIN
DR CCRID; 3111C0001CCC000052
DR ChEMBL-Cells; CHEMBL3308365
DR ChEMBL-Targets; CHEMBL614916
DR CLS; 300424/p609_SK-MEL-1
DR Cosmic; 688052
DR Cosmic; 888065
DR Cosmic; 909723
DR Cosmic; 928696
DR Cosmic; 1022279
DR Cosmic; 1303052
DR Cosmic; 1459639
DR Cosmic; 1669128
DR Cosmic; 1995632
DR Cosmic-CLP; 909723
DR DSMZ; ACC-303
DR GDSC; 909723
DR GEO; GSM784507
DR GEO; GSM827506
DR GEO; GSM887582
DR GEO; GSM888665
DR GEO; GSM1670436
DR IGRhCellID; SKMEL1
DR KCB; KCB 200724YJ
DR KCLB; 30067
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=4879578;
RX PubMed=6895502;
RX PubMed=8755562;
RX PubMed=21725359;
RX PubMed=22460905;
RX PubMed=24576830;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-1
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2004-052.
CC Doubling time: ~100 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Thoracic lymph duct.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 13,16
ST D21S11: 29,32.2
ST D3S1358: 14,16
ST D5S818: 12,13
ST D7S820: 12
ST D8S1179: 13,16
ST FGA: 18,20
ST Penta D: 11,13
ST Penta E: 7,21
ST TH01: 6
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-10
AC CVCL_6020
SY SK-MEL 10
RX PubMed=327080;
RX PubMed=833871;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-100
AC CVCL_6067
SY SK-Mel-100; SK-MEL 100; SK-Mel 100; SKMEL-100; SKMEL100; DY-Mel
DR Cosmic; 685206
DR Cosmic; 721848
DR Cosmic; 1122257
DR Cosmic; 1507611
DR Cosmic; 1669160
DR Cosmic; 2233670
DR Cosmic; 2440476
DR GEO; GSM555179
DR GEO; GSM784522
DR Lonza; 1336
RX PubMed=2983346;
RX PubMed=6933476;
RX PubMed=7747814;
RX PubMed=15299072;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-101
AC CVCL_6068
SY DZ-Mel
DR Cosmic; 923391
RX PubMed=6933476;
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-102
AC CVCL_4U05
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-103
AC CVCL_6069
SY SK-Mel-103; SKMEL-103; SkMel103; SKMEL103
DR Cosmic; 685207
DR Cosmic; 1054850
DR Cosmic; 1122258
DR Cosmic; 1507613
DR Cosmic; 1669161
DR GEO; GSM555180
DR GEO; GSM784512
DR Lonza; 1337
RX PubMed=7747814;
RX PubMed=17308088;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-104
AC CVCL_4U06
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-105
AC CVCL_6070
SY SK-Mel-105; SKMEL-105
DR Cosmic; 1669162
DR GEO; GSM784523
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-106
AC CVCL_6071
SY EE-Mel
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-108
AC CVCL_6072
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-109
AC CVCL_6073
SY SK-Mel-109; SK-MEL109; SKMEL-109
DR Cosmic; 1669163
DR GEO; GSM784518
RX PubMed=3005411;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-11
AC CVCL_D702
SY SK-Mel-11; SKMEL-11; AF-Mel
DR Cosmic; 1669132
DR GEO; GSM784514
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-110
AC CVCL_3875
SY SK-Mel-110; SK-Mel 110; SKMEL-110; EI-Mel
DR BTO; BTO:0004994
DR Cosmic; 1669164
RX PubMed=1716514;
RX PubMed=2983346;
RX PubMed=6864164;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-111
AC CVCL_U938
SY SK-Mel-111; EJ-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-112
AC CVCL_6963
SY SK-Mel-112; EK-Mel
DR Cosmic; 923392
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-113
AC CVCL_6074
SY SK-Mel-113; SKMEL-113; EL-Mel
DR Cosmic; 721830
DR Cosmic; 1060421
DR Cosmic; 1669165
DR GEO; GSM784519
RX PubMed=2983346;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-114
AC CVCL_U936
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-115
AC CVCL_8075
DR Cosmic; 1507602
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-117
AC CVCL_6075
SY SK-Mel-117; SKMEL-117
DR Cosmic; 1669166
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-118
AC CVCL_6076
SY SK-Mel-118; SK-mel-118; SKMEL-118; EQ-Mel
DR Cosmic; 1669167
DR GEO; GSM784524
RX PubMed=6864164;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-119
AC CVCL_6077
SY SK-Mel-119; SK Mel 119; SKMEL-119; SKMEL119
DR Cosmic; 706089
DR Cosmic; 721807
DR Cosmic; 851034
DR Cosmic; 888833
DR Cosmic; 897473
DR Cosmic; 1054853
DR Cosmic; 1507604
DR Cosmic; 1669168
DR Cosmic; 2233669
RX PubMed=7747814;
RX PubMed=10766161;
RX PubMed=15009714;
RX PubMed=17308088;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Misspelling: 'SK-ME-119' in Cosmic 2233669.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-12
AC CVCL_6021
SY SK-Mel-12; SKMEL-12; AG-Mel
DR Cosmic; 923384
DR Cosmic; 1669133
DR GEO; GSM784515
RX PubMed=327080;
RX PubMed=7747814;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-122
AC CVCL_4U00
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-123
AC CVCL_4U01
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-124
AC CVCL_8076
DR Cosmic; 923393
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-125
AC CVCL_4U02
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-127
AC CVCL_6078
SY SK-Mel-127; SK MEL 127; SKMEL-127; EZ-Mel
DR Cosmic; 721814
DR Cosmic; 1669169
RX PubMed=1716514;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-128
AC CVCL_6079
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-129
AC CVCL_4U03
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-13
AC CVCL_6022
SY SK-Mel-13; SKMEL-13; SKMEL13; AH-Mel
DR Cosmic; 721822
DR Cosmic; 889040
DR Cosmic; 928711
DR Cosmic; 1669134
DR GEO; GSM170980
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=978138;
RX PubMed=1716514;
RX PubMed=2983346;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=15048078;
RX PubMed=17516929;
RX PubMed=21725359;
RX PubMed=23039341;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-130
AC CVCL_6080
SY SK-Mel-130; SKMEL-130
DR Cosmic; 933131
DR Cosmic; 1507605
DR Cosmic; 1669170
DR Cosmic; 2233671
DR GEO; GSM784525
RX PubMed=6582512;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-131
AC CVCL_6081
SY SK-Mel-131; SK-mel-131; SK-Mel 131; SK Mel 131; Sk Mel131; SKMEL-131; FD-Mel
DR Cosmic; 851055
DR Cosmic; 706112
DR Cosmic; 721849
DR Cosmic; 888847
DR Cosmic; 923394
DR Cosmic; 933132
DR Cosmic; 1020273
DR Cosmic; 1060428
DR Cosmic; 1507595
DR Cosmic; 1669171
DR Cosmic; 2233672
RX PubMed=2453881;
RX PubMed=2983346;
RX PubMed=6864164;
RX PubMed=7747814;
RX PubMed=9692547;
RX PubMed=10766161;
RX PubMed=15009714;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-132
AC CVCL_4U04
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-133
AC CVCL_6082
SY SK-Mel-133; SK-Mel 133; SKMEL-133; FF-MEL; FF-Mel
DR Cosmic; 1669172
RX PubMed=2983346;
RX PubMed=7814883;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-135
AC CVCL_6083
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-136
AC CVCL_8077
DR Cosmic; 721812
RX PubMed=1716514;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-139
AC CVCL_4U07
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-14
AC CVCL_6023
SY SK-Mel-14; AI-Mel
RX PubMed=327080;
RX PubMed=978138;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-140
AC CVCL_U907
RX PubMed=1716514;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-144
AC CVCL_6084
SY SK-Mel-144
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-145
AC CVCL_8078
DR Cosmic; 923395
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-146
AC CVCL_6085
SY SK-Mel-146; SKMEL-146
DR Cosmic; 721805
DR Cosmic; 933118
DR Cosmic; 1669173
RX PubMed=1716514;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-147
AC CVCL_3876
SY SK-Mel-147; SK MEL 147; SKMEL-147; SkMel147; SKMEL147; FT-Mel
DR Cosmic; 685208
DR Cosmic; 721808
DR Cosmic; 933133
DR Cosmic; 1054851
DR Cosmic; 1122259
DR Cosmic; 1247853
DR Cosmic; 1507623
DR Cosmic; 1669174
DR Cosmic; 2233673
DR GEO; GSM555181
DR Lonza; 1338
RX PubMed=1716514;
RX PubMed=6864164;
RX PubMed=7747814;
RX PubMed=17308088;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-15
AC CVCL_6964
SY SK-Mel-15; SKMEL-15; BO-Mel
DR Cosmic; 1669135
RX PubMed=833871;
RX PubMed=978138;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-150
AC CVCL_8079
DR Cosmic; 923396
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-153
AC CVCL_6087
SY SK-Mel-153; SKMEL-153
DR Cosmic; 721831
DR Cosmic; 1507627
DR Cosmic; 1669175
DR Cosmic; 2233674
RX PubMed=6582512;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-158
AC CVCL_8080
DR Cosmic; 923397
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-16
AC CVCL_1E23
SY SK-Mel-16
RX PubMed=327080;
RX PubMed=833871;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-161
AC CVCL_6088
SY SK-Mel-161; SKMEL-161
DR Cosmic; 721833
DR Cosmic; 1669176
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-162
AC CVCL_4U08
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-163
AC CVCL_U940
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-165
AC CVCL_J708
SY GL-Mel
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-166
AC CVCL_8081
DR Cosmic; 721834
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-168
AC CVCL_U941
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-169
AC CVCL_U942
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-17
AC CVCL_6024
SY SK-Mel-17; AJ-Mel
DR Cosmic; 721809
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-170
AC CVCL_6089
SY SK-Mel-170; SKMEL-170
DR Cosmic; 933117
DR Cosmic; 1669177
RX PubMed=3081645;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-172
AC CVCL_J709
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-173
AC CVCL_6090
SY SK-Mel-173; SKMEL-173; SKMEL173
DR Cosmic; 685209
DR Cosmic; 933115
DR Cosmic; 1054847
DR Cosmic; 1122260
DR Cosmic; 1155285
DR Cosmic; 1507628
DR Cosmic; 1669178
DR Cosmic; 2233675
DR GEO; GSM555182
DR GEO; GSM784511
DR Lonza; 1339
RX PubMed=7747814;
RX PubMed=17308088;
RX PubMed=21725359;
RX PubMed=24576830;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-174
AC CVCL_6091
SY SK-Mel-174; SKMEL-174
DR Cosmic; 1669179
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-176
AC CVCL_6092
SY SK-Mel-176; SKMEL-176
DR Cosmic; 1669180
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-177
AC CVCL_4U09
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-178
AC CVCL_6093
SY SK-Mel-178; SKMEL-178
DR Cosmic; 923398
DR Cosmic; 1669181
DR GEO; GSM784526
RX PubMed=7747814;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-18
AC CVCL_U933
SY AK-Mel
RX PubMed=327080;
RX PubMed=833871;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-181
AC CVCL_6094
SY SK-Mel-181; SKMEL-181
DR Cosmic; 1507597
DR Cosmic; 1669182
DR Cosmic; 2233676
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-182
AC CVCL_6095
SY SK-Mel-182; SKMEL-182
DR Cosmic; 1669183
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-186
AC CVCL_6096
SY SK-Mel-186; SK-Mel 186; SKMEL-186
DR Cosmic; 721813
DR Cosmic; 923399
DR Cosmic; 1507614
DR Cosmic; 1669184
DR Cosmic; 2233677
RX PubMed=1716514;
RX PubMed=7747814;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-187
AC CVCL_6097
SY SK-Mel-187; SKMEL-187; SKMEL187
DR Cosmic; 685210
DR Cosmic; 1054845
DR Cosmic; 1122261
DR Cosmic; 1507593
DR Cosmic; 1669185
DR Cosmic; 2233678
DR GEO; GSM555183
DR GEO; GSM784527
DR Lonza; 1340
RX PubMed=7747814;
RX PubMed=17308088;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-188
AC CVCL_6098
SY SK-Mel-188; SKMEL-188
DR Cosmic; 933116
DR Cosmic; 1669186
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-19
AC CVCL_6025
SY SK-Mel-19; SKMEL-19; SkMEL-19; SK-MEL19; Sk Mel19; SKMEL19; AL-Mel
DR ChEMBL-Cells; CHEMBL3307448
DR ChEMBL-Targets; CHEMBL614915
DR Cosmic; 685202
DR Cosmic; 721841
DR Cosmic; 886830
DR Cosmic; 923385
DR Cosmic; 933126
DR Cosmic; 1047686
DR Cosmic; 1060427
DR Cosmic; 1122255
DR Cosmic; 1669136
DR GEO; GSM156032
DR GEO; GSM555175
DR GEO; GSM784508
DR Lonza; 1332
RX PubMed=833871;
RX PubMed=978138;
RX PubMed=2983346;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=17260012;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Omics: Array-based CGH.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-190
AC CVCL_6099
SY SK-Mel-190; SKMEL-190
DR Cosmic; 1507617
DR Cosmic; 1669187
DR Cosmic; 2233679
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-191
AC CVCL_6100
SY SK-Mel-191; SKMEL-191
DR Cosmic; 1669188
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-192
AC CVCL_6101
SY SK-Mel-192; SKMEL-192; SKMEL192
DR Cosmic; 685211
DR Cosmic; 1122262
DR Cosmic; 1669189
DR GEO; GSM555184
DR Lonza; 1341
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-196
AC CVCL_6102
SY SK-Mel-196; SKMEL-196
DR Cosmic; 933134
DR Cosmic; 1669190
DR GEO; GSM784528
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-197
AC CVCL_8082
SY SK-Mel-197; SK-MEL 197; SK-Mel 197; SKMEL-197; SKMEL197
DR Cosmic; 685212
DR Cosmic; 1122263
DR GEO; GSM555185
DR Lonza; 1342
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-198
AC CVCL_6103
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-199
AC CVCL_6104
SY SK-Mel-199; SKMEL-199; SK-MEL-199A; SK-MEL-199 (adhesion); SK-MEL-199S; SK-MEL-199 (suspension)
DR Cosmic; 1669192
DR Cosmic; 1669193
DR GEO; GSM784529
DR GEO; GSM784530
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-2
AC CVCL_0069
SY SK-Mel-2; SK-mel-2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2
DR BTO; BTO:0003476
DR CLO; CLO_0009041
DR EFO; EFO_0002079
DR ATCC; HTB-68
DR BioSample; SAMN03471882
DR BioSample; SAMN03472752
DR CCLE; SKMEL2_SKIN
DR CGH-DB; 9322-4
DR ChEMBL-Cells; CHEMBL3307743
DR ChEMBL-Cells; CHEMBL3308684
DR ChEMBL-Targets; CHEMBL614858
DR ChEMBL-Targets; CHEMBL614917
DR CLS; 300423/NA
DR Cosmic; 724824
DR Cosmic; 875885
DR Cosmic; 897468
DR Cosmic; 905235
DR Cosmic; 905955
DR Cosmic; 974073
DR Cosmic; 974257
DR Cosmic; 1006555
DR Cosmic; 1022288
DR Cosmic; 1044266
DR Cosmic; 1045411
DR Cosmic; 1067222
DR Cosmic; 1092632
DR Cosmic; 1132585
DR Cosmic; 1155283
DR Cosmic; 1175871
DR Cosmic; 1303053
DR Cosmic; 1305367
DR Cosmic; 1458964
DR Cosmic; 1459662
DR Cosmic; 1477419
DR Cosmic; 1669129
DR Cosmic; 1995633
DR Cosmic; 1998475
DR Cosmic; 2159450
DR Cosmic; 2479250
DR Cosmic-CLP; 905955
DR GDSC; 905955
DR GEO; GSM50204
DR GEO; GSM50266
DR GEO; GSM188225
DR GEO; GSM188255
DR GEO; GSM188314
DR GEO; GSM750824
DR GEO; GSM799356
DR GEO; GSM799419
DR GEO; GSM847115
DR GEO; GSM844688
DR GEO; GSM844689
DR GEO; GSM887585
DR GEO; GSM888668
DR GEO; GSM1153426
DR GEO; GSM1181281
DR GEO; GSM1181359
DR GEO; GSM1670437
DR KCLB; 30068
DR SKY/M-FISH/CGH; 2820
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=2041050;
RX PubMed=7999427;
RX PubMed=8755562;
RX PubMed=15467732;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19727395;
RX PubMed=21725359;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24576830;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=45
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-2
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 779.
CC Doubling time: 45.5 hours (DTP).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SKm12' in ChEMBL CHEMBL614858 and CHEMBL3308684.
CC Discontinued: CLS; 300423; true.
CC Derived from metastatic site: Thigh skin.
ST Source(s): ATCC; Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,11 (ATCC)
ST D13S317: 11 (Cosmic-CLP; PubMed=19372543; PubMed=25877200)
ST D16S539: 8,9
ST D18S51: 15,16
ST D19S433: 12,15
ST D21S11: 29,30
ST D3S1358: 14,16
ST D5S818: 11,12,13 (ATCC)
ST D5S818: 12,13 (Cosmic-CLP; PubMed=19372543; PubMed=25877200)
ST D7S820: 11,12
ST D8S1179: 12,13
ST FGA: 19,25
ST Penta D: 10,15
ST Penta E: 7,16
ST TH01: 9
ST TPOX: 8,9
ST vWA: 16,17 (ATCC)
ST vWA: 17 (Cosmic-CLP; PubMed=19372543; PubMed=25877200)
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-2-Luc
AC CVCL_J266
DR JCRB; JCRB1393
DR JCRB; NIHS0640
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0640; true.
CC Derived from metastatic site: Thigh skin.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 8,9
ST D5S818: 12,13
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0069 ! SK-MEL-2
SX Male
CA Cancer cell line
//
ID SK-MEL-20
AC CVCL_U925
SY AM-Mel
RX PubMed=833871;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-200
AC CVCL_6105
SY SK-Mel-200; SKMEL-200
DR Cosmic; 1669194
DR GEO; GSM784531
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-202
AC CVCL_6106
SY SK-Mel-202; SKMEL-202
DR Cosmic; 1669195
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-203
AC CVCL_U908
RX PubMed=1716514;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-204
AC CVCL_U909
RX PubMed=1716514;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-205
AC CVCL_6107
SY SK-Mel-205; SKMEL-205
DR Cosmic; 1669196
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-207
AC CVCL_6108
SY SK-Mel-207; SKMEL-207
DR Cosmic; 1669197
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-208
AC CVCL_6109
SY SK-Mel-208; SKMEL-208
DR Cosmic; 1669198
DR GEO; GSM784532
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-209
AC CVCL_6110
SY SK-Mel-209; SKMEL-209
DR Cosmic; 1669199
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-21
AC CVCL_3877
SY SK-Mel-21; SK MEL 21; SK-MEL21; AN-Mel
DR BTO; BTO:0002966
DR Cosmic; 897471
DR Cosmic; 923386
DR Cosmic; 933127
DR Cosmic; 1669137
RX PubMed=327080;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=7747814;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-210-3
AC CVCL_D772
SY SKMEL-210-3; SK-Mel-210
DR Cosmic; 1669200
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-215-1
AC CVCL_U911
SY SKMEL-215-1; SK-Mel-215
DR Cosmic; 1669201
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-217
AC CVCL_6111
SY SK-Mel-217; SKMEL-217
DR Cosmic; 1669202
DR GEO; GSM784533
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-22
AC CVCL_6026
SY SK-Mel-22; SKMEL-22; SK-MEL-022; AO-Mel
DR Cosmic; 1669138
DR GEO; GSM784520
RX PubMed=833871;
RX PubMed=978138;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-222
AC CVCL_6112
SY SK-Mel-222; SKMEL-222
DR Cosmic; 1669203
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-227
AC CVCL_6113
SY SK-Mel-227; SKMEL-227
DR Cosmic; 1669204
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-228
AC CVCL_6114
SY SK-Mel-228; SKMEL-228
DR Cosmic; 1669205
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-229
AC CVCL_6115
SY SK-Mel-229; SKMEL-229
DR Cosmic; 1669206
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-23
AC CVCL_6027
SY SK-Mel-23; SK-Mel 23; SK-mel-23; SK MEL 23; SK Mel 23; Sk Mel23; SKMEL-23; SKMEL23; SK23-MEL; SK23-mel; SK23; AP-Mel
DR BTO; BTO:0005333
DR EFO; EFO_0006490
DR BioSample; SAMN03470872
DR BioSample; SAMN03473194
DR CGH-DB; 9318-4
DR Cosmic; 706107
DR Cosmic; 721823
DR Cosmic; 851051
DR Cosmic; 876705
DR Cosmic; 888852
DR Cosmic; 897493
DR Cosmic; 905231
DR Cosmic; 1060423
DR Cosmic; 1303054
DR Cosmic; 1507594
DR Cosmic; 1669139
DR GEO; GSM206542
DR GEO; GSM784516
DR Lonza; 1343
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=978138;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=9692547;
RX PubMed=10766161;
RX PubMed=15009714;
RX PubMed=15467732;
RX PubMed=17308088;
RX PubMed=21725359;
RX PubMed=24576830;
RX PubMed=25485619;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D16S539: 11,13
ST D18S51: 14,21
ST D21S11: 26,29
ST D2S1338: 20,25
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 10,11
ST FGA: 18,22,23
ST Penta D: 9.1,11,12
ST Penta E: 12
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-230
AC CVCL_6116
SY SK-Mel-230; SKMEL-230
DR Cosmic; 1669207
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-232
AC CVCL_6117
SY SK-Mel-232; SKMEL-232
DR Cosmic; 1669208
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-233
AC CVCL_6118
SY SK-Mel-233; SKMEL-233
DR Cosmic; 1669209
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-234
AC CVCL_6119
SY SK-Mel-234; SKMEL-234
DR Cosmic; 933139
DR Cosmic; 1669210
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-235
AC CVCL_4Z29
SY SKMEL-235
DR Cosmic; 2233680
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-237
AC CVCL_6120
SY SK-Mel-237; SKMEL-237
DR Cosmic; 1669211
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-238
AC CVCL_6121
SY SK-Mel-238; SKMEL-238
DR Cosmic; 1669212
DR GEO; GSM784534
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-239
AC CVCL_6122
SY SK-Mel-239; SKMEL-239
DR Cosmic; 1507603
DR Cosmic; 1669213
DR GEO; GSM784535
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-24
AC CVCL_0599
SY Sk-Mel-24; SK Mel 24; SKMEL-24; SK-Mel24; SKMEL24; SKMel24; AQ-Mel
DR BTO; BTO:0005861
DR CLO; CLO_0009042
DR EFO; EFO_0006487
DR CLDB; cl7124
DR ATCC; HTB-71
DR BioSample; SAMN03473230
DR CCLE; SKMEL24_SKIN
DR ChEMBL-Cells; CHEMBL3308324
DR ChEMBL-Targets; CHEMBL2366314
DR Cosmic; 687441
DR Cosmic; 851405
DR Cosmic; 909725
DR Cosmic; 932997
DR Cosmic; 1022274
DR Cosmic; 1054858
DR Cosmic; 1102581
DR Cosmic; 1155265
DR Cosmic; 1458965
DR Cosmic; 1459651
DR Cosmic; 1507625
DR Cosmic; 1669140
DR Cosmic; 1995634
DR Cosmic-CLP; 909725
DR GDSC; 909725
DR GEO; GSM784509
DR GEO; GSM887583
DR GEO; GSM888666
DR GEO; GSM1670438
DR ICLC; HTL02001
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=978138;
RX PubMed=7459858;
RX PubMed=10709110;
RX PubMed=17308088;
RX PubMed=21654344;
RX PubMed=21725359;
RX PubMed=22460905;
RX PubMed=24576830;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-24
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2003-078.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 9,12
ST D18S51: 16
ST D21S11: 29,31.2
ST D3S1358: 15
ST D5S818: 9,13
ST D7S820: 9,12
ST D8S1179: 14,15
ST FGA: 22,23
ST Penta D: 9
ST Penta E: 11,12
ST TH01: 6,9
ST TPOX: 11
ST vWA: 15
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-241
AC CVCL_8083
DR Cosmic; 933140
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-243
AC CVCL_6123
SY SK-Mel-243; SKMEL-243
DR Cosmic; 1669214
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-244
AC CVCL_6124
SY SK-Mel-244; SKMEL-244
DR Cosmic; 1669215
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-245
AC CVCL_6125
SY SK-Mel-245
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-246
AC CVCL_6126
SY SK-Mel-246; SKMEL-246
DR Cosmic; 1669216
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-249
AC CVCL_6961
SY JU-MEL
RX PubMed=7814883;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-25
AC CVCL_6028
SY SK-Mel-25; SK Mel 25; SK 25; AR-Mel
DR ChEMBL-Cells; CHEMBL3308005
DR ChEMBL-Targets; CHEMBL612706
DR CLS; 300336/NA
RX PubMed=978138;
RX PubMed=6895502;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-250
AC CVCL_6962
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-252
AC CVCL_6127
SY SK-Mel-252; SKMEL-252
DR Cosmic; 1669217
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-256
AC CVCL_6128
SY SK-Mel-256; SKMEL-256; JX-MEL
DR Cosmic; 1669218
RX PubMed=7814883;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-258
AC CVCL_6129
DR Cosmic; 933112
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-26
AC CVCL_6029
SY SK-Mel-26; SKMEL-26; AS-Mel
DR Cosmic; 1669141
RX PubMed=327080;
RX PubMed=978138;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=21725359;
RX PubMed=24576830;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mel-26-human-melanoma-cell-line
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-546.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-MEL-263
AC CVCL_6130
SY SKMEL-263
DR Cosmic; 1669219
RX PubMed=17308088;
RX PubMed=21725359;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-264
AC CVCL_6131
SY SK-Mel-264; SKMEL-264
DR Cosmic; 1669220
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-265
AC CVCL_6132
SY SK-Mel-265; SKMEL-265
DR Cosmic; 1669221
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-266
AC CVCL_6133
SY SK-Mel-266; SKMEL-266
DR Cosmic; 1669222
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-267
AC CVCL_6134
SY SK-Mel-267; SKMEL-267; SK-Mel 267
DR Cosmic; 1669223
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-268
AC CVCL_6135
SY SK-Mel-268; SKMEL-268
DR Cosmic; 1669224
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-269
AC CVCL_6136
SY SK-Mel-269; SKMEL-269
DR Cosmic; 1669225
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-27
AC CVCL_6030
SY SK-Mel-27; SK-Mel/27; AT-Mel
DR Cosmic; 1507592
DR GEO; GSM784517
RX PubMed=327080;
RX PubMed=978138;
RX PubMed=6933476;
RX PubMed=6935474;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-27-1
AC CVCL_U913
SY SKMEL-27-1
DR Cosmic; 1669142
RX PubMed=21725359;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6030 ! SK-MEL-27
CA Cancer cell line
//
ID SK-MEL-27-2
AC CVCL_U914
SY SKMEL-27-2
DR Cosmic; 1669143
RX PubMed=21725359;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6030 ! SK-MEL-27
CA Cancer cell line
//
ID SK-MEL-271
AC CVCL_6137
SY SK-Mel-271; SKMEL-271
DR Cosmic; 1669226
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-272
AC CVCL_6138
SY SK-Mel-272; SKMEL-272
DR Cosmic; 1669227
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-275
AC CVCL_6139
SY SK-Mel-275; SKMEL-275
DR Cosmic; 1669228
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-276
AC CVCL_6140
SY SK-Mel-276; SKMEL-276
DR Cosmic; 1669229
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-279
AC CVCL_6141
SY SK-Mel-279; SKMEL-279
DR Cosmic; 1669230
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-28
AC CVCL_0526
SY SK-Mel-28; SK Mel 28; SK-MEL 28; SK.MEL.28; SK MEL 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SKMEL28; SKMel28; SKmel28; AU-Mel; P-36; P36
DR BTO; BTO:0002131
DR CLO; CLO_0009043
DR EFO; EFO_0003081
DR MCCL; MCC:0000426
DR CLDB; cl4321
DR CLDB; cl4954
DR ATCC; HTB-72
DR BCRJ; 0289
DR BioSample; SAMN03470899
DR BioSample; SAMN03472092
DR BioSample; SAMN03472754
DR CCLE; SKMEL28_SKIN
DR CGH-DB; 9317-4
DR ChEMBL-Cells; CHEMBL3307334
DR ChEMBL-Cells; CHEMBL3308494
DR ChEMBL-Targets; CHEMBL614216
DR ChEMBL-Targets; CHEMBL614919
DR CLS; 300337/p495_SK-MEL-28
DR Cosmic; 686472
DR Cosmic; 686476
DR Cosmic; 687442
DR Cosmic; 706106
DR Cosmic; 721824
DR Cosmic; 851050
DR Cosmic; 874384
DR Cosmic; 874446
DR Cosmic; 875887
DR Cosmic; 886831
DR Cosmic; 888846
DR Cosmic; 897491
DR Cosmic; 898252
DR Cosmic; 905230
DR Cosmic; 905954
DR Cosmic; 928748
DR Cosmic; 932712
DR Cosmic; 933135
DR Cosmic; 974072
DR Cosmic; 974262
DR Cosmic; 1006554
DR Cosmic; 1007156
DR Cosmic; 1022271
DR Cosmic; 1045407
DR Cosmic; 1047687
DR Cosmic; 1054859
DR Cosmic; 1067227
DR Cosmic; 1092633
DR Cosmic; 1102386
DR Cosmic; 1109809
DR Cosmic; 1132589
DR Cosmic; 1155280
DR Cosmic; 1155570
DR Cosmic; 1175872
DR Cosmic; 1183772
DR Cosmic; 1187579
DR Cosmic; 1221590
DR Cosmic; 1238109
DR Cosmic; 1295337
DR Cosmic; 1303055
DR Cosmic; 1305368
DR Cosmic; 1312350
DR Cosmic; 1425350
DR Cosmic; 1458966
DR Cosmic; 1459645
DR Cosmic; 1477319
DR Cosmic; 1477408
DR Cosmic; 1507598
DR Cosmic; 1598350
DR Cosmic; 1665022
DR Cosmic; 1669144
DR Cosmic; 1995635
DR Cosmic; 1998476
DR Cosmic; 2159448
DR Cosmic; 2479251
DR Cosmic-CLP; 905954
DR GDSC; 905954
DR GEO; GSM50205
DR GEO; GSM50267
DR GEO; GSM156050
DR GEO; GSM171012
DR GEO; GSM188226
DR GEO; GSM188256
DR GEO; GSM188315
DR GEO; GSM206543
DR GEO; GSM228378
DR GEO; GSM276739
DR GEO; GSM750825
DR GEO; GSM784506
DR GEO; GSM799357
DR GEO; GSM799420
DR GEO; GSM844690
DR GEO; GSM847116
DR GEO; GSM887584
DR GEO; GSM888667
DR GEO; GSM952581
DR GEO; GSM1138790
DR GEO; GSM1153427
DR GEO; GSM1153428
DR GEO; GSM1181282
DR GEO; GSM1181283
DR GEO; GSM1588919
DR GEO; GSM1670439
DR ICLC; HTL99010
DR LINCS; 51101
DR Lonza; 79
DR RCB; RCB1930
DR SKY/M-FISH/CGH; 2745
RX PubMed=327080;
RX PubMed=978138;
RX PubMed=1716514;
RX PubMed=2041050;
RX PubMed=2068080;
RX PubMed=2983346;
RX PubMed=6203018;
RX PubMed=6349783;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=7999427;
RX PubMed=10766161;
RX PubMed=11016658;
RX PubMed=14692828;
RX PubMed=15009714;
RX PubMed=15299072;
RX PubMed=15467732;
RX PubMed=17088437;
RX PubMed=17260012;
RX PubMed=17308088;
RX PubMed=17363583;
RX PubMed=17516929;
RX PubMed=19147755;
RX PubMed=19372543;
RX PubMed=20041153;
RX PubMed=21725359;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24576830;
RX PubMed=25485619;
RX PubMed=27087056;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=47
WW http://www.addexbio.com/productdetail?pid=66
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-28
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-524.
CC Doubling time: 35.1 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: RCB; RCB1930; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; PubMed=19372543; PubMed=25877200; PubMed=27087056; RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12 (ATCC; CLS; Cosmic-CLP; PubMed=27087056; RCB)
ST CSF1PO: 10 (PubMed=19372543; PubMed=25877200)
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 12,16
ST D19S433: 14
ST D21S11: 28,29
ST D2S1338: 18
ST D3S1358: 16,18
ST D5S818: 11,13 (ATCC; Cosmic-CLP; PubMed=27087056; RCB)
ST D5S818: 13 (CLS; PubMed=19372543; PubMed=25877200)
ST D7S820: 9.3,10 (ATCC)
ST D7S820: 10 (CLS; Cosmic-CLP; PubMed=19372543; PubMed=25877200; PubMed=27087056; RCB)
ST D8S1179: 13
ST FGA: 19
ST Penta D: 9,10
ST Penta E: 8,12
ST TH01: 7
ST TPOX: 8,12 (ATCC; CLS; Cosmic-CLP; PubMed=27087056; RCB)
ST TPOX: 12 (PubMed=19372543; PubMed=25877200)
ST vWA: 16,19 (ATCC; CLS; Cosmic-CLP; PubMed=25877200; PubMed=27087056; RCB)
ST vWA: 19 (PubMed=19372543)
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-28-Luc
AC CVCL_J267
DR JCRB; JCRB1376
DR JCRB; NIHS0641
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0641; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 13
ST D7S820: 9.3,10
ST TH01: 7
ST TPOX: 8,12
ST vWA: 19
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0526 ! SK-MEL-28
SX Male
CA Cancer cell line
//
ID SK-MEL-28-VR
AC CVCL_AP99
RX PubMed=26497853;
CC Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0526 ! SK-MEL-28
SX Male
CA Cancer cell line
//
ID SK-MEL-281
AC CVCL_6142
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-282
AC CVCL_6143
SY SK-Mel-282; SKMEL-282
DR Cosmic; 1669231
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-283
AC CVCL_6144
SY SK-Mel-283; SKMEL-283
DR Cosmic; 1669232
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-284
AC CVCL_6145
SY SK-Mel-284; SKMEL-284
DR Cosmic; 1669233
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-285
AC CVCL_6146
SY SK-Mel-285; SKMEL-285
DR Cosmic; 1669234
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-28DDR1-PLXAZD
AC CVCL_IM75
SY SkMel28DDR1-PLXAZD
DR GEO; GSM1588921
RX PubMed=26359985;
CC Selected for resistance to: ChEBI; CHEBI:90227; Selumetinib (AZD6244).
CC Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0526 ! SK-MEL-28
SX Male
CA Cancer cell line
//
ID SK-MEL-28R1-PLX
AC CVCL_IM76
SY SkMel28R1-PLX
DR GEO; GSM1588920
RX PubMed=26359985;
CC Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0526 ! SK-MEL-28
SX Male
CA Cancer cell line
//
ID SK-MEL-29
AC CVCL_6031
SY SK-Mel-29; SKMEL-29; SKMEL29; AV-Mel
DR Cosmic; 685203
DR Cosmic; 933136
DR Cosmic; 1669145
DR GEO; GSM555176
DR GEO; GSM784513
DR Lonza; 1333
RX PubMed=978138;
RX PubMed=2983346;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=6935474;
RX PubMed=21725359;
RX PubMed=24576830;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mel-29-human-melanoma-cell-line
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-525.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-3
AC CVCL_0550
SY SK-Mel-3; Sk-mel-3; SK-Mel3; SKMEL3
DR BTO; BTO:0002132
DR CLO; CLO_0009044
DR EFO; EFO_0002333
DR ATCC; HTB-69
DR BioSample; SAMN03472882
DR CCLE; SKMEL3_SKIN
DR ChEMBL-Cells; CHEMBL3307449
DR ChEMBL-Targets; CHEMBL614920
DR Cosmic; 687443
DR Cosmic; 874445
DR Cosmic; 888063
DR Cosmic; 909724
DR Cosmic; 1022286
DR Cosmic; 1047688
DR Cosmic; 1459671
DR Cosmic; 1995636
DR Cosmic; 2159449
DR Cosmic-CLP; 909724
DR DSMZ; ACC-321
DR GDSC; 909724
DR GEO; GSM156045
DR GEO; GSM827519
DR GEO; GSM887588
DR GEO; GSM888671
DR GEO; GSM1670440
DR IGRhCellID; SKMEL3
DR KCLB; 30069
DR NCBI_Iran; C458
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=8755562;
RX PubMed=17260012;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-3
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-523.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13
ST D16S539: 11
ST D18S51: 10,18
ST D21S11: 29,30
ST D3S1358: 17,18
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 14
ST FGA: 24
ST Penta D: 9,13
ST Penta E: 11,15
ST TH01: 6
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-MEL-30
AC CVCL_0039
SY SK-Mel-30; SK Mel 30; SKMEL-30; Sk Mel30; AW-Mel
DR BTO; BTO:0002133
DR CLO; CLO_0009045
DR EFO; EFO_0006488
DR CLDB; cl4323
DR BioSample; SAMN03473251
DR CCLE; SKMEL30_SKIN
DR ChEMBL-Cells; CHEMBL3308128
DR ChEMBL-Targets; CHEMBL1075577
DR Cosmic; 706090
DR Cosmic; 721825
DR Cosmic; 851035
DR Cosmic; 888061
DR Cosmic; 888834
DR Cosmic; 909726
DR Cosmic; 933128
DR Cosmic; 1022283
DR Cosmic; 1060425
DR Cosmic; 1669146
DR Cosmic-CLP; 909726
DR DSMZ; ACC-151
DR GDSC; 909726
DR GEO; GSM784510
DR GEO; GSM887586
DR GEO; GSM888669
DR GEO; GSM1670441
RX PubMed=978138;
RX PubMed=1067619;
RX PubMed=1716514;
RX PubMed=3081645;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=10766161;
RX PubMed=15009714;
RX PubMed=21725359;
RX PubMed=22460905;
RX PubMed=24576830;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.proteinatlas.org/learn/cellines
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mel-30-human-melanoma-cell-line
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-526.
CC Doubling time: ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,11
ST D16S539: 8,11
ST D18S51: 13,15
ST D21S11: 29,31.2
ST D3S1358: 15,16
ST D5S818: 9,12
ST D7S820: 8,9
ST D8S1179: 8,14
ST FGA: 20,21
ST Penta D: 12
ST Penta E: 5,14
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-301
AC CVCL_6147
SY SK-Mel-301; SKMEL-301
DR Cosmic; 1669235
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-304
AC CVCL_6148
SY SK-Mel-304; SKMEL-304
DR Cosmic; 1669236
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-306
AC CVCL_6149
SY SK-Mel-306; SKMEL-306
DR Cosmic; 1669237
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-307
AC CVCL_6150
SY SK-Mel-307; SKMEL-307
DR Cosmic; 1669238
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-309B
AC CVCL_U912
SY SKMEL-309B; SK-Mel-309
DR Cosmic; 1669239
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-31
AC CVCL_0600
SY Sk-Mel-31; SKMEL-31; SKMel-31; SkMel31; SKMEL31; AX-Mel
DR CLO; CLO_0009046
DR EFO; EFO_0006489
DR ATCC; HTB-73
DR BioSample; SAMN03472881
DR CCLE; SKMEL31_SKIN
DR Cosmic; 688054
DR Cosmic; 851406
DR Cosmic; 932998
DR Cosmic; 933113
DR Cosmic; 1022273
DR Cosmic; 1047689
DR Cosmic; 1102384
DR Cosmic; 1459643
DR Cosmic; 1669147
DR Cosmic; 2159444
DR Cosmic; 2479254
DR Cosmic-CLP; 909727
DR GDSC; 909727
DR GEO; GSM156033
DR GEO; GSM276762
DR GEO; GSM887587
DR GEO; GSM888670
DR GEO; GSM1670442
DR KCLB; 30073
DR Lonza; 1344
RX PubMed=978138;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=17260012;
RX PubMed=21725359;
RX PubMed=22460905;
RX PubMed=24576830;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-31
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-527.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 30073; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 13
ST D18S51: 15
ST D21S11: 30,32.2
ST D3S1358: 17,18
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 12,14
ST FGA: 24
ST Penta D: 9
ST Penta E: 12,18
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-MEL-313
AC CVCL_1T59
SY SK-Mel-313
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-315-02
AC CVCL_E090
SY SK-Mel-315-02; SKMEL-315-02
DR Cosmic; 1669240
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E091 ! SK-MEL-315-03
OI CVCL_E092 ! SK-MEL-315-05
CA Cancer cell line
//
ID SK-MEL-315-03
AC CVCL_E091
SY SKMEL-315-03
DR Cosmic; 1669241
RX PubMed=21725359;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E090 ! SK-MEL-315-02
OI CVCL_E092 ! SK-MEL-315-05
CA Cancer cell line
//
ID SK-MEL-315-05
AC CVCL_E092
SY SK-Mel-315-05; SKMEL-315-05
DR Cosmic; 1669242
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E090 ! SK-MEL-315-02
OI CVCL_E091 ! SK-MEL-315-03
CA Cancer cell line
//
ID SK-MEL-316
AC CVCL_6151
SY SK-Mel-316
DR Cosmic; 1669243
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-318
AC CVCL_1T60
SY SK-Mel-318
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-32
AC CVCL_6032
SY SK-Mel-32; SKMEL-32; SK-Mel 32; AY-Mel
DR Cosmic; 1669148
RX PubMed=6935474;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-MEL-321A
AC CVCL_D771
SY SK-Mel-321A; SKMEL-321A
DR Cosmic; 1669244
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E089 ! SK-MEL-321B
CA Cancer cell line
//
ID SK-MEL-321B
AC CVCL_E089
SY SK-Mel-321B; SKMEL-321B
DR Cosmic; 1669245
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D771 ! SK-MEL-321A
CA Cancer cell line
//
ID SK-MEL-323
AC CVCL_6152
SY SK-Mel-323; SKMEL-323
DR Cosmic; 1669246
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-325
AC CVCL_6153
SY SK-Mel-325; SKMEL-325
DR Cosmic; 1669247
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-326
AC CVCL_6154
SY SK-Mel-326; SKMEL-326
DR Cosmic; 1669248
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-33
AC CVCL_6033
SY SK-Mel-33; AZ-Mel
DR Cosmic; 923387
RX PubMed=2983346;
RX PubMed=6864164;
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-330
AC CVCL_6155
SY SK-Mel-330; SKMEL-330
DR Cosmic; 1669249
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-332
AC CVCL_1T61
SY SK-Mel-332
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-334
AC CVCL_6156
SY SK-Mel-334; SKMEL-334
DR Cosmic; 1669250
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-339
AC CVCL_6157
SY SK-Mel-339; SKMEL-339
DR Cosmic; 1669251
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-34
AC CVCL_8084
SY BA-Mel
DR Cosmic; 721842
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-341
AC CVCL_6158
SY SKMEL-341
DR Cosmic; 1669252
RX PubMed=21725359;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-346
AC CVCL_6159
SY SK-Mel-346; SKMEL-346
DR Cosmic; 1669253
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-35
AC CVCL_6034
SY SK-Mel-35; SKMEL-35; BB-Mel
DR Cosmic; 1669149
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-351
AC CVCL_6160
SY SK-Mel-351; SKMEL-351
DR Cosmic; 1669254
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-359
AC CVCL_6161
SY SK-Mel-359; SKMEL-359
DR Cosmic; 1669255
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-36
AC CVCL_6035
SY SK-Mel-36; SKMEL-36; BC-Mel
DR Cosmic; 1669150
RX PubMed=978138;
RX PubMed=1778766;
RX PubMed=6933476;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-364
AC CVCL_6162
SY SK-Mel-364; SKMEL-364
DR Cosmic; 1669256
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-366
AC CVCL_6163
SY SK-Mel-366; SKMEL-366
DR Cosmic; 1669257
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-367
AC CVCL_6164
SY SK-Mel-367; SKMEL-367
DR Cosmic; 1669258
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-369
AC CVCL_6165
SY SK-Mel-369; SKMEL-369
DR Cosmic; 1669259
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-37
AC CVCL_3878
SY SK-Mel-37; SK-MEL37; SK-Mel 37; SK MEL 37; Sk Mel37; SKMEL-37; SK-37; BD-Mel
DR BTO; BTO:0002967
DR Cosmic; 706102
DR Cosmic; 721826
DR Cosmic; 851046
DR Cosmic; 888842
DR Cosmic; 933137
DR Cosmic; 1303056
DR Cosmic; 1669151
RX PubMed=978138;
RX PubMed=1778766;
RX PubMed=2983346;
RX PubMed=3081645;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=9692547;
RX PubMed=10766161;
RX PubMed=15009714;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-38
AC CVCL_U926
SY BE-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-380
AC CVCL_6166
SY SK-Mel-380; SKMEL-380
DR Cosmic; 1669260
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-381
AC CVCL_6167
SY SK-Mel-381; SKMEL-381
DR Cosmic; 1669261
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-39
AC CVCL_6036
SY SK-Mel-39; SK-Mel 39; SK Mel 39; Sk Mel39; SKMEL-39; BF-Mel
DR Cosmic; 706098
DR Cosmic; 851042
DR Cosmic; 888840
DR Cosmic; 897487
DR Cosmic; 933138
DR Cosmic; 1669152
RX PubMed=9692547;
RX PubMed=10766161;
RX PubMed=15009714;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-390
AC CVCL_6168
SY SK-Mel-390; SKMEL-390
DR Cosmic; 1669262
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-391
AC CVCL_1T62
SY SK-Mel-391
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-393
AC CVCL_1T63
SY SK-Mel-393
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-394
AC CVCL_1T64
SY SK-Mel-394
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-398
AC CVCL_1T65
SY SK-Mel-398
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-40
AC CVCL_6037
SY SK-Mel-40; SKMEL-40; BG-Mel
DR Cosmic; 721844
DR Cosmic; 1669153
RX PubMed=1778766;
RX PubMed=6933476;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-400
AC CVCL_1T66
SY SK-Mel-400
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-406
AC CVCL_1T67
SY SK-Mel-406
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-408
AC CVCL_1T68
SY SK-Mel-408
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-41
AC CVCL_6038
SY SK-Mel-41; SKMEL-41; BH-Mel
DR Cosmic; 1669154
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-410
AC CVCL_1T69
SY SK-Mel-410
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-411
AC CVCL_1T70
SY SK-Mel-411
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-412Parotid
AC CVCL_1T71
SY SK-Mel-412Parotid
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-413-2
AC CVCL_1T72
SY SK-Mel-413-2
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-42
AC CVCL_6039
SY SK-Mel-42; BR-Mel
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-423A
AC CVCL_1T73
SY SK-Mel-423A
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T74 ! SK-MEL-423B
CA Cancer cell line
//
ID SK-MEL-423B
AC CVCL_1T74
SY SK-Mel-423B
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T73 ! SK-MEL-423A
CA Cancer cell line
//
ID SK-MEL-426
AC CVCL_1T75
SY SK-Mel-426
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-427
AC CVCL_1T76
SY SK-Mel-427
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-428
AC CVCL_1T77
SY SK-Mel-428
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-43
AC CVCL_U927
SY BS-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-MEL-430
AC CVCL_1T78
SY SK-Mel-430
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-431
AC CVCL_1T79
SY SK-Mel-431
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-432
AC CVCL_1T80
SY SK-Mel-432
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-435
AC CVCL_1T81
SY SK-Mel-435
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-439
AC CVCL_1T82
SY SK-Mel-439
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-44
AC CVCL_6040
SY SK-Mel 44; BT-Mel
DR Cosmic; 721827
RX PubMed=2983346;
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-441
AC CVCL_1T83
SY SK-Mel-441
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-444
AC CVCL_1T84
SY SK-Mel-444
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-445
AC CVCL_1T85
SY SK-Mel-445
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-446
AC CVCL_1T86
SY SK-Mel-446
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-447
AC CVCL_1T87
SY SK-Mel-447
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-45
AC CVCL_U928
SY BU-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-451
AC CVCL_1T88
SY SK-Mel-451
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-452
AC CVCL_1T89
SY SK-Mel-452
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-455
AC CVCL_1T90
SY SK-Mel-455
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-457
AC CVCL_1T91
SY SK-Mel-457
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-459
AC CVCL_1T92
SY SK-Mel-459
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-46
AC CVCL_U929
SY BV-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-462
AC CVCL_1T93
SY SK-Mel-462
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-464A
AC CVCL_1T94
SY SK-Mel-464a
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T95 ! SK-MEL-464B
CA Cancer cell line
//
ID SK-MEL-464B
AC CVCL_1T95
SY SK-Mel-464b
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T94 ! SK-MEL-464A
CA Cancer cell line
//
ID SK-MEL-47
AC CVCL_U930
SY BW-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-479
AC CVCL_1T96
SY SK-Mel-479
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-48
AC CVCL_U931
SY BX-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-481
AC CVCL_1T97
SY SK-Mel-481
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-483
AC CVCL_1T98
SY SK-Mel-483
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-49
AC CVCL_6229
SY BZ-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MEL-495
AC CVCL_1T99
SY SK-Mel-495
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-498
AC CVCL_1U00
SY SK-Mel-498
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-5
AC CVCL_0527
SY SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel
DR BTO; BTO:0002134
DR CLO; CLO_0009047
DR EFO; EFO_0005720
DR MCCL; MCC:0000427
DR CLDB; cl7123
DR ATCC; HTB-70
DR BioSample; SAMN03472753
DR CCLE; SKMEL5_SKIN
DR CGH-DB; 9316-4
DR ChEMBL-Cells; CHEMBL3307744
DR ChEMBL-Targets; CHEMBL614922
DR CLS; 300157/p634_SK-MEL-5
DR Cosmic; 686475
DR Cosmic; 688055
DR Cosmic; 875886
DR Cosmic; 905229
DR Cosmic; 905956
DR Cosmic; 932996
DR Cosmic; 974074
DR Cosmic; 974258
DR Cosmic; 1022282
DR Cosmic; 1092634
DR Cosmic; 1132588
DR Cosmic; 1175873
DR Cosmic; 1247851
DR Cosmic; 1303057
DR Cosmic; 1305369
DR Cosmic; 1312351
DR Cosmic; 1458967
DR Cosmic; 1459648
DR Cosmic; 1477410
DR Cosmic; 1481415
DR Cosmic; 1507626
DR Cosmic; 1669130
DR Cosmic; 1998477
DR Cosmic; 2159434
DR Cosmic; 2479253
DR Cosmic-CLP; 905956
DR ENCODE; ENCBS029HXQ
DR ENCODE; ENCBS324XRL
DR ENCODE; ENCBS398HNX
DR ENCODE; ENCBS465YNJ
DR ENCODE; ENCBS518AAA
DR ENCODE; ENCBS519AAA
DR ENCODE; ENCBS524EJL
DR ENCODE; ENCBS697RNA
DR ENCODE; ENCBS981ZNI
DR GDSC; 905956
DR GEO; GSM50206
DR GEO; GSM50268
DR GEO; GSM171011
DR GEO; GSM188227
DR GEO; GSM188257
DR GEO; GSM188316
DR GEO; GSM226866
DR GEO; GSM750826
DR GEO; GSM799358
DR GEO; GSM799421
DR GEO; GSM847117
DR GEO; GSM844691
DR GEO; GSM887589
DR GEO; GSM888672
DR GEO; GSM1138791
DR GEO; GSM1153429
DR GEO; GSM1181267
DR GEO; GSM1181310
DR GEO; GSM1670443
DR ICLC; HTL01023
DR KCLB; 30070
DR Lonza; 1202
DR SKY/M-FISH/CGH; 2821
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=2041050;
RX PubMed=7747814;
RX PubMed=7999427;
RX PubMed=11016658;
RX PubMed=15299072;
RX PubMed=15467732;
RX PubMed=17088437;
RX PubMed=17363583;
RX PubMed=17516929;
RX PubMed=19372543;
RX PubMed=21725359;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24576830;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=46
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-5
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-522.
CC Doubling time: 70 hours (PubMed=25984343); 25.2 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Axillary lymph node.
ST Source(s): ATCC; CLS; Cosmic-CLP; KCLB; PubMed=19372543
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 10,12
ST D16S539: 10,12
ST D18S51: 15,16
ST D19S433: 14,15
ST D21S11: 29
ST D2S1338: 17,25
ST D3S1358: 16,17
ST D5S818: 11,13
ST D7S820: 9,12
ST D8S1179: 12,15
ST FGA: 20.2,22.2
ST Penta D: 9,11
ST Penta E: 5,12
ST TH01: 6,9
ST TPOX: 11
ST vWA: 14,18 (ATCC; CLS; Cosmic-CLP; KCLB)
ST vWA: 14 (PubMed=19372543)
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-MEL-50
AC CVCL_U935
SY CA-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-506
AC CVCL_1U01
SY SK-Mel-506
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-507
AC CVCL_1U02
SY SK-Mel-507
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-509
AC CVCL_1U03
SY SK-Mel-509
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-51
AC CVCL_6041
SY CB-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-513
AC CVCL_1U04
SY SK-Mel-513
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-52
AC CVCL_8085
SY Sk-Mel-52; CC-Mel
DR Cosmic; 721828
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-524
AC CVCL_1U05
SY SK-Mel-524
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-529
AC CVCL_1U06
SY SK-Mel-529
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-534
AC CVCL_1U07
SY SK-Mel-534
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-538
AC CVCL_1U08
SY SK-Mel-538
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-55
AC CVCL_6042
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-56
AC CVCL_6046
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-57
AC CVCL_6043
SY CH-Mel
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-6
AC CVCL_U932
SY AB-Mel
RX PubMed=833871;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-MEL-60
AC CVCL_6047
SY CK-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-61
AC CVCL_6044
SY SK-Mel-61; CL-Mel
DR Cosmic; 721836
DR Cosmic; 923388
DR Cosmic; 933129
RX PubMed=2983346;
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-62
AC CVCL_8086
SY CM-Mel
DR Cosmic; 721837
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-63
AC CVCL_6045
SY SK-Mel-63; Sk Mel 63; SKMEL63; Sk Mel63; SkMel63; CN-Mel
DR Cosmic; 706095
DR Cosmic; 721811
DR Cosmic; 851040
DR Cosmic; 888838
DR Cosmic; 897477
DR Cosmic; 933130
DR Cosmic; 1054852
RX PubMed=1716514;
RX PubMed=6933476;
RX PubMed=10766161;
RX PubMed=15009714;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-64
AC CVCL_6048
SY SK-Mel-64; SKMEL-64; CO-Mel
DR Cosmic; 721838
DR Cosmic; 1669155
RX PubMed=2983346;
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-65
AC CVCL_6050
SY SK-Mel-65
DR Cosmic; 721815
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-68
AC CVCL_6051
SY CR-Mel
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-69
AC CVCL_6058
SY CS-Mel
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-7
AC CVCL_D854
SY SK-Mel-7; SKMEL-7; AC-Mel
DR Cosmic; 1669131
RX PubMed=327080;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-72
AC CVCL_6052
SY SK-Mel-72
DR Cosmic; 721839
DR Cosmic; 923389
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-73
AC CVCL_6053
SY SK-Mel-73; SKMEL-73
DR Cosmic; 721840
DR Cosmic; 1669156
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-75
AC CVCL_6054
SY SK-Mel-75; SKMEL-75
DR Cosmic; 721829
DR Cosmic; 933114
DR Cosmic; 1060424
DR Cosmic; 1669157
RX PubMed=6582512;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-76
AC CVCL_6221
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-78
AC CVCL_6056
SY SK-Mel-78; SKMEL78; DC-Mel
DR Cosmic; 721845
DR Cosmic; 1507606
DR Cosmic; 2233681
RX PubMed=2983346;
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-79
AC CVCL_6222
SY DD-Mel
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-8
AC CVCL_6960
SY AD-Mel
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=978138;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-80
AC CVCL_6057
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-81
AC CVCL_6223
DR Cosmic; 721846
RX PubMed=1716514;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-83
AC CVCL_6059
SY DH-Mel
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-85
AC CVCL_6224
SY SK-Mel-85; SK-MEL 85; SKMEL-85; SKMEL85; SK-MEL-085; DJ-Mel
DR Cosmic; 685204
DR Cosmic; 1669158
DR GEO; GSM555177
DR GEO; GSM784521
DR Lonza; 1334
RX PubMed=7747814;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-86
AC CVCL_6225
SY SK-Mel-86; DK-Mel
DR Cosmic; 923390
RX PubMed=6933476;
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-87
AC CVCL_6060
SY DL-Mel
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-88
AC CVCL_6049
SY SK-Mel-88; SKMEL88; DM-Mel
DR Cosmic; 721847
RX PubMed=2983346;
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-89
AC CVCL_6226
SY DN-Mel
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-9
AC CVCL_U934
SY AE-Mel
RX PubMed=327080;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-90
AC CVCL_6227
SY SK-Mel-90; SKMEL-90; DO-Mel
DR Cosmic; 1669159
RX PubMed=6864164;
RX PubMed=6933476;
RX PubMed=21725359;
RX PubMed=24576830;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-91
AC CVCL_6228
SY DP-Mel
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-93 DX-1
AC CVCL_5651
AS CVCL_3879; CVCL_U902
SY SK-MEL-93-DX-1; SK-MEL-93 DX1; SK-MEL-93 (DX1); DX-1; DX1; SK-MEL-93(1); SK-MEL-93-1; SK-MEL-93; SK-Mel-93; SK-MEL93; SKMel-93; SKMEL93; SKMel93
DR BTO; BTO:0002968
DR Cosmic; 721816
DR Cosmic; 926000
DR Cosmic; 933119
DR Cosmic; 1060426
RX PubMed=2886213;
RX PubMed=6864164;
RX PubMed=6976407;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Subcutaneous; left thigh.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5652 ! SK-MEL-93 DX-2
OI CVCL_5650 ! SK-MEL-93 DX-3
OI CVCL_A432 ! SK-MEL-93 DX-4
OI CVCL_A433 ! SK-MEL-93 DX-5
OI CVCL_A434 ! SK-MEL-93 DX-6
OI CVCL_A435 ! SK-MEL-93 DX-B
SX Female
CA Cancer cell line
//
ID SK-MEL-93 DX-2
AC CVCL_5652
AS CVCL_6062
SY SK-MEL-93-DX-2; SK-MEL-93 DX2; SK-MEL-93 (DX2); DX-2; DX2; SK-MEL-93(2); SK-MEL-93-2; DX-Mel-2
DR Cosmic; 721817
DR Cosmic; 926001
DR Cosmic; 933120
RX PubMed=1716514;
RX PubMed=2886213;
RX PubMed=2983346;
RX PubMed=3081645;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=6976407;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Hypodermis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5651 ! SK-MEL-93 DX-1
OI CVCL_5650 ! SK-MEL-93 DX-3
OI CVCL_A432 ! SK-MEL-93 DX-4
OI CVCL_A433 ! SK-MEL-93 DX-5
OI CVCL_A434 ! SK-MEL-93 DX-6
OI CVCL_A435 ! SK-MEL-93 DX-B
SX Female
CA Cancer cell line
//
ID SK-MEL-93 DX-3
AC CVCL_5650
AS CVCL_U903
SY SK-MEL-93-DX-3; SK-MEL-93 DX3; SK-MEL-93 (DX3); DX-3; DX3; SK-MEL-93(3); SK-MEL-93-3; DX-Mel-3
DR BTO; BTO:0003988
DR Cosmic; 721806
DR Cosmic; 926002
DR Cosmic; 932703
DR Cosmic; 933121
DR KCLB; 80012
RX PubMed=1716514;
RX PubMed=2886213;
RX PubMed=2983346;
RX PubMed=6582512;
RX PubMed=6976407;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Hypodermis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5651 ! SK-MEL-93 DX-1
OI CVCL_5652 ! SK-MEL-93 DX-2
OI CVCL_A432 ! SK-MEL-93 DX-4
OI CVCL_A433 ! SK-MEL-93 DX-5
OI CVCL_A434 ! SK-MEL-93 DX-6
OI CVCL_A435 ! SK-MEL-93 DX-B
SX Female
CA Cancer cell line
//
ID SK-MEL-93 DX-4
AC CVCL_A432
AS CVCL_U904
SY SK-MEL-93-DX-4; SK-MEL-93 DX4; SK-MEL-93 (DX4); DX-4; DX4; SK-MEL-93(4); DX-Mel-4
DR Cosmic; 721818
DR Cosmic; 926003
DR Cosmic; 933122
RX PubMed=1716514;
RX PubMed=2886213;
RX PubMed=2983346;
RX PubMed=6976407;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Hypodermis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5651 ! SK-MEL-93 DX-1
OI CVCL_5652 ! SK-MEL-93 DX-2
OI CVCL_5650 ! SK-MEL-93 DX-3
OI CVCL_A433 ! SK-MEL-93 DX-5
OI CVCL_A434 ! SK-MEL-93 DX-6
OI CVCL_A435 ! SK-MEL-93 DX-B
SX Female
CA Cancer cell line
//
ID SK-MEL-93 DX-5
AC CVCL_A433
AS CVCL_U905
SY SK-MEL-93-DX-5; SK-MEL-93 DX5; SK-MEL-93 (DX5); DX-5; DX5; SK-MEL-93(5)
DR Cosmic; 721819
DR Cosmic; 926004
DR Cosmic; 933123
RX PubMed=2886213;
RX PubMed=6976407;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Hypodermis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5651 ! SK-MEL-93 DX-1
OI CVCL_5652 ! SK-MEL-93 DX-2
OI CVCL_5650 ! SK-MEL-93 DX-3
OI CVCL_A432 ! SK-MEL-93 DX-4
OI CVCL_A434 ! SK-MEL-93 DX-6
OI CVCL_A435 ! SK-MEL-93 DX-B
SX Female
CA Cancer cell line
//
ID SK-MEL-93 DX-6
AC CVCL_A434
AS CVCL_U906
SY SK-MEL-93-DX-6; SK-MEL-93 DX 6; SK-MEL-93 DX6; SK-MEL-93 (DX6); DX-6; DX6; SK-MEL-93(6); DX-Mel-6
DR Cosmic; 721820
DR Cosmic; 926005
DR Cosmic; 933124
RX PubMed=1716514;
RX PubMed=2886213;
RX PubMed=2983346;
RX PubMed=6976407;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Hypodermis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5651 ! SK-MEL-93 DX-1
OI CVCL_5652 ! SK-MEL-93 DX-2
OI CVCL_5650 ! SK-MEL-93 DX-3
OI CVCL_A432 ! SK-MEL-93 DX-4
OI CVCL_A433 ! SK-MEL-93 DX-5
OI CVCL_A435 ! SK-MEL-93 DX-B
SX Female
CA Cancer cell line
//
ID SK-MEL-93 DX-B
AC CVCL_A435
SY DX-B; DX B
RX PubMed=2886213;
RX PubMed=6976407;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5651 ! SK-MEL-93 DX-1
OI CVCL_5652 ! SK-MEL-93 DX-2
OI CVCL_5650 ! SK-MEL-93 DX-3
OI CVCL_A432 ! SK-MEL-93 DX-4
OI CVCL_A433 ! SK-MEL-93 DX-5
OI CVCL_A434 ! SK-MEL-93 DX-6
SX Female
CA Transformed cell line
//
ID SK-MEL-94
AC CVCL_3880
SY SK-Mel-94; SKMEL94
DR Cosmic; 685205
DR Cosmic; 1122256
DR GEO; GSM555178
DR Lonza; 1335
RX PubMed=7747814;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-95
AC CVCL_6064
SY DT-Mel
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-96
AC CVCL_U939
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-97
AC CVCL_6065
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MEL-98
AC CVCL_6066
SY DW-Mel
RX PubMed=6933476;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MES-1
AC CVCL_0630
AS CVCL_8913
SY SK MES 1; SKMES-1; SK-Mes-1; SKMES1; SK-MES; SKMES
DR BTO; BTO:0002203
DR CLO; CLO_0009033
DR CLO; CLO_0009048
DR CLO; CLO_0009049
DR EFO; EFO_0002334
DR CLDB; cl4325
DR CLDB; cl4326
DR CLDB; cl4329
DR ATCC; HTB-58
DR BioSample; SAMN03473164
DR CCLE; SKMES1_LUNG
DR CCRID; 3111C0001CCC000262
DR CCRID; 3131C0001000700110
DR CGH-DB; 191-1
DR CGH-DB; 9180-4
DR ChEMBL-Cells; CHEMBL3307450
DR ChEMBL-Cells; CHEMBL3308366
DR ChEMBL-Targets; CHEMBL613528
DR ChEMBL-Targets; CHEMBL614923
DR CLS; 300339/p1465_SK-MES-1
DR Cosmic; 687832
DR Cosmic; 909728
DR Cosmic; 933577
DR Cosmic; 934464
DR Cosmic; 1006538
DR Cosmic; 1071896
DR Cosmic; 1089225
DR Cosmic; 1176620
DR Cosmic; 1219089
DR Cosmic; 1239912
DR Cosmic; 1434962
DR Cosmic; 1995637
DR Cosmic; 2060529
DR Cosmic; 2125289
DR Cosmic-CLP; 909728
DR DSMZ; ACC-353
DR ECACC; 91091804
DR ECACC; 93120837
DR GDSC; 909728
DR GEO; GSM62971
DR GEO; GSM206544
DR GEO; GSM513971
DR GEO; GSM514561
DR GEO; GSM784266
DR GEO; GSM827318
DR GEO; GSM887590
DR GEO; GSM888673
DR GEO; GSM1374881
DR GEO; GSM1670444
DR ICLC; HTL95004
DR IGRhCellID; SKMES1
DR IZSLER; BS TCL 72
DR LINCS; 50043
DR KCB; KCB 200821YJ
DR KCLB; 30058
DR NCBI_Iran; C562
DR TOKU-E; 3142
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=833871;
RX PubMed=2990217;
RX PubMed=6935474;
RX PubMed=7736387;
RX PubMed=14581340;
RX PubMed=15746151;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mes-1-lung-cell-line
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2009-091.
CC Doubling time: ~50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ECACC; 91091804; probable.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 13
ST D18S51: 17
ST D21S11: 29,30
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8
ST D8S1179: 13,14
ST FGA: 20,24
ST Penta D: 12,13
ST Penta E: 5,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MG-1
AC CVCL_1698
SY SKMG1; AJ
DR BioSample; SAMN03151837
DR BioSample; SAMN03472786
DR ChEMBL-Cells; CHEMBL3308547
DR ChEMBL-Targets; CHEMBL2366151
DR Cosmic; 909729
DR Cosmic; 2367547
DR Cosmic-CLP; 909729
DR GDSC; 909729
DR GEO; GSM1670445
DR IFO; IFO50344
RX PubMed=6182568;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=20143388;
RX PubMed=27397505;
WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Marcus derivative (PubMed=20143388).
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: IFO; IFO50344; probable.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 12,15
ST D13S317: 11
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 9,11 (Cosmic-CLP)
ST D7S820: 9 (JCRB)
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3019 ! Marcus
SX Female
CA Cancer cell line
//
ID SK-MG-10
AC CVCL_8568
RX PubMed=6182568;
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-11
AC CVCL_8569
RX PubMed=6182568;
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-12
AC CVCL_8570
RX PubMed=6182568;
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-13
AC CVCL_8571
RX PubMed=6182568;
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-14
AC CVCL_GS21
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-15
AC CVCL_8572
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-16
AC CVCL_8573
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-17
AC CVCL_8574
SY SK-MG 17
DR Cosmic; 1038408
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-2
AC CVCL_8575
RX PubMed=6182568;
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-21
AC CVCL_Y195
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-26
AC CVCL_D701
SY SK-MG 26; SKMG26
DR Cosmic; 1038414
DR Cosmic; 1672407
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-3
AC CVCL_8576
SY SKMG-3; SKMG3
DR Cosmic; 847808
DR Cosmic; 1175819
DR Cosmic; 1217676
DR Cosmic; 2550360
RX PubMed=2994648;
RX PubMed=6182568;
RX PubMed=6582512;
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-4
AC CVCL_8577
SY SKMG4; SK-MG4
RX PubMed=6182568;
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-5
AC CVCL_GS19
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-6
AC CVCL_GS20
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-7
AC CVCL_8578
RX PubMed=6182568;
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-8
AC CVCL_Y196
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MG-9
AC CVCL_8579
SY SK-MG 9
DR Cosmic; 1038409
RX PubMed=6182568;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-MM-1
AC CVCL_A478
SY SK-MM1; SKMM-1; SKMM1; SK-MY-1; SK-My-1
DR EFO; EFO_0005457
DR BioSample; SAMN03470877
DR Cosmic; 720782
DR Cosmic; 760399
DR Cosmic; 2081407
DR Cosmic; 2302414
DR Cosmic; 2367273
DR Cosmic; 2391803
DR DSMZ; ACC-758
DR GEO; GSM143343
DR SKY/M-FISH/CGH; 2544
RX PubMed=2506399;
RX PubMed=6582512;
RX PubMed=8943038;
RX PubMed=10557056;
RX PubMed=10936422;
RX PubMed=11429052;
RX PubMed=12886255;
RX PubMed=17171682;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-multiple-myeloma-cell-line-sk-mm-1
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 440.
CC Doubling time: ~48 hours (DSMZ).
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 13,14
ST D18S51: 16,17
ST D19S433: 13
ST D21S11: 28,32
ST D2S1338: 22,26
ST D3S1358: 14,17
ST D5S818: 8,11
ST D7S820: 8,12
ST D8S1179: 14
ST FGA: 24
ST Penta D: 2.2,13
ST Penta E: 10,12
ST TH01: 7
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-MM-2
AC CVCL_1699
SY SK-MM2; SKMM-2; SKMM2
DR CLO; CLO_0009050
DR EFO; EFO_0005458
DR BioSample; SAMN03472942
DR CCLE; SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308277
DR ChEMBL-Targets; CHEMBL2366232
DR Cosmic; 720793
DR Cosmic; 753612
DR Cosmic; 2081408
DR Cosmic; 2302409
DR Cosmic; 2367263
DR Cosmic-CLP; 753612
DR DSMZ; ACC-430
DR GDSC; 753612
DR GEO; GSM887591
DR GEO; GSM888674
DR GEO; GSM1374882
DR GEO; GSM1670446
RX PubMed=2506399;
RX PubMed=8943038;
RX PubMed=10936422;
RX PubMed=21173094;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-multiple-myeloma-cell-line-sk-mm-2
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1989-002.
CC Doubling time: 85 hours (PubMed=25984343); ~100 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 11
ST D18S51: 11
ST D21S11: 30,31.2
ST D3S1358: 16
ST D5S818: 9,11
ST D7S820: 8,11
ST D8S1179: 12,13
ST FGA: 21
ST Penta D: 11,15
ST Penta E: 10,20
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,20
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-N-AS
AC CVCL_1700
SY SKN-AS; SKNAS
DR BTO; BTO:0002827
DR CLO; CLO_0009051
DR EFO; EFO_0002859
DR CLDB; cl4330
DR CLDB; cl4331
DR ATCC; CRL-2137
DR BioSample; SAMN03473210
DR CCLE; SKNAS_AUTONOMIC_GANGLIA
DR CGH-DB; 61-1
DR CGH-DB; 9098-4
DR ChEMBL-Cells; CHEMBL3308785
DR ChEMBL-Targets; CHEMBL1075578
DR Cosmic; 724828
DR Cosmic; 848935
DR Cosmic; 930074
DR Cosmic; 1019941
DR Cosmic; 1109104
DR Cosmic; 1162002
DR Cosmic; 1167418
DR Cosmic; 1518070
DR Cosmic; 1526646
DR Cosmic; 1543772
DR Cosmic; 2058112
DR Cosmic; 2239472
DR Cosmic; 2393642
DR Cosmic; 2485950
DR Cosmic-CLP; 724828
DR ECACC; 94092302
DR GDSC; 724828
DR GEO; GSM563352
DR GEO; GSM692855
DR GEO; GSM887592
DR GEO; GSM888675
DR GEO; GSM1670449
DR ICLC; HTL95026
DR IGRhCellID; SKNAS
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX DOI=10.1159/00040702;
RX PubMed=2987426;
RX PubMed=7838528;
RX PubMed=11550280;
RX PubMed=12702577;
RX PubMed=22213050;
RX PubMed=22460905;
RX PubMed=23202128;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=SK-N-AS
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-509.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9
ST D16S539: 14
ST D18S51: 14,15
ST D21S11: 32.2,33.2
ST D3S1358: 14
ST D5S818: 11,12
ST D7S820: 11,13
ST D8S1179: 13,14
ST FGA: 20,22
ST Penta D: 9
ST Penta E: 7,14
ST TH01: 9.3
ST TPOX: 11,12
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-N-BE(1)
AC CVCL_9898
SY SKNBE(1); SKNBE-1
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=29704;
RX PubMed=2535691;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/SK-N-BE1_Cell_Line_Data_Sheet_COGcell_org.pdf
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Bone marrow.
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 9,11
ST D18S51: 14,16
ST D19S433: 12,13
ST D21S11: 30,32.2
ST D2S1338: 17,23
ST D3S1358: 19
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 22,25
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0528 ! SK-N-BE(2)
SX Male
CA Cancer cell line
//
ID SK-N-BE(2)
AC CVCL_0528
SY SK-N-BE2; SKNBE(2); SKNBE-2; SKNBE2; SK-N-BE; SKNBE
DR BTO; BTO:0002696
DR CLO; CLO_0009052
DR MCCL; MCC:0000505
DR CLDB; cl4332
DR CLDB; cl4333
DR ATCC; CRL-2271
DR BCRJ; 0381
DR BioSample; SAMN03472880
DR BioSample; SAMN03473451
DR CCLE; SKNBE2_AUTONOMIC_GANGLIA
DR Cosmic; 1019928
DR Cosmic; 2485941
DR DSMZ; ACC-632
DR ECACC; 95011815
DR GEO; GSM554389
DR GEO; GSM563358
DR GEO; GSM692869
DR GEO; GSM827352
DR GEO; GSM887593
DR GEO; GSM888676
DR GEO; GSM1366411
DR GEO; GSM1670450
DR ICLC; HTL96015
DR KCB; KCB 201199YJ
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1007/978-1-4757-1647-4_13;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=29704;
RX PubMed=62055;
RX PubMed=2535691;
RX PubMed=6582512;
RX PubMed=7838528;
RX PubMed=11550280;
RX PubMed=20631050;
RX PubMed=22213050;
RX PubMed=22460905;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/SK-N-BE2_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-565.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-be-2-human-neuroblastoma-cell-line
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-530.
CC Doubling time: ~36 hours (DSMZ).
CC Omics: Array-based CGH.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; COG; DSMZ; PubMed=25877200
ST Amelogenin: X,Y (ATCC; COG; PubMed=25877200)
ST Amelogenin: X (DSMZ)
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 9,11
ST D18S51: 16 (COG)
ST D18S51: 14,16 (PubMed=25877200)
ST D19S433: 12,13
ST D21S11: 30,32.2 (COG)
ST D21S11: 30,31,32.2 (PubMed=25877200)
ST D2S1338: 17,23
ST D3S1358: 19
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 22,25
ST Penta D: 13,14
ST Penta E: 14,18
ST TH01: 6,7 (ATCC; COG; PubMed=25877200)
ST TH01: 6 (DSMZ)
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9898 ! SK-N-BE(1)
SX Male
CA Cancer cell line
//
ID SK-N-BE(2)-C
AC CVCL_0529
SY SK-N-BE(2)C; SK-N-BE-2c; SK-N-BE(2C); SK-N-BE2C; SK_N_BE2C; BE(2)-C; BE(2)C; BE2-C; BE2_C; Be2-C; BE2C; Be2C
DR BTO; BTO:0004782
DR CLO; CLO_0001915
DR CLO; CLO_0009053
DR EFO; EFO_0005725
DR MCCL; MCC:0000428
DR CLDB; cl413
DR CLDB; cl4334
DR ATCC; CRL-2268
DR BioSample; SAMN03471855
DR Cosmic; 688061
DR Cosmic; 922659
DR Cosmic; 1162003
DR Cosmic; 1167421
DR Cosmic; 1526648
DR ECACC; 95011817
DR ENCODE; ENCBS271SFD
DR ENCODE; ENCBS403ENC
DR ENCODE; ENCBS427ENC
DR ENCODE; ENCBS982TUR
DR GEO; GSM651567
DR GEO; GSM651568
DR GEO; GSM945241
DR GEO; GSM945283
DR GEO; GSM923434
DR ICLC; HTL96018
DR IGRhCellID; BE2C
DR NCBI_Iran; C577
DR PRIDE; PXD003596
RX PubMed=1985865;
RX PubMed=2535691;
RX PubMed=6582512;
RX PubMed=23202128;
RX PubMed=23325432;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/BE2-C_Myers_protocol.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-162.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-be-2-c-human-neuroblastoma-cell-line
CC Part of: ENCODE project common cell types; tier 3.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-532.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; ECACC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 11
ST vWA: 18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0528 ! SK-N-BE(2)
SX Male
CA Cancer cell line
//
ID SK-N-BE(2)-M17
AC CVCL_0167
SY BE(2)-M17; BE(2)M17; BE(2)M-17; BE2-M17
DR BTO; BTO:0002104
DR CLO; CLO_0001916
DR MCCL; MCC:0000059
DR CLDB; cl407
DR ATCC; CRL-2267
DR BioSample; SAMN03471024
DR BioSample; SAMN03472366
DR CCRID; 3111C0001CCC000076
DR Cosmic; 753616
DR Cosmic; 1167416
DR Cosmic-CLP; 753616
DR ECACC; 95011816
DR GDSC; 753616
DR GEO; GSM1669614
DR JCRB; JCRB9131
DR JCRB; NIHS0221
DR Lonza; 1236
DR NCBI_Iran; C614
RX PubMed=2535691;
RX PubMed=27397505;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-be-2-m17-human-neuroblastoma-cell-line
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-531.
CC Doubling time: 20-24 hours (ECACC).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: JCRB; JCRB9131; true.
CC Discontinued: JCRB; NIHS0221; true.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11
ST D18S51: 14
ST D19S433: 12,13
ST D21S11: 30,32.2
ST D2S1338: 17,23
ST D3S1358: 19
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 22,25
ST Penta D: 13,14
ST Penta E: 14,18
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18 (ATCC; ECACC; PubMed=25877200)
ST vWA: 17,18 (Cosmic-CLP; JCRB)
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0528 ! SK-N-BE(2)
SX Male
CA Cancer cell line
//
ID SK-N-DZ
AC CVCL_1701
SY SKNDZ
DR BTO; BTO:0004217
DR CLO; CLO_0009054
DR EFO; EFO_0005721
DR CLDB; cl4335
DR ATCC; CRL-2149
DR BioSample; SAMN03473093
DR CCLE; SKNDZ_AUTONOMIC_GANGLIA
DR CGH-DB; 77-1
DR CGH-DB; 9094-4
DR ChEMBL-Cells; CHEMBL3308474
DR ChEMBL-Targets; CHEMBL1075579
DR Cosmic; 688086
DR Cosmic; 897447
DR Cosmic; 930076
DR Cosmic; 1019931
DR Cosmic; 1109370
DR Cosmic; 1162004
DR Cosmic; 1167415
DR Cosmic; 2058115
DR Cosmic; 2485951
DR Cosmic-CLP; 688086
DR ECACC; 94092305
DR ENCODE; ENCBS373BOT
DR ENCODE; ENCBS439FDS
DR ENCODE; ENCBS478IFE
DR ENCODE; ENCBS514GVM
DR ENCODE; ENCBS520AAA
DR ENCODE; ENCBS521AAA
DR ENCODE; ENCBS580YYW
DR ENCODE; ENCBS707BMT
DR ENCODE; ENCBS715HTH
DR ENCODE; ENCBS773LCT
DR ENCODE; ENCBS893THB
DR GDSC; 688086
DR GEO; GSM887594
DR GEO; GSM888677
DR GEO; GSM1366412
DR GEO; GSM1670451
DR IGRhCellID; SKNDZ
DR Lonza; 1190
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX DOI=10.1159/00040702;
RX PubMed=2987426;
RX PubMed=12702577;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,11
ST D18S51: 15,17
ST D21S11: 29,31
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 12,13
ST D8S1179: 12,13
ST FGA: 18,22
ST Penta D: 9,14
ST Penta E: 7,10
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-N-FI
AC CVCL_1702
SY SK_N_FI; SKNFI; SK-N-F1; SKNF1
DR BTO; BTO:0004218
DR CLO; CLO_0009056
DR CLO; CLO_0009057
DR EFO; EFO_0002338
DR CLDB; cl4336
DR CLDB; cl4337
DR ATCC; CRL-2142
DR BioSample; SAMN03473095
DR CCLE; SKNFI_AUTONOMIC_GANGLIA
DR ChEMBL-Cells; CHEMBL3308278
DR ChEMBL-Targets; CHEMBL2366120
DR Cosmic; 688087
DR Cosmic; 930077
DR Cosmic; 965555
DR Cosmic; 1019946
DR Cosmic; 1109102
DR Cosmic; 1162005
DR Cosmic; 1212540
DR Cosmic; 1518064
DR Cosmic; 1526649
DR Cosmic; 1543769
DR Cosmic; 2058111
DR Cosmic; 2393644
DR Cosmic-CLP; 688087
DR ECACC; 94092304
DR GDSC; 688087
DR GEO; GSM393037
DR GEO; GSM692854
DR GEO; GSM827414
DR GEO; GSM887595
DR GEO; GSM888678
DR GEO; GSM1670453
DR ICLC; HTL97020
DR IGRhCellID; SKNFI
DR IGRhCellID; SKNFI%20GEO
DR Lonza; 1196
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX DOI=10.1159/00040702;
RX PubMed=2987426;
RX PubMed=7838528;
RX PubMed=11550280;
RX PubMed=15150091;
RX PubMed=22213050;
RX PubMed=22460905;
RX PubMed=23202128;
RX PubMed=24792489;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.cogcell.org/dl/NB_Data_Sheets/SK-N-FI_Cell_Line_Data_Sheet_COGcell_org.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SN-N-FI' in Cosmic 2393644.
ST Source(s): ATCC; COG; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,14
ST D16S539: 11,12
ST D18S51: 12,14
ST D19S433: 12
ST D21S11: 28,30
ST D2S1338: 17,18
ST D3S1358: 16,18
ST D5S818: 12,13
ST D7S820: 8,9
ST D8S1179: 11,12
ST FGA: 22
ST Penta D: 2.2,13
ST Penta E: 11,20
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-N-LE
AC CVCL_5G80
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2987426;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-N-LO
AC CVCL_4569
SY SK-N-L0; SKN-LO; SKNLO
DR BTO; BTO:0004787
DR CLS; 300400/p758_SK-N-LO
DR Cosmic; 1078368
DR Cosmic; 1212539
DR GEO; GSM393039
DR IGRhCellID; SKNLO%20GEO
RX DOI=10.1159/00040702;
RX PubMed=2987426;
RX PubMed=7591257;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Caution: It is not certain if this is a neuroblastoma cell line as indicated by CLS or an Ewing sarcoma cell line as indicated in PubMed=7591257.
ST Source(s): CLS; COG
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 12
ST D18S51: 12
ST D19S433: 13,14
ST D21S11: 27,28
ST D2S1338: 16,20
ST D3S1358: 14,17
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 12,15
ST FGA: 25 (CLS)
ST FGA: 20,25 (COG)
ST Penta D: 9,13
ST Penta E: 7
ST TH01: 10
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-N-MC
AC CVCL_0530
SY SKNMC; SK-NM-C; SK-NMC
DR BTO; BTO:0002914
DR CLO; CLO_0009058
DR EFO; EFO_0002860
DR MCCL; MCC:0000429
DR CLDB; cl4338
DR CLDB; cl4339
DR CLDB; cl4340
DR CLDB; cl4341
DR CLDB; cl4342
DR CLDB; cl4343
DR ATCC; HTB-10
DR BioSample; SAMN01821666
DR BioSample; SAMN03151999
DR CCLE; SKNMC_BONE
DR CCRID; 3111C0001CCC000263
DR CCRID; 3131C0001000700050
DR ChEMBL-Cells; CHEMBL3307551
DR ChEMBL-Targets; CHEMBL614163
DR CLS; 300340/p797_SK-N-MC
DR Cosmic; 753613
DR Cosmic; 897448
DR Cosmic; 922655
DR Cosmic; 1078367
DR Cosmic; 1078391
DR Cosmic; 1082511
DR Cosmic; 1084314
DR Cosmic; 2228233
DR Cosmic; 2250468
DR Cosmic; 2301579
DR DSMZ; ACC-203
DR ECACC; 90022302
DR ENCODE; ENCBS203EZT
DR ENCODE; ENCBS366AET
DR ENCODE; ENCBS400ENC
DR ENCODE; ENCBS426ENC
DR ENCODE; ENCBS556HGY
DR GEO; GSM393038
DR GEO; GSM510009
DR GEO; GSM824868
DR GEO; GSM824869
DR GEO; GSM887596
DR GEO; GSM888679
DR GEO; GSM945247
DR GEO; GSM945264
DR GEO; GSM1676318
DR GEO; GSM1701651
DR IGRhCellID; SKNMC%20GEO
DR IZSLER; BS TCL 93
DR KCB; KCB 2012033YJ
DR KCLB; 30010
DR Lonza; 82
DR NCBI_Iran; C535
DR TOKU-E; 3148
RX DOI=10.1007/978-1-4757-1647-4_13;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=29704;
RX PubMed=62055;
RX PubMed=327080;
RX PubMed=2987426;
RX PubMed=4748425;
RX PubMed=6582512;
RX PubMed=7037175;
RX PubMed=7459858;
RX PubMed=7591257;
RX PubMed=8617485;
RX PubMed=19787792;
RX PubMed=20143388;
RX PubMed=22460905;
RX PubMed=23325432;
RX PubMed=24312454;
RX PubMed=25010205;
RX PubMed=25223734;
RX PubMed=26351324;
WW http://genome.ucsc.edu/encode/protocols/cell/human/SK-N-MC_protocol.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-97.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-mc-human-neuroblastoma-cell-line
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor (PubMed=20143388).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 776.
CC Doubling time: ~48 hours (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Supra-orbital region.
ST Source(s): ATCC; CLS; COG; DSMZ; KCLB; PubMed=24312454
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D18S51: 13,14
ST D19S433: 13,15.2
ST D21S11: 30,31.2
ST D2S1338: 17,21
ST D3S1358: 15 (CLS; KCLB)
ST D3S1358: 15,16 (PubMed=24312454)
ST D5S818: 11
ST D7S820: 8
ST D8S1179: 10
ST FGA: 21,25
ST Penta D: 9,13
ST Penta E: 16,18
ST TH01: 9.3
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C7542; Askin tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-N-MC-IXC
AC CVCL_1398
SY MC-IXC; MCIXC
DR BTO; BTO:0005372
DR CLO; CLO_0007615
DR EFO; EFO_0002230
DR ATCC; CRL-2270
DR BioSample; SAMN03472918
DR ChEMBL-Cells; CHEMBL3308758
DR ChEMBL-Targets; CHEMBL1075495
DR Cosmic; 688068
DR Cosmic; 908118
DR Cosmic-CLP; 908118
DR GDSC; 908118
DR GEO; GSM1670077
DR IGRhCellID; MCIXC
DR TOKU-E; 4055
RX PubMed=4748425;
RX PubMed=27397505;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-mc-ixc-human-neuroblastoma-cell-line
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2010-067.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Supra-orbital region.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D18S51: 13,14,15
ST D19S433: 13,15.2
ST D21S11: 30,31.2
ST D2S1338: 17,21
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 8
ST D8S1179: 10
ST FGA: 21,25
ST Penta D: 9,13
ST Penta E: 16,18
ST TH01: 9.3
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C7542; Askin tumor
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0530 ! SK-N-MC
SX Female
CA Cancer cell line
//
ID SK-N-PI
AC CVCL_S664
SY SK-N-P1
DR Cosmic; 1078366
DR GEO; GSM393036
DR IGRhCellID; SKNPI%20GEO
RX PubMed=7591257;
CC Miscellaneous: Only mentioned as a Ewing sarcoma cell line in PubMed=7591257.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-N-RA
AC CVCL_AQ53
RX DOI=10.1159/00040702;
RX PubMed=24792489;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9
ST D16S539: 14
ST D18S51: 14,15
ST D19S433: 12,14
ST D21S11: 32.2,33.2
ST D2S1338: 17,24
ST D3S1358: 14
ST D5S818: 11,12
ST D7S820: 11,13
ST D8S1179: 13,14
ST FGA: 20,22
ST TH01: 9.3
ST TPOX: 11,12
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-N-SH
AC CVCL_0531
SY SK N SH; SKN-SH; SK-NSH; SKNSH; NSH
DR BTO; BTO:0001620
DR CLO; CLO_0009059
DR CLO; CLO_0050268
DR EFO; EFO_0003072
DR MCCL; MCC:0000430
DR CLDB; cl4345
DR CLDB; cl4347
DR CLDB; cl4348
DR CLDB; cl4349
DR CLDB; cl4351
DR CLDB; cl4352
DR ATCC; HTB-11
DR BioSample; SAMN01821600
DR BioSample; SAMN03472879
DR CCLE; SKNSH_AUTONOMIC_GANGLIA
DR CCRID; 3111C0001CCC000086
DR CCRID; 3131C0001000700051
DR CCRID; 3142C0001000000047
DR CGH-DB; 62-1
DR CGH-DB; 9093-4
DR ChEMBL-Cells; CHEMBL3307745
DR ChEMBL-Targets; CHEMBL614924
DR Cosmic; 697284
DR Cosmic; 717431
DR Cosmic; 801743
DR Cosmic; 848936
DR Cosmic; 922656
DR Cosmic; 923830
DR Cosmic; 930078
DR Cosmic; 947706
DR Cosmic; 1019929
DR Cosmic; 1037355
DR Cosmic; 1078393
DR Cosmic; 1082519
DR Cosmic; 1099151
DR Cosmic; 1109108
DR Cosmic; 1109371
DR Cosmic; 1153800
DR Cosmic; 1153806
DR Cosmic; 1162006
DR Cosmic; 1167420
DR Cosmic; 1167993
DR Cosmic; 1518079
DR Cosmic; 1526640
DR Cosmic; 2058116
DR Cosmic; 2131595
DR Cosmic; 2239469
DR Cosmic; 2393645
DR Cosmic; 2485952
DR Cosmic-CLP; 717431
DR ECACC; 86012802
DR ENCODE; ENCBS018DDZ
DR ENCODE; ENCBS324TZB
DR ENCODE; ENCBS360ENC
DR ENCODE; ENCBS361ENC
DR ENCODE; ENCBS362ENC
DR ENCODE; ENCBS363ENC
DR ENCODE; ENCBS364ENC
DR ENCODE; ENCBS365ENC
DR ENCODE; ENCBS376ENC
DR ENCODE; ENCBS428ENC
DR ENCODE; ENCBS433ENC
DR ENCODE; ENCBS434ENC
DR ENCODE; ENCBS435ENC
DR ENCODE; ENCBS436ENC
DR ENCODE; ENCBS437ENC
DR ENCODE; ENCBS438ENC
DR ENCODE; ENCBS489AAA
DR ENCODE; ENCBS490AAA
DR ENCODE; ENCBS491AAA
DR ENCODE; ENCBS492AAA
DR ENCODE; ENCBS495AAA
DR ENCODE; ENCBS500EWH
DR ENCODE; ENCBS592MTQ
DR GDSC; 717431
DR GEO; GSM314027
DR GEO; GSM333814
DR GEO; GSM563357
DR GEO; GSM692864
DR GEO; GSM887597
DR GEO; GSM888680
DR GEO; GSM923419
DR GEO; GSM1008585
DR GEO; GSM1622296
DR GEO; GSM1670454
DR ICLC; HTL96019
DR IZSLER; BS TCL 143
DR KCB; KCB 200426YJ
DR KCLB; 30011
DR Lonza; 80
DR RCB; RCB0426
DR TOKU-E; 3149
DR Wikidata; Q28308636
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1007/978-1-4757-1647-4_13;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX DOI=10.1159/00040702;
RX PubMed=29704;
RX PubMed=62055;
RX PubMed=833871;
RX PubMed=922665;
RX PubMed=2535691;
RX PubMed=2846152;
RX PubMed=2987426;
RX PubMed=4748425;
RX PubMed=6582512;
RX PubMed=6888561;
RX PubMed=6935474;
RX PubMed=7037175;
RX PubMed=7838528;
RX PubMed=8617485;
RX PubMed=10074188;
RX PubMed=11550280;
RX PubMed=12702577;
RX PubMed=18923524;
RX PubMed=22213050;
RX PubMed=22460905;
RX PubMed=23325432;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/SK-N-SH_Myers_protocol.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-398.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-neuroblastoma-cell-line-sk-n-sh
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-529.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'SK-N-CH'.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 8,13
ST D18S51: 13,16
ST D21S11: 31,31.2
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 7,10
ST D8S1179: 15
ST FGA: 23.2,24
ST Penta D: 10,12
ST Penta E: 7,11
ST TH01: 7,10
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-N-SH_RA
AC CVCL_D044
SY SK-N-SH Retinoic acid
DR EFO; EFO_0002802
DR ENCODE; ENCBS172JMM
DR ENCODE; ENCBS366ENC
DR ENCODE; ENCBS367ENC
DR ENCODE; ENCBS404ENC
DR ENCODE; ENCBS606NNZ
DR ENCODE; ENCBS718MJZ
DR ENCODE; ENCBS767VYD
DR ENCODE; ENCBS799ICU
DR GEO; GSM472912
DR GEO; GSM472913
DR GEO; GSM472917
DR GEO; GSM945202
DR GEO; GSM945209
DR GEO; GSM945210
DR GEO; GSM945317
RX PubMed=23325432;
CC Part of: ENCODE project common cell types; tier 3.
CC Omics: DNA methylation analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0531 ! SK-N-SH
SX Female
CA Cancer cell line
//
ID SK-Neo
AC CVCL_8597
SY SKNeo
RX PubMed=9717829;
RX PubMed=17513613;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
DI NCIt; C40318; Vulvar leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0628 ! SK-LMS-1
SX Female
CA Cancer cell line
//
ID SK-NEP-1
AC CVCL_0631
SY SKNEP-1; SKNEP1; SKNEP
DR CLO; CLO_0009055
DR EFO; EFO_0002337
DR CLDB; cl4353
DR ATCC; HTB-48
DR BioSample; SAMN03472745
DR ChEMBL-Cells; CHEMBL3308141
DR ChEMBL-Targets; CHEMBL1075580
DR CLS; 300341/p618_SK-NEP-1
DR Cosmic; 688125
DR Cosmic; 909730
DR Cosmic; 1112129
DR Cosmic; 1196558
DR Cosmic; 2060801
DR Cosmic; 2228232
DR Cosmic; 2294587
DR Cosmic-CLP; 909730
DR GDSC; 909730
DR GEO; GSM827180
DR GEO; GSM845556
DR GEO; GSM844692
DR GEO; GSM1670452
DR IGRhCellID; SKNEP1
DR IZSLER; BS TCL 61
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6244232;
RX PubMed=7459858;
RX PubMed=17154184;
RX PubMed=25010205;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-nep-1-human-ewing-sarcoma-cell-line
WW http://tcpaportal.org/mclp/
CC Problematic cell line: Misidentified. Originally thought to be a Wilm's tumor cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2008-052.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; CLS; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11
ST D18S51: 15,17
ST D21S11: 29,31
ST D3S1358: 14,15
ST D5S818: 13
ST D7S820: 8,10
ST D8S1179: 12
ST FGA: 24
ST Penta D: 11,12
ST Penta E: 7,18
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 15,19
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-OS-10
AC CVCL_1E47
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=833871;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Lung.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-OS-3B
AC CVCL_1E41
SY OS3B
RX PubMed=833871;
RX PubMed=4329447;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-OV-1
AC CVCL_X208
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=833871;
RX PubMed=1013510;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-OV-3
AC CVCL_0532
SY SKOV-3; SK.OV.3; SKOV3; Skov3; SKO3
DR BTO; BTO:0000948
DR CLO; CLO_0009063
DR EFO; EFO_0002340
DR MCCL; MCC:0000431
DR CLDB; cl4354
DR CLDB; cl4355
DR CLDB; cl4356
DR ATCC; HTB-77
DR BioSample; SAMN03471310
DR CCLE; SKOV3_OVARY
DR CCRID; 3111C0001CCC000027
DR CCRID; 3131C0001000700107
DR CCRID; 3142C0001000000090
DR ChEMBL-Cells; CHEMBL3307443
DR ChEMBL-Cells; CHEMBL3307746
DR ChEMBL-Targets; CHEMBL614904
DR ChEMBL-Targets; CHEMBL614925
DR CLS; 300342/p657_SK-OV-3
DR Cosmic; 687925
DR Cosmic; 688110
DR Cosmic; 755846
DR Cosmic; 809115
DR Cosmic; 844348
DR Cosmic; 849611
DR Cosmic; 875858
DR Cosmic; 897436
DR Cosmic; 897739
DR Cosmic; 905959
DR Cosmic; 906578
DR Cosmic; 920359
DR Cosmic; 923106
DR Cosmic; 924150
DR Cosmic; 927563
DR Cosmic; 932983
DR Cosmic; 947358
DR Cosmic; 948289
DR Cosmic; 949228
DR Cosmic; 991320
DR Cosmic; 1044243
DR Cosmic; 1057759
DR Cosmic; 1066218
DR Cosmic; 1070900
DR Cosmic; 1071897
DR Cosmic; 1092635
DR Cosmic; 1102817
DR Cosmic; 1113276
DR Cosmic; 1129658
DR Cosmic; 1139226
DR Cosmic; 1175886
DR Cosmic; 1176622
DR Cosmic; 1305333
DR Cosmic; 1312193
DR Cosmic; 1312359
DR Cosmic; 1436037
DR Cosmic; 1482526
DR Cosmic; 1523762
DR Cosmic; 1524361
DR Cosmic; 1707561
DR Cosmic; 1708388
DR Cosmic; 1709249
DR Cosmic; 1998478
DR Cosmic; 2301586
DR Cosmic; 2464670
DR Cosmic; 2582807
DR Cosmic-CLP; 905959
DR ECACC; 91091004
DR GDSC; 905959
DR GEO; GSM50223
DR GEO; GSM50287
DR GEO; GSM183338
DR GEO; GSM183341
DR GEO; GSM313702
DR GEO; GSM459638
DR GEO; GSM459643
DR GEO; GSM459644
DR GEO; GSM459645
DR GEO; GSM659405
DR GEO; GSM750833
DR GEO; GSM784565
DR GEO; GSM799368
DR GEO; GSM799431
DR GEO; GSM827322
DR GEO; GSM847159
DR GEO; GSM851940
DR GEO; GSM887598
DR GEO; GSM888681
DR GEO; GSM1001423
DR GEO; GSM1001424
DR GEO; GSM1001486
DR GEO; GSM1153439
DR GEO; GSM1181272
DR GEO; GSM1181301
DR GEO; GSM1374883
DR GEO; GSM1670455
DR ICLC; HTL01014
DR IGRhCellID; SKOV3
DR IZSLER; BS TCL 84
DR KCB; KCB 200810YJ
DR KCLB; 30077
DR LINCS; 50044
DR NCBI_Iran; C209
DR PRIDE; PXD001402
DR SKY/M-FISH/CGH; 1438
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1423261;
RX PubMed=1892748;
RX PubMed=2041050;
RX PubMed=2653399;
RX PubMed=4016745;
RX PubMed=6582512;
RX PubMed=7459858;
RX PubMed=9041185;
RX PubMed=10972993;
RX PubMed=11793438;
RX PubMed=12080474;
RX PubMed=12417041;
RX PubMed=12960427;
RX PubMed=17088437;
RX PubMed=17726699;
RX PubMed=19372543;
RX PubMed=22328975;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=23839242;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24023729;
RX PubMed=24434149;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27235858;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=27
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SK-OV-3
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-19.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-ovarian-cell-line-sk-ov-3
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Part of: OCCP ovarian cancer cell line panel.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-528.
CC Doubling time: 75 hours (PubMed=25984343); 48.7 hours (DTP).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Exosome proteome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SCOV-3' in ChEMBL CHEMBL614904 and CHEMBL3307443.
CC Misspelling: Occasionally 'SCOV3'.
CC Discontinued: ICLC; HTL01014; true.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=11416159; PubMed=19372543; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 12
ST D18S51: 16,17,18 (CLS; PubMed=11416159)
ST D18S51: 16,17 (PubMed=19372543; PubMed=25230021_ECACC_version; PubMed=25877200)
ST D18S51: 16,18 (PubMed=25230021_academic_version)
ST D19S433: 14,14.2
ST D21S11: 30,31,31.2 (CLS; PubMed=11416159)
ST D21S11: 30,31.2 (PubMed=19372543; PubMed=25230021; PubMed=25877200)
ST D2S1338: 18,23
ST D3S1358: 14 (CLS; PubMed=25230021; PubMed=25877200)
ST D3S1358: 13,14 (PubMed=19372543)
ST D5S818: 11
ST D7S820: 13,14
ST D8S1179: 14,15
ST FGA: 24,25,26 (CLS; PubMed=11416159)
ST FGA: 24,25 (KCLB; PubMed=25230021_academic_version; PubMed=25877200)
ST FGA: 23,24,25 (PubMed=25230021_ECACC_version)
ST Penta D: 12,13
ST Penta E: 5,13
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 17,18 (ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=11416159; PubMed=25230021_ECACC_version; PubMed=25877200)
ST vWA: 18 (PubMed=19372543)
ST vWA: 17 (PubMed=25230021_acedemic_version)
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-OV-3-Luc
AC CVCL_4Y20
DR JCRB; NIHS0737
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SK-OV-3/CBP
AC CVCL_D621
SY SKOV3/CBP; S-car
RX PubMed=15254775;
RX PubMed=17269733;
CC Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SK-OV-3/CDDP
AC CVCL_D622
SY SKOV3/CDDP
RX PubMed=17269733;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SK-OV-3/CMV-Luc
AC CVCL_4Y19
DR JCRB; NIHS0736
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SK-OV-4
AC CVCL_X008
SY SKOV-4; SKOV4
DR BioSample; SAMN03151613
DR GEO; GSM851941
RX PubMed=6582512;
RX PubMed=22710073;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1094 ! C-33 A
SX Female
CA Cancer cell line
//
ID SK-OV-6
AC CVCL_A457
SY SKOV-6; SKOV6
DR BioSample; SAMN03151614
DR Cosmic; 923107
DR Cosmic; 1709253
DR GEO; GSM851942
RX PubMed=6582512;
RX PubMed=22328975;
RX PubMed=22710073;
RX PubMed=25230021;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).
CC Part of: OCCP ovarian cancer cell line panel.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1094 ! C-33 A
SX Female
CA Cancer cell line
//
ID SK-OV-8
AC CVCL_A458
SY SKOV-8; SKOV8
DR Cosmic; 1709254
RX PubMed=8349167;
RX PubMed=22328975;
RX PubMed=22710073;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-p53-1
AC CVCL_8598
SY SKp53-1
RX PubMed=9717829;
DI NCIt; C40318; Vulvar leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0628 ! SK-LMS-1
SX Female
CA Cancer cell line
//
ID SK-p53-2
AC CVCL_8599
SY SKp53-2
RX PubMed=9717829;
DI NCIt; C40318; Vulvar leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0628 ! SK-LMS-1
SX Female
CA Cancer cell line
//
ID SK-p53-3
AC CVCL_8600
SY SKp53-3
RX PubMed=9717829;
DI NCIt; C40318; Vulvar leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0628 ! SK-LMS-1
SX Female
CA Cancer cell line
//
ID SK-PC-1
AC CVCL_4054
SY SK-PC1
DR BTO; BTO:0002823
DR Cosmic; 710871
DR Cosmic; 948737
RX PubMed=7723277;
RX PubMed=9665481;
RX PubMed=11169957;
RX PubMed=11787853;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SK-PC-1
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-PC-3
AC CVCL_4055
DR Cosmic; 948729
RX PubMed=7723277;
RX PubMed=9665481;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SK-PC-3
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Omentum.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-PN-AG
AC CVCL_M167
RX PubMed=3024811;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-PN-DW
AC CVCL_1703
DR CLO; CLO_0009064
DR CLDB; cl4358
DR ATCC; CRL-2139
DR BioSample; SAMN03472556
DR ChEMBL-Cells; CHEMBL3308886
DR ChEMBL-Targets; CHEMBL2366108
DR Cosmic; 684073
DR Cosmic; 909731
DR Cosmic; 1078390
DR Cosmic; 1718431
DR Cosmic-CLP; 909731
DR ECACC; 94092301
DR GDSC; 909731
DR GEO; GSM1670456
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2987426;
RX PubMed=3024811;
RX PubMed=27397505;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 12
ST D5S818: 13,14
ST D7S820: 8,14
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-PN-LI
AC CVCL_A748
SY SK-PNET-Li; SKPNETLI
DR Cosmic; 1078389
DR Cosmic; 2228234
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2987426;
RX PubMed=3024811;
RX PubMed=25010205;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-PN-WA
AC CVCL_M168
RX PubMed=3024811;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-1
AC CVCL_4017
SY SK-RC 1; SKRC-1
DR BTO; BTO:0003193
RX PubMed=479762;
RX PubMed=2386958;
RX PubMed=6582512;
RX PubMed=6864164;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 42 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-10
AC CVCL_6175
SY SKRC-10
RX PubMed=479762;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=27993170;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-11
AC CVCL_6176
RX PubMed=479762;
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-12
AC CVCL_6177
SY SKRC-12
DR Cosmic; 945057
RX PubMed=479762;
RX PubMed=2386958;
RX PubMed=6582512;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-13
AC CVCL_6178
DR Cosmic; 737185
RX PubMed=479762;
RX PubMed=2386958;
RX PubMed=27993170;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 42 hours (PubMed=2386958).
CC Derived from metastatic site: Brain.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-14
AC CVCL_6179
SY SKRC-14
DR Cosmic; 945058
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-15
AC CVCL_6180
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-16
AC CVCL_GS24
RX PubMed=6582512;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-17
AC CVCL_4018
SY SK-RC 17; SKRC-17
DR BTO; BTO:0003196
DR Cosmic; 737186
DR Cosmic; 945059
RX PubMed=2386958;
RX PubMed=6582512;
RX PubMed=27993170;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Soft tissue.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-18
AC CVCL_6181
SY SKRC18; SKRC-18; SKRC 18
RX PubMed=2386958;
RX PubMed=27993170;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 42 hours (PubMed=2386958).
CC Derived from metastatic site: Lymph node.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-2
AC CVCL_6169
SY SKRC-02
DR Cosmic; 737183
RX PubMed=479762;
RX PubMed=2386958;
RX PubMed=6582512;
RX PubMed=6864164;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 60 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-20
AC CVCL_V605
SY SKRC-20; SKRC20
DR CCLE; SKRC20_KIDNEY
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 55 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-21
AC CVCL_6182
SY SKRC-21
RX PubMed=2386958;
RX PubMed=27993170;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 38 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-26A
AC CVCL_6183
SY SK-RC-26a
RX PubMed=2386958;
RX PubMed=27993170;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Lung.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3120 ! SK-RC-26B
CA Cancer cell line
//
ID SK-RC-26B
AC CVCL_3120
SY SK-RC-26b; SK-RC 26B; SKRC-26B; SK-RC26b
DR BTO; BTO:0004781
RX PubMed=2386958;
RX PubMed=27993170;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Lymph node.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6183 ! SK-RC-26A
CA Cancer cell line
//
ID SK-RC-28
AC CVCL_6184
SY SKRC28
DR Cosmic; 972918
RX PubMed=2386958;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=7915601;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-29
AC CVCL_4019
SY SK-RC 29; SKRC-29
DR BTO; BTO:0003197
DR Cosmic; 737187
DR Cosmic; 945060
DR GEO; GSM374462
RX PubMed=2386958;
RX PubMed=6864164;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 36 hours (PubMed=2386958).
CC Derived from metastatic site: Ovary.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-RC-3
AC CVCL_6170
SY SK-RC 3
RX PubMed=479762;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-RC-30
AC CVCL_6185
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-31
AC CVCL_6186
SY SKRC-31; SKRC31
DR CCLE; SKRC31_KIDNEY
DR GEO; GSM374463
RX PubMed=2386958;
RX PubMed=25984343;
RX PubMed=27993170;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 120 hours (PubMed=25984343).
CC Derived from metastatic site: Lung.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-33
AC CVCL_6187
SY SKRC-33; SKRC33
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-35
AC CVCL_4020
SY SK-RC 35; SKRC-35
DR BTO; BTO:0003198
DR Cosmic; 737180
RX PubMed=2386958;
RX PubMed=6582512;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 30 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-37
AC CVCL_6188
SY SKRC37
DR Cosmic; 737181
DR Cosmic; 972885
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-38
AC CVCL_6189
SY SK-RC 38; SKRC-38; SKRC38
DR GEO; GSM374464
RX PubMed=2386958;
RX PubMed=6864164;
RX PubMed=27993170;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Lung.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-39
AC CVCL_4021
SY SK-RC 39; SKRC-39; SKRC 39
DR BTO; BTO:0003199
RX PubMed=2386958;
RX PubMed=27993170;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 42 hours (PubMed=2386958).
CC Derived from metastatic site: Soft tissue.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-4
AC CVCL_6171
RX PubMed=479762;
RX PubMed=2386958;
RX PubMed=6582512;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-40
AC CVCL_6190
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-41
AC CVCL_6191
RX PubMed=2386958;
RX PubMed=6864164;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-42
AC CVCL_6192
SY SK-RC 42; SKRC-42
DR Cosmic; 737188
DR GEO; GSM374465
RX PubMed=2386958;
RX PubMed=27993170;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 48 hours (PubMed=2386958).
CC Derived from metastatic site: Bone.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-44
AC CVCL_4022
SY SK-RC 44; SKRC-44
DR BTO; BTO:0003200
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-45
AC CVCL_4016
SY SK-RC 45; SKRC-45; SKRC45
DR BTO; BTO:0003201
DR Cosmic; 737189
RX PubMed=2386958;
RX PubMed=27993170;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 48 hours (PubMed=2386958).
CC Derived from metastatic site: Adrenal gland.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-46
AC CVCL_6193
DR Cosmic; 737190
RX PubMed=2386958;
RX PubMed=27993170;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Bone.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-47
AC CVCL_6194
SY SKRC 47
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-48
AC CVCL_6195
SY SKRC48
DR Cosmic; 972919
RX PubMed=2386958;
RX PubMed=7915601;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-49
AC CVCL_6196
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 42 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-5
AC CVCL_6172
RX PubMed=479762;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-51
AC CVCL_6197
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-52
AC CVCL_6198
SY SK-RC 52; SKRC-52
DR Cosmic; 945061
DR GEO; GSM374466
RX PubMed=2386958;
RX PubMed=27993170;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 36 hours (PubMed=2386958).
CC Derived from metastatic site: Mediastinum.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-53
AC CVCL_6199
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-54
AC CVCL_6200
SY SKRC-54
RX PubMed=2386958;
RX PubMed=27993170;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Lung.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-54V
AC CVCL_6201
RX PubMed=16818659;
CC Derived from metastatic site: Lung.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6200 ! SK-RC-54
CA Cancer cell line
//
ID SK-RC-55
AC CVCL_6202
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-56
AC CVCL_6203
SY SKRC56
DR Cosmic; 972886
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 48 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-57
AC CVCL_6204
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 48 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-58
AC CVCL_6205
SY SKRC58
DR Cosmic; 972887
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 36 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-59
AC CVCL_6206
SY SKRC-59; SKRC59
DR Cosmic; 945062
DR Cosmic; 972888
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 36 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-6
AC CVCL_4023
SY SK-RC 6; SKRC-6; SKRC6
DR BTO; BTO:0003194
RX PubMed=479762;
RX PubMed=2386958;
RX PubMed=6582512;
RX PubMed=6864164;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 60 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-60
AC CVCL_6207
RX PubMed=2386958;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-61
AC CVCL_6208
SY SKRC61
DR Cosmic; 972920
RX PubMed=2386958;
RX PubMed=7915601;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 48 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-62
AC CVCL_6209
SY SKRC62
DR Cosmic; 972921
RX PubMed=2386958;
RX PubMed=7915601;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: 96 hours (PubMed=2386958).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RC-7
AC CVCL_4024
SY SK-RC 7; SKRC-7
DR BTO; BTO:0003195
RX PubMed=479762;
RX PubMed=2386958;
RX PubMed=6582512;
RX PubMed=27993170;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-8
AC CVCL_6173
SY SKRC8; SKRC-8; SKRC-08
DR Cosmic; 972916
RX PubMed=479762;
RX PubMed=2386958;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=7915601;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-9
AC CVCL_6174
SY SKRC-9; SK-RC9; SK-RC-09; SKRC9M
DR Cosmic; 737184
DR Cosmic; 972917
RX PubMed=479762;
RX PubMed=2386958;
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=7915601;
RX PubMed=27993170;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Brain.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-RC-99
AC CVCL_4025
SY SK-RC 99; SKRC-99
DR BTO; BTO:0003202
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SK-RST
AC CVCL_K279
SY Swine Kidney-RST
DR ATCC; CRL-2842
RX PubMed=19508353;
OX NCBI_TaxID=9823; ! Sus scrofa
SX Male
CA Spontaneously immortalized cell line
//
ID SK-SC-1
AC CVCL_1E48
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SK-UT-1
AC CVCL_0533
SY SK UT 1; SKUT-1; SKUT1; Skut1
DR BTO; BTO:0002034
DR CLO; CLO_0009065
DR EFO; EFO_0002341
DR MCCL; MCC:0000432
DR ATCC; HTB-114
DR BioSample; SAMN03471095
DR CCLE; SKUT1_SOFT_TISSUE
DR ChEMBL-Cells; CHEMBL3308848
DR ChEMBL-Targets; CHEMBL2366316
DR CLS; 300455/p492_SK-UT-1
DR Cosmic; 687595
DR Cosmic; 848888
DR Cosmic; 909732
DR Cosmic; 923382
DR Cosmic; 1071895
DR Cosmic; 1091504
DR Cosmic; 1176619
DR Cosmic; 1622903
DR Cosmic-CLP; 909732
DR GDSC; 909732
DR GEO; GSM887599
DR GEO; GSM888682
DR GEO; GSM1670457
DR GEO; GSM1676327
DR GEO; GSM1701660
DR IGRhCellID; SKUT1
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=22460905;
RX PubMed=26351324;
RX PubMed=27397505;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-329.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-ut-1-human-uterine-leiomyosarcoma-cell-line
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-537.
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 13,14
ST D18S51: 11,16
ST D21S11: 29,32.2
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 9,10
ST D8S1179: 13,15
ST FGA: 22,24
ST Penta D: 11,15
ST Penta E: 17
ST TH01: 7
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C6340; Uterine corpus leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK-UT-1B
AC CVCL_2250
SY SKUT1B; SK-UT 1B; SKUT-1B; Skut1B
DR BTO; BTO:0003725
DR CLO; CLO_0009066
DR CLDB; cl4359
DR ATCC; HTB-115
DR BioSample; SAMN03471096
DR BioSample; SAMN03472878
DR ChEMBL-Cells; CHEMBL3307682
DR ChEMBL-Targets; CHEMBL614678
DR CLS; 300406/p535_SK-UT-1B
DR Cosmic; 713478
DR Cosmic; 871555
DR Cosmic; 889118
DR Cosmic; 1007164
DR Cosmic; 1066227
DR Cosmic; 1091505
DR GEO; GSM185152
DR GEO; GSM185153
DR GEO; GSM844693
DR GEO; GSM844694
DR GEO; GSM1676334
DR GEO; GSM1701666
DR IGRhCellID; SKUT1B
DR IZSLER; BS TCL 210
RX PubMed=327080;
RX PubMed=2372783;
RX PubMed=2766249;
RX PubMed=3383166;
RX PubMed=6935474;
RX PubMed=9541971;
RX PubMed=26351324;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-ut-1b-human-uterine-leiomyosarcoma-cell-line
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2010-071.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,13
ST D16S539: 12,14
ST D18S51: 11,17
ST D19S433: 12,13
ST D21S11: 29,32.2
ST D2S1338: 19,21
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 9,10
ST D8S1179: 14,15
ST FGA: 22,23
ST Penta D: 11,14
ST Penta E: 17
ST TH01: 7
ST TPOX: 8 (ATCC; CLS)
ST TPOX: 5,8 (PubMed=25877200)
ST vWA: 16
DI NCIt; C6340; Uterine corpus leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0533 ! SK-UT-1
SX Female
CA Cancer cell line
//
ID SK-UT-2
AC CVCL_IW37
SY SKUT2
DR Cosmic; 1576465
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SK24
AC CVCL_4V70
RX PubMed=10771091;
RX PubMed=11330054;
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID SK3/VP16
AC CVCL_Y203
DR CGH-DB; 9124-4
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
CC Derived from metastatic site: Pericardial effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7005 ! ACC-LC-172
SX Male
CA Cancer cell line
//
ID SK32
AC CVCL_4708
DR BTO; BTO:0003220
RX PubMed=10771091;
RX PubMed=11330054;
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Ska-3-68
AC CVCL_S488
DR Cosmic; 688109
RX PubMed=12068308;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SKBR3-AZDRa
AC CVCL_EI04
RX PubMed=26883193;
CC Selected for resistance to: ChEBI; CHEBI:132986; Sapitinib (AZD8931).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0033 ! SK-BR-3
SX Female
CA Cancer cell line
//
ID SKBR3-AZDRb
AC CVCL_EI05
RX PubMed=26883193;
CC Selected for resistance to: ChEBI; CHEBI:132986; Sapitinib (AZD8931).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0033 ! SK-BR-3
SX Female
CA Cancer cell line
//
ID SKBR3-AZDRc
AC CVCL_EI06
DR PRIDE; PXD002057
RX PubMed=26883193;
CC Selected for resistance to: ChEBI; CHEBI:132986; Sapitinib (AZD8931).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0033 ! SK-BR-3
SX Female
CA Cancer cell line
//
ID SKBR3-LAP[r]
AC CVCL_4V68
WW http://www.chemoscreen.com/product/skbr3-lapr-dna
CC Selected for resistance to: ChEBI; CHEBI:49603; Lapatinib.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0033 ! SK-BR-3
SX Female
CA Cancer cell line
//
ID SKBR3-LAPRa
AC CVCL_EI07
RX PubMed=26883193;
CC Selected for resistance to: ChEBI; CHEBI:49603; Lapatinib.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0033 ! SK-BR-3
SX Female
CA Cancer cell line
//
ID SKBR3-LAPRb
AC CVCL_EI08
RX PubMed=26883193;
CC Selected for resistance to: ChEBI; CHEBI:49603; Lapatinib.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0033 ! SK-BR-3
SX Female
CA Cancer cell line
//
ID SKBR3-PR
AC CVCL_EQ69
SY SKBR3 PR
DR GEO; GSM183442
DR GEO; GSM183443
RX PubMed=17560336;
CC Knockout cell: Method=shRNA knockdown; HGNC; 9588; PTEN.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0033 ! SK-BR-3
SX Female
CA Cancer cell line
//
ID SkCa1
AC CVCL_HC05
DR GEO; GSM29836
DR GEO; GSM29837
DR GEO; GSM29838
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa10
AC CVCL_HC14
DR GEO; GSM29863
DR GEO; GSM29864
DR GEO; GSM29865
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa11
AC CVCL_HC15
DR GEO; GSM29866
DR GEO; GSM29867
DR GEO; GSM29868
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa12
AC CVCL_HC16
DR GEO; GSM29869
DR GEO; GSM29870
DR GEO; GSM29871
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa13
AC CVCL_HC17
DR GEO; GSM29872
DR GEO; GSM29873
DR GEO; GSM29874
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa14
AC CVCL_HC18
DR GEO; GSM29875
DR GEO; GSM29876
DR GEO; GSM29877
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa15
AC CVCL_HC19
DR GEO; GSM29878
DR GEO; GSM29879
DR GEO; GSM29880
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa2
AC CVCL_HC06
DR GEO; GSM29839
DR GEO; GSM29840
DR GEO; GSM29841
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa3
AC CVCL_HC07
DR GEO; GSM29842
DR GEO; GSM29843
DR GEO; GSM29844
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa4
AC CVCL_HC08
DR GEO; GSM29845
DR GEO; GSM29846
DR GEO; GSM29847
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa5
AC CVCL_HC09
DR GEO; GSM29848
DR GEO; GSM29849
DR GEO; GSM29850
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa6
AC CVCL_HC10
DR GEO; GSM29851
DR GEO; GSM29852
DR GEO; GSM29853
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa7
AC CVCL_HC11
DR GEO; GSM29854
DR GEO; GSM29855
DR GEO; GSM29856
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa8
AC CVCL_HC12
DR GEO; GSM29857
DR GEO; GSM29858
DR GEO; GSM29859
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SkCa9
AC CVCL_HC13
DR GEO; GSM29860
DR GEO; GSM29861
DR GEO; GSM29862
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SKE-hTERT
AC CVCL_Z586
RX PubMed=16621759;
CC Transfected with: HGNC; 11730; TERT.
CC Breed/subspecies: Large white.
OX NCBI_TaxID=9823; ! Sus scrofa
OI CVCL_Z587 ! SKE-Spon
OI CVCL_Z588 ! SKE-SV40LT
CA Telomerase immortalized cell line
//
ID SKE-Spon
AC CVCL_Z587
RX PubMed=16621759;
CC Breed/subspecies: Large white.
OX NCBI_TaxID=9823; ! Sus scrofa
OI CVCL_Z586 ! SKE-hTERT
OI CVCL_Z588 ! SKE-SV40LT
CA Spontaneously immortalized cell line
//
ID SKE-SV40LT
AC CVCL_Z588
RX PubMed=16621759;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Large white.
OX NCBI_TaxID=9823; ! Sus scrofa
OI CVCL_Z586 ! SKE-hTERT
OI CVCL_Z587 ! SKE-Spon
CA Transformed cell line
//
ID SKG-I
AC CVCL_2793
SY SKG-1; SKG1
DR BioSample; SAMN03472778
DR Cosmic; 877459
DR Cosmic; 1152537
DR IFO; IFO50308
RX PubMed=3029293;
RX PubMed=6163305;
RX PubMed=6174649;
RX PubMed=7196935;
CC Doubling time: 35-42 hours (PubMed=7196935).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 10
ST D5S818: 12
ST D7S820: 10
ST TH01: 7
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SKG-I/TS
AC CVCL_4J75
RX PubMed=12845668;
CC Transfected with: HGNC; 12441; TYMS.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2793 ! SKG-I
SX Female
CA Cancer cell line
//
ID SKG-II
AC CVCL_2794
SY SKG-2; SKG2
DR BioSample; SAMN03470893
DR BioSample; SAMN03472779
DR Cosmic; 877460
DR Cosmic; 1152538
DR IFO; IFO50309
DR JCRB; JCRB0171
RX PubMed=3029293;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: JCRB; JCRB0171; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 11
ST D18S51: 18
ST D19S433: 14,16.2
ST D21S11: 28
ST D2S1338: 20
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 13
ST FGA: 22
ST Penta D: 10
ST Penta E: 12
ST TH01: 7,9 (JCRB)
ST TH01: 9 (PubMed=25877200)
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SKG-II-SF
AC CVCL_8159
SY SKG-II SF
DR CLO; CLO_0050918
DR RCB; RCB0685
RX PubMed=9573483;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11
ST TH01: 9
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2794 ! SKG-II
SX Female
CA Cancer cell line
//
ID SKG-II/LUC
AC CVCL_4J76
SY SKG-II/luciferase
RX PubMed=12239455;
RX PubMed=12845668;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2794 ! SKG-II
SX Female
CA Cancer cell line
//
ID SKG-II/TS
AC CVCL_4J77
RX PubMed=12239455;
RX PubMed=12845668;
CC Transfected with: HGNC; 12441; TYMS.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2794 ! SKG-II
SX Female
CA Cancer cell line
//
ID SKG-IIIa
AC CVCL_1704
SY SKG-IIIA; SKG IIIa; SKG-3a; SKG3A; SKG3a
DR CLO; CLO_0050923
DR BioSample; SAMN01821739
DR BioSample; SAMN03470894
DR BioSample; SAMN03471660
DR ChEMBL-Cells; CHEMBL3308786
DR ChEMBL-Targets; CHEMBL1075581
DR Cosmic; 877461
DR Cosmic; 930298
DR Cosmic; 1152539
DR Cosmic; 1995630
DR Cosmic-CLP; 930298
DR GDSC; 930298
DR GEO; GSM1670429
DR IFO; IFO50310
DR JCRB; JCRB0232
DR RCB; RCB1892
DR TKG; TKG 0462
RX PubMed=6699456;
RX PubMed=9290701;
RX PubMed=15099960;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,11
ST D18S51: 16
ST D19S433: 13
ST D21S11: 31.2,32.2
ST D2S1338: 19,26
ST D3S1358: 16
ST D5S818: 10,11
ST D7S820: 10 (JCRB)
ST D7S820: 10,12 (Cosmic-CLP; PubMed=25877200; RCB; TKG)
ST D8S1179: 11,15
ST FGA: 21,22
ST Penta D: 9
ST Penta E: 10
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2795 ! SKG-IIIb
SX Female
CA Cancer cell line
//
ID SKG-IIIb
AC CVCL_2795
SY SKG-3b; SKG3B; SKG3b
DR BioSample; SAMN03470895
DR BioSample; SAMN03472780
DR Cosmic; 1152540
DR GEO; GSM827212
DR IFO; IFO50311
DR JCRB; JCRB0232.1
RX PubMed=3029293;
RX PubMed=6699456;
RX PubMed=15099960;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Omics: Transcriptome analysis.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,11
ST D18S51: 16
ST D19S433: 13
ST D21S11: 31.2
ST D2S1338: 26
ST D3S1358: 16
ST D5S818: 10,11
ST D7S820: 10,12
ST D8S1179: 11,15
ST FGA: 22
ST Penta D: 9
ST Penta E: 10
ST TH01: 9 (JCRB)
ST TH01: 6,9 (PubMed=25877200)
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1704 ! SKG-IIIa
SX Female
CA Cancer cell line
//
ID SKH-R
AC CVCL_0I62
DR CCLV; CCLV-RIE 0483
RX PubMed=19941903;
CC Group: Reptilian cell line.
OX NCBI_TaxID=31138; ! Trachemys scripta elegans
CA Spontaneously immortalized cell line
//
ID SKH1
AC CVCL_C124
SY SKH-1
DR Cosmic; 919117
DR Cosmic; 1012118
RX PubMed=8313895;
RX PubMed=15156182;
RX PubMed=16408098;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SKI-DLCL-1
AC CVCL_E053
SY SKI-DLBCL1; SKI; SKI-DCLC; GM20259
DR CLO; CLO_0027837
DR EFO; EFO_0005460
DR Coriell; GM20259
DR Cosmic; 1945191
RX PubMed=11426565;
RX PubMed=23292937;
CC Omics: Deep exome analysis.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SKiPSc1
AC CVCL_GQ04
RX PubMed=27558616;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID SKK-1
AC CVCL_S607
DR Cosmic; 1465963
RX PubMed=15996938;
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SKM-1
AC CVCL_0098
SY SKM1
DR EFO; EFO_0006753
DR BioSample; SAMN03470798
DR BioSample; SAMN03473113
DR CCLE; SKM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308216
DR ChEMBL-Targets; CHEMBL2366085
DR Cosmic; 787477
DR Cosmic; 909722
DR Cosmic; 975300
DR Cosmic; 1012119
DR Cosmic; 1078731
DR Cosmic; 1465964
DR Cosmic; 1551462
DR Cosmic; 2131566
DR Cosmic-CLP; 909722
DR DSMZ; ACC-547
DR GDSC; 909722
DR GEO; GSM482513
DR GEO; GSM887581
DR GEO; GSM888664
DR GEO; GSM1374880
DR GEO; GSM1670435
DR JCRB; JCRB0118
DR JCRB; NIHS0147
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~48 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0147; true.
ST Source(s): Cosmic-CLP; DSMZ; JCRB; PubMed=25877200
ST Amelogenin: X (Cosmic-CLP; JCRB)
ST Amelogenin: X,Y (DSMZ; PubMed=25877200)
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 9,11
ST D18S51: 14,15
ST D21S11: 31.2,32.2
ST D3S1358: 18
ST D5S818: 10,12
ST D7S820: 10,11
ST D8S1179: 11,13
ST FGA: 22,23
ST Penta D: 9,12
ST Penta E: 15,20
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SKM-1/HHT
AC CVCL_IM24
RX PubMed=22967374;
CC Selected for resistance to: ChEBI; CHEBI:71019; Omacetaxine mepesuccinate (Homoharringtonine; HHT).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0098 ! SKM-1
SX Male
CA Cancer cell line
//
ID SKMEL5/R
AC CVCL_IW12
RX PubMed=26365896;
CC Selected for resistance to: ChEBI; CHEBI:90295; PLX-4720.
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0527 ! SK-MEL-5
SX Female
CA Cancer cell line
//
ID SKMES-1-Taxol
AC CVCL_X336
RX PubMed=18503785;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Omics: Proteome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0630 ! SK-MES-1
SX Male
CA Cancer cell line
//
ID SKMES-1-Taxotere
AC CVCL_X337
RX PubMed=18503785;
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC Omics: Proteome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0630 ! SK-MES-1
SX Male
CA Cancer cell line
//
ID SKN
AC CVCL_3167
DR CLO; CLO_0050881
DR BioSample; SAMN03470820
DR BioSample; SAMN03472277
DR Cosmic; 1330908
DR Cosmic-CLP; 1240215
DR GDSC; 1240215
DR GEO; GSM827211
DR GEO; GSM1670447
DR IFO; IFO50314
DR JCRB; JCRB0173
DR RCB; RCB0513
RX PubMed=556976;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 8,12
ST TH01: 8
ST TPOX: 8
ST vWA: 18,19 (JCRB)
ST vWA: 19 (Cosmic-CLP; RCB)
DI NCIt; C6340; Uterine corpus leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SKN-3
AC CVCL_3168
SY SKN3
DR BioSample; SAMN03472486
DR CGH-DB; 370-2
DR Cosmic; 1530758
DR Cosmic; 1530759
DR Cosmic-CLP; 1299059
DR GDSC; 1299059
DR GEO; GSM827179
DR GEO; GSM1670448
DR JCRB; JCRB1039
RX PubMed=17599052;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 10,12
ST D5S818: 9
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 18,20
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SKNO-1
AC CVCL_2196
SY Skno-1; SKNO1
DR BioSample; SAMN03473440
DR Cosmic; 787478
DR Cosmic; 975301
DR Cosmic; 1149337
DR Cosmic; 1281353
DR Cosmic; 1524841
DR Cosmic; 2306239
DR DSMZ; ACC-690
DR GEO; GSM236805
DR GEO; GSM236841
DR JCRB; JCRB1170
RX PubMed=7772516;
RX PubMed=9738977;
RX PubMed=15843827;
RX PubMed=25984343;
CC Doubling time: 24 hours (PubMed=25984343); ~35-50 hours (DSMZ).
CC Omics: shRNA library screening.
ST Source(s): DSMZ; JCRB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 10,11
ST D5S818: 10,13
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C7961; Adult acute myeloid leukemia with maturation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SKO-007
AC CVCL_4974
SY SKO007; U-226AR1; U-266 AR1
DR CLO; CLO_0009061
DR EFO; EFO_0002339
DR ATCC; CRL-8033-1
DR IGRhCellID; SKO007
RX PubMed=6159646;
RX PubMed=6864164;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 10
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 5,7
ST TPOX: 8
ST vWA: 17
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0566 ! U266B1
SX Male
CA Cancer cell line
//
ID SKO-007 clone J3
AC CVCL_4975
SY Clone J3 of SKO-007
DR CLO; CLO_0009062
DR ATCC; CRL-8033-2
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 10
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 5,7
ST TPOX: 8
ST vWA: 17
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4974 ! SKO-007
SX Male
CA Cancer cell line
//
ID SKOV-3/Luc
AC CVCL_M089
WW http://www.cellbiolabs.com/skov-3-reporter-cells
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKOV-3/RFP
AC CVCL_M090
WW http://www.cellbiolabs.com/skov-3-reporter-cells
CC Transfected with: UniProtKB; Q9U6Y8; RFP.
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKOV-3TR
AC CVCL_4V89
RX PubMed=10095106;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKOV3-luc-D3
AC CVCL_5J38
SY SKOV-3-luc-D3
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: PerkinElmer; Catalog number 119276.
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKOV3-Red-FLuc
AC CVCL_5J11
SY SKOV3 Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW119276
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKOV3.ip1
AC CVCL_0C84
SY SKOV3ip1; SKOV3IP1; SKOV3IP
RX PubMed=8094034;
RX PubMed=27561551;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep proteome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKOV3/TR
AC CVCL_HF69
RX PubMed=25815442;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKOV3/VP
AC CVCL_Y280
DR CGH-DB; 9125-4
RX PubMed=7911742;
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKPT-0193 Cl.1
AC CVCL_R942
RX PubMed=8807581;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Spontaneously hypertensive rat (SHR).
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R943 ! SKPT-0193 Cl.2
OI CVCL_R944 ! SKPT-0193 Cl.5
SX Male
CA Transformed cell line
//
ID SKPT-0193 Cl.2
AC CVCL_R943
RX PubMed=8807581;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Spontaneously hypertensive rat (SHR).
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R942 ! SKPT-0193 Cl.1
OI CVCL_R944 ! SKPT-0193 Cl.5
SX Male
CA Transformed cell line
//
ID SKPT-0193 Cl.5
AC CVCL_R944
RX PubMed=8807581;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Spontaneously hypertensive rat (SHR).
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R942 ! SKPT-0193 Cl.1
OI CVCL_R943 ! SKPT-0193 Cl.2
SX Male
CA Transformed cell line
//
ID SKPT-1092 Cl.1
AC CVCL_R945
RX PubMed=8807581;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Spontaneously hypertensive rat (SHR).
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R946 ! SKPT-1092 Cl.2
SX Male
CA Transformed cell line
//
ID SKPT-1092 Cl.2
AC CVCL_R946
RX PubMed=8807581;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Spontaneously hypertensive rat (SHR).
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R945 ! SKPT-1092 Cl.1
SX Male
CA Transformed cell line
//
ID SKR1
AC CVCL_G366
DR TKG; TKG 0700
RX PubMed=9183637;
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SKS
AC CVCL_S989
RX PubMed=11408806;
DI NCIt; C7982; Cervical small cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SKT-1A
AC CVCL_Y112
RX PubMed=2972890;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y113 ! SKT-1B
SX Male
CA Cancer cell line
//
ID SKT-1B
AC CVCL_Y113
SY SKT1B
DR Cosmic; 919150
RX PubMed=2972890;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y112 ! SKT-1A
SX Male
CA Cancer cell line
//
ID SKVLB0.03
AC CVCL_IN03
SY SK VLB 0.03; SKVLB (0.03)
RX PubMed=2565764;
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKVLB0.06
AC CVCL_IN04
SY SK VLB 0.06; SKVLB (0.06)
RX PubMed=2565764;
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKVLB1
AC CVCL_IN05
SY SKVLB 1; SKVLB-1; SK VLB 1; SKVLB (1.0); SKVLB
RX PubMed=2565764;
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKVCR0.015
AC CVCL_IN06
SY SK VCR 0.015; SKVCR (0.015)
RX PubMed=2565764;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKVCR0.1
AC CVCL_IN07
SY SK VCR 0.1
RX PubMed=2565764;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKVCR0.25
AC CVCL_IN08
SY SK VCR 0.25
RX PubMed=2565764;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKVCR2.0
AC CVCL_IN09
SY SKVCR 2.0; SK VCR 2
DR GEO; GSM183342
DR GEO; GSM183344
RX PubMed=2565764;
RX PubMed=17726699;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID SKW 6.4
AC CVCL_3796
SY SKW6.4; Skw6.4; SKW6-Cl4; SKW6-CL4; SWK6 clone 4; SKW6-4
DR BTO; BTO:0001936
DR CLO; CLO_0009067
DR ATCC; TIB-215
DR ChEMBL-Cells; CHEMBL3307453
DR ChEMBL-Targets; CHEMBL614928
RX PubMed=6339249;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=SKW6-Cl4
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 9,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 17,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SKW-3
AC CVCL_2197
SY SKW3
DR CLO; CLO_0009068
DR CLO; CLO_0051007
DR CLDB; cl4362
DR BioSample; SAMN03151818
DR BioSample; SAMN03473523
DR CLS; 300343/p2953_SKW-3
DR Cosmic; 913412
DR Cosmic; 919156
DR Cosmic; 933546
DR Cosmic; 1524820
DR Cosmic; 1641385
DR DSMZ; ACC-53
DR NCBI_Iran; C182
DR RCB; RCB1168
DR TKG; TKG 0247
RX PubMed=7849311;
RX PubMed=9933131;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a KE-37 derivative (PubMed=20143388).
CC Doubling time: ~30-40 hours (DSMZ).
ST Source(s): DSMZ; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1327 ! KE-37
SX Male
CA Cancer cell line
//
ID SKW-4
AC CVCL_A477
SY SKW4; SKW 4
DR Cosmic; 999779
RX PubMed=6329938;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SKW3/Clo
AC CVCL_4V58
RX PubMed=25461250;
CC Problematic cell line: Contaminated. Parent cell line (SKW-3) has been shown to be a KE-37 derivative.
CC Selected for resistance to: ChEBI; CHEBI:681569; Clofarabine (CAFdA).
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2197 ! SKW-3
SX Male
CA Cancer cell line
//
ID SL-1-TC
AC CVCL_AS19
SY SL-1
DR TKG; TKG 0136
DR TKG; TKG 0639
CC Derived from metastatic site: Lymph node.
CC Breed/subspecies: ACI/N.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID SL-15
AC CVCL_Y285
DR GEO; GSM866165
RX PubMed=16049984;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35425; Splenic lymphoma with circulating villous lymphocytes
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SL-29
AC CVCL_5587
DR CLO; CLO_0009072
DR ATCC; CRL-1590
DR BCRJ; 0367
CC Group: Bird cell line.
CC Breed/subspecies: White Leghorn SPAFAS.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Finite cell line
//
ID SL-ZSU-1
AC CVCL_Z321
SY SL-zsu-1; ZSU-SL-1
RX CelloPub=CLPUB00174;
RX DOI=10.3923/jas.2007.4040.4043;
RX PubMed=21335011;
CC Group: Insect cell line.
CC Doubling time: 100-144 hours (CelloPub=CLPUB00174).
OX NCBI_TaxID=69820; ! Spodoptera litura
SX Female
CA Spontaneously immortalized cell line
//
ID Sl/Sl4
AC CVCL_6525
DR CLO; CLO_0009069
DR ATCC; CRL-2452
RX PubMed=1380155;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Sl/Sl4 hSCF220
AC CVCL_6526
DR CLO; CLO_0009070
DR ATCC; CRL-2453
RX PubMed=1380155;
CC Transfected with: HGNC; 6343; KITLG.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6525 ! Sl/Sl4
CA Transformed cell line
//
ID Sl/Sl4 hSCF248
AC CVCL_6527
DR CLO; CLO_0009071
DR ATCC; CRL-2454
RX PubMed=1380155;
CC Transfected with: HGNC; 6343; KITLG.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6525 ! Sl/Sl4
CA Transformed cell line
//
ID SL1
AC CVCL_X934
SY SL-1
DR CGH-DB; 9206-4
RX PubMed=4321974;
RX PubMed=6018567;
RX PubMed=14293797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SL12
AC CVCL_F832
RX PubMed=6201262;
CC Breed/subspecies: AKR.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID SL12.1
AC CVCL_F833
RX PubMed=6201262;
CC Breed/subspecies: AKR.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F832 ! SL12
CA Cancer cell line
//
ID SL12.4
AC CVCL_F834
RX PubMed=6201262;
CC Breed/subspecies: AKR.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F832 ! SL12
CA Cancer cell line
//
ID SL4c
AC CVCL_U294
RX PubMed=2414213;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID SLC
AC CVCL_5365
SY Sato Lung Cancer; Sato Lung Carcinoma
DR CLO; CLO_0050828
DR RCB; RCB2862
DR TKG; TKG 0135
CC Breed/subspecies: Donryu.
DI NCIt; C64112; Carcinoma of the rat lung
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID Sld1
AC CVCL_E235
RX PubMed=3595763;
CC Breed/subspecies: (WC x C57BL/6)-Sl/Sld.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID Sld2
AC CVCL_E236
RX PubMed=3595763;
CC Breed/subspecies: (WC x C57BL/6)-Sl/Sld.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID Sld3
AC CVCL_E237
RX PubMed=3595763;
CC Breed/subspecies: (WC x C57BL/6)-Sl/Sld.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID SLE005
AC CVCL_E829
SY SLE
DR dbMHC; 49020
DR ECACC; 88052059
DR IHW; IHW9059
DR IMGT/HLA; 11391
WW http://bioinformatics.hsanmartino.it/ecbr/cl59.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SLET-1
AC CVCL_F756
SY Sheep Lymphatic Endothelial Transformed-1
RX PubMed=10100190;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [776].
OX NCBI_TaxID=9940; ! Ovis aries
CA Transformed cell line
//
ID SLF [Leiostomus]
AC CVCL_S947
SY Spot Liver Fibroblastic
RX DOI=10.1016/0044-8486(94)00382-X;
CC Group: Fish cell line.
OX NCBI_TaxID=59837; ! Leiostomus xanthurus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SLF [Rat]
AC CVCL_IQ78
SY Spiral Ligament Fibrocyte
RX PubMed=17214269;
CC Doubling time: 28.0 +- 8.2 hours (PubMed=17214269).
CC Transformant: Ad12-SV40.
CC Breed/subspecies: Wistar Kyoto.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID SLK
AC CVCL_9569
SY KS-SLK
DR BioSample; SAMN03151616
DR NIH-ARP; 9402-141
DR SKY/M-FISH/CGH; 3862
RX PubMed=7520247;
RX PubMed=22987579;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Caki-1 derivative (PubMed=22987579).
CC Derived from metastatic site: Skin.
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0234 ! Caki-1
SX Male
CA Cancer cell line
//
ID SLMT-1
AC CVCL_E305
SY SLMT1
DR TOKU-E; 3591
RX PubMed=11165320;
RX PubMed=15885884;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SLN
AC CVCL_S948
CC Group: Fish cell line.
OX NCBI_TaxID=59837; ! Leiostomus xanthurus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SLR 20
AC CVCL_V606
SY SLR20
DR CCLE; SLR20_KIDNEY
DR GEO; GSM374467
RX PubMed=19470766;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 24 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SLR 21
AC CVCL_V607
SY SLR21
DR CCLE; SLR21_KIDNEY
DR Cosmic; 2520630
DR GEO; GSM374468
RX PubMed=19470766;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 60 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SLR 22
AC CVCL_V608
SY SLR22
DR Cosmic; 2520634
DR GEO; GSM374469
RX PubMed=19470766;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SLR 23
AC CVCL_V609
SY SLR23
DR CCLE; SLR23_KIDNEY
DR Cosmic; 2520635
DR GEO; GSM374470
RX PubMed=19470766;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 40 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SLR 24
AC CVCL_V610
SY SLR24
DR CCLE; SLR24_KIDNEY
DR Cosmic; 2520643
DR GEO; GSM374471
RX PubMed=19470766;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 30 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SLR 25
AC CVCL_V611
SY SLR25
DR CCLE; SLR25_KIDNEY
DR Cosmic; 2520639
DR GEO; GSM374472
RX PubMed=19470766;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 80 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SLR 26
AC CVCL_V612
SY SLR26
DR CCLE; SLR26_KIDNEY
DR Cosmic; 2520644
DR GEO; GSM374473
DR GEO; GSM482712
RX PubMed=19470766;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 55 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SLT4
AC CVCL_3922
DR BTO; BTO:0004892
CC Part of: BLA-40 bladder carcinoma cell line panel.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID SLUGEO
AC CVCL_F723
DR IMGT/HLA; 11392
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SLW
AC CVCL_S949
CC Group: Fish cell line.
OX NCBI_TaxID=59837; ! Leiostomus xanthurus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SM [Human B-cell]
AC CVCL_E830
SY S.M.
DR dbMHC; 49021
DR ECACC; 94061621
DR IHW; IHW9353
DR IMGT/HLA; 11350
WW http://bioinformatics.hsanmartino.it/ecbr/cl353.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SM [Human chondrosarcoma]
AC CVCL_M607
RX PubMed=16039953;
CC Doubling time: 36 hours (PubMed=16039953).
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SM-1
AC CVCL_IU19
SY SM1
DR EFO; EFO_0002706
DR BioSamples; SAMEA365986
DR BioSamples; SAMEA366011
DR GEO; GSM38808
DR GEO; GSM38809
RX PubMed=10554028;
RX PubMed=15613351;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C8285; AIDS related immunoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SM-AP1
AC CVCL_D117
RX PubMed=19622142;
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D118 ! SM-AP2
OI CVCL_D119 ! SM-AP3
OI CVCL_D120 ! SM-AP4
OI CVCL_D121 ! SM-AP5
SX Female
CA Cancer cell line
//
ID SM-AP2
AC CVCL_D118
RX PubMed=19622142;
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D117 ! SM-AP1
OI CVCL_D119 ! SM-AP3
OI CVCL_D120 ! SM-AP4
OI CVCL_D121 ! SM-AP5
SX Female
CA Cancer cell line
//
ID SM-AP3
AC CVCL_D119
RX PubMed=19622142;
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D117 ! SM-AP1
OI CVCL_D118 ! SM-AP2
OI CVCL_D120 ! SM-AP4
OI CVCL_D121 ! SM-AP5
SX Female
CA Cancer cell line
//
ID SM-AP4
AC CVCL_D120
RX PubMed=19622142;
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D117 ! SM-AP1
OI CVCL_D118 ! SM-AP2
OI CVCL_D119 ! SM-AP3
OI CVCL_D121 ! SM-AP5
SX Female
CA Cancer cell line
//
ID SM-AP5
AC CVCL_D121
RX PubMed=19622142;
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D117 ! SM-AP1
OI CVCL_D118 ! SM-AP2
OI CVCL_D119 ! SM-AP3
OI CVCL_D120 ! SM-AP4
SX Female
CA Cancer cell line
//
ID SM-E
AC CVCL_0C26
RX PubMed=7736387;
RX PubMed=9815546;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SM-MI-1
AC CVCL_W283
DR CGH-DB; 9285-4
DR Cosmic; 905199
RX PubMed=15467732;
CC Misspelling: 'SM-M1-1' in CGH-DB 9285-4.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Sm-MT
AC CVCL_5588
SY SmMT
RX PubMed=4060590;
OX NCBI_TaxID=9378; ! Suncus murinus
CA Cancer cell line
//
ID SM1
AC CVCL_D051
SY HVTs-SM1
RX PubMed=10764661;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Conditionally immortalized cell line
//
ID SM1/9
AC CVCL_0A33
RX PubMed=7570575;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID SM2-1
AC CVCL_H200
DR Cosmic; 2144976
RX PubMed=19035443;
RX PubMed=22578220;
CC From: Department of Dermatology; Shinshu University; Japan.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SM25/3
AC CVCL_0A34
RX PubMed=7570575;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID SM27-1045
AC CVCL_F765
DR CLO; CLO_0009078
DR ATCC; HB-11917
RX Patent=US6127135;
CC Monoclonal antibody target: Human stem and progenitor cells marker EM10.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID SM3
AC CVCL_H202
RX PubMed=19035443;
RX PubMed=22578220;
CC From: Department of Dermatology; Shinshu University; Japan.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SM5
AC CVCL_D158
SY SM-5
DR BTO; BTO:0004275
RX PubMed=15051493;
RX PubMed=18544163;
CC Omics: Proteome analysis by 2D-DE/MS.
CC Breed/subspecies: C57BL/6J-Trp53tm1Tyj.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID SM7
AC CVCL_D159
SY SM-7
DR BTO; BTO:0004276
RX PubMed=15051493;
RX PubMed=18544163;
CC Omics: Proteome analysis by 2D-DE/MS.
CC Breed/subspecies: C57BL/6J-Trp53tm1Tyj.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID SMA-497
AC CVCL_6E76
SY P497
RX PubMed=3806112;
RX PubMed=7435141;
RX PubMed=10493969;
CC Breed/subspecies: VM/Dk.
DI NCIt; C21932; Mouse astrocytic tumours
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6E75 ! SMA-540
OI CVCL_8580 ! SMA-560
CA Cancer cell line
//
ID SMA-540
AC CVCL_6E75
SY P540
RX PubMed=3806112;
RX PubMed=7435141;
CC Breed/subspecies: VM/Dk.
DI NCIt; C21932; Mouse astrocytic tumours
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6E76 ! SMA-497
OI CVCL_8580 ! SMA-560
CA Cancer cell line
//
ID SMA-560
AC CVCL_8580
SY SMA 560; SMA560; P560
DR PRIDE; PXD000589
RX PubMed=3806112;
RX PubMed=7435141;
RX PubMed=9402588;
RX PubMed=25894527;
CC Omics: Cell surface proteome.
CC Breed/subspecies: VM/Dk.
DI NCIt; C21932; Mouse astrocytic tumours
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6E76 ! SMA-497
OI CVCL_6E75 ! SMA-540
CA Cancer cell line
//
ID SMA-iPS1
AC CVCL_L670
DR ISCR; 1994
RX PubMed=22673189;
CC From: Guangzhou Medical College; China.
DI NCIt; C85075; Spinal muscular atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L671 ! SMA-iPS2
SX Female
CA Induced pluripotent stem cell
//
ID SMA-iPS2
AC CVCL_L671
DR ISCR; 1995
RX PubMed=22673189;
CC From: Guangzhou Medical College; China.
DI NCIt; C85075; Spinal muscular atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L670 ! SMA-iPS1
SX Female
CA Induced pluripotent stem cell
//
ID Smac.4M
AC CVCL_1E65
WW http://axiogenesis.com/products/murine-smooth-muscle-cells/smac-4m.html
CC From: Axiogenesis AG; Germany.
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID SMAP1dm
AC CVCL_F960
SY SMAP1-deficient macrophage
DR TKG; TKG 0661
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID SMAT1
AC CVCL_U449
RX PubMed=9510068;
RX PubMed=15541572;
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID SMB
AC CVCL_S863
SY SIM-1
DR Cosmic; 1388896
RX PubMed=2844401;
CC Derived from metastatic site: Skin.
DI NCIt; C8776; Peripheral primitive neuroectodermal tumor of bone
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SMC-1
AC CVCL_J121
DR CCRID; 3131C0001000700085
RX PubMed=3159086;
DI NCIt; C9351; Pleural mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SMC-L001
AC CVCL_X018
DR Cosmic; 2563250
RX PubMed=24569940;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SmcMF
AC CVCL_T067
RX PubMed=23674870;
CC Doubling time: 17.2 hours (PubMed=23674870).
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID SME-1
AC CVCL_T726
SY Silurus Meridionalis Embryo-1
RX CelloPub=CLPUB00253;
CC Group: Fish cell line.
OX NCBI_TaxID=175797; ! Silurus meridionalis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SMF No.12
AC CVCL_0H75
DR SKIP; SKIP000569
RX PubMed=24859480;
DI NCIt; C27701; Secondary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H70 ! SMF No.5
OI CVCL_0H71 ! SMF No.6
OI CVCL_0H72 ! SMF No.7
OI CVCL_0H73 ! SMF No.8
OI CVCL_0H74 ! SMF No.9
OI CVCL_0H76 ! SMF No.15
OI CVCL_0H77 ! SMF No.16
OI CVCL_0H78 ! SMF No.17
OI CVCL_0H79 ! SMF No.20
OI CVCL_0H80 ! SMF No.21
SX Female
CA Induced pluripotent stem cell
//
ID SMF No.15
AC CVCL_0H76
DR SKIP; SKIP000570
RX PubMed=24859480;
DI NCIt; C27701; Secondary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H70 ! SMF No.5
OI CVCL_0H71 ! SMF No.6
OI CVCL_0H72 ! SMF No.7
OI CVCL_0H73 ! SMF No.8
OI CVCL_0H74 ! SMF No.9
OI CVCL_0H75 ! SMF No.12
OI CVCL_0H77 ! SMF No.16
OI CVCL_0H78 ! SMF No.17
OI CVCL_0H79 ! SMF No.20
OI CVCL_0H80 ! SMF No.21
SX Female
CA Induced pluripotent stem cell
//
ID SMF No.16
AC CVCL_0H77
DR SKIP; SKIP000571
RX PubMed=24859480;
DI NCIt; C27701; Secondary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H70 ! SMF No.5
OI CVCL_0H71 ! SMF No.6
OI CVCL_0H72 ! SMF No.7
OI CVCL_0H73 ! SMF No.8
OI CVCL_0H74 ! SMF No.9
OI CVCL_0H75 ! SMF No.12
OI CVCL_0H76 ! SMF No.15
OI CVCL_0H78 ! SMF No.17
OI CVCL_0H79 ! SMF No.20
OI CVCL_0H80 ! SMF No.21
SX Female
CA Induced pluripotent stem cell
//
ID SMF No.17
AC CVCL_0H78
DR SKIP; SKIP000572
RX PubMed=24859480;
DI NCIt; C27701; Secondary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H70 ! SMF No.5
OI CVCL_0H71 ! SMF No.6
OI CVCL_0H72 ! SMF No.7
OI CVCL_0H73 ! SMF No.8
OI CVCL_0H74 ! SMF No.9
OI CVCL_0H75 ! SMF No.12
OI CVCL_0H76 ! SMF No.15
OI CVCL_0H77 ! SMF No.16
OI CVCL_0H79 ! SMF No.20
OI CVCL_0H80 ! SMF No.21
SX Female
CA Induced pluripotent stem cell
//
ID SMF No.20
AC CVCL_0H79
DR SKIP; SKIP000573
RX PubMed=24859480;
DI NCIt; C27701; Secondary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H70 ! SMF No.5
OI CVCL_0H71 ! SMF No.6
OI CVCL_0H72 ! SMF No.7
OI CVCL_0H73 ! SMF No.8
OI CVCL_0H74 ! SMF No.9
OI CVCL_0H75 ! SMF No.12
OI CVCL_0H76 ! SMF No.15
OI CVCL_0H77 ! SMF No.16
OI CVCL_0H78 ! SMF No.17
OI CVCL_0H80 ! SMF No.21
SX Female
CA Induced pluripotent stem cell
//
ID SMF No.21
AC CVCL_0H80
DR SKIP; SKIP000574
RX PubMed=24859480;
DI NCIt; C27701; Secondary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H70 ! SMF No.5
OI CVCL_0H71 ! SMF No.6
OI CVCL_0H72 ! SMF No.7
OI CVCL_0H73 ! SMF No.8
OI CVCL_0H74 ! SMF No.9
OI CVCL_0H75 ! SMF No.12
OI CVCL_0H76 ! SMF No.15
OI CVCL_0H77 ! SMF No.16
OI CVCL_0H78 ! SMF No.17
OI CVCL_0H79 ! SMF No.20
SX Female
CA Induced pluripotent stem cell
//
ID SMF No.5
AC CVCL_0H70
DR SKIP; SKIP000565
RX PubMed=24859480;
DI NCIt; C27701; Secondary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H71 ! SMF No.6
OI CVCL_0H72 ! SMF No.7
OI CVCL_0H73 ! SMF No.8
OI CVCL_0H74 ! SMF No.9
OI CVCL_0H75 ! SMF No.12
OI CVCL_0H76 ! SMF No.15
OI CVCL_0H77 ! SMF No.16
OI CVCL_0H78 ! SMF No.17
OI CVCL_0H79 ! SMF No.20
OI CVCL_0H80 ! SMF No.21
SX Female
CA Induced pluripotent stem cell
//
ID SMF No.6
AC CVCL_0H71
DR SKIP; SKIP000566
RX PubMed=24859480;
DI NCIt; C27701; Secondary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H70 ! SMF No.5
OI CVCL_0H72 ! SMF No.7
OI CVCL_0H73 ! SMF No.8
OI CVCL_0H74 ! SMF No.9
OI CVCL_0H75 ! SMF No.12
OI CVCL_0H76 ! SMF No.15
OI CVCL_0H77 ! SMF No.16
OI CVCL_0H78 ! SMF No.17
OI CVCL_0H79 ! SMF No.20
OI CVCL_0H80 ! SMF No.21
SX Female
CA Induced pluripotent stem cell
//
ID SMF No.7
AC CVCL_0H72
DR SKIP; SKIP000567
RX PubMed=24859480;
DI NCIt; C27701; Secondary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H70 ! SMF No.5
OI CVCL_0H71 ! SMF No.6
OI CVCL_0H73 ! SMF No.8
OI CVCL_0H74 ! SMF No.9
OI CVCL_0H75 ! SMF No.12
OI CVCL_0H76 ! SMF No.15
OI CVCL_0H77 ! SMF No.16
OI CVCL_0H78 ! SMF No.17
OI CVCL_0H79 ! SMF No.20
OI CVCL_0H80 ! SMF No.21
SX Female
CA Induced pluripotent stem cell
//
ID SMF No.8
AC CVCL_0H73
DR SKIP; SKIP000568
RX PubMed=24859480;
DI NCIt; C27701; Secondary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H70 ! SMF No.5
OI CVCL_0H71 ! SMF No.6
OI CVCL_0H72 ! SMF No.7
OI CVCL_0H74 ! SMF No.9
OI CVCL_0H75 ! SMF No.12
OI CVCL_0H76 ! SMF No.15
OI CVCL_0H77 ! SMF No.16
OI CVCL_0H78 ! SMF No.17
OI CVCL_0H79 ! SMF No.20
OI CVCL_0H80 ! SMF No.21
SX Female
CA Induced pluripotent stem cell
//
ID SMF No.9
AC CVCL_0H74
RX PubMed=24859480;
DI NCIt; C27701; Secondary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H70 ! SMF No.5
OI CVCL_0H71 ! SMF No.6
OI CVCL_0H72 ! SMF No.7
OI CVCL_0H73 ! SMF No.8
OI CVCL_0H75 ! SMF No.12
OI CVCL_0H76 ! SMF No.15
OI CVCL_0H77 ! SMF No.16
OI CVCL_0H78 ! SMF No.17
OI CVCL_0H79 ! SMF No.20
OI CVCL_0H80 ! SMF No.21
SX Female
CA Induced pluripotent stem cell
//
ID SMG-C10
AC CVCL_6953
SY SMG C10; SMGC10
RX PubMed=9112124;
RX PubMed=9825893;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID SMG-C6
AC CVCL_6954
SY SMG C6; SMGC6
DR BTO; BTO:0004220
RX PubMed=9112124;
RX PubMed=9825893;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID SMIE
AC CVCL_9Y73
SY RSMG 2C-2
RX PubMed=2164809;
RX PubMed=9426293;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12 [E1A].
CC Miscellaneous: Assignment of SMIE to RSMG 2C-2 by personal communication of Tabak L.A.
CC Breed/subspecies: Long-Evans.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID sMISK
AC CVCL_W333
RX PubMed=7531680;
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W332 ! MISK81-5
SX Female
CA Cancer cell line
//
ID SMITH
AC CVCL_W397
RX CelloPub=CLPUB00019;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SMKT-R1
AC CVCL_A749
SY SMKT-R-1; SMKTR1
RX PubMed=1433606;
RX PubMed=2051699;
RX PubMed=2815432;
RX PubMed=27993170;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SMKT-R2
AC CVCL_A750
SY SMKT-R-2; SMKTR2
DR Cosmic; 849380
RX PubMed=1433606;
RX PubMed=2051699;
RX PubMed=2815432;
RX PubMed=11146448;
RX PubMed=27993170;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SMKT-R3
AC CVCL_A751
SY SMKT-R-3; SMKTR3
DR Cosmic; 849381
RX PubMed=1433606;
RX PubMed=2051699;
RX PubMed=2815432;
RX PubMed=11146448;
RX PubMed=27993170;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SMKT-R4
AC CVCL_A752
SY SMKT-R-4; SMKTR4
RX PubMed=1433606;
RX PubMed=2051699;
RX PubMed=27993170;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SML, clone 4D8
AC CVCL_6446
SY SML; Squirrel Monkey Lymphoblastic cell line
DR CLO; CLO_0009090
DR ATCC; CRL-2311
RX PubMed=10090044;
WW http://www.mdanderson.org/education-and-research/departments-programs-and-labs/programs-centers-institutes/michale-e-keeling-center-for-comparative-medicine-and-research/animal-resources/squirel-monkey-cell-lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=39432; ! Saimiri boliviensis boliviensis
SX Male
CA Transformed cell line
//
ID SMMC-7721
AC CVCL_0534
AS CVCL_B400
SY SMMC 7721; SMMC7721; H7721; H-7721
DR BTO; BTO:0003227
DR MCCL; MCC:0000433
DR CCRID; 3111C0001CCC000087
DR CCRID; 3131C0001000700052
DR CCRID; 3142C0001000000063
DR CCRID; 3153C0001000000015
DR ChEMBL-Cells; CHEMBL3308059
DR ChEMBL-Targets; CHEMBL613831
DR Cosmic; 852773
DR Cosmic; 1060081
DR Cosmic; 1499248
DR GEO; GSM936777
DR GEO; GSM1374884
RX PubMed=17552011;
RX PubMed=23505090;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-587.html
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'SMMU-7721'.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SMMU-1
AC CVCL_DG22
RX PubMed=7511044;
RX PubMed=8755562;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DG23 ! SMMU-2
CA Cancer cell line
//
ID SMMU-2
AC CVCL_DG23
SY SMMU2
RX PubMed=7511044;
RX PubMed=8755562;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DG22 ! SMMU-1
CA Cancer cell line
//
ID SMOV-1
AC CVCL_S916
SY SMOV1
RX DOI=10.1007/BF02492857;
CC Doubling time: 61.4 hours (DOI=10.1007/BF02492857).
CC Derived from metastatic site: Ascites.
DI NCIt; C4182; Serous surface papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SMOV-2
AC CVCL_S920
SY SMOV2
RX PubMed=10695021;
CC Doubling time: 48.2 hours (PubMed=10695021).
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SMRC-1
AC CVCL_5898
RX PubMed=11737483;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SMRC-3
AC CVCL_5899
RX PubMed=11737483;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SMS-CTR
AC CVCL_A770
SY SMS_CTR; SMSCTR
DR Cosmic; 802048
DR Cosmic; 1097752
DR Cosmic; 1718105
DR Cosmic; 2355930
RX PubMed=2302710;
RX PubMed=8275086;
RX PubMed=21948088;
RX PubMed=23882450;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Reynolds C.P.; Children's Hospital of Los Angeles; Los Angeles; USA.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): COG; PubMed=21948088
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 10,11
ST D18S51: 13
ST D19S433: 14
ST D21S11: 29,31.2
ST D2S1338: 24
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 10,12
ST FGA: 21,22
ST TH01: 6
ST TPOX: 8,12
ST vWA: 18,19
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SMS-KAN
AC CVCL_7131
DR CGH-DB; 9096-4
DR Cosmic; 717425
DR Cosmic; 848932
DR Cosmic; 922671
DR Cosmic; 923826
DR Cosmic; 930079
DR Cosmic; 1019938
DR Cosmic; 1526650
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=3456456;
RX PubMed=7037175;
RX PubMed=12702577;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/SMS-KAN_Cell_Line_Data_Sheet_COGcell_org.pdf
CC Doubling time: ~95 hours (PubMed=3456456).
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 11,13
ST D18S51: 17,21
ST D19S433: 12
ST D21S11: 28,30
ST D2S1338: 18,19
ST D3S1358: 15,17
ST D5S818: 9,13
ST D7S820: 8,9
ST D8S1179: 14,16
ST FGA: 19,21
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7132 ! SMS-KANR
SX Female
CA Cancer cell line
//
ID SMS-KANR
AC CVCL_7132
DR Cosmic; 922672
DR Cosmic; 1890105
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=3456456;
RX PubMed=7037175;
RX PubMed=23202128;
WW http://www.cogcell.org/dl/NB_Data_Sheets/SMS-KANR_Cell_Line_Data_Sheet_COGcell_org.pdf
CC Doubling time: ~69 hours (PubMed=3456456).
CC Derived from metastatic site: Bone marrow.
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 11,13
ST D18S51: 17,21
ST D19S433: 12
ST D21S11: 28,30
ST D2S1338: 18,19
ST D3S1358: 15,17
ST D5S818: 9,13
ST D7S820: 8,9
ST D8S1179: 14,16
ST FGA: 19,21
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7131 ! SMS-KAN
SX Female
CA Cancer cell line
//
ID SMS-KCL
AC CVCL_AQ28
RX PubMed=7037175;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 10,11
ST D18S51: 15,19
ST D19S433: 14,15
ST D21S11: 30,31.2
ST D2S1338: 17,22
ST D3S1358: 14,15
ST D5S818: 11
ST D7S820: 9,11
ST D8S1179: 13,14
ST FGA: 19,22
ST TH01: 9.3
ST TPOX: 11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7133 ! SMS-KCN
OI CVCL_7134 ! SMS-KCNR
SX Male
CA Transformed cell line
//
ID SMS-KCN
AC CVCL_7133
SY KCN; NB07C
DR BTO; BTO:0003548
DR CGH-DB; 71-1
DR CGH-DB; 9091-4
DR Cosmic; 717426
DR Cosmic; 848940
DR Cosmic; 923827
DR Cosmic; 1019932
DR Cosmic; 1162007
DR Cosmic; 1890077
DR Cosmic; 2393632
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2535691;
RX PubMed=3456456;
RX PubMed=7037175;
RX PubMed=12702577;
RX PubMed=15150091;
RX PubMed=23202128;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/SMS-KCN_Cell_Line_Data_Sheet_COGcell_org.pdf
CC Doubling time: ~109 hours (PubMed=3456456).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Genome sequenced.
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 10,11
ST D18S51: 15,19
ST D19S433: 14,15
ST D21S11: 30,31.2
ST D2S1338: 17,22
ST D3S1358: 14,15
ST D5S818: 11
ST D7S820: 9,11
ST D8S1179: 13,14
ST FGA: 19,22
ST TH01: 9.3
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AQ28 ! SMS-KCL
OI CVCL_7134 ! SMS-KCNR
SX Male
CA Cancer cell line
//
ID SMS-KCNR
AC CVCL_7134
SY SMSKCNR; KCNR; KCN-R
DR CGH-DB; 9100-4
DR Cosmic; 848941
DR Cosmic; 922673
DR Cosmic; 1019950
DR Cosmic; 1109112
DR Cosmic; 1153804
DR Cosmic; 1167413
DR Cosmic; 1518067
DR Cosmic; 1526651
DR Cosmic; 2239460
DR Cosmic; 2393633
DR GEO; GSM692866
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=3456456;
RX PubMed=7037175;
RX PubMed=7838528;
RX PubMed=12702577;
RX PubMed=22213050;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/SMS-KCNR_Cell_Line_Data_Sheet_COGcell_org.pdf
CC Doubling time: ~72 hours (PubMed=3456456).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 10,11
ST D18S51: 15,19
ST D19S433: 14,15
ST D21S11: 30,31.2
ST D2S1338: 17,22
ST D3S1358: 14,15
ST D5S818: 11
ST D7S820: 9,11
ST D8S1179: 13,14
ST FGA: 19,22
ST TH01: 9.3
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AQ28 ! SMS-KCL
OI CVCL_7133 ! SMS-KCN
SX Male
CA Cancer cell line
//
ID SMS-LHN
AC CVCL_9539
DR Cosmic; 717429
DR Cosmic; 848931
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7037175;
RX PubMed=8242562;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/SMS-LHN_Cell_Line_Data_Sheet_COGcell_org.pdf
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9,13
ST D16S539: 8,9
ST D18S51: 16,19
ST D19S433: 15
ST D21S11: 27,28
ST D2S1338: 17,19
ST D3S1358: 16,18
ST D5S818: 10,11
ST D7S820: 8,11
ST D8S1179: 13,14
ST FGA: 19,23
ST TH01: 9.3,10
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SMS-MSN
AC CVCL_7135
DR Cosmic; 930080
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=3456456;
RX PubMed=7037175;
CC Doubling time: ~85 hours (PubMed=3456456).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SMS-SAL
AC CVCL_AQ29
RX PubMed=7037175;
RX PubMed=11986953;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 16,19
ST D19S433: 13,14
ST D21S11: 29,31.2
ST D2S1338: 19
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 10,11
ST FGA: 19
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7136 ! SMS-SAN
SX Female
CA Transformed cell line
//
ID SMS-SAN
AC CVCL_7136
SY SMS SAN
DR Cosmic; 717428
DR Cosmic; 848933
DR Cosmic; 1019951
DR Cosmic; 1162008
DR Cosmic; 1890107
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=3456456;
RX PubMed=7037175;
RX PubMed=23202128;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/SMS-SAN_Cell_Line_Data_Sheet_COGcell_org.pdf
CC Doubling time: ~71 hours (PubMed=3456456).
CC Derived from metastatic site: Bone marrow.
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 16,19
ST D19S433: 13,14
ST D21S11: 29,31.2
ST D2S1338: 19
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 10,11
ST FGA: 19
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AQ29 ! SMS-SAL
SX Female
CA Cancer cell line
//
ID SMS-SB
AC CVCL_AQ30
SY SMS/SB; SB
DR Cosmic; 1226861
DR Cosmic; 922680
DR Cosmic; 2361361
DR Cosmic; 2491100
RX PubMed=6778921;
RX PubMed=8547074;
RX PubMed=9067587;
RX PubMed=9207458;
RX PubMed=11986953;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 7,10
ST D13S317: 11,12
ST D16S539: 11,14
ST D18S51: 16,17
ST D19S433: 12,15
ST D21S11: 28,30
ST D2S1338: 19,22
ST D3S1358: 16,17
ST D5S818: 12,14
ST D7S820: 8,10
ST D8S1179: 14
ST FGA: 18.2,21
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 18,21
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SMT/2A LNM
AC CVCL_3601
DR CLO; CLO_0009091
DR ATCC; CRL-6602
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Derived from metastatic site: Lymph node.
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_Y904 ! Rama 900
SX Female
CA Cancer cell line
//
ID SMTK-1
AC CVCL_GS48
RX PubMed=15160996;
CC From: Matsumoto; Shinsyu University School of Medicine; Matsumoto; Japan.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SMU1-10
AC CVCL_IN93
RX PubMed=9170108;
WW https://www.abmgood.com/Immortalized-Mouse-Smooth-Muscle/Myometrial-Like-Cells-(SMU1-10)-T0651.html
CC Characteristics: At the permissive temperature (33 Celsius) grow continuously. At the restrictive temperature (39 Celsius) stop dividing and ultimately die within 3 weeks.
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Conditionally immortalized cell line
//
ID SMYM-PRGP
AC CVCL_H199
DR Cosmic; 2144973
RX PubMed=17488338;
RX PubMed=19035443;
RX PubMed=22578220;
CC Omics: Deep exome analysis.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SN-1
AC CVCL_B075
DR Cosmic; 996312
DR Cosmic; 998747
DR Cosmic; 1037663
DR Cosmic; 2393017
RX PubMed=10706136;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SN-512
AC CVCL_8759
DR CLO; CLO_0051544
DR BioSample; SAMN03472137
DR RCB; RCB1429
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 8
ST D16S539: 13
ST D5S818: 10
ST D7S820: 11
ST TH01: 9
ST TPOX: 8,9
ST vWA: 14
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SN-56/OBR
AC CVCL_4457
DR BTO; BTO:0003557
RX PubMed=10806392;
CC Transfected with: HGNC; 6554; LEPR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4456 ! SN56
CA Hybrid cell line
//
ID SN-Mel
AC CVCL_7137
DR Cosmic; 1109810
DR Cosmic; 1295342
RX PubMed=11121133;
RX PubMed=18384130;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SN-SY-1
AC CVCL_N584
DR Cosmic; 1206121
RX PubMed=9378564;
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SN-T4
AC CVCL_M849
RX PubMed=3167823;
DI NCIt; C3513; Esophageal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M848 ! SNO
SX Male
CA Cancer cell line
//
ID SN12A1
AC CVCL_D105
RX PubMed=3731078;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1705 ! SN12C
OI CVCL_D106 ! SN12K1
OI CVCL_D107 ! SN12L1
OI CVCL_D108 ! SN12S1
SX Male
CA Cancer cell line
//
ID SN12C
AC CVCL_1705
SY SN-12C
DR BTO; BTO:0004221
DR ChEMBL-Cells; CHEMBL3307518
DR ChEMBL-Targets; CHEMBL614054
DR Cosmic; 687942
DR Cosmic; 849372
DR Cosmic; 897464
DR Cosmic; 905979
DR Cosmic; 974307
DR Cosmic; 1044262
DR Cosmic; 1092636
DR Cosmic; 1175852
DR Cosmic; 1305377
DR Cosmic; 1312365
DR Cosmic; 1998479
DR Cosmic-CLP; 905979
DR GDSC; 905979
DR GEO; GSM50230
DR GEO; GSM50294
DR GEO; GSM579204
DR GEO; GSM579205
DR GEO; GSM579404
DR GEO; GSM750840
DR GEO; GSM799376
DR GEO; GSM799439
DR GEO; GSM847160
DR GEO; GSM844695
DR GEO; GSM844696
DR GEO; GSM1153449
DR GEO; GSM1181307
DR GEO; GSM1181325
DR GEO; GSM1670459
DR KCLB; 80025
DR SKY/M-FISH/CGH; 2804
RX PubMed=2041050;
RX PubMed=2706827;
RX PubMed=3731078;
RX PubMed=8053494;
RX PubMed=11146448;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=20952505;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=36
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 29.5 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=19372543
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 9
ST D16S539: 11
ST D18S51: 12
ST D19S433: 14
ST D21S11: 29,30
ST D2S1338: 17,25
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 12
ST FGA: 21,22
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 15
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D105 ! SN12A1
OI CVCL_D106 ! SN12K1
OI CVCL_D107 ! SN12L1
OI CVCL_D108 ! SN12S1
SX Male
CA Cancer cell line
//
ID SN12C-PM6
AC CVCL_9549
SY SN12CPM6; SN12-PM6; SN12PM6; PM6; LM1
DR GEO; GSM374474
DR GEO; GSM579206
DR GEO; GSM579401
DR KCLB; 80026
RX PubMed=2706827;
RX PubMed=8053494;
RX PubMed=10987313;
RX PubMed=20952505;
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1705 ! SN12C
SX Male
CA Cancer cell line
//
ID SN12C-PM6-2
AC CVCL_DG80
SY LM2
DR GEO; GSM579207
DR GEO; GSM579208
DR GEO; GSM579402
DR GEO; GSM579403
RX PubMed=20952505;
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9549 ! SN12C-PM6
SX Male
CA Cancer cell line
//
ID SN12K1
AC CVCL_D106
DR ChEMBL-Cells; CHEMBL3307784
DR ChEMBL-Targets; CHEMBL1909241
RX PubMed=3731078;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D105 ! SN12A1
OI CVCL_1705 ! SN12C
OI CVCL_D107 ! SN12L1
OI CVCL_D108 ! SN12S1
SX Male
CA Cancer cell line
//
ID SN12L1
AC CVCL_D107
RX PubMed=3731078;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D105 ! SN12A1
OI CVCL_1705 ! SN12C
OI CVCL_D106 ! SN12K1
OI CVCL_D108 ! SN12S1
SX Male
CA Cancer cell line
//
ID SN12S1
AC CVCL_D108
RX PubMed=3731078;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D105 ! SN12A1
OI CVCL_1705 ! SN12C
OI CVCL_D106 ! SN12K1
OI CVCL_D107 ! SN12L1
SX Male
CA Cancer cell line
//
ID SN161
AC CVCL_5U32
RX PubMed=1855225;
RX PubMed=2185890;
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC Derived from metastatic site: Lymph node.
CC Breed/subspecies: 129 x NIH Swiss.
DI NCIt; C21609; Mouse squamous cell carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID SN36
AC CVCL_F954
SY SN-36
DR TKG; TKG 0171
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID SN4741
AC CVCL_S466
RX PubMed=9870933;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/J x C57BL/6) F2 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID SN56
AC CVCL_4456
SY SN-56; SN56.B5.G4; SN56 B5 G4
DR BTO; BTO:0003556
DR EFO; EFO_0002081
RX PubMed=2331789;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2132 ! N18TG2
CA Hybrid cell line
//
ID SNA-BLL
AC CVCL_E831
SY SNANI-BLL; SNA
DR dbMHC; 49022
DR ECACC; 94050325
DR IHW; IHW9245
DR IMGT/HLA; 11394
WW http://bioinformatics.hsanmartino.it/ecbr/cl245.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SNB-19
AC CVCL_0535
SY SNB.19; SNB19
DR BTO; BTO:0003761
DR CLO; CLO_0009093
DR EFO; EFO_0002342
DR MCCL; MCC:0000434
DR ATCC; CRL-2219
DR BioSample; SAMN03151977
DR BioSample; SAMN03471000
DR BioSample; SAMN03472567
DR CCLE; SNB19_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3307552
DR ChEMBL-Targets; CHEMBL614164
DR Cosmic; 875894
DR Cosmic; 897439
DR Cosmic; 905966
DR Cosmic; 974241
DR Cosmic; 1044249
DR Cosmic; 1092637
DR Cosmic; 1305361
DR Cosmic; 1312343
DR Cosmic; 1746950
DR Cosmic; 1998480
DR Cosmic; 2302333
DR Cosmic; 2367548
DR Cosmic; 2550361
DR DSMZ; ACC-325
DR GEO; GSM50178
DR GEO; GSM50242
DR GEO; GSM326246
DR GEO; GSM750785
DR GEO; GSM799326
DR GEO; GSM799389
DR GEO; GSM847161
DR GEO; GSM844697
DR GEO; GSM887600
DR GEO; GSM888683
DR GEO; GSM1153396
DR GEO; GSM1181304
DR GEO; GSM1181321
DR IGRhCellID; SNB19
DR JCRB; NIHS0294
DR SKY/M-FISH/CGH; 2822
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2041050;
RX PubMed=3121170;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=20143388;
RX PubMed=22460905;
RX PubMed=22570425;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24335698;
RX PubMed=27807467;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://dtp.cancer.gov/discovery_development/nci-60/u251_snb-19.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=55
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-111.html
WW http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a U-251MG derivative (PubMed=20143388, PubMed=22570425).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 34.6 hours (DTP); ~24 hours (DSMZ).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2219; true.
CC Discontinued: JCRB; NIHS0294; true.
ST Source(s): ATCC; DSMZ; PubMed=19372543; PubMed=25877200
ST Amelogenin: X,Y (ATCC; DSMZ; PubMed=19372543)
ST Amelogenin: X (PubMed=25877200)
ST CSF1PO: 11,12 (ATCC; DSMZ; PubMed=25877200)
ST CSF1PO: 12 (PubMed=19372543)
ST D13S317: 10,11
ST D16S539: 12
ST D18S51: 13
ST D19S433: 13,15
ST D21S11: 29
ST D2S1338: 22,24
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 10,12 (ATCC; DSMZ; PubMed=25877200)
ST D7S820: 10 (PubMed=19372543)
ST D8S1179: 13,15
ST FGA: 21 (PubMed=19372543)
ST FGA: 21,25 (PubMed=25877200)
ST Penta D: 12
ST Penta E: 7,10
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0021 ! U-251MG
SX Male
CA Cancer cell line
//
ID SNB-56
AC CVCL_B320
SY SNB56
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=3121170;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNB-75
AC CVCL_1706
SY SNB.75; SNB75
DR BTO; BTO:0004222
DR ChEMBL-Cells; CHEMBL3307616
DR ChEMBL-Targets; CHEMBL614451
DR Cosmic; 687583
DR Cosmic; 875895
DR Cosmic; 905982
DR Cosmic; 974242
DR Cosmic; 1092638
DR Cosmic; 1175820
DR Cosmic; 1305362
DR Cosmic; 1312344
DR Cosmic; 1436042
DR Cosmic; 1998481
DR Cosmic; 2367549
DR Cosmic-CLP; 905982
DR GDSC; 905982
DR GEO; GSM50179
DR GEO; GSM50243
DR GEO; GSM750786
DR GEO; GSM799327
DR GEO; GSM799390
DR GEO; GSM847162
DR GEO; GSM844698
DR GEO; GSM844699
DR GEO; GSM844700
DR GEO; GSM1153397
DR GEO; GSM1181270
DR GEO; GSM1181313
DR GEO; GSM1670460
DR LINCS; 50045
DR SKY/M-FISH/CGH; 2823
RX PubMed=2041050;
RX PubMed=3121170;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=22336246;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=56
WW http://tcpaportal.org/mclp/
CC Part of: JFCR39 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 62.8 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=19372543
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 11,13
ST D18S51: 18
ST D19S433: 13,14
ST D21S11: 30
ST D2S1338: 17,23
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 9,11 (Cosmic-CLP)
ST D7S820: 9 (PubMed=19372543)
ST D8S1179: 12
ST FGA: 19,23
ST TH01: 6,9 (Cosmic-CLP)
ST TH01: 9 (PubMed=19372543)
ST TPOX: 8,10
ST vWA: 16,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNB-78
AC CVCL_B321
SY SNB78
DR ChEMBL-Cells; CHEMBL3307969
DR ChEMBL-Targets; CHEMBL612543
DR Cosmic; 1436043
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=3121170;
RX PubMed=22336246;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC Part of: JFCR39 cancer cell line panel.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNEC-MI
AC CVCL_9481
RX PubMed=15218315;
DI NCIt; C116318; Nasal cavity and paranasal sinus small cell neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID sNF02.2
AC CVCL_K280
SY sNF02-2
DR ATCC; CRL-2885
DR BioSample; SAMN03471811
DR Cosmic; 1644554
RX PubMed=14762442;
RX PubMed=22346343;
CC Derived from metastatic site: Lung.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,12
ST vWA: 16
DI NCIt; C3273; Neurofibromatosis type 1
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID sNF94.3
AC CVCL_K164
DR ATCC; CRL-2886
DR BioSample; SAMN03471812
RX PubMed=14762442;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 10,12
ST D7S820: 9,14
ST TH01: 7,9.3
ST TPOX: 11,12
ST vWA: 17,18
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID sNF96.2
AC CVCL_K281
SY SNF96.2; sNF96-2
DR ATCC; CRL-2884
DR BioSample; SAMN03471810
DR Cosmic; 1644553
RX PubMed=14762442;
RX PubMed=22346343;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 11
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 11
ST vWA: 17,19
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNG-II
AC CVCL_3170
SY SNGII
DR BioSample; SAMN03472781
DR Cosmic; 1241343
DR Cosmic; 2030482
DR IFO; IFO50312
DR JCRB; JCRB0175
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Discontinued: JCRB; JCRB0175; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 9,12
ST D16S539: 12,13
ST D5S818: 6,12
ST D7S820: 9,13
ST TH01: 9
ST TPOX: 11
ST vWA: 15,16,17
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNG-M
AC CVCL_1707
SY SNGM
DR BioSample; SAMN03470892
DR BioSample; SAMN03472782
DR CCLE; SNGM_ENDOMETRIUM
DR ChEMBL-Cells; CHEMBL3308466
DR ChEMBL-Targets; CHEMBL1075582
DR Cosmic; 909735
DR Cosmic; 1152552
DR Cosmic; 1241347
DR Cosmic; 2030483
DR Cosmic-CLP; 909735
DR GDSC; 909735
DR GEO; GSM827242
DR GEO; GSM887601
DR GEO; GSM888684
DR GEO; GSM1670461
DR IFO; IFO50313
DR JCRB; JCRB0179
RX PubMed=858140;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Obturator lymph node.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11 (Cosmic-CLP; PubMed=25877200)
ST D13S317: 8,10,11 (JCRB)
ST D16S539: 10,12 (Cosmic-CLP)
ST D16S539: 10,11,12 (JCRB; PubMed=25877200)
ST D18S51: 12,18,19
ST D19S433: 13.2,14,15
ST D21S11: 29,30
ST D2S1338: 19,24,25
ST D3S1358: 13,14,15
ST D5S818: 9,13
ST D7S820: 10,12,13 (Cosmic-CLP)
ST D7S820: 10,11 (JCRB)
ST D7S820: 10,11,12 (PubMed=25877200)
ST D8S1179: 11,13
ST FGA: 22
ST Penta D: 8,11
ST Penta E: 11,14
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 17,20 (Cosmic-CLP; PubMed=25877200)
ST vWA: 17,18,20 (JCRB)
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S914 ! SNG-P
SX Female
CA Cancer cell line
//
ID SNG-P
AC CVCL_S914
RX PubMed=858140;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1707 ! SNG-M
SX Female
CA Cancer cell line
//
ID SNK-1
AC CVCL_A671
SY SNK1
DR Cosmic; 1542073
DR GEO; GSM472003
RX PubMed=11881730;
RX PubMed=12780797;
RX PubMed=19194464;
RX PubMed=21052088;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNK-10
AC CVCL_A672
SY SNK10
DR Cosmic; 1534878
DR Cosmic; 2025328
DR GEO; GSM472004
DR GEO; GSM472005
RX PubMed=12780797;
RX PubMed=21052088;
RX PubMed=22102884;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C126348; Chronic active Epstein-Barr virus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNK-57
AC CVCL_3923
SY SNK57
DR BTO; BTO:0003480
DR TKG; TKG 0701
RX PubMed=9183630;
CC Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
ST Source(s): TKG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNK-6
AC CVCL_A673
SY SNK6
DR Cosmic; 1534873
DR Cosmic; 1542074
DR Cosmic; 2025327
DR Cosmic; 2390118
DR GEO; GSM472006
RX PubMed=11157488;
RX PubMed=12780797;
RX PubMed=19194464;
RX PubMed=21052088;
RX PubMed=22102884;
RX PubMed=25586472;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNL 76/7
AC CVCL_K227
SY SNL76/7
DR ATCC; SCRC-1049
DR ECACC; 07032801
CC Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: SIM.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3420 ! STO
SX Female
CA Transformed cell line
//
ID SNLP 76/7-4
AC CVCL_K228
DR ATCC; SCRC-1050
CC Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC Selected for resistance to: ChEBI; CHEBI:17939; Puromycin.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: SIM.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K227 ! SNL 76/7
SX Female
CA Transformed cell line
//
ID SNO
AC CVCL_M848
SY SN
RX PubMed=174997;
RX PubMed=3167823;
DI NCIt; C3513; Esophageal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNP
AC CVCL_IP76
RX PubMed=26726024;
CC Doubling time: 26.2 hours (PubMed=26726024).
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID SNT-13
AC CVCL_A674
SY SNT13
DR Cosmic; 2390217
DR GEO; GSM349852
DR GEO; GSM349853
DR GEO; GSM472007
RX PubMed=12780797;
RX PubMed=20132662;
RX PubMed=21052088;
RX PubMed=25586472;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C126348; Chronic active Epstein-Barr virus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SNT-15
AC CVCL_A675
SY SNT15
DR Cosmic; 2390122
DR GEO; GSM349854
DR GEO; GSM349855
DR GEO; GSM472008
RX PubMed=12780797;
RX PubMed=20132662;
RX PubMed=21052088;
RX PubMed=22102884;
RX PubMed=25586472;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C126348; Chronic active Epstein-Barr virus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SNT-16
AC CVCL_A676
SY SNT16
RX PubMed=12780797;
RX PubMed=22102884;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C126348; Chronic active Epstein-Barr virus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SNT-8
AC CVCL_A677
SY SNT8
DR Cosmic; 2390121
DR GEO; GSM349850
DR GEO; GSM349851
DR GEO; GSM472009
RX PubMed=11157488;
RX PubMed=12780797;
RX PubMed=20132662;
RX PubMed=21052088;
RX PubMed=22102884;
RX PubMed=25586472;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1
AC CVCL_0099
SY SNU1; NCI-SNU-1
DR BTO; BTO:0005786
DR CLO; CLO_0009094
DR EFO; EFO_0002343
DR ATCC; CRL-5971
DR BCRC; 60210
DR BioSample; SAMN03472628
DR CCLE; SNU1_STOMACH
DR ChEMBL-Cells; CHEMBL3307455
DR ChEMBL-Targets; CHEMBL614931
DR Cosmic; 685584
DR Cosmic; 724854
DR Cosmic; 737362
DR Cosmic; 848136
DR Cosmic; 887260
DR Cosmic; 908444
DR Cosmic; 921595
DR Cosmic; 1090450
DR Cosmic; 1154647
DR Cosmic; 1187294
DR Cosmic; 1294954
DR Cosmic; 1528871
DR Cosmic; 1995595
DR Cosmic; 2069772
DR Cosmic; 2484960
DR Cosmic-CLP; 908444
DR GDSC; 908444
DR GEO; GSM267421
DR GEO; GSM267428
DR GEO; GSM267435
DR GEO; GSM267442
DR GEO; GSM562406
DR GEO; GSM827406
DR GEO; GSM844701
DR GEO; GSM887614
DR GEO; GSM888698
DR GEO; GSM1237679
DR GEO; GSM1237704
DR GEO; GSM1374885
DR GEO; GSM1670273
DR GEO; GSM1670462
DR IGRhCellID; SNU1
DR KCLB; 00001
RX PubMed=2158397;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=10674020;
RX PubMed=18804159;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Microsatellite instability: Instable (MSI-high) (PubMed=10674020; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB
ST Amelogenin: X,Y
ST CSF1PO: 12,13 (ATCC; Cosmic-CLP)
ST CSF1PO: 12,14 (KCLB)
ST D13S317: 11,14 (ATCC; Cosmic-CLP)
ST D13S317: 12,14 (KCLB)
ST D16S539: 9,12
ST D3S1358: 16,17
ST D5S818: 12,13 (ATCC; Cosmic-CLP)
ST D5S818: 13 (KCLB)
ST D7S820: 9,12
ST FGA: 22
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 14
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1-DOX
AC CVCL_L042
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0099 ! SNU-1
SX Male
CA Cancer cell line
//
ID SNU-1000
AC CVCL_5000
SY SNU1000
DR KCLB; 01000
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 96 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 8
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 10,12
ST FGA: 22.2
ST TH01: 9
ST TPOX: 11
ST vWA: 18
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1005
AC CVCL_5001
SY SNU1005
DR KCLB; 01005
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 8
ST FGA: 24
ST TH01: 9,10
ST TPOX: 11
ST vWA: 17
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1033
AC CVCL_5002
SY SNU1033
DR CCLE; SNU1033_LARGE_INTESTINE
DR Cosmic; 738855
DR GEO; GSM1448078
DR KCLB; 01033
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=25926053;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 42 hours (PubMed=10362137).
CC Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10
ST D3S1358: 14,17
ST D5S818: 13
ST D7S820: 12
ST FGA: 23
ST TH01: 9
ST TPOX: 11
ST vWA: 17,19
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1040
AC CVCL_5003
SY SNU1040; NCI-SNU-1040
DR CCLE; SNU1040_LARGE_INTESTINE
DR Cosmic; 738857
DR Cosmic; 848830
DR Cosmic-CLP; 1659823
DR GDSC; 1659823
DR GEO; GSM887602
DR GEO; GSM888685
DR GEO; GSM1448189
DR GEO; GSM1670463
DR KCLB; 01040
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=25926053;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 63 hours (PubMed=10362137).
CC Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053)) / Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; KCLB
ST Amelogenin: X,Y
ST CSF1PO: 11,12 (Cosmic-CLP)
ST CSF1PO: 12 (KCLB)
ST D13S317: 12
ST D16S539: 9,10
ST D3S1358: 16,18
ST D5S818: 10,13
ST D7S820: 11,13
ST FGA: 23
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17,18,19 (Cosmic-CLP)
ST vWA: 17,19 (KCLB)
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1041
AC CVCL_L085
SY SNU 1041; SNU1041
DR CCLE; SNU1041_UPPER_AERODIGESTIVE_TRACT
DR KCLB; 01041
RX CelloPub=CLPUB00001;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,11
ST D3S1358: 15
ST D5S818: 9
ST D7S820: 8,12
ST FGA: 24,25
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 14,18
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1047
AC CVCL_5004
SY SNU1047
DR Cosmic; 738858
DR Cosmic; 848831
DR Cosmic; 875423
DR GEO; GSM1448085
DR KCLB; 01047
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 36 hours (PubMed=10362137).
CC Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST CSF1PO: 9,11
ST D13S317: 10,11
ST D3S1358: 15,16
ST D5S818: 8,12
ST D7S820: 8,10
ST FGA: 18,21
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,21
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1066
AC CVCL_5005
SY SNU1066
DR BTO; BTO:0005924
DR CCLE; SNU1066_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 934176
DR KCLB; 01066
RX PubMed=10369293;
RX PubMed=19956504;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=10369293).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,12
ST D3S1358: 17
ST D5S818: 9,11
ST D7S820: 12
ST FGA: 23
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1076
AC CVCL_5006
SY SNU1076; NCI-SNU-1076
DR BTO; BTO:0005922
DR CCLE; SNU1076_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 934177
DR GEO; GSM887603
DR GEO; GSM888686
DR KCLB; 01076
RX PubMed=10369293;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 36 hours (PubMed=10369293).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D3S1358: 15
ST D5S818: 9,12
ST D7S820: 11,12
ST FGA: 24,25
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1077
AC CVCL_5007
SY SNU1077
DR CCLE; SNU1077_ENDOMETRIUM
DR GEO; GSM887604
DR GEO; GSM888687
DR KCLB; 01077
RX PubMed=9299262;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 43 hours (PubMed=9299262).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST D13S317: 12
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 8
ST FGA: 24,25
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1079
AC CVCL_5008
SY SNU1079; SNU 1079; NCI-SNU-1079
DR CCLE; SNU1079_BILIARY_TRACT
DR Cosmic; 738874
DR GEO; GSM887605
DR GEO; GSM888688
DR KCLB; 01079
RX CelloPub=CLPUB00275;
RX PubMed=12107841;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 72 hours (PubMed=12107841).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D3S1358: 15
ST D5S818: 10,13
ST D7S820: 8,12
ST FGA: 22
ST TH01: 8
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1103
AC CVCL_5009
SY SNU1103
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-1105
AC CVCL_5010
SY SNU1105; NCI-SNU-1105
DR CCLE; SNU1105_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 2516037
DR GEO; GSM887606
DR GEO; GSM888689
DR KCLB; 01105
RX PubMed=11776963;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 84 hours (PubMed=11776963); 73 hours (PubMed=25984343).
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 8,11
ST FGA: 24,25
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1118
AC CVCL_5011
SY SNU1118
DR KCLB; 01118
RX PubMed=11776963;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 78 hours (PubMed=11776963).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8
ST D3S1358: 14,15
ST D5S818: 9,12
ST D7S820: 8
ST FGA: 23,25
ST TH01: 9
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1160
AC CVCL_5012
SY SNU1160
DR KCLB; 01160
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 54 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1181
AC CVCL_5013
SY SNU1181
DR Cosmic; 1322287
DR GEO; GSM1448219
DR KCLB; 01181
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 52 hours (PubMed=20176655).
CC Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Liver.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 10,12
ST D18S51: 17
ST D19S433: 14,15
ST D21S11: 29,32.2
ST D2S1338: 25
ST D3S1358: 16
ST D5S818: 10
ST D7S820: 10,11
ST D8S1179: 10,12
ST FGA: 18,23
ST TH01: 9
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-119
AC CVCL_5014
SY SNU119; NCI-SNU-119
DR CCLE; SNU119_OVARY
DR GEO; GSM887608
DR GEO; GSM888691
DR KCLB; 00119
RX PubMed=9299249;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=27561551;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 53 hours (PubMed=9299249).
CC Omics: Deep proteome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 10,11
ST FGA: 25
ST TH01: 7
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1196
AC CVCL_5015
SY SNU1196
DR CCLE; SNU1196_BILIARY_TRACT
DR Cosmic; 738876
DR GEO; GSM887607
DR GEO; GSM888690
DR KCLB; 01196
RX CelloPub=CLPUB00275;
RX PubMed=12107841;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=12107841).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9
ST D3S1358: 14,15
ST D5S818: 11
ST D7S820: 8,11
ST FGA: 24,25
ST TH01: 5,7
ST TPOX: 10,11
ST vWA: 14,16
DI NCIt; C36077; Hilar cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SNU-1197
AC CVCL_5016
SY SNU1197
DR CCLE; SNU1197_LARGE_INTESTINE
DR Cosmic; 738859
DR KCLB; 01197
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 60 hours (PubMed=10362137).
CC Microsatellite instability: Stable (MSS) (PubMed=10674020).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D3S1358: 18
ST D5S818: 10,12
ST D7S820: 11,12
ST FGA: 23
ST TH01: 8,9
ST TPOX: 7,8
ST vWA: 17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1214
AC CVCL_5017
SY SNU1214; NCI-SNU-1214
DR BTO; BTO:0005923
DR CCLE; SNU1214_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 934178
DR GEO; GSM887609
DR GEO; GSM888692
DR KCLB; 01214
RX PubMed=10369293;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 96 hours (PubMed=10369293).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9
ST D3S1358: 16
ST D5S818: 9,10
ST D7S820: 8,9
ST FGA: 19
ST TH01: 7,9
ST TPOX: 11
ST vWA: 16,19
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1235
AC CVCL_5018
SY SNU1235
DR Cosmic; 1322288
DR GEO; GSM1448190
DR KCLB; 01235
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 45 hours (PubMed=20176655).
CC Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 13
ST D16S539: 9,12
ST D18S51: 13
ST D19S433: 14.2,15.2
ST D21S11: 30
ST D2S1338: 19
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 8,12
ST D8S1179: 12,16
ST FGA: 23
ST TH01: 9
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1245
AC CVCL_5019
SY SNU1245
DR KCLB; 01245
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 54 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 9,11
ST FGA: 22
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1272
AC CVCL_8788
AS CVCL_5020
SY SNU1272; NCI-SNU-1272
DR CCLE; SNU1272_KIDNEY
DR GEO; GSM887610
DR GEO; GSM888693
DR KCLB; 01272
RX PubMed=10619961;
RX PubMed=14634222;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=27993170;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 153 hours (PubMed=10619961).
CC Microsatellite instability: Stable (MSS) (PubMed=10619961).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SNU-1271' in PubMed=19956504.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D3S1358: 16
ST D5S818: 10,12
ST D7S820: 11,12
ST FGA: 21
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 15,18
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1299
AC CVCL_5021
SY SNU1299
DR KCLB; 01299
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D3S1358: 15,16
ST D5S818: 7,11
ST D7S820: 11
ST FGA: 22
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1327
AC CVCL_5022
SY SNU1327
DR Cosmic; 1484499
DR KCLB; 01327
RX PubMed=21290211;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 42 hours (PubMed=21290211).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,13
ST FGA: 18
ST TH01: 9
ST TPOX: 10,11
ST vWA: 18,19
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1330
AC CVCL_5023
SY SNU1330
DR Cosmic; 1484500
DR KCLB; 01330
RX PubMed=21290211;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 39 hours (PubMed=21290211).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 8
ST FGA: 22
ST TH01: 9
ST TPOX: 8
ST vWA: 14
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1406
AC CVCL_5024
SY SNU1406
DR Cosmic; 1322289
DR GEO; GSM1448191
DR KCLB; 01406
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 25 hours (PubMed=20176655).
CC Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 11,12
ST D18S51: 13,20
ST D19S433: 14.2,16.2
ST D21S11: 30,33.2
ST D2S1338: 17,23
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 8,11
ST D8S1179: 14,16
ST FGA: 21,22
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1411
AC CVCL_5025
SY SNU1411
DR Cosmic; 1322290
DR GEO; GSM1448157
DR KCLB; 01411
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 38 hours (PubMed=20176655).
CC Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 12,13
ST D18S51: 14
ST D19S433: 14
ST D21S11: 30
ST D2S1338: 19,24
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 11
ST D8S1179: 15
ST FGA: 23,24
ST TH01: 9
ST TPOX: 8
ST vWA: 20
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1460
AC CVCL_5026
SY SNU1460
DR Cosmic; 1322291
DR GEO; GSM1448158
DR KCLB; 01460
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 67 hours (PubMed=20176655).
CC Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 10
ST D18S51: 13
ST D19S433: 13,14.2
ST D21S11: 30.2,31
ST D2S1338: 23,24
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 13
ST FGA: 21,23
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1528
AC CVCL_T037
DR Cosmic; 2068084
DR KCLB; 01528
RX PubMed=24141649;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 110 hours (PubMed=24141649).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 9
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 11
ST FGA: 24
ST TH01: 9.3
ST TPOX: 11
ST vWA: 17
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1544
AC CVCL_5027
SY SNU1544
DR Cosmic; 1322292
DR GEO; GSM1448192
DR KCLB; 01544
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 42 hours (PubMed=20176655).
CC Microsatellite instability: Instable (MSI-high) (PubMed=20176655; PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 8,14
ST D18S51: 12,17
ST D19S433: 14.2,16.2
ST D21S11: 29,30
ST D2S1338: 19
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 10
ST FGA: 20,24
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14,20
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1553
AC CVCL_T038
DR Cosmic; 2068085
DR KCLB; 01553
RX PubMed=24141649;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 89 hours (PubMed=24141649).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D3S1358: 17
ST D5S818: 10
ST D7S820: 12
ST FGA: 22,23
ST TH01: 7,9
ST TPOX: 11,12
ST vWA: 16,17
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1581
AC CVCL_T039
DR Cosmic; 2068086
DR KCLB; 01581
RX PubMed=24141649;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 47 hours (PubMed=24141649).
CC Derived from metastatic site: Pericardial effusion.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 8,10
ST FGA: 19,24
ST TH01: 6,8
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-16
AC CVCL_0076
SY SNU16; NCI-SNU-16
DR BTO; BTO:0004987
DR CLO; CLO_0009095
DR EFO; EFO_0002344
DR ATCC; CRL-5974
DR BCRC; 60212
DR BioSample; SAMN03473127
DR CCLE; SNU16_STOMACH
DR ChEMBL-Cells; CHEMBL3307273
DR ChEMBL-Targets; CHEMBL613529
DR Cosmic; 685588
DR Cosmic; 687558
DR Cosmic; 737365
DR Cosmic; 848138
DR Cosmic; 887247
DR Cosmic; 908446
DR Cosmic; 921597
DR Cosmic; 1067204
DR Cosmic; 1090452
DR Cosmic; 1154649
DR Cosmic; 1187295
DR Cosmic; 1294962
DR Cosmic; 1528873
DR Cosmic; 1995596
DR Cosmic; 2069774
DR Cosmic; 2443799
DR Cosmic; 2484966
DR Cosmic-CLP; 908446
DR GDSC; 908446
DR GEO; GSM267423
DR GEO; GSM267430
DR GEO; GSM267437
DR GEO; GSM267444
DR GEO; GSM562407
DR GEO; GSM827556
DR GEO; GSM828829
DR GEO; GSM844702
DR GEO; GSM887611
DR GEO; GSM888695
DR GEO; GSM1237680
DR GEO; GSM1237705
DR GEO; GSM1374886
DR GEO; GSM1670274
DR IGRhCellID; SNU16
DR KCLB; 00016
RX PubMed=2158397;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC Part of: MD Anderson Cell Lines Project.
CC Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC Part of: Seoul National University (SNU) cell line collection.
CC Microsatellite instability: Stable (MSS) (PubMed=10674020; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 11,13
ST D18S51: 14,16
ST D21S11: 29,33.2
ST D3S1358: 15,16
ST D5S818: 10,13
ST D7S820: 12
ST D8S1179: 14
ST FGA: 23
ST Penta D: 9,12
ST Penta E: 11,17
ST TH01: 6,9
ST TPOX: 11
ST vWA: 16
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-16-DOX
AC CVCL_L043
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0076 ! SNU-16
SX Female
CA Cancer cell line
//
ID SNU-1684
AC CVCL_5028
SY SNU1684
DR Cosmic; 1322293
DR GEO; GSM1448205
DR KCLB; 01684
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 53 hours (PubMed=20176655).
CC Microsatellite instability: Instable (MSI-high) (PubMed=20176655; PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 8
ST D16S539: 9,10
ST D18S51: 12
ST D19S433: 14,15.2
ST D21S11: 28
ST D2S1338: 18,23
ST D3S1358: 17
ST D5S818: 10,11
ST D7S820: 9,13
ST D8S1179: 11,15
ST FGA: 20,21
ST TH01: 9
ST TPOX: 8,10
ST vWA: 14,17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-17
AC CVCL_5029
SY SNU17
DR KCLB; 00017
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D3S1358: 15
ST D5S818: 10,12
ST D7S820: 9
ST FGA: 23
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1746
AC CVCL_5030
SY SNU1746
DR Cosmic; 1322294
DR GEO; GSM1448206
DR KCLB; 01746
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 42 hours (PubMed=20176655).
CC Microsatellite instability: Instable (MSI-high) (PubMed=20176655; PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X,Y
ST CSF1PO: 7,9
ST D13S317: 9
ST D16S539: 9,14
ST D18S51: 13,18
ST D19S433: 13,17.2
ST D21S11: 28,33
ST D2S1338: 18,24
ST D3S1358: 14,17
ST D5S818: 11,12,13 (KCLB)
ST D5S818: 12,13 (PubMed=20176655)
ST D7S820: 8,11
ST D8S1179: 11
ST FGA: 17,22
ST TH01: 6
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C7967; Colon signet ring cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-175
AC CVCL_5031
SY SNU175; NCI-SNU-175
DR CCLE; SNU175_LARGE_INTESTINE
DR Cosmic; 738861
DR Cosmic; 848826
DR Cosmic; 2302007
DR Cosmic-CLP; 1659928
DR GDSC; 1659928
DR GEO; GSM887612
DR GEO; GSM888696
DR GEO; GSM1346853
DR GEO; GSM1448216
DR GEO; GSM1670464
DR KCLB; 00175
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25926053;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 33 hours (PubMed=10362137).
CC Microsatellite instability: Instable (MSI-high) (PubMed=10674020; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Peritoneum.
ST Source(s): Cosmic-CLP; KCLB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 9,12
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 11
ST FGA: 19,21
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1750
AC CVCL_8914
DR Cosmic; 1661032
DR KCLB; 01750
RX PubMed=22361929;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 74 hours (PubMed=22361929).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 11
ST FGA: 24
ST TH01: 6
ST TPOX: 9
ST vWA: 14,18
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-182
AC CVCL_0090
SY SNU182; NCI-SNU-182
DR BTO; BTO:0003760
DR CLO; CLO_0009096
DR EFO; EFO_0002345
DR ATCC; CRL-2235
DR BioSample; SAMN03473221
DR CCLE; SNU182_LIVER
DR Cosmic; 684198
DR Cosmic; 873399
DR Cosmic; 928141
DR Cosmic; 1995638
DR Cosmic; 2162540
DR Cosmic; 2321040
DR Cosmic-CLP; 1240216
DR GDSC; 1240216
DR GEO; GSM481446
DR GEO; GSM565919
DR GEO; GSM887613
DR GEO; GSM888697
DR GEO; GSM936778
DR GEO; GSM1670465
DR IGRhCellID; SNU182
DR KCLB; 00182
RX PubMed=7543080;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=25485619;
RX PubMed=25574106;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,14 (ATCC; Cosmic-CLP; PubMed=25877200)
ST D13S317: 14 (KCLB)
ST D16S539: 11,13
ST D18S51: 16
ST D21S11: 29,34.2
ST D3S1358: 17 (KCLB)
ST D3S1358: 16,18 (PubMed=25877200)
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 10
ST FGA: 22,24
ST Penta D: 9
ST Penta E: 20
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17 (ATCC; Cosmic-CLP; PubMed=25877200)
ST vWA: 17,18 (KCLB)
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-1958
AC CVCL_T040
DR Cosmic; 2068087
DR KCLB; 01958
RX PubMed=24141649;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 53 hours (PubMed=24141649).
CC Misspelling: 'SNU-1598' in Cosmic 2068087.
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 9,10
ST D3S1358: 15
ST D5S818: 9,11
ST D7S820: 8,11
ST FGA: 19,21
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-1967
AC CVCL_8915
DR KCLB; 01967
DR Cosmic; 1661033
RX PubMed=22361929;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 49 hours (PubMed=22361929).
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 12,13
ST FGA: 22
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-20
AC CVCL_5032
SY SNU20
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-201
AC CVCL_5033
SY SNU201; NCI-SNU-201
DR CCLE; SNU201_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 2516038
DR GEO; GSM887615
DR GEO; GSM888699
DR KCLB; 00201
RX PubMed=11776963;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 61 hours (PubMed=11776963); 58 hours (PubMed=25984343).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D3S1358: 15,16
ST D5S818: 9,10
ST D7S820: 8,11
ST FGA: 18,25
ST TH01: 6,8
ST TPOX: 9
ST vWA: 16,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-213
AC CVCL_5034
SY SNU213; NCI-SNU-213
DR CCLE; SNU213_PANCREAS
DR Cosmic; 707181
DR GEO; GSM887616
DR GEO; GSM888700
DR KCLB; 00213
RX PubMed=12037578;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 11
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 9
ST FGA: 23
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-216
AC CVCL_3946
SY SNU216; NCI-SNU-216
DR BTO; BTO:0004988
DR EFO; EFO_0006754
DR BioSample; SAMN03473182
DR CCLE; SNU216_STOMACH
DR CGH-DB; 124-1
DR CGH-DB; 9012-4
DR Cosmic; 685589
DR Cosmic; 848139
DR Cosmic; 1067205
DR Cosmic; 1090453
DR Cosmic; 1151969
DR Cosmic; 1528874
DR Cosmic; 2484970
DR GEO; GSM887617
DR GEO; GSM888701
DR GEO; GSM1374887
DR KCLB; 00216
RX PubMed=9033653;
RX PubMed=15723654;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Characteristics: Homozygous for the TP53 p.Val216Met mutation.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 10,13
ST D18S51: 16
ST D21S11: 30,33.2
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 13,16
ST FGA: 21
ST Penta D: 9,13
ST Penta E: 5
ST TH01: 7
ST TPOX: 9
ST vWA: 14,20
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-228
AC CVCL_5035
SY SNU228
DR KCLB; 00228
RX PubMed=10619961;
RX PubMed=19956504;
RX PubMed=27993170;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 24 hours (PubMed=10619961).
CC Microsatellite instability: Stable (MSS) (PubMed=10619961).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D3S1358: 16
ST D5S818: 10,12
ST D7S820: 10,12
ST FGA: 23
ST TH01: 6,9
ST TPOX: 8
ST vWA: 14
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-2292
AC CVCL_5036
SY SNU2292
DR Cosmic; 1484501
DR KCLB; 02292
RX PubMed=21290211;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 72 hours (PubMed=21290211).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 11
ST FGA: 23,24
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-2315
AC CVCL_5037
SY SNU2315
DR Cosmic; 1484502
DR KCLB; 02315
RX PubMed=21290211;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 141 hours (PubMed=21290211).
CC Derived from metastatic site: Lymph node.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9
ST D3S1358: 17
ST D5S818: 10,13
ST D7S820: 10,11
ST FGA: 23,25
ST TPOX: 11
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-2372
AC CVCL_T041
DR Cosmic; 2068088
DR KCLB; 02372
RX PubMed=24141649;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 78 hours (PubMed=24141649).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D3S1358: 15.2,18.2
ST D5S818: 12
ST D7S820: 11
ST FGA: 25
ST TPOX: 8
ST vWA: 17
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-245
AC CVCL_5038
SY SNU245; NCI-SNU-245
DR CCLE; SNU245_BILIARY_TRACT
DR Cosmic; 738866
DR GEO; GSM887618
DR GEO; GSM888702
DR KCLB; 00245
RX CelloPub=CLPUB00275;
RX PubMed=12107841;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 54 hours (PubMed=12107841).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,13
ST D3S1358: 17,19
ST D5S818: 7
ST D7S820: 8,10
ST FGA: 21.2,24
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SNU-247
AC CVCL_5039
SY SNU247
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-251
AC CVCL_5040
SY SNU251
DR KCLB; 00251
RX PubMed=9299249;
RX PubMed=19956504;
RX PubMed=22710073;
RX PubMed=23415752;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 46 hours (PubMed=9299249).
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 10,12
ST FGA: 20
ST TH01: 8
ST TPOX: 12
ST vWA: 15,18
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-2535
AC CVCL_R756
DR Cosmic; 1859888
DR KCLB; 02535
RX PubMed=23344087;
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,11
ST D3S1358: 15
ST D5S818: 10,12
ST D7S820: 11
ST FGA: 24,27
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-254
AC CVCL_5041
SY SNU254
DR Cosmic; 1322283
DR GEO; GSM1448207
DR KCLB; 00254
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 50 hours (PubMed=20176655).
CC Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9
ST D18S51: 12
ST D19S433: 12,15.2
ST D21S11: 31
ST D2S1338: 23
ST D3S1358: 16,17
ST D5S818: 10,11
ST D7S820: 11,13
ST D8S1179: 13,15
ST FGA: 24,25
ST TH01: 7
ST TPOX: 8,12
ST vWA: 14,17
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-265
AC CVCL_5042
SY SNU265
RX PubMed=9542645;
RX PubMed=11507201;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-267
AC CVCL_5043
SY SNU267
DR KCLB; 00267
RX PubMed=10619961;
RX PubMed=19956504;
RX PubMed=27993170;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 24 hours (PubMed=10619961).
CC Microsatellite instability: Stable (MSS) (PubMed=10619961).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 10,12
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 10,12
ST FGA: 24,25
ST TH01: 7,10
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-283
AC CVCL_5044
SY SNU283; NCI-SNU-283
DR CCLE; SNU283_LARGE_INTESTINE
DR Cosmic; 738862
DR Cosmic; 2302008
DR Cosmic-CLP; 1659929
DR GEO; GSM887619
DR GEO; GSM888703
DR GEO; GSM1346854
DR GEO; GSM1448123
DR GEO; GSM1670466
DR KCLB; 00283
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25926053;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 42 hours (PubMed=10362137).
CC Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Omentum.
ST Source(s): Cosmic-CLP; KCLB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,11
ST D16S539: 9,12
ST D3S1358: 15,18
ST D5S818: 9
ST D7S820: 11
ST FGA: 23,25
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,19
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-285
AC CVCL_5045
SY SNU285
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SNU-291
AC CVCL_5046
SY SNU291; SNU-291BL; SNU-291EBV
DR KCLB; 00291EBV
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-299
AC CVCL_5047
SY SNU299
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SNU-306
AC CVCL_T042
DR Cosmic; 2068082
RX PubMed=24141649;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 152 hours (PubMed=24141649).
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-308
AC CVCL_5048
SY SNU308; NCI-SNU-308
DR CCLE; SNU308_BILIARY_TRACT
DR ChEMBL-Cells; CHEMBL3307456
DR ChEMBL-Targets; CHEMBL614932
DR Cosmic; 738869
DR GEO; GSM887620
DR GEO; GSM888704
DR KCLB; 00308
RX CelloPub=CLPUB00275;
RX PubMed=12107841;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=12107841).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D3S1358: 16
ST D5S818: 9
ST D7S820: 7,12
ST FGA: 25,26
ST TH01: 8
ST TPOX: 8
ST vWA: 16
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SNU-315
AC CVCL_5049
SY SNU315
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-321
AC CVCL_5050
SY SNU321
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-324
AC CVCL_5051
SY SNU324; NCI-SNU-324
DR CCLE; SNU324_PANCREAS
DR Cosmic; 707182
DR GEO; GSM887621
DR GEO; GSM888705
DR KCLB; 00324
RX PubMed=12037578;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 11
ST FGA: 21,22
ST TH01: 7,9
ST TPOX: 10,11
ST vWA: 18,19
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-328
AC CVCL_5052
SY SNU328
RX PubMed=10619961;
RX PubMed=19956504;
RX PubMed=27993170;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 120 hours (PubMed=10619961).
CC Microsatellite instability: Stable (MSS) (PubMed=10619961).
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-333
AC CVCL_5053
SY SNU333
DR KCLB; 00333
RX PubMed=10619961;
RX PubMed=19956504;
RX PubMed=27993170;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 76 hours (PubMed=10619961).
CC Microsatellite instability: Stable (MSS) (PubMed=10619961).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D3S1358: 17
ST D5S818: 11,13
ST D7S820: 9,13
ST FGA: 22,23
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-334
AC CVCL_T043
DR Cosmic; 2068083
RX PubMed=24141649;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 80 hours (PubMed=24141649).
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-349
AC CVCL_5054
SY SNU349; NCI-SNU-349
DR CCLE; SNU349_KIDNEY
DR GEO; GSM888706
DR KCLB; 00349
RX PubMed=10619961;
RX PubMed=14634222;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=27993170;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 120 hours (PubMed=10619961).
CC Microsatellite instability: Instable (MSI) (PubMed=10619961).
CC Omics: SNP array analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,10
ST D3S1358: 14
ST D5S818: 10,11,13
ST D7S820: 10,11
ST FGA: 23,24
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-354
AC CVCL_3947
SY SNU354
DR BTO; BTO:0003190
DR ChEMBL-Cells; CHEMBL3307310
DR ChEMBL-Targets; CHEMBL614165
DR Cosmic; 2023865
DR GEO; GSM1374888
DR KCLB; 00354
RX PubMed=7543080;
RX PubMed=16616112;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Characteristics: Has lost chromosome Y.
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 8,11
ST D13S317: 10,11
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 7,11
ST FGA: 21,22
ST TH01: 9
ST TPOX: 11
ST vWA: 17
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-368
AC CVCL_3948
SY SNU368
DR BTO; BTO:0003169
DR Cosmic; 2023866
DR GEO; GSM1374889
DR KCLB; 00368
RX PubMed=7543080;
RX PubMed=16616112;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Characteristics: Has lost chromosome Y.
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST CSF1PO: 10,13
ST D13S317: 8,9
ST D3S1358: 16
ST D5S818: 10
ST D7S820: 11,12
ST FGA: 25
ST TH01: 6,9
ST TPOX: 9,11
ST vWA: 14,17
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-371
AC CVCL_5055
SY SNU371
DR Cosmic; 1484497
RX PubMed=21290211;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 98 hours (PubMed=21290211).
DI NCIt; C3732; Pulmonary blastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-373
AC CVCL_5056
SY SNU373
DR Cosmic; 1024885
DR Cosmic; 1065284
RX PubMed=17134824;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 41 hours (PubMed=17134824).
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-374
AC CVCL_5057
SY SNU374; SNU-374BL; SNU-374EBV
DR KCLB; 00374EBV
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 10,11
ST FGA: 22,26
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SNU-387
AC CVCL_0250
SY SNU387; NCI-SNU-387
DR BTO; BTO:0003191
DR CLO; CLO_0009097
DR EFO; EFO_0002346
DR ATCC; CRL-2237
DR BioSample; SAMN03471848
DR BioSample; SAMN03473190
DR CCLE; SNU387_LIVER
DR ChEMBL-Cells; CHEMBL3308817
DR ChEMBL-Targets; CHEMBL1075583
DR Cosmic; 684199
DR Cosmic; 873397
DR Cosmic; 909736
DR Cosmic; 928142
DR Cosmic; 1995639
DR Cosmic; 2023867
DR Cosmic; 2162530
DR Cosmic; 2321035
DR Cosmic-CLP; 909736
DR GDSC; 909736
DR GEO; GSM481453
DR GEO; GSM565921
DR GEO; GSM887622
DR GEO; GSM888707
DR GEO; GSM936779
DR GEO; GSM1670467
DR IGRhCellID; SNU387
DR KCLB; 00387
DR PRIDE; PXD002486
RX PubMed=7543080;
RX PubMed=16616112;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=25485619;
RX PubMed=25574106;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 12
ST D16S539: 9
ST D18S51: 14
ST D21S11: 31
ST D3S1358: 16
ST D5S818: 10,12
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 22
ST Penta D: 8
ST Penta E: 16
ST TH01: 7
ST TPOX: 8,9
ST vWA: 14,16 (ATCC; Cosmic-CLP; KCLB)
ST vWA: 14 (PubMed=25877200)
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-398
AC CVCL_0077
SY SNU398; NCI-SNU-398
DR BTO; BTO:0003170
DR CLO; CLO_0009098
DR EFO; EFO_0002347
DR MCCL; MCC:0000435
DR ATCC; CRL-2233
DR BioSample; SAMN03473191
DR CCLE; SNU398_LIVER
DR ChEMBL-Cells; CHEMBL3307619
DR ChEMBL-Targets; CHEMBL614454
DR Cosmic; 873393
DR Cosmic; 928143
DR Cosmic; 1187337
DR Cosmic; 1995640
DR Cosmic; 2009538
DR Cosmic; 2023868
DR Cosmic; 2162531
DR Cosmic; 2321036
DR Cosmic-CLP; 1240217
DR GDSC; 1240217
DR GEO; GSM481448
DR GEO; GSM565922
DR GEO; GSM827415
DR GEO; GSM887623
DR GEO; GSM888708
DR GEO; GSM936780
DR GEO; GSM1374890
DR GEO; GSM1670468
DR IGRhCellID; SNU398
DR KCLB; 00398
RX PubMed=7543080;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=25485619;
RX PubMed=25574106;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Characteristics: Has lost chromosome Y.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 10,14
ST D18S51: 15
ST D21S11: 29
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 12
ST FGA: 22,23 (KCLB)
ST FGA: 23 (PubMed=25877200)
ST Penta D: 14
ST Penta E: 12
ST TH01: 7,9 (ATCC; Cosmic-CLP; PubMed=25877200)
ST TH01: 8,9 (KCLB)
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-407
AC CVCL_5058
SY SNU407; NCI-SNU-407
DR CCLE; SNU407_LARGE_INTESTINE
DR Cosmic; 738863
DR Cosmic; 848827
DR Cosmic; 875422
DR Cosmic-CLP; 1660034
DR GDSC; 1660034
DR GEO; GSM887624
DR GEO; GSM888709
DR GEO; GSM1448217
DR GEO; GSM1670469
DR KCLB; 00407
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=25926053;
RX PubMed=27397505;
WW http://www.addexbio.com/productdetail?pid=377
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 42 hours (PubMed=10362137).
CC Microsatellite instability: Instable (MSI-high) (PubMed=10674020; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Buttock.
ST Source(s): AddexBio; Cosmic-CLP; KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,10
ST D16S539: 11,12
ST D3S1358: 15,18
ST D5S818: 10,11 (AddexBio; KCLB)
ST D5S818: 10 (Cosmic-CLP)
ST D7S820: 8,10
ST FGA: 22
ST TH01: 6
ST TPOX: 7,8
ST vWA: 14,16
ST D3S1358: 15,18
ST FGA: 22
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-410
AC CVCL_5059
SY SNU410; NCI-SNU-410
DR CCLE; SNU410_PANCREAS
DR Cosmic; 707183
DR GEO; GSM887625
DR GEO; GSM888710
DR KCLB; 00410
RX PubMed=12037578;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 12,14
ST FGA: 23
ST TH01: 9
ST TPOX: 8,12
ST vWA: 17
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-423
AC CVCL_0366
SY SNU423; NCI-SNU-423
DR BTO; BTO:0003187
DR CLO; CLO_0009099
DR EFO; EFO_0002348
DR ATCC; CRL-2238
DR BioSample; SAMN03471849
DR BioSample; SAMN03473132
DR CCLE; SNU423_LIVER
DR ChEMBL-Cells; CHEMBL3308367
DR ChEMBL-Targets; CHEMBL1075584
DR Cosmic; 871513
DR Cosmic; 909737
DR Cosmic; 1177681
DR Cosmic; 1995641
DR Cosmic; 2023869
DR Cosmic; 2162532
DR Cosmic; 2321037
DR Cosmic-CLP; 909737
DR GDSC; 909737
DR GEO; GSM565923
DR GEO; GSM887626
DR GEO; GSM888711
DR GEO; GSM936781
DR GEO; GSM1670470
DR IGRhCellID; SNU423
DR KCLB; 00423
RX PubMed=7543080;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=25485619;
RX PubMed=25574106;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12 (ATCC; KCLB; PubMed=25877200)
ST CSF1PO: 11,12,13 (Cosmic-CLP)
ST D13S317: 10,13
ST D16S539: 9
ST D18S51: 12,13
ST D21S11: 30
ST D3S1358: 17,18 (KCLB)
ST D3S1358: 17 (PubMed=25877200)
ST D5S818: 10
ST D7S820: 12
ST D8S1179: 11,16
ST FGA: 21,24
ST Penta D: 9
ST Penta E: 11,12
ST TH01: 6,9 (ATCC; Cosmic-CLP)
ST TH01: 9 (KCLB; PubMed=25877200)
ST TPOX: 8
ST vWA: 15
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-444
AC CVCL_5060
SY SNU444
RX PubMed=11776963;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=11776963).
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-445
AC CVCL_5061
SY SNU445
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SNU-447
AC CVCL_5062
SY SNU447
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-449
AC CVCL_0454
SY SNU449; NCI-SNU-449
DR BTO; BTO:0003188
DR CLO; CLO_0009100
DR EFO; EFO_0002349
DR ATCC; CRL-2234
DR BioSample; SAMN03471847
DR BioSample; SAMN03473133
DR CCLE; SNU449_LIVER
DR ChEMBL-Cells; CHEMBL3308480
DR ChEMBL-Targets; CHEMBL1075585
DR Cosmic; 684200
DR Cosmic; 871511
DR Cosmic; 873396
DR Cosmic; 909738
DR Cosmic; 928144
DR Cosmic; 1187338
DR Cosmic; 1995642
DR Cosmic; 2009539
DR Cosmic; 2023870
DR Cosmic; 2162541
DR Cosmic; 2321041
DR Cosmic-CLP; 909738
DR GDSC; 909738
DR GEO; GSM481452
DR GEO; GSM565924
DR GEO; GSM887627
DR GEO; GSM888712
DR GEO; GSM936782
DR GEO; GSM1374891
DR GEO; GSM1670471
DR IGRhCellID; SNU449
DR KCLB; 00449
RX PubMed=7543080;
RX PubMed=16616112;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=25485619;
RX PubMed=25574106;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Characteristics: Has lost chromosome Y.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X,Y (ATCC; KCLB)
ST Amelogenin: X (Cosmic-CLP; PubMed=25877200)
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 9
ST D18S51: 14,16
ST D21S11: 29,31
ST D3S1358: 15,16
ST D5S818: 10
ST D7S820: 8,13
ST D8S1179: 10,13
ST FGA: 22,24
ST Penta D: 10,11
ST Penta E: 10,15
ST TH01: 6,9
ST TPOX: 11
ST vWA: 14,16
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-46
AC CVCL_5063
SY SNU46
DR BTO; BTO:0005927
DR CCLE; SNU46_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 934173
DR GEO; GSM887629
DR GEO; GSM888714
DR KCLB; 00046
RX CelloPub=CLPUB00001;
RX PubMed=10369293;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 36 hours (PubMed=10369293).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 10,11
ST FGA: 21,24
ST TH01: 9
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-466
AC CVCL_5064
SY SNU466; NCI-SNU-466
DR CCLE; SNU466_CENTRAL_NERVOUS_SYSTEM
DR GEO; GSM887628
DR GEO; GSM888713
DR KCLB; 00466
RX PubMed=11776963;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 54 hours (PubMed=11776963).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,12
ST D3S1358: 15,18
ST D5S818: 7,12
ST D7S820: 10,12
ST FGA: 22,24
ST TH01: 6,9
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-475
AC CVCL_0497
SY SNU475; NCI-SNU-475
DR BTO; BTO:0003189
DR CLO; CLO_0009101
DR EFO; EFO_0002350
DR ATCC; CRL-2236
DR BioSample; SAMN03471846
DR BioSample; SAMN03473134
DR CCLE; SNU475_LIVER
DR ChEMBL-Cells; CHEMBL3308787
DR ChEMBL-Targets; CHEMBL1075586
DR Cosmic; 684201
DR Cosmic; 871512
DR Cosmic; 873403
DR Cosmic; 909739
DR Cosmic; 928145
DR Cosmic; 2023871
DR Cosmic; 2162533
DR Cosmic; 2321038
DR Cosmic-CLP; 909739
DR GDSC; 909739
DR GEO; GSM481449
DR GEO; GSM565920
DR GEO; GSM887630
DR GEO; GSM888715
DR GEO; GSM936783
DR GEO; GSM1670472
DR IGRhCellID; SNU475
DR KCLB; 00475
RX PubMed=7543080;
RX PubMed=16616112;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=25485619;
RX PubMed=25574106;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Characteristics: Has lost chromosome Y.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 12
ST D18S51: 13
ST D21S11: 28,30
ST D3S1358: 14
ST D5S818: 10,13
ST D7S820: 7,12 (ATCC; Cosmic-CLP; KCLB)
ST D7S820: 7 (PubMed=25877200)
ST D8S1179: 13,14
ST FGA: 23
ST Penta D: 9,12
ST Penta E: 5,16
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 14
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-478
AC CVCL_5065
SY SNU478; NCI-SNU-478
DR CCLE; SNU478_BILIARY_TRACT
DR Cosmic; 738871
DR GEO; GSM887631
DR GEO; GSM888716
DR KCLB; 00478
DR PRIDE; PXD002657
RX CelloPub=CLPUB00275;
RX PubMed=12107841;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=26951071;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 52 hours (PubMed=12107841).
CC Omics: Deep proteome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D3S1358: 16,17
ST D5S818: 9,12
ST D7S820: 8,11
ST FGA: 24
ST TH01: 7
ST TPOX: 10,11
ST vWA: 15,16
DI NCIt; C6650; Ampulla of Vater adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SNU-479
AC CVCL_5066
SY SNU479
DR Cosmic; 1322284
DR GEO; GSM1448208
DR KCLB; 00479
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 44 hours (PubMed=20176655).
CC Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 9,11
ST D18S51: 17
ST D19S433: 13,14
ST D21S11: 32.2
ST D2S1338: 19
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 9,12
ST D8S1179: 10,12
ST FGA: 22,24
ST TH01: 6,7
ST TPOX: 9,12
ST vWA: 16,17
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-482
AC CVCL_5067
SY SNU482
DR KCLB; 00482
RX PubMed=10619961;
RX PubMed=14634222;
RX PubMed=19956504;
RX PubMed=27993170;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 60 hours (PubMed=10619961).
CC Microsatellite instability: Stable (MSS) (PubMed=10619961).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D3S1358: 16
ST D5S818: 10,11
ST D7S820: 11
ST FGA: 22,23
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-484
AC CVCL_0100
SY SNU484
DR BTO; BTO:0003479
DR EFO; EFO_0006755
DR BioSample; SAMN03473176
DR CGH-DB; 125-1
DR CGH-DB; 9013-4
DR Cosmic; 685590
DR Cosmic; 848140
DR Cosmic; 921598
DR Cosmic; 1067206
DR Cosmic; 1090454
DR Cosmic; 1294958
DR Cosmic; 1528875
DR Cosmic; 2484965
DR GEO; GSM1374892
DR KCLB; 00484
RX PubMed=9033653;
RX PubMed=10812166;
RX PubMed=15723654;
RX PubMed=18804159;
RX PubMed=19956504;
RX PubMed=24807215;
RX PubMed=25485619;
CC Part of: Seoul National University (SNU) cell line collection.
CC Characteristics: Homozygous for the TP53 p.Gly266Glu mutation.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 13,15
ST D21S11: 30
ST D3S1358: 18
ST D5S818: 10
ST D7S820: 12
ST D8S1179: 14
ST FGA: 19,23
ST Penta D: 12
ST Penta E: 22
ST TH01: 7
ST TPOX: 8
ST vWA: 18
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-487
AC CVCL_5068
SY SNU487
DR KCLB; 00487
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 52 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,12
ST D3S1358: 15,16
ST D5S818: 10
ST D7S820: 10,13
ST FGA: 23
ST TH01: 9,9.3
ST TPOX: 11
ST vWA: 14,16
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-489
AC CVCL_5069
SY SNU489; NCI-SNU-489
DR CCLE; SNU489_CENTRAL_NERVOUS_SYSTEM
DR GEO; GSM888717
DR KCLB; 00489
RX PubMed=11776963;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=11776963).
CC Omics: SNP array analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,11
ST D3S1358: 15,17
ST D5S818: 10,13
ST D7S820: 7,11
ST FGA: 21,23
ST TH01: 9
ST TPOX: 10,11
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-494
AC CVCL_5070
SY SNU494
DR Cosmic; 707184
RX PubMed=12037578;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-5
AC CVCL_0078
SY SNU5; NCI-SNU-5
DR BTO; BTO:0004986
DR CLO; CLO_0009102
DR EFO; EFO_0002351
DR MCCL; MCC:0000436
DR ATCC; CRL-5973
DR BCRC; 60213
DR BioSample; SAMN03470906
DR CCLE; SNU5_STOMACH
DR CCRID; 3131C0001001200013
DR ChEMBL-Cells; CHEMBL3307458
DR ChEMBL-Targets; CHEMBL614934
DR Cosmic; 685587
DR Cosmic; 687559
DR Cosmic; 737363
DR Cosmic; 848137
DR Cosmic; 868237
DR Cosmic; 908445
DR Cosmic; 921596
DR Cosmic; 1066231
DR Cosmic; 1067203
DR Cosmic; 1090451
DR Cosmic; 1154648
DR Cosmic; 1187293
DR Cosmic; 1294960
DR Cosmic; 1329187
DR Cosmic; 1482072
DR Cosmic; 1528872
DR Cosmic; 1995597
DR Cosmic; 2069773
DR Cosmic; 2484972
DR Cosmic-CLP; 908445
DR GDSC; 908445
DR GEO; GSM267422
DR GEO; GSM267429
DR GEO; GSM267436
DR GEO; GSM267443
DR GEO; GSM562408
DR GEO; GSM827398
DR GEO; GSM828830
DR GEO; GSM844703
DR GEO; GSM887634
DR GEO; GSM888720
DR GEO; GSM1237681
DR GEO; GSM1237706
DR GEO; GSM1374893
DR GEO; GSM1670275
DR GEO; GSM1670473
DR IGRhCellID; SNU5
DR KCLB; 00005
RX PubMed=2158397;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: MET genetic alteration cell panel (ATCC TCP-1036).
CC Part of: Seoul National University (SNU) cell line collection.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,9 (ATCC; Cosmic-CLP; PubMed=25877200)
ST D13S317: 8 (KCLB)
ST D16S539: 13
ST D18S51: 13
ST D19S433: 13.2,15
ST D21S11: 29
ST D2S1338: 17
ST D3S1358: 16
ST D5S818: 10
ST D7S820: 8,12
ST D8S1179: 14,15
ST FGA: 21
ST Penta D: 9,13
ST Penta E: 18,19
ST TH01: 9
ST TPOX: 11
ST vWA: 15,16
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-503
AC CVCL_5071
SY SNU503; NCI-SNU-503
DR CCLE; SNU503_LARGE_INTESTINE
DR Cosmic; 738864
DR GEO; GSM887632
DR GEO; GSM888718
DR GEO; GSM1448209
DR KCLB; 00503
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=25926053;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 64 hours (PubMed=10362137).
CC Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Abdominal wall.
ST Source(s): KCLB
ST CSF1PO: 11
ST D13S317: 10
ST D3S1358: 15
ST D5S818: 10
ST D7S820: 10
ST FGA: 22
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-520
AC CVCL_5072
SY SNU520; NCI-SNU-520
DR CCLE; SNU520_STOMACH
DR Cosmic; 685591
DR GEO; GSM887633
DR GEO; GSM888719
DR KCLB; 00520
RX PubMed=9033653;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D3S1358: 14,15
ST D5S818: 10,13
ST D7S820: 9,11
ST FGA: 21
ST TH01: 8,9
ST TPOX: 7,8
ST vWA: 17,18
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-523
AC CVCL_5073
SY SNU523
DR KCLB; 00523
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 72 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Discontinued: KCLB; 00523; probable.
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-538
AC CVCL_5074
SY SNU538; SNU-538BL; SNU-538EBV
DR KCLB; 00538EBV
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,9
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 10
ST FGA: 21,24
ST TH01: 9
ST TPOX: 9,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-539
AC CVCL_5075
SY SNU539
DR KCLB; 00539
RX PubMed=9299262;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 46 hours (PubMed=9299262).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 14
ST D3S1358: 15,18
ST D5S818: 11
ST D7S820: 8
ST FGA: 23,26
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-55
AC CVCL_E107
SY SNU55; NCI-SNU-55
RX PubMed=8806092;
CC Part of: Seoul National University (SNU) cell line collection.
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SNU-563
AC CVCL_5076
SY SNU563
DR KCLB; 00563
RX PubMed=9299249;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 67 hours (PubMed=9299249).
CC Discontinued: KCLB; 00563; probable.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-585
AC CVCL_5077
SY SNU585
DR BTO; BTO:0005926
DR Cosmic; 934174
DR KCLB; 00585
RX CelloPub=CLPUB00001;
RX PubMed=10369293;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 54 hours (PubMed=10369293).
CC Discontinued: KCLB; 00585; probable.
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-601
AC CVCL_0101
SY SNU601; NCI-SNU-601
DR EFO; EFO_0006756
DR BioSample; SAMN03473177
DR CCLE; SNU601_STOMACH
DR CGH-DB; 126-1
DR CGH-DB; 9014-4
DR Cosmic; 685585
DR Cosmic; 848141
DR Cosmic; 869513
DR Cosmic; 921599
DR Cosmic; 1090455
DR Cosmic; 1294955
DR Cosmic; 1528876
DR Cosmic; 2484961
DR GEO; GSM888721
DR GEO; GSM1374894
DR KCLB; 00601
RX PubMed=9033653;
RX PubMed=10812166;
RX PubMed=15723654;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Characteristics: Homozygous for the TP53 p.Arg273Leu mutation.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 12
ST D18S51: 14
ST D21S11: 29,30
ST D3S1358: 16
ST D5S818: 10
ST D7S820: 9,11
ST D8S1179: 13,14
ST FGA: 23
ST Penta D: 8,15
ST Penta E: 11,18
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-61
AC CVCL_5078
SY SNU61; NCI-SNU-61
DR CCLE; SNU61_LARGE_INTESTINE
DR Cosmic; 738860
DR Cosmic-CLP; 1660035
DR GDSC; 1660035
DR GEO; GSM887635
DR GEO; GSM888722
DR GEO; GSM1448086
DR GEO; GSM1670474
DR KCLB; 00061
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=25926053;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 39 hours (PubMed=10362137).
CC Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Liver.
ST Source(s): Cosmic-CLP; KCLB
ST Amelogenin: X (Cosmic-CLP)
ST Amelogenin: X,Y (KCLB)
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 12
ST D3S1358: 15
ST D5S818: 11 (Cosmic-CLP)
ST D5S818: 9,11 (KCLB)
ST D7S820: 8
ST FGA: 22,26
ST TH01: 9
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-620
AC CVCL_5079
SY SNU620; NCI-SNU-620
DR BTO; BTO:0005171
DR EFO; EFO_0006757
DR BioSample; SAMN03473178
DR CCLE; SNU620_STOMACH
DR Cosmic; 685592
DR Cosmic; 848142
DR Cosmic; 921600
DR Cosmic; 1090456
DR Cosmic; 1528877
DR Cosmic; 2484958
DR GEO; GSM887636
DR GEO; GSM888723
DR GEO; GSM1374895
DR KCLB; 00620
RX PubMed=9033653;
RX PubMed=10812166;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 9,11
ST D18S51: 14,15
ST D21S11: 31,32,32.2
ST D3S1358: 17,18
ST D5S818: 11
ST D7S820: 13
ST D8S1179: 13
ST FGA: 24 (KCLB)
ST FGA: 19,24 (PubMed=25877200)
ST Penta D: 11,13
ST Penta E: 15,22
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,18 (KCLB)
ST vWA: 16,17,18 (PubMed=25877200)
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-620-5FU
AC CVCL_L044
SY SNU-620R-5-FU/1000
DR KCLB; 00620-5FU
RX PubMed=14734480;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5079 ! SNU-620
SX Female
CA Cancer cell line
//
ID SNU-620-ADR
AC CVCL_L084
SY SNU-620-ADR/300
DR KCLB; 00620-ADR
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D3S1358: 17,18
ST D5S818: 11
ST D7S820: 13
ST FGA: 19,24
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,17,18
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5079 ! SNU-620
SX Female
CA Cancer cell line
//
ID SNU-620-CIS
AC CVCL_L045
SY SNU-620R-CIS/2000
RX PubMed=14734480;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5079 ! SNU-620
SX Female
CA Cancer cell line
//
ID SNU-620-DOX
AC CVCL_L046
SY SNU-620R-DOX/300
RX PubMed=14734480;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5079 ! SNU-620
SX Female
CA Cancer cell line
//
ID SNU-626
AC CVCL_5080
SY SNU626; NCI-SNU-626
DR CCLE; SNU626_CENTRAL_NERVOUS_SYSTEM
DR GEO; GSM887637
DR GEO; GSM888724
DR KCLB; 00626
RX PubMed=11776963;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 92 hours (PubMed=11776963).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 10
ST D3S1358: 17
ST D5S818: 9,13
ST D7S820: 10,11
ST FGA: 19
ST TH01: 6,9
ST TPOX: 11
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-638
AC CVCL_0102
SY SNU638
DR EFO; EFO_0006758
DR BioSample; SAMN03473180
DR BTO; BTO:0003478
DR CGH-DB; 127-1
DR CGH-DB; 9015-4
DR ChEMBL-Cells; CHEMBL3307747
DR ChEMBL-Targets; CHEMBL614935
DR Cosmic; 685583
DR Cosmic; 848143
DR Cosmic; 869511
DR Cosmic; 921601
DR Cosmic; 1067207
DR Cosmic; 1090457
DR Cosmic; 1294961
DR Cosmic; 1528878
DR Cosmic; 2036662
DR Cosmic; 2484959
DR GEO; GSM1374896
DR KCLB; 00638
RX PubMed=9033653;
RX PubMed=10812166;
RX PubMed=15723654;
RX PubMed=19956504;
RX PubMed=24807215;
RX PubMed=25485619;
CC Part of: Seoul National University (SNU) cell line collection.
CC Characteristics: Heterozygous for the TP53 p.Arg282Trp mutation.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 11,13
ST D18S51: 14,16
ST D21S11: 30.2,31
ST D3S1358: 15
ST D5S818: 10,14 (KCLB)
ST D5S818: 10,13,14,15 (PubMed=25877200)
ST D7S820: 9,10
ST D8S1179: 11,13
ST FGA: 17,27
ST Penta D: 9
ST Penta E: 14,18
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,19
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-638-5FU
AC CVCL_L047
SY SNU-638R-5-FU/50000
RX PubMed=14734480;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0102 ! SNU-638
SX Male
CA Cancer cell line
//
ID SNU-638-CIS
AC CVCL_L048
SY SNU-638R-CIS/400
RX PubMed=14734480;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0102 ! SNU-638
SX Male
CA Cancer cell line
//
ID SNU-668
AC CVCL_5081
SY SNU668; NCI-SNU-668
DR EFO; EFO_0006759
DR BioSample; SAMN03473141
DR CCLE; SNU668_STOMACH
DR CGH-DB; 128-1
DR CGH-DB; 9016-4
DR Cosmic; 685593
DR Cosmic; 921602
DR Cosmic; 1066232
DR Cosmic; 1294956
DR Cosmic; 1528879
DR Cosmic; 2484962
DR GEO; GSM888725
DR GEO; GSM1374897
DR KCLB; 00668
RX PubMed=9033653;
RX PubMed=10812166;
RX PubMed=15723654;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Characteristics: Homozygous for the TP53 p.Ser251Asn mutation.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 11,12
ST D18S51: 13
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 9,11
ST D8S1179: 14,15
ST FGA: 23
ST Penta D: 9
ST Penta E: 16,19
ST TH01: 8
ST TPOX: 9
ST vWA: 17
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-668-5FU
AC CVCL_L049
SY SNU-668R-5-FU/4000
RX PubMed=14734480;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5081 ! SNU-668
SX Male
CA Cancer cell line
//
ID SNU-668-CIS
AC CVCL_L050
SY SNU-668R-CIS/400
RX PubMed=14734480;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5081 ! SNU-668
SX Male
CA Cancer cell line
//
ID SNU-668-DOX
AC CVCL_L051
SY SNU-668R-DOX/50
RX PubMed=14734480;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5081 ! SNU-668
SX Male
CA Cancer cell line
//
ID SNU-682
AC CVCL_5082
SY SNU682
DR KCLB; 00682
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D3S1358: 15,18
ST D5S818: 9,12
ST D7S820: 8,10
ST FGA: 24
ST TH01: 6,9
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-685
AC CVCL_5083
SY SNU685; NCI-SNU-685
DR CCLE; SNU685_ENDOMETRIUM
DR GEO; GSM888726
DR KCLB; 00685
RX PubMed=9299262;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 20 hours (PubMed=9299262).
CC Omics: SNP array analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8
ST D3S1358: 14
ST D5S818: 12
ST D7S820: 8,12
ST FGA: 21
ST TH01: 6,9.3
ST TPOX: 9
ST vWA: 17,19
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-70
AC CVCL_5084
SY SNU70
DR Cosmic; 1322282
DR GEO; GSM1448210
DR KCLB; 00070
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 118 hours (PubMed=20176655).
CC Microsatellite instability: Stable (MSS) (PubMed=20176655).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 11
ST D18S51: 13
ST D19S433: 14
ST D21S11: 31,32.2
ST D2S1338: 18,19
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 8,11
ST D8S1179: 12,14
ST FGA: 21
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 16,19
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-703
AC CVCL_5085
SY SNU703
DR KCLB; 00703
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,13
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 12,13
ST FGA: 22,23
ST TH01: 9
ST TPOX: 8
ST vWA: 16
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-719
AC CVCL_5086
SY SNU719; NCI-SNU-719
DR EFO; EFO_0006760
DR BioSample; SAMN03473188
DR CCLE; SNU719_STOMACH
DR CGH-DB; 129-1
DR CGH-DB; 9017-4
DR Cosmic; 685594
DR Cosmic; 848144
DR Cosmic; 869512
DR Cosmic; 921603
DR Cosmic; 1090458
DR Cosmic; 1294959
DR Cosmic; 1528880
DR GEO; GSM888727
DR KCLB; 00719
RX PubMed=9033653;
RX PubMed=10812166;
RX PubMed=15016554;
RX PubMed=15723654;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 9,10
ST D18S51: 13,15
ST D21S11: 29,30
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 12
ST FGA: 21,23
ST Penta D: 10,11
ST Penta E: 11,16
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-719-5FU
AC CVCL_L052
SY SNU-719R-5-FU/600
RX PubMed=14734480;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5086 ! SNU-719
SX Male
CA Cancer cell line
//
ID SNU-719-DOX
AC CVCL_L053
SY SNU-719R-DOX/100
RX PubMed=14734480;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5086 ! SNU-719
SX Male
CA Cancer cell line
//
ID SNU-738
AC CVCL_5087
SY SNU738; NCI-SNU-738
DR CCLE; SNU738_CENTRAL_NERVOUS_SYSTEM
DR GEO; GSM887638
DR GEO; GSM888728
DR KCLB; 00738
RX PubMed=11776963;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 56 hours (PubMed=11776963).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: Y
ST CSF1PO: 10
ST D13S317: 8
ST D3S1358: 16
ST D5S818: 13
ST FGA: 23
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3288; Oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-739
AC CVCL_5088
SY SNU739
DR GEO; GSM1374898
DR KCLB; 00739
RX PubMed=11819450;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 20 hours (PubMed=11819450).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 9,11
ST FGA: 24
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-761
AC CVCL_5089
SY SNU761; NCI-SNU-761
DR CCLE; SNU761_LIVER
DR GEO; GSM887639
DR GEO; GSM888729
DR GEO; GSM1374899
DR KCLB; 00761
RX PubMed=11819450;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 24 hours (PubMed=11819450).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 10
ST D3S1358: 15,17
ST D5S818: 9,12
ST D7S820: 9
ST FGA: 23,24
ST TH01: 9
ST TPOX: 11
ST vWA: 16
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-769A
AC CVCL_5090
SY SNU769A
DR Cosmic; 738865
DR Cosmic; 848828
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 45 hours (PubMed=10362137).
CC Microsatellite instability: Instable (MSI) (PubMed=10674020).
CC Derived from metastatic site: Lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5091 ! SNU-769B
SX Male
CA Cancer cell line
//
ID SNU-769B
AC CVCL_5091
SY SNU769B
DR Cosmic; 738854
DR Cosmic; 848829
DR GEO; GSM1448218
DR KCLB; 00769B
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 42 hours (PubMed=10362137).
CC Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST CSF1PO: 11,14
ST D13S317: 8,12
ST D3S1358: 13,15
ST TH01: 7,8
ST TPOX: 8
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5090 ! SNU-769A
SX Male
CA Cancer cell line
//
ID SNU-778
AC CVCL_5092
SY SNU778
DR KCLB; 00778
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D3S1358: 14,16
ST D5S818: 10,12
ST D7S820: 8,10
ST FGA: 23.2
ST TH01: 9.3
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-790
AC CVCL_5093
SY SNU790
DR Cosmic; 1024886
DR Cosmic; 1065285
DR Cosmic; 1151968
DR KCLB; 00790
RX PubMed=17134824;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 33 hours (PubMed=17134824).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 9,10
ST D3S1358: 16,17
ST D5S818: 10,12
ST D7S820: 11,12
ST FGA: 20,25
ST TH01: 9
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-791
AC CVCL_5094
SY SNU791
RX PubMed=11776963;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 60 hours (PubMed=11776963).
DI NCIt; C3288; Oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-796
AC CVCL_5095
SY SNU796
DR Cosmic; 1322285
DR KCLB; 00796
RX PubMed=20176655;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 121 hours (PubMed=20176655).
CC Microsatellite instability: Stable (MSS) (PubMed=20176655).
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8,11
ST D16S539: 11,12
ST D18S51: 13
ST D19S433: 13,14
ST D21S11: 29,30
ST D2S1338: 18,23
ST D3S1358: 15
ST D5S818: 9,11
ST D7S820: 10,13
ST D8S1179: 10
ST FGA: 22,23
ST TH01: 7,9
ST TPOX: 8
ST vWA: 18
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-8
AC CVCL_5096
SY SNU8
DR CCLE; SNU8_OVARY
DR KCLB; 00008
RX PubMed=9299249;
RX PubMed=19956504;
RX PubMed=23839242;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 44 hours (PubMed=9299249).
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 8,9
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8,12
ST FGA: 20,26
ST TH01: 7,9
ST TPOX: 11
ST vWA: 17
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-80
AC CVCL_5097
SY SNU80
DR Cosmic; 1024884
DR Cosmic; 1065283
DR KCLB; 00080
RX PubMed=17134824;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 37 hours (PubMed=17134824).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,10
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 12,13
ST FGA: 20,23
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-81
AC CVCL_5098
SY SNU81; NCI-SNU-81
DR CCLE; SNU81_LARGE_INTESTINE
DR Cosmic; 738853
DR Cosmic-CLP; 1660036
DR GDSC; 1660036
DR GEO; GSM888730
DR GEO; GSM1448159
DR GEO; GSM1670475
DR KCLB; 00081
RX PubMed=10362137;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=25926053;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 30 hours (PubMed=10362137).
CC Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; KCLB
ST Amelogenin: X (Cosmic-CLP)
ST Amelogenin: X,Y (KCLB)
ST CSF1PO: 11,13
ST D13S317: 9,10
ST D16S539: 9,12
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 12
ST FGA: 19,25
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-817
AC CVCL_5099
SY SNU817; SNU-817BL; SNU-817EBV
DR KCLB; 00817EBV
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 10
ST D3S1358: 15,16
ST D5S818: 10,12
ST D7S820: 11,13
ST FGA: 20,21
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 12,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-840
AC CVCL_5100
SY SNU840; NCI-SNU-840
DR CCLE; SNU840_OVARY
DR GEO; GSM887640
DR GEO; GSM888731
DR KCLB; 00840
RX PubMed=9299249;
RX PubMed=10748297;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 40 hours (PubMed=9299249); 36 hours (PubMed=25984343).
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 12
ST FGA: 26,51.2
ST TH01: 7,9
ST TPOX: 9
ST vWA: 14,17
DI NCIt; C4270; Malignant ovarian Brenner tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-869
AC CVCL_5101
SY SNU869
DR CCLE; SNU869_BILIARY_TRACT
DR Cosmic; 738872
DR KCLB; 00869
DR PRIDE; PXD002657
RX CelloPub=CLPUB00275;
RX PubMed=12107841;
RX PubMed=19956504;
RX PubMed=26951071;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=12107841).
CC Omics: Deep proteome analysis.
ST Source(s): KCLB
ST CSF1PO: 10
ST D13S317: 12
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 8,11
ST FGA: 23
ST TH01: 7,9
ST TPOX: 8,10
ST vWA: 15
DI NCIt; C6650; Ampulla of Vater adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SNU-878
AC CVCL_5102
SY SNU878; NCI-SNU-878
DR CCLE; SNU878_LIVER
DR GEO; GSM887641
DR GEO; GSM888732
DR GEO; GSM1374900
DR KCLB; 00878
DR PRIDE; PXD002486
RX PubMed=11819450;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 25 hours (PubMed=11819450).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D3S1358: 15
ST D5S818: 9,12
ST D7S820: 9,11
ST FGA: 23,26
ST TH01: 7
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-886
AC CVCL_5103
SY SNU886; NCI-SNU-886
DR CCLE; SNU886_LIVER
DR GEO; GSM888733
DR GEO; GSM1374901
DR KCLB; 00886
RX PubMed=11819450;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 29 hours (PubMed=11819450).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,9
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 11,12
ST FGA: 21,24
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,20
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-889
AC CVCL_5104
SY SNU889
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-899
AC CVCL_5105
SY SNU899; NCI-SNU-899
DR BTO; BTO:0005925
DR CCLE; SNU899_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 934175
DR GEO; GSM887642
DR GEO; GSM888734
DR KCLB; 00899
RX CelloPub=CLPUB00001;
RX PubMed=10369293;
RX PubMed=17923759;
RX PubMed=19956504;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 48 hours (PubMed=10369293).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 10,13
ST FGA: 21
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-9
AC CVCL_5106
SY SNU9
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-902
AC CVCL_5107
SY SNU902
DR KCLB; 00902
RX PubMed=9219839;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 52 hours (PubMed=9219839).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,12
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 10,11
ST FGA: 22
ST TH01: 9
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-963
AC CVCL_5108
SY SNU963
DR Cosmic; 1484498
RX PubMed=21290211;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 149 hours (PubMed=21290211).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-977
AC CVCL_5109
SY SNU977
DR Cosmic; 1322286
DR GEO; GSM1448211
DR KCLB; 00977
RX PubMed=20176655;
RX PubMed=25926053;
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 63 hours (PubMed=20176655).
CC Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20176655
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 10
ST D18S51: 15
ST D19S433: 13
ST D3S1358: 16
ST D21S11: 29
ST D2S1338: 19,22
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 10
ST FGA: 20
ST TH01: 7
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-99
AC CVCL_5110
SY SNU99
RX PubMed=9542645;
RX PubMed=19956504;
CC Part of: Seoul National University (SNU) cell line collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SNU-C1
AC CVCL_1708
SY SNUC1; NCI-SNU-C1
DR CLO; CLO_0009103
DR EFO; EFO_0006761
DR ATCC; CRL-5972
DR BioSample; SAMN03472966
DR CCLE; SNUC1_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308249
DR ChEMBL-Targets; CHEMBL2366304
DR Cosmic; 687539
DR Cosmic; 910905
DR Cosmic; 1187319
DR Cosmic; 1995643
DR Cosmic; 2302009
DR Cosmic-CLP; 910905
DR GDSC; 910905
DR GEO; GSM844704
DR GEO; GSM887643
DR GEO; GSM888735
DR GEO; GSM1346855
DR GEO; GSM1448115
DR GEO; GSM1670476
DR KCLB; 0000C1
RX PubMed=3479249;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=19956504;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 31 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 9,11
ST D18S51: 16
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 10
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 24
ST Penta D: 9,10
ST Penta E: 13,16
ST TH01: 7,9
ST TPOX: 11,12
ST vWA: 16,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-C2A
AC CVCL_1709
SY SNUC2A; NCI-SNU-C2A; C2A
DR CLO; CLO_0009104
DR ATCC; CCL-250.1
DR BioSample; SAMN03471382
DR CCLE; SNUC2A_LARGE_INTESTINE
DR Cosmic; 687540
DR Cosmic; 848824
DR GEO; GSM887644
DR GEO; GSM888736
DR GEO; GSM1448096
DR KCLB; 0000C2A
RX PubMed=3479249;
RX PubMed=8806095;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=25926053;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Doubling time: 50 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053).
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'SUN-C2A'.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 9,12
ST D16S539: 8,9
ST D3S1358: 13
ST D5S818: 8,9
ST D7S820: 13,16
ST FGA: 20,22
ST TH01: 9
ST TPOX: 8
ST vWA: 15,19,20 (ATCC)
ST vWA: 15,19 (KCLB)
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1710 ! SNU-C2B
SX Female
CA Cancer cell line
//
ID SNU-C2B
AC CVCL_1710
SY SNUC2B; NCI-SNU-C2B
DR CLO; CLO_0009105
DR ATCC; CCL-250
DR BioSample; SAMN03471381
DR ChEMBL-Cells; CHEMBL3308279
DR ChEMBL-Targets; CHEMBL2366279
DR Cosmic; 687541
DR Cosmic; 909740
DR Cosmic; 1218880
DR Cosmic; 1312311
DR Cosmic; 1479583
DR Cosmic; 1995644
DR Cosmic; 2302010
DR Cosmic-CLP; 909740
DR ECACC; 96020932
DR GDSC; 909740
DR GEO; GSM741262
DR GEO; GSM1346856
DR GEO; GSM1374902
DR GEO; GSM1448087
DR GEO; GSM1670477
DR KCLB; 0000C2B
RX PubMed=8806092;
RX PubMed=19956504;
RX PubMed=20606684;
RX PubMed=24755471;
RX PubMed=25926053;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Microsatellite instability: Instable (MSI-high) (PubMed=2592653; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC; KCLB
ST Amelogenin: X
ST CSF1PO: 11,13,14 (ATCC)
ST CSF1PO: 11,14 (Cosmic-CLP; ECACC; KCLB)
ST D13S317: 9,10,11 (ATCC; Cosmic-CLP)
ST D13S317: 9,10 (ECACC; KCLB)
ST D16S539: 8,9
ST D3S1358: 13
ST D5S818: 8,9
ST D7S820: 13,16 (ATCC; Cosmic-CLP; KCLB)
ST D7S820: 12,13 (ECACC)
ST FGA: 20,23
ST TH01: 9
ST TPOX: 8
ST vWA: 15,18,19 (ATCC; Cosmic-CLP)
ST vWA: 15,19 (ECACC)
ST vWA: 15,18 (KCLB)
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1709 ! SNU-C2A
SX Female
CA Cancer cell line
//
ID SNU-C4
AC CVCL_5111
SY SNU C4; SNUC4; NCI-SNU-C4; C4
DR CCLE; SNUC4_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3307457
DR ChEMBL-Targets; CHEMBL614933
DR Cosmic; 848825
DR Cosmic; 2302011
DR GEO; GSM887645
DR GEO; GSM888737
DR GEO; GSM1448127
DR KCLB; 0000C4
RX PubMed=3479249;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=10674020;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25926053;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SNU-4c' in ChEMBL CHEMBL614933 and CHEMBL3307457.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,9
ST D3S1358: 16,20
ST D5S818: 8,9
ST D7S820: 8
ST FGA: 20,21
ST TH01: 7,9
ST TPOX: 11
ST vWA: 14,15
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SNU-C5
AC CVCL_5112
SY SNUC5; NCI-SNU-C5; SNU-C5/WT
DR CCLE; SNUC5_LARGE_INTESTINE
DR Cosmic-CLP; 1674021
DR GDSC; 1674021
DR GEO; GSM887646
DR GEO; GSM888738
DR GEO; GSM1448131
DR GEO; GSM1670478
DR KCLB; 0000C5
RX PubMed=3479249;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=19956504;
RX PubMed=22460905;
RX PubMed=25926053;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Seoul National University (SNU) cell line collection.
CC Microsatellite instability: Instable (MSI-high) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; KCLB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8
ST D16S539: 8,13
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 12 (Cosmic-CLP)
ST D7S820: 12,13 (KCLB)
ST FGA: 19,23
ST TH01: 6,9
ST TPOX: 8
ST vWA: 15
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNU-C5/5FU-R
AC CVCL_V482
RX PubMed=17845510;
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5112 ! SNU-C5
SX Female
CA Cancer cell line
//
ID SNU-C5/IRT-R
AC CVCL_V483
RX PubMed=17845510;
CC Selected for resistance to: ChEBI; CHEBI:80630; Irinotecan (Camptothecin-11; CPT-11).
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5112 ! SNU-C5
SX Female
CA Cancer cell line
//
ID SNU-C5/OXT-R
AC CVCL_V484
RX PubMed=17845510;
CC Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5112 ! SNU-C5
SX Female
CA Cancer cell line
//
ID SNU_MM1393_BM
AC CVCL_IW63
RX PubMed=25343143;
CC Characteristics: IL6 dependent.
CC Doubling time: ~48 hours (PubMed=25343143).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IW64 ! SNU_MM1393_SC
SX Male
CA Cancer cell line
//
ID SNU_MM1393_SC
AC CVCL_IW64
RX PubMed=25343143;
CC Characteristics: IL6 independent.
CC Doubling time: ~48 hours (PubMed=25343143).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IW63 ! SNU_MM1393_BM
SX Male
CA Cancer cell line
//
ID SNUCML-02
AC CVCL_D773
DR Cosmic; 1429043
RX PubMed=20438801;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SNUhES1
AC CVCL_9945
SY SNUhES 1; Kor-hES16; SNUe001-A
DR hPSCreg; SNUe001-A
DR ISCR; 1402
RX PubMed=15671144;
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010003.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES10
AC CVCL_B998
SY SNUhES 10; Kor-hES21
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010010.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SNUhES11
AC CVCL_9946
SY SNUhES 11; Kor-hES3; SNUe005-A
DR hPSCreg; SNUe005-A
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010011.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES12
AC CVCL_B995
SY SNUhES 12; Kor-hES22
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010012.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SNUhES14
AC CVCL_B996
SY SNUhES 14; Kor-hES23
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010013.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES16
AC CVCL_9947
SY SNUhES 16; Kor-hES4; SNUe006-A
DR hPSCreg; SNUe006-A
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010014.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES18
AC CVCL_L116
SY SNUhES 18; Kor-hES24
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010025.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES19
AC CVCL_B997
SY SNUhES 19; Kor-hES25
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010015.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES2
AC CVCL_9948
SY SNUhES 2; Kor-hES17; SNUe002-A
DR hPSCreg; SNUe002-A
DR ISCR; 1403
RX PubMed=15671144;
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010004.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SNUhES3
AC CVCL_9949
SY SNUhES 3; SNUhES#3; Kor-hES1; SNUe003-A
DR hPSCreg; SNUe003-A
DR ISCR; 1404
RX PubMed=15671144;
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010005.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES31
AC CVCL_L117
SY SNUhES 31; Kor-hES26
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010037.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES32
AC CVCL_L118
SY SNUhES 32; Kor-hES27
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010051.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES33
AC CVCL_L119
SY SNUhES 33; Kor-hES50
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011001.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES34
AC CVCL_L120
SY SNUhES 34; Kor-hES51
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011002.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SNUhES35
AC CVCL_L121
SY SNUhES 35; Kor-hES52
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011003.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES36
AC CVCL_Y990
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012009.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID SNUhES37
AC CVCL_L122
SY SNUhES 37; Kor-hES53
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011004.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES38
AC CVCL_L123
SY SNUhES 38; Kor-hES54
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011005.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SNUhES39
AC CVCL_Y991
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014001.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES4
AC CVCL_9950
SY SNUhES 4; SNUhES-4; Kor-hES2; SNUe004-A
DR hPSCreg; SNUe004-A
DR ISCR; 1921
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010006.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES40
AC CVCL_Y992
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014002.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SNUhES41
AC CVCL_IS20
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014003.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES42
AC CVCL_IS10
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12015001.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID SNUhES43
AC CVCL_IS11
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12015002.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES44
AC CVCL_IS12
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016005.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES5
AC CVCL_B999
SY SNUhES 5; Kor-hES18
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010007.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES6
AC CVCL_C000
SY SNUhES 6; Kor-hES19
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010008.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUhES7
AC CVCL_C001
SY SNUhES 7; Kor-hES20
RX PubMed=24159464;
CC From: Seoul National University; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010009.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID SNUOT-Rb1
AC CVCL_6210
SY SNUOT-RB1
DR BTO; BTO:0003759
RX PubMed=17671685;
RX PubMed=18799932;
CC Doubling time: 24 hours (PubMed=17671685).
CC Omics: Array-based CGH.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SNUOT-Rb4
AC CVCL_IQ57
SY SNUOT-RB4
RX PubMed=18799932;
CC Omics: Array-based CGH.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SO-MI
AC CVCL_4764
RX PubMed=12772193;
WW http://capcelllines.ca/details.asp?id=161
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SO-Rb50
AC CVCL_D543
SY SO-RB50; So-Rb50; SO-Rb 50
RX CelloPub=CLPUB00236;
RX PubMed=2086157;
RX PubMed=8253182;
RX PubMed=9639853;
RX PubMed=11877168;
CC Doubling time: 44.32 hours (CelloPub=CLPUB00236).
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SO-Rb50/CBP
AC CVCL_0U08
RX CelloPub=CLPUB00236;
CC Doubling time: 50.9 hours (CelloPub=CLPUB00236).
CC Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D543 ! SO-Rb50
SX Female
CA Cancer cell line
//
ID SO-Rb70
AC CVCL_W459
RX PubMed=9639853;
RX PubMed=11877168;
RX PubMed=12580037;
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SOB-15
AC CVCL_6447
DR BTO; BTO:0005474
DR CLO; CLO_0009106
DR ATCC; CRL-2301
RX PubMed=7543343;
CC Group: Fish cell line.
CC Breed/subspecies: Shasta.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SOCS3-/- ESC
AC CVCL_AW04
SY SOCS-3-Null ES Cells
RX PubMed=16123385;
CC Knockout cell: Method=KO mouse; MGI; MGI:1201791; Socs3.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID SODk1
AC CVCL_6448
SY SODK1; SODK1293
DR CLO; CLO_0009107
DR ATCC; CRL-12386
RX PubMed=9847362;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Discontinued: ATCC; CRL-12386; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 9
ST D5S818: 8,9
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID SOE00363IN
AC CVCL_E206
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9490; ! Saguinus oedipus
SX Female
CA Transformed cell line
//
ID SOE00364IN
AC CVCL_E207
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9490; ! Saguinus oedipus
SX Male
CA Transformed cell line
//
ID SOE00365IN
AC CVCL_E208
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9490; ! Saguinus oedipus
SX Male
CA Transformed cell line
//
ID SOE00366IN
AC CVCL_E209
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9490; ! Saguinus oedipus
SX Male
CA Transformed cell line
//
ID SOE00367IN
AC CVCL_E210
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9490; ! Saguinus oedipus
SX Male
CA Transformed cell line
//
ID SOE00368IN
AC CVCL_E211
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9490; ! Saguinus oedipus
SX Female
CA Transformed cell line
//
ID Sog9
AC CVCL_D242
SY sog9
DR CCLV; CCLV-RIE 0297
RX PubMed=7745676;
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D241 ! Gro2C
SX Male
CA Spontaneously immortalized cell line
//
ID SOgE
AC CVCL_Y592
RX PubMed=12124462;
RX PubMed=25903999;
CC Group: Bird cell line.
CC Group: Vaccine production cell line.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
HI CVCL_3450 ! QM7
CA Cancer cell line
//
ID SOJ
AC CVCL_B464
RX PubMed=2083222;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SOJ-6
AC CVCL_B465
RX PubMed=2083222;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B464 ! SOJ
CA Cancer cell line
//
ID SOL,CA
AC CVCL_E832
SY SOL, CA
DR dbMHC; 49023
DR ECACC; 94082252
DR IHW; IHW9152
DR IMGT/HLA; 11695
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl152.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Sol8
AC CVCL_6449
SY Soleus clone 8
DR CLO; CLO_0009108
DR ATCC; CRL-2174
DR BCRC; 60512
RX PubMed=2456580;
RX PubMed=2894633;
RX PubMed=11162846;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID SOM-4D10
AC CVCL_2198
DR CLO; CLO_0009109
DR DSMZ; ACC-480
CC Doubling time: ~20-30 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID SOSP-9607
AC CVCL_4V80
RX PubMed=20016965;
RX PubMed=25017716;
CC Doubling time: 29.79 +- 0.57 hours (PubMed=25017716).
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SOSP-9607/CDDP
AC CVCL_4V81
RX PubMed=25017716;
CC Doubling time: 45.11 +- 2.37 hours (PubMed=25017716).
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4V80 ! SOSP-9607
SX Male
CA Cancer cell line
//
ID SOSP-9607/F4
AC CVCL_4V82
SY F4
RX PubMed=20016965;
CC Doubling time: 31 +- 3 hours (PubMed=20016965).
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4V80 ! SOSP-9607
SX Male
CA Cancer cell line
//
ID SOSP-9607/F5M2
AC CVCL_4V83
SY F5M2
RX PubMed=20016965;
CC Doubling time: 20 +- 2 hours (PubMed=20016965).
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4V80 ! SOSP-9607
SX Male
CA Cancer cell line
//
ID SP+
AC CVCL_1Y11
SY SP (HTLV)
DR NIH-ARP; 3059-159
RX PubMed=7564472;
CC Characteristics: HTLV-1 producing cell line.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SP-1
AC CVCL_R987
SY Silver Perch-1
RX PubMed=407147;
CC Group: Fish cell line.
OX NCBI_TaxID=331523; ! Bairdiella chrysoura
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SP-2
AC CVCL_R988
SY Silver Perch-2
RX DOI=10.1007/BF02618106;
CC Group: Fish cell line.
OX NCBI_TaxID=331523; ! Bairdiella chrysoura
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SP-49
AC CVCL_D022
SY Sp-49; SP49
DR Cosmic; 1070709
DR Cosmic; 2296991
DR GEO; GSM115806
RX PubMed=3121553;
RX PubMed=9738977;
RX PubMed=16960149;
RX PubMed=19358282;
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C121 ! SP-50B
OI CVCL_M655 ! SP-52EB
OI CVCL_C122 ! SP-53
SX Female
CA Cancer cell line
//
ID SP-50B
AC CVCL_C121
RX PubMed=2548699;
RX PubMed=8971032;
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D022 ! SP-49
OI CVCL_M655 ! SP-52EB
OI CVCL_C122 ! SP-53
SX Female
CA Cancer cell line
//
ID SP-52EB
AC CVCL_M655
RX PubMed=2548699;
RX PubMed=8971032;
RX PubMed=9738977;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D022 ! SP-49
OI CVCL_C121 ! SP-50B
OI CVCL_C122 ! SP-53
SX Female
CA Transformed cell line
//
ID SP-53
AC CVCL_C122
SY SP53
DR Cosmic; 1070710
DR Cosmic; 2296998
DR GEO; GSM119539
RX PubMed=2548699;
RX PubMed=8971032;
RX PubMed=9738977;
RX PubMed=12683869;
RX PubMed=16960149;
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D022 ! SP-49
OI CVCL_C121 ! SP-50B
OI CVCL_M655 ! SP-52EB
SX Female
CA Cancer cell line
//
ID SP-6.5
AC CVCL_7997
SY SP 6.5; SP6.5; SP6_5
DR BTO; BTO:0002737
DR Cosmic; 986620
DR Cosmic; 1628411
RX PubMed=9154388;
RX PubMed=10892885;
RX PubMed=15645125;
RX PubMed=15714118;
RX PubMed=17487557;
RX PubMed=22236444;
CC Omics: Transcriptome analysis.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SP-8.0
AC CVCL_W928
SY SP8.0
RX PubMed=10892885;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Sp-E-HNU11
AC CVCL_0A19
RX DOI=10.16380/j.kcxb.2011.05.007;
CC Group: Insect cell line.
CC Doubling time: 42 hours (DOI=10.16380/j.kcxb.2011.05.007).
OX NCBI_TaxID=7386; ! Sarcophaga peregrina
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SP-R
AC CVCL_0I80
DR CCLV; CCLV-RIE 0279
OX NCBI_TaxID=9940; ! Ovis aries
CA Spontaneously immortalized cell line
//
ID SP02#1
AC CVCL_V201
SY ESi001-A
DR BioSamples; SAMEA3302942
DR hPSCreg; ESi001-A
DR ISCR; 2237
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_SP_2_1.pdf
CC From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID SP08#1
AC CVCL_V202
SY ESi002-A
DR BioSamples; SAMEA3303008
DR hPSCreg; ESi002-A
DR ISCR; 2238
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_SP_8_1.pdf
CC From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID SP1
AC CVCL_AZ65
SY SPI
RX PubMed=1317363;
RX PubMed=3191495;
CC Breed/subspecies: CBA/J.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID SP1-3M
AC CVCL_AZ66
RX PubMed=1317363;
CC Caution: Could be identical to AC2M2 (CVCL_AZ67).
CC Breed/subspecies: CBA/J.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_AZ65 ! SP1
SX Female
CA Cancer cell line
//
ID SP13#4
AC CVCL_V203
SY ESi006-A
DR BioSamples; SAMEA3303225
DR hPSCreg; ESi006-A
DR ISCR; 2239
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_SP_13_4.pdf
CC From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID Sp1K
AC CVCL_4304
SY Sp1K (NBL-10); Sp 1 K (NBL-10); Sp 1 K; Sp1.K; NBL-10
DR CLO; CLO_0009110
DR CLDB; cl4380
DR ATCC; CCL-78
DR ATCC; CRL-6262
DR ECACC; 89120705
CC Group: Cetacean cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CCL-78; true.
CC Discontinued: ATCC; CRL-6262; true.
CC Discontinued: ECACC; 89120705; probable.
OX NCBI_TaxID=103590; ! Stenella frontalis
SX Male
CA Finite cell line
//
ID Sp2ab
AC CVCL_Z067
SY SP2ab
RX PubMed=19187782;
WW http://www.enzolifesciences.com/ENZ-70008/sp2ab-myeloma-fusion-partner/
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
SX Female
CA Cancer cell line
//
ID Sp2/0-Ag14
AC CVCL_2199
SY SP2/0-Ag14; SP2/0-AG14; SP2/0-ag14; Sp2/O-Ag14; SP2/O-Ag14; Sp2/0-Ag-14; SP2-0-Ag14; SP2/0 Ag-14; SP-2/0-AG14; Sp 2/0-Ag 14; Sp2/0; SP2/0; Sp2/O; SP2/O; SP-2; SP2; GM03569; GM03569B; GM3569
DR BTO; BTO:0002291
DR CLO; CLO_0009112
DR CLO; CLO_0009113
DR CLO; CLO_0009114
DR CLO; CLO_0009115
DR CLO; CLO_0017241
DR CLO; CLO_0050178
DR CLDB; cl4382
DR CLDB; cl4383
DR CLDB; cl4384
DR CLDB; cl4385
DR CLDB; cl4386
DR ATCC; CRL-1581
DR ATCC; CRL-8287
DR BCRC; 60034
DR BCRJ; 0227
DR CCRID; 3111C0001CCC000054
DR CCRID; 3111C0002000000011
DR CCRID; 3131C0001000800018
DR CCRID; 3142C0001000000019
DR CCRID; 3153C0001000000025
DR CLS; 400481/p756_Sp20-Ag14
DR Coriell; GM03569
DR DSMZ; ACC-146
DR ECACC; 08060101
DR ECACC; 85072401
DR JCRB; JCRB9084
DR KCB; KCB 92021YJ
DR KCLB; 21581
DR NCBI_Iran; C129
DR RCB; RCB0209
DR TKG; TKG 0248
RX PubMed=714156;
CC Group: Hybridoma fusion partner cell line.
CC Doubling time: ~30-40 hours (DSMZ).
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
SX Female
CA Cancer cell line
//
ID Sp2/0-Ag14-Turbodoma
AC CVCL_G697
DR ECACC; 03092501
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
SX Female
CA Cancer cell line
//
ID Sp2/01-Ag
AC CVCL_6450
DR CLO; CLO_0009111
DR ATCC; CRL-8006
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID Sp2/08A2
AC CVCL_J171
SY SP2/08A2; Sp2/08AZ; SP2/08AZ
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
SX Female
CA Cancer cell line
//
ID Sp2/5
AC CVCL_D037
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
SX Female
CA Cancer cell line
//
ID Sp2/mIL-6
AC CVCL_C561
DR CLO; CLO_0009116
DR ATCC; CRL-2016
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Transfected with: MGI; MGI:96559; Il6.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
SX Female
CA Cancer cell line
- 公告/新闻